Sentence,class,file
"[http://dx.doi.org/10.2174/1567202611666140408104831] [PMID:  24712647]  [83] Neasta, J.; Barak, S.; Hamida, S.B.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
[http://dx.doi.org/10.1016/j.molmed.,OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/  10.1016/j.cellsig.2011.08.010] [PMID: 21906675]  [88] Chong, Z.Z.",OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.18632/  aging.100440] [PMID: 22388478]  [90] Sanghera, K.P.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1016/j.mcn.2011.03.010]  [PMID: 21463685]  [91] Huang, Q.; Sheibani, N. High glucose promotes retinal endothelial  cell migration through activation of Src, PI3K/Akt1/eNOS, and  ERKs.",OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1152/ajpcell.00322.2008] [PMID: 18945941]  [92] Kim, D.I.",OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1101/gad.1134603] [PMID:  14597666]  [94] Wang, B.; Atherton, P.; Patel, R.; Manning, G.; Donnelly, R.  Antiangiogenic effects and transcriptional regulation of pigment  epithelium-derived factor in diabetic retinopathy.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1016/j.mvr.2010.02.012]  [PMID: 20219495]  [95] Cai, J.; Ahmad, S.; Jiang, W.G.",OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.2337/  diabetes.52.12.2959] [PMID: 14633857]  [96] Zhao, C.; Yasumura, D.; Li, X.; Matthes, M.; Lloyd, M.; Nielsen,  G.; Ahern, K.; Snyder, M.; Bok, D.; Dunaief, J.L.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1172/  JCI44303] [PMID: 21135502]  [97] Shah, O.J.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.2337/diabetes.54.9.2674]  [PMID: 16123357]  [103] Krebs, M.; Brunmair, B.; Brehm, A.; Artwohl, M.; Szendroedi, J.;  Nowotny, P.; Roth, E.; Fürnsinn, C.; Promintzer, M.; Anderwald,  C.; Bischof, M.; Roden, M. The Mammalian target of rapamycin  pathway regulates nutrient-sensitive glucose uptake in man.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.2337/db06- 1016] [PMID: 17329620]  [104] Kennedy, A.; Frank, R.N.",OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1002/jcp.20525] [PMID: 16245301]  [107] Poulaki, V.; Joussen, A.M.; Mitsiades, N.; Mitsiades, C.S.",OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1016/S0002-9440(10)63311-1] [PMID:  15277220]  [108] Demidenko, Z.N.",OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.4161/cc.10.10.15789]  [PMID: 21521942]  [109] Poulaki, V.; Qin, W.; Joussen, A.M.; Hurlbut, P.; Wiegand, S.J.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
[http://dx.doi.org/10.1016/j.ghir.,OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.4161/cc.8.12.8606] [PMID: 19471117]  [116] Dejneka, N.S.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/  10.1124/jpet.106.104158] [PMID: 16682453]  [123] Treins, C.; Murdaca, J.; Obberghen, E.V.",OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1167/iovs.06-0322] [PMID:  17065532]  [128] Saishin, Y.; Saishin, Y.; Takahashi, K. Lima, Silva, R.; Hylton, D.;  Rudge, J. S.; Wiegand, S. J.; Campochiaro, P. A. VEGF- TRAPR1R2 suppresses choroidal neovascularization and VEGF- induced breakdown of the blood-retinal barrier.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1002/jcp.10246] [PMID:  12652651]  [129] Mathews, M.K.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1242/jcs.125773] [PMID: 23641065]  [133] Blommaart, E.F.; Luiken, J.J.; Blommaart, P.J.",OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1074/jbc.270.5.2320]  [PMID: 7836465]  [134] Bain, J.; Plater, L.; Elliott, M.; Shpiro, N.; Hastie, C.J.",OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1042/  BJ20070797] [PMID: 17850214]  [135] Horton, J.D.",OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1016/j.cell.2011.06.034] [PMID:  21816276]  [138] Rosen, E.D.",OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
[http://dx.doi.org/10.1038/nrm2066] [PMID: 17139329],Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.2337/diabetes.53.11.2748] [PMID: 15504954]  [141] Kim, J.B.; Wright, H.M.; Wr ight, M.; Spiege lman, B.M.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
[http://dx.doi.org/10.1016/j.cell.2011.,OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1093/  hmg/ddr306] [PMID: 21752829]  [145] Settembre, C.; Di Malta, C.; Po lito, V.A.",OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1038/emboj.2012.32] [PMID: 22343943]  [147] Sarkar, S.; Rubinsztein, D.C. Small molecule enhancers of autophagy  for neurodegenerative diseases.",OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1039/b804606a] [PMID: 18704227]  [148] Ozcan, U.; Yilmaz, E.; Ozcan, L.; Furuhashi, M.; Va illancourt,   E.; Smith, R.O.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1038/nrm2199] [PMID: 17565364]  [152] Lee, A.H.; Iwakoshi, N.N.",OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1128/MCB.23.21.7448-7459.2003] [PMID:  14559994]  [153] Ryoo, H.D.",OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
[http://dx.doi.org/10.1038/sj.,Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1371/journal.pone.0038616] [PMID:  22715395] [156] Crighton, D.; Wilkinson, S.; O’Prey, J.; Syed, N.; Smith, P.;  Harrison, P.R.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1016/  j.bbaexp.2007.02.002] [PMID: 17397945]  [158] Crighton, D.; Wilkinson, S.; Ryan, K.M.",OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.4161/auto.3438] [PMID: 17102582]  [159] Lorin, S.; Borges, A.; Ribeiro Dos Santos, L.; Souquère, S.;  Pierron, G.; Ryan, K.M.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1158/0008-5472.CAN-09- 1270] [PMID: 19706754]  [160] Lorin S, Borges A, Ribeiro Dos Santos L, Souquère S, Pierron G,  Ryan KM, Codogno P, Djavaheri-Mergny M. c-Jun NH2-terminal  kinase activation is essential for DRAM-dependent induction of  autophagy and apoptosis in 2-methoxyestradiol-treated Ewing  sarcoma cells.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1016/j.bbrc.2009.10.149] [PMID: 19895784]  [164] Yoon, J.H.",OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1007/s11033-011-0835-x] [PMID: 21584698]  [165] Kabeya, Y.; Mizushima, N.; Ueno, T.; Yamamoto, A.; Kirisako, T.;  Noda, T.; Kominami, E.; Ohsumi, Y.; Yoshimori, T. LC3, a  mammalian homologue of yeast Apg8p, is localized in  autophagosome membranes after processing.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.4161/auto.1.2.1697] [PMID: 16874052]  [167] Calkin, A.C.; Forbes, J.M.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1161/01.ATV.0000177813.99577.6b]  [PMID: 16020748]  [168] Ji, S.; Kronenberg, G.; Balkaya, M.; Färber, K.; Gertz, K.;  Kettenmann, H.; Endres, M. Acute neuroprotection by pioglitazone  after mild brain ischemia without effect on long-term outcome.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.2337/db10- 0638] [PMID: 20566666]  [170] Higuchi, A.; Ohashi, K.; Shibata, R.; Sono-Romane lli, S.;   Walsh, K.; Ouchi, N. Thiazolidinediones reduce pathological  neovascularization in ischemic retina via an adiponectin-dependent",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1167/iovs.12- 10488] [PMID: 22956604]  [172] Li, P.; Xu, X.; Zheng, Z.; Zhu, B.; Shi, Y.; Liu, K. Protective  effects of rosiglitazone on retinal neuronal damage in diabetic rats.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.3109/  02713683.2011.572220] [PMID: 21599458]  [173] Jiang, Y.; Thakran, S.; Bheemreddy, R.; Ye, E.A.",OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1074/jbc.M114.583880] [PMID:  25086044]  [174] Murata, T.; Hata, Y.; Ishibashi, T.; Kim, S.; Hsueh, W. A. Murata,  T.; Hata, Y.; Ishibashi, T.; Kim, S.; Hsueh, W.A.",OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1001/archopht.119.5.709] [PMID: 11346398]  [175] Shen, L.Q.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1016/j.jcjo.2013.04.003] [PMID: 23931472]  [179] Zhang, S.; Gu, H.; Hu, N. Role of Peroxisome Proliferator- Activated Receptor γ in Ocular Diseases.",OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1080/  J157v02n02_05] [PMID: 15277096]  [181] Rodrigues, G.A.",OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1167/iovs.10-5715] [PMID: 20847119]  [182] Herm, R.J. Age-related macular degeneration.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1056/NEJMc081470]  [PMID: 18927955]  [183] Kowluru, R.A.; Kanwar, M. Effects of curcumin on retinal  oxidative stress and inflammation in diabetes.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1186/1743-7075-4-8] [PMID:  17437639]  [184] Keech, A.C.; Mitchell, P.; Summanen, P.A.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.2337/dc09-0565] [PMID: 19638526]  [187] Dejneka, N.S.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1016/j.transproceed.2010.07.083] [PMID:  20970607]  [189] Sonis, S.; Treister, N.; Chawla, S.; Demetri, G.; Haluska, F.  Preliminary characterization of oral lesions associated with  inhibitors of mammalian target of rapamycin in cancer patients.",OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
[http://dx.doi.org/10.1200/JCO.,Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1007/s11255-009-9644-8]  [PMID: 19774480]  [194] Mustata, G.T.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.2337/diabetes.54.2.517] [PMID: 15677510]  [195] Zhang, B.; Osborne, N.N.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1016/j.brainres.2006.09.067] [PMID:  17084820]  [196] Koh, P.O.",OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.1142/  S0192415X10008196] [PMID: 20626058]  [197] Dugas, B.; Charbonnier, S.; Baarine, M.; Ragot, K.; Delmas, D.;  Ménétrier, F.; Lherminier, J.; Malvitte, L.; Khalfaoui, T.; Bron, A.;  Creuzot-Garcher, C.; Latruffe, N.; Lizard, G. Effects of oxysterols  on cell viability, infl ammatory cytokines, VEGF, and reactive  oxygen species production on human retinal cells: cytoprotective  effects and prevention of VEGF secretion by resveratrol.",Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
[http://dx.doi.org/10.1155/  2014/658589] [PMID: 25530759],Non-OADS,/arxiv_data1/oa_pdf/10/b4/CN-14-810.PMC5333581.pdf
"[http://dx.doi.org/10.2337/diacare.24.11.1936] [PMID: 11679460]  [2] DuBose, S.N.",Non-OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
"[http://dx.doi.org/10.1016/j.jpeds.2015.05.046] [PMID: 26164381]  [3] Chojnowski, P.; Wasyluk, J.; Grabska-Liberek, I. Diabetes-  epidemiology and pathogenesis.",OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
"[http://dx.doi.org/10.1046/j.1442-9071.2000.00296.x] [PMID:  10981781]  [9] Klein, R.; Klein, B.E.",OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
[http://dx.doi.org/10.1001/archopht.1984.01040030398010] [PMID:  6367724]  [10] Intensive blood-glucose control with sulphonylureas or insulin  compared with conventional treatment and risk of complications in  patients with type 2 diabetes (UKPDS 33).,Non-OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
"[http://dx.doi.org/10.1136/bjo.2004.062547] [PMID: 15923516]  [12] Balmer, D.; Emery, M.; Andreux, P.; Auwerx, J.; Ginet, V.; Puyal,  J.; Schorderet, D.F.",OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
[http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
"[http://dx.doi.org/10.1016/  j.preteyeres.2011.05.002] [PMID: 21635964]  [19] Bryl, A.; Mrugacz, M.; Krajewska, M. Immunological aspects of  the diabetic retinopathy development.",Non-OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
"[http://dx.doi.org/10.4103/0301- 4738.151464] [PMID: 25686060]  [21] Cheung, C.M.",Non-OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
"[http://dx.doi.org/10.1007/  s12177-013-9104-7] [PMID: 24596941]  [25] Zong, H.; Ward, M.; Stitt, A.W.",OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
[http://dx.doi.org/10.1046/j.,Non-OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
"[http://dx.doi.org/10.1111/cns.12150] [PMID:  23870489]  [28] Simó, R.; Hernández, C. Neurodegeneration in the diabetic eye:  new insights and therapeutic perspectives.",Non-OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
[http://dx.doi.org/10.1016/j.tem.2013.,OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
"[http://dx.doi.org/10.1016/j.exer.2015.08.009] [PMID: 26297614]  [30] Serrarbassa, P.D.",OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
"[http://dx.doi.org/10.1590/S0004- 27492008000300030] [PMID: 18641842]  [31] Lang, G.E.",Non-OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
"[http://dx.doi.org/10.1055/s-0033-1350766] [PMID: 23986191]  [32] Wilczyński, M.; Dzivgielewski, K. [Results of laser photo-  coagulation in patients with diabetic retinopathy developed as a  complication of diabetes type 2].",Non-OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
"[http://dx.doi.org/10.1167/iovs.10-5931] [PMID: 20926810]  [34] Ng, J.S.",OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
[http://dx.doi.org/10.1167/iovs.07-1157] [PMID: 18385083]  [35] Retina and vitreous.,Non-OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
"[http://dx.doi.org/10.1167/iovs.08-3143] [PMID: 19151397]  [40] Demir, M.; Oba, E.; Sensoz, H.; Ozdal, E. Retinal nerve fiber layer  and ganglion cell complex thickness in patients with type 2  diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
"[http://dx.doi.org/10.4103/0301-4738.136234] [PMID: 25005202]  [41] Zeng, H.Y.",OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
"[http://dx.doi.org/10.1016/j.ajpath.2011.04.018] [PMID: 21712024]  [43] Yu, Y.; Chen, H.; Su, S.B.",OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
"[http://dx.doi.org/10.1186/s12974-015-0368-7] [PMID: 26245868]  [44] Karlstetter, M.; Scholz, R.; Rutar, M.; Wong, W.T.",Non-OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
[http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
"[http://dx.doi.org/10.1159/  000328979] [PMID: 21921569]  [50] Lieth, E.; LaNoue, K.F.",OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
"[http://dx.doi.org/10.1006/  exer.2000.0840] [PMID: 10843776]  [51] Sakai, O.; Uchida, T.; Roggia, M.F.",OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
"[http://dx.doi.org/10.1007/s12035-014-8732-7] [PMID:  24826918]  [53] Ng, Y.K.",OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
"[http://dx.doi.org/  10.1016/j.exer.2015.04.013] [PMID: 25912193]  [56] Bove, P.F.",OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
"[http://dx.doi.org/10.1016/j.redox.2015.07.008] [PMID:  26233704]  [59] Husain, K.; Hernandez, W.; Ansari, R.A.; Ferder, L. Inflammation,  oxidative stress and renin angiotensin system in atherosclerosis.",Non-OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
"[http://dx.doi.org/10.1126/science.1227901] [PMID: 23307732]  [59] Blandini, F. An update on the potential role of excitotoxicity in the  pathogenesis of Parkinson’s disease.",Non-OADS,/arxiv_data1/oa_pdf/b8/20/CN-14-826.PMC5333582.pdf
"[http://dx.doi.org/10.1053/j.gastro.2012.10.003] [PMID: 23063970]  [2] Filaretova, L. The hypothalamic-pituitary-adrenocortical system:  Hormonal brain-gut interaction and gastroprotection.",Non-OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/10.1016/  j.autneu.2006.01.005] [PMID: 16481222]  [3] Holzer, P.; Farzi, A. Neuropeptides and the microbiota-gut-brain  axis.",OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/10.5056/jnm14162] [PMID: 25611064]  [5] Wood, J.D.",OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/10.1152/physiol.00034.2004] [PMID:  15546849]  [6] Pavlov, I.P.",Non-OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/  10.1016/j.bpg.2014.10.001] [PMID: 25439064]  [10] Burokas, A.; Moloney, R.D.",OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/10.1016/bs.aambs.2015.02.001]  [PMID: 25911232]  [11] Saulnier, D.M.",OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/10.1007/s00335-013-9488-5] [PMID:  24281320]  [13] Gunion, M.W.",Non-OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/10.1016/0006-8993(87)90693-7] [PMID: 3496936]  [15] Konturek, P.C.",OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/10.1038/138032a0]  [17] Cannon, W.B.",Non-OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
[http://dx.doi.org/10.1111/j.1749-6632.,Non-OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/10.3109/10253890.2012.710919] [PMID:  22845714]  [21] Hernandez, D.E.",Non-OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/  10.1159/000122852] [PMID: 431775]  [28] Weiss, J.M.",Non-OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/10.1037/h0031582] [PMID: 5166074]  [29] Black, H.E.",OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/10.1177/  019262338801600214] [PMID: 3055231]  [30] Bonfils, S.; Hardouin, J-P.; Rossi, G.; Richier, G.; Lambling, A.  Les ulceration gastriques provoquees chez le rat blanc par la  cortisone et la delta-cortisone.",Non-OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/10.1001/jama.1951.03670330021007] [PMID:  14873720]  [34] Gray, S.J.",Non-OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/  10.1056/NEJM198307073090105] [PMID: 6343871]  [37] Robert, A.; Northam, J.I.",OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/10.1007/BF02283881] [PMID: 5309628]  [38] Sandweiss, D.J.",Non-OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/10.1016/S0049-0172(05)  80039-3] [PMID: 8122121]  [40] Brodie, D.A.",OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/10.1210/  edrv-5-1-25] [PMID: 6368214]  [46] Filaretova, L.P.",Non-OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/  10.1016/S0928-4257(01)00069-9] [PMID: 11595419]  [50] Filaretova, L.P.; Bagaeva, T.R.",OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/  10.1196/annals.1410.005] [PMID: 19120111]  [51] Filaretova, L.; Morozova, O.; Laszlo, F.; Morschl, E.; Zelena, D.  Does chronic stress enhance the risk of diseases?",Non-OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/10.4149/endo_2013_04_177]  [PMID: 24156706]  [52] Guth, P.H.",OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/  10.1196/annals.1296.034] [PMID: 15240380]  [55] Lu, N.Z.",Non-OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/10.1007/s11154- 007-9059-8] [PMID: 18049904]  [58] Moguilewsky, M.; Philibert, D. RU 38486: potent anti-  glucocorticoid activity correlated with strong binding to the  cytosolic glucocorticoid receptor followed by an impaired  activation.",Non-OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/10.1055/s-2007-1000781] [PMID: 7911118]  [61] Rivier, C.L.",Non-OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/10.1210/en.2002-0117] [PMID:  12746300]  [62] Taché, Y.; Brunnhuber, S. From Hans Selye’s discovery of  biological stress to the identification of corticotropin-releasing  factor signaling pathways: implication in stress-related functional  bowel diseases.",Non-OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
"[http://dx.doi.org/10.1016/  0024-3205(90)90539-4] [PMID: 2215074]  [68] Mikics, E.; Kruk, M.R.",OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3f/02/CN-14-876.PMC5333583.pdf
[http://dx.doi.org/10.1016/j.cgh.,OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/  10.1097/01.mog.0000194792.36466.5c] [PMID: 16319671]  [3] Manning, A.P.",Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1136/gut.41.3.394]  [PMID: 9378398]  [5] W.R.G., Management of irritable bowel syndrome.",Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1053/  gast.2002.33741] [PMID: 12016433]  [7] van Zanten, S.V.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1053/j.gastro.2004.12.006] [PMID:  15765393]  [9] Choi, M.G.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
[http://dx.doi.org/10.5056/jnm.2011.17.3.,Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1186/1757-4749-2-3] [PMID: 20465787]  [13] Camilleri, M. Peripheral mechanisms in irritable bowel s yndrome.",Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1053/  gast.2002.37095] [PMID: 12454866]  [15] Camilleri, M. Mechanisms in IBS: something old, something new,  something borrowed.",Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/  10.1097/MPG.0b013e31823d34c3] [PMID: 22027566]  [17] Larauche, M.; Mulak, A.; Taché, Y.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1016/j.expneurol.2011.04.020] [PMID:  21575632]  [18] Barreau, F.; Salvador-Cartier, C.; Houdeau, E.; Bueno, L.;  Fioramonti, J.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
[http://dx.doi.org/10.1152/ajpgi.,Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1053/bega.1999.0037] [PMID: 10580919]  [27] Spiller, R.; Garsed, K. Postinfectious irritable bowel s yndrome.",Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
[http://dx.doi.org/10.1038/ajg.,Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1159/000350054] [PMID:  23712295]  [30] Collins, S.M.",Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1053/j.gastro.2009.01.075] [PMID:  19457424]  [31] Mayer, E.A.",Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1053/j.gastro.2006.10.026] [PMID: 17188960]  [32] Gros, D.F.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
[http://dx.doi.org/10.1016/j.janxdis.,OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1016/S0006-8993  (00)03305-9] [PMID: 11223001]  [36] Niddam, D.M.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1053/gast.2002.33584] [PMID:  12055608]  [38] Mayer, E.A.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1586/egh.10.88] [PMID: 21309671]  [40] Chitkara, D.K.",Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1097/00006842-197505000-00003]  [PMID: 1178795]  [42] Hofer, M.A.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1016/0031-9384(75)90217-6] [PMID:  1221454]  [43] Coutinho, S.V.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1152/  ajpgi.00240.2001] [PMID: 11804852]  [44] Barreau, F.; Ferrier, L.; Fioramonti, J.; Bueno, L. New insights in  the etiology and pathophysiology of irritable bowel syndrome:  contribution of neonatal stress models.",Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1203/PDR.0b013e3180db2949]  [PMID: 17622962]  [45] Shanks, N.; Windle, R.J.; Perks, P.A.",Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1016/S0079-6123(08)  62132-9] [PMID: 10737052]  [48] Anand, K.J.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1159/000014197] [PMID:  10657682]  [49] Sternberg, W.F.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
[http://dx.doi.org/10.1016/j.pain.,OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1016/  0304-3959(90)90021-5] [PMID: 2195438]  [57] Hughes, P.A.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.3389/fnins.2011.00016] [PMID: 21390285]  [60] Gué, M.; Del Rio-Lacheze, C.; Eutamene, H.; Théodorou, V.;  Fioramonti, J.; Buéno, L. Stress-induced visceral hypersens itivity  to rectal distension in rats: role of CRF and mast cells.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1152/  ajpgi.00500.2004] [PMID: 15746211]  [64] Larauche, M.; Mulak, A.; Kim, Y.S.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1002/nau.22207] [PMID:  22473515]  [66] Söderholm, J.D.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1053/gast.2002.36019] [PMID: 12360472]  [67] Kim, Y.S.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
[http://dx.doi.org/10.5056/jnm.2014.,Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1023/B:DDAS.0000011609.68882.3a] [PMID:  14992442]  [71] Qin, H.Y.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1007/s00535-010-0321-6]  [PMID: 20848144]  [72] Qin, H. Y.; Xiao, H. T.; Leung, F. P.; Yang, Z. J.; Wu, J. C.; Sung,  J. J.; Xu, H. X.; Tong, X. D.; Bian, Z. X. JCM-16021, a Chinese  Herbal Formula, Attenuated Vis ceral Hyperalgesia in TNBS- Induced Postinflammatory Irritable Bowel Syndrome through  Reducing Colonic EC Cell Hyperplasia and Serotonin Availability  in Rats.",Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1136/  gut.47.6.804] [PMID: 11076879]  [76] Zhao, R.; Baig, M.K.",Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1053/j.gastro.2004.04.006] [PMID:  15236184] [81] Barbara, G.; Vallance, B.A.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1016/S0140-6736  (96)90341-4] [PMID: 8544549]  [83] Rodríguez, L.A.; Ruigómez, A.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1124/jpet.102.035287] [PMID: 12130729]  [86] Trimble, N.; Johnson, A.C.; Foster, A.; Greenwood-van Meerveld,  B. Corticotropin-releasing factor receptor 1-deficient mice show  decreased anxiety and colonic sensitivity.",Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1111/j.1365- 2982.2007.00951.x] [PMID: 17539891]  [87] Chrousos, G.P.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
[http://dx.doi.org/10.1038/nrendo.,Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1111/nmo.12133] [PMID: 23594365]  [90] Leng, Y.X.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1016/j.dld.2009.07.009] [PMID:  19665953]  [92] Houghton, L.A.; Rogers, J.; Whorwell, P.J.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1046/j.1365- 2036.1997.00189.x] [PMID: 9218083]  [93] But, I.; Goldstajn, M.S.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1155/1999/598659]  [98] Delaney, C.P.",Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1038/  nrd2668] [PMID: 19172688]  [99] Delvaux, M.; Louvel, D.; Lagier, E.; Scherrer, B.; Abitbol, J.L.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
[http://dx.doi.org/10.1111/j.1365-2036.2008.,Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1002/ana.410390114] [PMID:  8572673]  [102] Lacy, B.E.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1136/gut.2006.110858] [PMID: 17446306]  [104] Leventer, S.M.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
[http://dx.doi.org/10.1111/j.1365-2036.2007.,Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/  10.1136/gut.42.6.845] [PMID: 9691924]  [109] Sweetser, S.; Camilleri, M.; Linker Nord, S.J.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
[http://dx.doi.org/10.1152/ajpgi.00011.,Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/  10.1053/j.gastro.2006.11.002] [PMID: 17241888]  [111] De Ponti, F. Pharmacology of serotonin: what a clinician should  know.",Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1016/j.cgh.2007.12.015] [PMID:  18242143]  [113] Bouras, E.P.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1111/j.1365- 2036.2008.03881.x] [PMID: 19006537]  [117] Ringel-Kulka, T.; Palsson, O.S.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1097/MCG.0b013  e31820ca4d6] [PMID: 21436726]  [118] Lorenzo-Zúñiga, V.; Llop, E.; Suárez, C.; Alvarez, B.; Abreu, L.;  Espadaler, J.; Serra, J. I.31, a new combination of probiotics,  improves irritable bowel syndrome-related qua lity of life.",Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1136/gut.2005.066100] [PMID: 16105890]  [120] Sen, S.; Mullan, M.M.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1023/  A:1020597001460] [PMID: 12452404]  [121] O’Mahony, S.M.",Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
[http://dx.doi.org/10.1016/j.neuroscience.,OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1038/ajg.2014.202] [PMID: 25070051]  [123] Gibson, G.R.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1016/j.cgh.2012.10.031] [PMID: 23103907]  [133] Hyphantis, T.; Guthrie, E.; Tomenson, B.; Creed, F. Psycho-  dynamic interpersonal therapy and improvement in interpersonal  difficulties in people with severe irritable bowel s yndrome.",Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
[http://dx.doi.org/10.1016/j.pain.2009.07.,Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1111/j.1365-2036.2007.03437.x] [PMID:  17767479]  [140] Taneja, I.; Deepak, K.K.",Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1023/B:APBI.0000017861.60439.95] [PMID:  15077462]  [141] Gaylord, S.A.; Palsson, O.S.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/  10.1038/ajg.2011.184] [PMID: 21691341]  [142] Cho, C.H.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1002/0471728780.ch22]  [143] Jembrek, M.J.; Vlainic, J. GABA receptors: pharmacological  potential and pitfalls.",Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.2174/1381612821666150914121624] [PMID:  26365137]  [144] Ko, J.K.; Auyeung, K.K.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.2174/0929867321666140205132124] [PMID:  24524767]  [145] Sikiric, P.; Seiwerth, S.; Rucman, R.; Turkovic, B.; Rokotov, D.S.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1186/s12937-015-0022- 3] [PMID: 25880820]  [147] Costabile, A.; Santare lli, S.; Claus, S.P.",Non-OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1016/j.expneurol.2011.04.020] [PMID:  21575632]  [149] Mulak, A.; Taché, Y.; Larauche, M. Sex hormones in the  modulation of irritable bowel syndrome.",OADS,/arxiv_data1/oa_pdf/a5/5a/CN-14-842.PMC5333584.pdf
"[http://dx.doi.org/10.1111/j.1749- 6632.1990.tb16153.x] [PMID: 2201238]  [3] Taché, Y.; Kolve, E.; Maeda- Hagiwara, M.; Kauffman, G.L., Jr  Central nervous system action of calcitonin to alter experimental  gastric ulcers in rats.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1016/0016-5085(88)90622-1] [PMID: 3335286]  [4] Taché, Y. CNS peptides and regulation of gastric acid secretion.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1146/  annurev.ph.50.030188.000315] [PMID: 3288091]  [5] Taché, Y.; Ishikawa, T.; Gunion, M.; Raybould, H.E.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1016/0006- 8993(87)90546-4] [PMID: 3676774]  [9] Hernandez, D.E.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1016/0024-3205(86)90646-6]  [PMID: 2874463]  [10] Taché, Y.; Kolve, E.; Kauffman, G. Potent CNS action of  calcitonin to inhibit cysteamine-induced duodenal ulcers in rat.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/  10.1111/j.1749-6632.1990.tb16169.x] [PMID: 2167033]  [12] Wilhelmsen, I. Brain-gut axis as an example of the bio-psycho- social model.",Non-OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1007/s13238-013- 3017-x] [PMID: 23686721]  [14] Seiwerth, S.; Brcic, L.; Vuletic, L.B.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
[http://dx.doi.org/10.1016/  0928-4257(93)90038-U] [PMID: 8298609],OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1016/  S0928-4257(97)89474-0] [PMID: 9403784]  [24] Stupnisek, M.; Franjic, S.; Drmic, D.; Hrelec, M.; Kolenc, D.;  Radic, B.; Bojic, D.; Vcev, A.; Seiwerth, S.; Sikiric, P.  Pentadecapeptide BPC 157 reduces bleeding time and  thrombocytopenia after amputation in rats treated with heparin,  warfarin or aspirin.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1016/j.lfs.2011.01.015] [PMID: 21295044]  [27] Ilic, S.; Drmic, D.; Zarkovic, K.; Kolenc, D.; Coric, M.; Brcic, L.;  Klicek, R.; Radic, B.; Sever, M.; Djuzel, V.; Ivica, M.; Boban  Blagaic, A.; Zoricic, Z.; Anic, T.; Zoricic, I.; Djidic, S.; Romic, Z.;  Seiwerth, S.; Sikiric, P. High hepatotoxic dose of paracetamol  produces generalized convulsions and brain damage in rats.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1016/j.burns.2004.10.013] [PMID:  15774286]  [30] Sikiric, P.; Seiwerth, S.; Mise, S.; Staresinic, M.; Bedekovic, V.;  Zarkovic, N.; Borovic, S.; Gjurasin, M.; Boban-Blagaic, A.;  Batelja, L.; Rucman, R.; Anic, T. Corticosteroid-impairment of  healing and gastric pentadecapeptide BPC-157 creams in burned  mice.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1016/S0736-0266(03)00110-4] [PMID:  14554208]  [39] Krivic, A.; Sikiric, P. Comment on “Use of recombinant human  bone morphogenetic protein-2 to enhance tendon healing in a   bone tunnel ”.",Non-OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1016/S8756-3282(98)00180-X] [PMID:  10071911]  [42] Keremi, B.; Lohinai, Z.; Komora, P.; Duhaj, S.; Borsi, K.; Jobbagy- Ovari, G.; Kallo, K.; Szekely, A.D.; Fazekas, A.; Dobo-Nagy, C.;  Sikiric, P.; Varga, G. Antiinflammatory effect of BPC 157 on  experimental periodontitis in rats.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1016/  j.regpep.2009.11.005] [PMID: 19903499]  [44] Masnec, S.; Kokot, A.; Zlatar, M.; Kalauz, M.; Kunjko, K.; Radic,  B.; Klicek, R.; Drmic, D.; Lazic, R.; Brcic, L.; Radic, R.; Ivekovic,  R.; Seiwerth, S.; Sikiric, P. Perforating corneal injury in rat and  pentadecapeptide BPC 157.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1016/j.exer.2015.04.016] [PMID: 25912999]  [45] Chang, C.H.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1152/  japplphysiol.00945.2010] [PMID: 21030672]  [47] Tkalcević, V.I.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1016/  j.ejphar.2007.05.072] [PMID: 17628536]  [48] Stupnisek, M.; Kokot, A.; Drmic, D.; Hrelec Patrlj, M.; Zenko  Sever, A.; Kolenc, D.; Radic, B.; Suran, J.; Bojic, D.; Vcev, A.;  Seiwerth, S.; Sikiric, P. Pentadecapeptide BPC 157 Reduces  Bleeding and Thrombocytopenia after Amputation in Rats Treated  with Heparin, Warfarin, L-NAME and L-Arginine.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
[http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1016/  j.ejphar.2014.01.046] [PMID: 24486708]  [51] Lovric-Bencic, M.; Sikiric, P.; Hanzevacki, J.S.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1254/  jphs.95.19] [PMID: 15153646]  [52] Balenovic, D.; Bencic, M.L.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/  10.1016/j.regpep.2009.05.008] [PMID: 19465062]  [53] Barisic, I.; Balenovic, D.; Klicek, R.; Radic, B.; Nikitovic, B.;  Drmic, D.; Udovicic, M.; Strinic, D.; Bardak, D.; Berkopic, L.;  Djuzel, V.; Sever, M.; Cvjetko, I.; Romic, Z.; Sindic, A.; Bencic, M.L.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1016/S0928-4257(99)  00119-9] [PMID: 10672997]  [55] Boban-Blagaic, A.; Blagaic, V.; Romic, Z.; Jelovac, N.; Dodig, G.;  Rucman, R.; Petek, M.; Turkovic, B.; Seiwerth, S.; Sikiric, P. The  influence of gastric pentadecapeptide BPC 157 on acute and  chronic ethanol administration in mice.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1016/j.ejphar.2004.07.112] [PMID: 15381050]  [57] Sikiric, P.; Jelovac, N.; Jelovac-Gjeldum, A.; Dodig, G.; Staresinic,  M.; Anic, T.; Zoricic, I.; Rak, D.; Perovic, D.; Aralica, G.; Buljat,  G.; Prkacin, I.; Lovric-Bencic, M.; Separovic, J.; Seiwerth, S.;  Rucman, R.; Petek, M.; Turkovic, B.; Ziger, T.; Boban-Blagaic, A.;  Bedekovic, V.; Tonkic, A.; Babic, S. Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbances.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1016/  j.ejphar.2005.02.033] [PMID: 15840402]  [59] Tohyama, Y.; Sikirić, P.; Diksic, M. Effects of pentadecapeptide  BPC157 on regional serotonin synthesis in the rat brain: alpha- methyl-L-tryptophan autoradiographic measurements.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1016/S0014-2999(99)  00486-0] [PMID: 10499368]  [66] Jelovac, N.; Sikirić, P.; Rucman, R.; Petek, M.; Perović, D.;  Konjevoda, P.; Marović, A.; Seiwerth, S.; Grabarević, Z.;  Sumajstorcić, J.; Dodig, G.; Perić, J.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1007/BF02087908] [PMID: 8769287]  [68] Tudor, M.; Jandric, I.; Marovic, A.; Gjurasin, M.; Perovic, D.;  Radic, B.; Blagaic, A.B.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1016/j.regpep.2009.11.012] [PMID: 19931318]  [69] Perovic, D.; Buljat, G.; Kolenc, D.; Drmic, D.; Seiwerth, S.;  Sikiric, P. Spinal Cord Injury in Rat – Therapeutic Effect of  Pentadecapeptide BPC 157.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.2174/1381612821666150914121624] [PMID:  26365137]  [72] Pericić, D.; Strac, D.S.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1007/s00210-007- 0152-z] [PMID: 17377772]  [73] Prkacin, I.; Aralica, G.; Perovic, D.; Separovic, J.; Gjurasin, M.;  Lovric-Bencic, M.; Stancic-Rokotov, D.; Ziger, T.; Anic, T.;  Sikiric, P.; Seiwerth, S.; Staresinic, M.; Mise, S.; Rotkvic, I.; Jagic,  V.; Rucman, R.; Petek, M.; Turkovic, B.; Marovic, A.; Sjekavica,  I.; Sebecic, B.; Boban-Blagaic, A.; Ivasovic, Z.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1016/S0928-4257(01)00041- 9] [PMID: 11595453]  [74] Prkacin, I.; Separovic, J.; Aralicia, G.; Perovic, D.; Gjurasin, M.;  Lovric-Bencic, M.; Stancic-Rokotov, D.; Staresinic, M.; Anic, T.;  Mikus, D.; Sikiric, P.; Seiwerth, S.; Mise, S.; Rotkvic, I.; Jagic, V.;  Rucman, R.; Petek, M.; Turkovic, B.; Marovic, A.; Sebecic, B.;  Boban-Blagaic, A.; Kokic, N. Portal hypertension and liver lesions  in chronically alcohol drinking rats prevented and reversed by  stable gastric pentadecapeptide BPC 157 (PL-10, PLD-116), and  propranolol, but not ranitidine.",OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"[http://dx.doi.org/10.1007/s10787-015-0249-9] [PMID: 26563892]  [77] Kalogjera, L.; Ries, M.; Baudoin, T.; Ferencic, Z.; Trotic, R.; Pegan,  B. Dose-dependent protective effect of BPC 157 on capsaicin- induced rhinitis in rats.",Non-OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
[http://dx.doi.org/10.1007/BF02439711] [PMID:  9065615],Non-OADS,/arxiv_data1/oa_pdf/14/a0/CN-14-857.PMC5333585.pdf
"Since  local injection of botulinum toxin A has been successfully tested in animal models of gastric cancer [38] and prostate  cancer (Gustavo Ayala: personal communication) and since  botulinum toxin A seems to block the release of all kinds of neurotransmitters, two human clinical trials have been  initiated in Norway and USA (https://clinicaltrials.gov/  ct2/show/NCT01822210)(https://clinicaltrials.gov/ct2/show/NCT01520441).",Non-OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
"[http://dx.doi.org/10.1016/0002-9610(87)90195-4]  [PMID: 3541658]  [4] Yeo, C.J.",OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
"[http://dx.doi.org/10.1159/000331516] [PMID: 22095015]  [7] Møller, H.; Nissen, A.; Mosbech, J.",OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
"[http://dx.doi.org/10.1136/gut.35.7.946] [PMID: 8063222]  [9] Graham, D.Y.",Non-OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
"[http://dx.doi.org/10.1053/j.gastro.2015.01.040] [PMID:  25655557]  [11] Colin-Jones, D.G.",Non-OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
"[http://dx.doi.org/10.1016/  0140-6736(90)91888-H] [PMID: 1975342]  [13] Schumacher, M.C.",OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
"[http://dx.doi.org/  10.1038/nrgastro.2011.272] [PMID: 22330810]  [15] Olbe, L.; Carlsson, E.; Lindberg, P. A proton-pump inhibitor  expedition: the case histories of omeprazole and esomeprazole.",Non-OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
"[http://dx.doi.org/10.1007/s11894-008-0100-1] [PMID:  19006608]  [17] Han, Y.M.",Non-OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
"[http://dx.doi.org/10.1111/apha.12208] [PMID:  24279703]  [20] Hansson, L.E.",OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
"[http://dx.doi.org/10.1056/  NEJM199607253350404] [PMID: 8657240]  [21] Brinton, L.A.; Gridley, G.; Hrubec, Z.; Hoover, R.; Fraumeni, J.F.,  Jr Cancer risk following pernicious anaemia.",Non-OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
"[http://dx.doi.org/10.1038/bjc.1989.169] [PMID:  2736218]  [22] Caygill, C.P.",OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
"[http://dx.doi.org/10.1136/gut.32.7.740] [PMID: 1855679]  [25] Sipponen, P.; Kekki, M.; Haapakoski, J.; Ihamäki, T.; Siurala, M.  Gastric cancer risk in chronic atrophic gastritis: statistical calculations  of cross-sectional data.",OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
[http://dx.doi.org/10.1002/ijc.,Non-OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
[http://dx.doi.org/10.1002/ijc.,Non-OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
[http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
"[http://dx.doi.org/10.1016/  S0167-0115(00)00176-2] [PMID: 11033051]  [35] Aihara, T.; Fujishita, T.; Kanatani, K.; Furutani, K.; Nakamura, E.;  Taketo, M.M.",OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
"[http://dx.doi.org/10.1053/j.gastro.2003.09.018]  [PMID: 14724830]  [36] Cassaro, M.; Rugge, M.; Gutierrez, O.; Leandro, G.; Graham, D.Y.",Non-OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
"[http://dx.doi.org/10.1136/gutjnl-2014-307190] [PMID: 24951258]  [41] Stenström, B.; Zhao, C.M.",OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
"[http://dx.doi.org/  10.1093/carcin/bgm071] [PMID: 17389611]  [42] Vigen, R.A.; Kodama, Y.; Viset, T.; Fossmark, R.; Waldum, H.;  Kidd, M.; Wang, T.C.",OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
"[http://dx.doi.org/10.1152/ajpgi.00105.2004] [PMID: 15933222]  [48] Jobling, P.; Pundavela, J.; Oliveira, S.M.",OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
"[http://dx.doi.org/10.1158/0008-5472.CAN-14-3180] [PMID:  25795709]  [49] Magnon, C.; Hall, S.J.",OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
"[http://dx.doi.org/10.1016/j.stem.2011.02.021]  [PMID: 21549329]  [51] Hanoun, M.; Zhang, D.; Mizoguchi, T.; Pinho, S.; Pierce, H.;  Kunisaki, Y.; Lacombe, J.; Armstrong, S.A.; Dührsen, U.; Frenette,  P.S.",OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
"[http://dx.doi.org/10.1016/  j.stem.2014.06.020] [PMID: 25017722]  [52] Katayama, Y.; Ba ttista, M.; Kao, W.M.",OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
[http://dx.doi.org/10.1016/j.cell.2005.,OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
[http://dx.doi.org/10.1126/science.,Non-OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
"[http://dx.doi.org/10.1371/journal.pone.0119707] [PMID: 25803850]  [58] Shah, N.; Khurana, S.; Cheng, K.; Raufman, J.P. Muscarinic  receptors and ligands in cancer.",Non-OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
"[http://dx.doi.org/10.1152/ajpcell.00514.2008]  [PMID: 19036940]  [59] Takebe, N.; Miele, L.; Harris, P.J.",OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
"[http://dx.doi.org/10.1016/j.autneu.2013.12.007] [PMID:  24411268]  [61] Rosas-Ballina, M.; Olofsson, P.S.",OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
"[http://dx.doi.org/10.1126/science.1209985] [PMID: 21921156]  [62] Fuentes, J.M.",Non-OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
[http://dx.doi.org/10.1016/j.surg.2005.06.057] [PMID: 16269307],OADS,/arxiv_data1/oa_pdf/96/7b/CN-14-967.PMC5333586.pdf
"[http://dx.doi.org/10.2337/dc12-0669] [PMID: 23173134]  [4] Triolo, T.M.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.2337/dc08-1872] [PMID:  19407074]  [5] Wierusz-Wysocka, B.; Zozulińska,  D.; Knast, B.; Pisarczyk-Wiza,  D. [Appearance of undiagnosed diabetes me llitus in the population  of professionally active people in the urban areas].",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1007/s10753-013-9598-y] [PMID:  23371411]  [9] Zorena, K.; Myśliwska, J.; Myśliwiec, M.; Balcerska, A.;  Lipowski, P.; Raczyńska, K. [Interleukin-12, vascular endothelial  growth factor and tumor necrosis factor-alpha in the process of  neoangiogenesis of diabetic retinopathy in children].",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.2337/diabetes.47.5.815] [PMID:  9588455]  [11] Howell, S.J.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1007/s12035-014-8732-7] [PMID:  24826918]  [15] Ola, M.S.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.2174/1570159X12666140619205024] [PMID:  25342945]  [16] Sutter, E.E.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/  10.1155/2013/274726] [PMID: 24347823]  [18] Lung, J.C.; Swann, P.G.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1007/s10633-012-9343-0] [PMID:  22828871]  [19] Aghdam, S.Y.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1016/j.bbrc.2013.01.101] [PMID:  23391566]  [20] Hammes, H.P.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1155/2013/193604] [PMID:  24311895]  [23] Mancini, J.E.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1186/1471-2415- 13-14] [PMID: 23587252]  [24] Yamagishi, S.; Matsui, T. Soluble form of a receptor for advanced  glycation end products (sRAGE) as a biomarker.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.2741/e178]  [PMID: 20515790]  [25] Beisswenger, P.J.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1007/s00726-010-0784-z] [PMID: 21042818]  [26] Yan, S.F.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1080/  07853890902806576] [PMID: 19322705]  [27] Bharadwaj, A.S.; Appukuttan, B.; Wilmarth, P.A.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1016/j.preteyeres.2012.08.004] [PMID:  22982179]  [28] Fu, S.; Dong, S.; Zhu, M.; Sherry, D.M.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1021/pr900818g]  [PMID: 19905032]  [33] Herlein, J.A.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.2337/db07-1520] [PMID: 18420487]  [35] Cai, R.; Xue, W.; Liu, S.; Petersen, R.B.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1096/fj.14-265801]  [PMID: 25805836]  [36] Bandyopadhyay, M.; Rohrer, B. Matrix metalloproteinase activity  creates pro-angiogenic environment in primary human retinal  pigment epithelial cells exposed to complement.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1155/2014/678123] [PMID: 24527463]  [39] Jivabhai Patel, S.; Bany-Mohammed, F.; McNally, L.; Valencia,  G.B.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1167/iovs.14-15321] [PMID: 25670494]  [40] Mandal, L.K.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1016/j.jcjd.2013.05.004] [PMID: 24321721]  [41] Lee, J.J.; Hsiao, C.C.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1002/  glia.21246] [PMID: 21987367]  [44] Wang, L.; Deng, Q.Q.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1111/cns.12150] [PMID:  23870489]  [45] Al-Shabrawey, M.; Smith, S. Prediction of diabetic retinopathy:  role of oxidative stress and relevance of apoptotic biomarkers.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1007/s13167- 010-0002-9] [PMID: 23199041]  [46] Pothecary, C.A.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1016/j.neurobiolaging.2004.07.004]  [PMID: 15718056]  [47] Kannan, K.; Jain, S.K.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1371/journal.pgen.1003532]  [PMID: 23737756]  [49] Khalfaoui, T.; Basora, N.; Ouertani-Meddeb, A. Apoptotic factors  (Bcl-2 and Bax) and diabetic retinopathy in type 2 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/  10.1038/sj.eye.6702225] [PMID: 16424911]  [53] Yang, P.; Peairs, J.J.; Tano, R.; Zhang, N.; Tyrell, J.; Jaffe, G.J.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1016/  j.taap.2011.09.013] [PMID: 21982801]  [55] Mohr, S. Caspase-1/interleukin-1beta signaling in diabetic  retinopathy.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1210/me.2005-0268]  [PMID: 16556731]  [57] Kern, T.S.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.2353/ajpath.2010.091062]  [PMID: 20363911]  [58] Costa, G.N.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1016/j.mcn.2012.04.003] [PMID:  22522145]  [59] Oshitari, T.; Brown, D.; Roy, S. SiRNA strategy against  overexpression of extracellular matrix in diabetic retinopathy.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
[http://dx.doi.org/10.1016/j.exer.,OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.3109/02713683.2013.833248] [PMID:  24073601]  [61] Rogowicz-Frontczak, A.; Pilacinski, S.; Araszkiewicz, A.;  Zozulinska-Ziolkiewicz, D.; Wykretowicz, A.; Wierusz-Wysocka,  B. C-Reactive protein and soluble intracellular adhesion molecule- 1 are related to pulse wave reflection in type 1 diabetes 1C-1.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1111/1753- 0407.12129] [PMID: 24456036]  [62] Yu, Y.; Chen, H.; Su, S.B.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1186/s12974-015-0368-7] [PMID: 26245868]  [63] Abcouwer, S.F.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1111/  nyas.12412] [PMID: 24673341]  [64] Crane, I.J.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1007/s00281-008-0106-7] [PMID:  18305941]  [65] Cahoon, J.M.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1016/j.exer.2013.12.002] [PMID: 24333760]  [66] Zorena, K.; Malinowska, E.; Raczyńska, D.; Myśliwiec, M.;  Raczyńska, K. Serum concentrations of transforming growth  factor-Beta 1 in predicting the occurrence of diabetic retinopathy in  juvenile patients with type 1 diabetes mellitus.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1155/2013/614908] [PMID:  23671881]  [67] Oh, I.K.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/  10.2337/dc06-0556] [PMID: 16936148]  [71] Ersoy, L.; Ristau, T.; Hahn, M.; Karlstetter, M.; Langmann, T.;  Dröge, K.; Caramoy, A.; den Hollander, A.I.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1167/iovs.13-13420] [PMID:  24576882]  [72] Doria, A. Genetics of diabetes complications.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1155/  2013/540416] [PMID: 24066292]  [75] Awata, T.; Inoue, K.; Kurihara, S.; Ohkubo, T.; Watanabe, M.;  Inukai, K.; Inoue, I.; Katayama, S. A common polymorphism in the  5′-untranslated region of the VEGF gene is associated with diabetic  retinopathy in type 2 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.2337/diabetes.51.5.1635] [PMID: 11978667]  [76] Choudhuri, S.; Chowdhury, I.H.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1007/s11010-015-2417-z] [PMID: 25956512]  [77] Barengo, N.C.; Tuomilehto, J.O.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1093/eurheartj/eht 281]  [PMID: 23882068]  [79] Zorena, K.; Myśliwska, J.; Myśliwiec, M.; Rybarczyk-Kapturska,  K.; Malinowska, E.; Wiśniewski, P.; Raczyńska, K. Association  between vascular endothelial growth factor and hypertension in  children and adolescents type I diabetes mellitus.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1038/  jhh.2010.7] [PMID: 20164848]  [80] Pons, M.; Marin-Castaño, M.E.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1016/j.mvr.2014.01.002] [PMID:  24423616]  [83] Lieth, E.; Gardner, T.W.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1046/j.1442- 9071.2000.00222.x] [PMID: 11345341]  [84] Kim, D.Y.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1038/  srep00076] [PMID: 22355595] [87] Li, P.; Xu, X.; Zheng, Z.; Zhu, B.; Shi, Y.; Liu, K. Protective  effects of rosiglitazone on retinal neuronal damage in diabetic rats.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.3109/  02713683.2011.572220] [PMID: 21599458]  [88] Nissen, S.E.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/   10.1056/NEJMoa072761] [PMID: 17517853]  [89] Gonçalves, A.; Leal, E.; Paiva, A.; Teixeira Lemos, E.; Teixeira,  F.; Ribeiro, C.F.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/  10.1111/j.1463-1326.2011.01548.x] [PMID: 22151893]  [90] Gonçalves, A.; Marques, C.; Leal, E.; Ribeiro, C.F.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/  10.1016/j.bbadis.2014.04.013] [PMID: 24769045]  [91] Jung, K.I.",OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
[http://dx.doi.org/10.1016/j.preteyeres.,OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.1016/j.jep.2008.09.036] [PMID: 19013511]  [96] Dong, Z.; Tao, X.; Fu, X.; Wang, H.; Wang, D.; Zhang, T.  Protective effects of Purendan superfine powder on retinal neuron  apoptosis in a rat model of type 2 diabetes me llitus.",Non-OADS,/arxiv_data1/oa_pdf/ac/4e/CN-14-831.PMC5333588.pdf
"[http://dx.doi.org/10.2174/09298673113209990027] [PMID:  23745549]  [2] Simó, R.; Hernández, C. Neurodegeneration in the diabetic eye:  new insights and therapeutic perspectives.",Non-OADS,/arxiv_data1/oa_pdf/7b/dd/CN-14-805.PMC5333590.pdf
[http://dx.doi.org/10.1016/j.tem.2013.,OADS,/arxiv_data1/oa_pdf/7b/dd/CN-14-805.PMC5333590.pdf
"[http://dx.doi.org/10.1007/s00125-010-1900-z]  [PMID: 20835858]  [9] Zozulinska, D.; Wierusz-Wysocka, B. Hyperglycaemia and  Inflammation are culprits of late diabetic complications.",Non-OADS,/arxiv_data1/oa_pdf/7b/dd/CN-14-805.PMC5333590.pdf
[http://dx.doi.org/10.1016/j.exer.2005.,OADS,/arxiv_data1/oa_pdf/7b/dd/CN-14-805.PMC5333590.pdf
"[http://dx.doi.org/10.1177/000331979304400108] [PMID: 8380959]  [12] Wierusz-Wysocka, B.; Wysocki,  H.; Siekierka, H.; Wykretowicz,  A.; Szczepanik, A.; Klimas, R. Evidence of polymorphonuclear  neutrophils (PMN) activation in patients with diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/7b/dd/CN-14-805.PMC5333590.pdf
"[http://dx.doi.org/10.1016/  0168-8227(96)01289-2] [PMID: 8922534]  [14] Grykiel, K.; Zozulińska, D.; Kostrzewa, A.; Wiktorowicz, K.;  Wierusz-Wysocka, B.",OADS,/arxiv_data1/oa_pdf/7b/dd/CN-14-805.PMC5333590.pdf
"[http://dx.doi.org/10.1038/nature03875] [PMID: 16015319]  [16] Elahy, M.; Baindur-Hudson, S.; Cruzat, V.F.",OADS,/arxiv_data1/oa_pdf/7b/dd/CN-14-805.PMC5333590.pdf
"[http://dx.doi.org/10.1016/j.neuropharm.2009.06.028] [PMID:  19576912]  [18] Wu, Q.; Blakeley, L.R.",Non-OADS,/arxiv_data1/oa_pdf/7b/dd/CN-14-805.PMC5333590.pdf
"[http://dx.doi.org/10.4239/wjd.v6.i2.312] [PMID:  25789112]  [21] Chihara, E.; Matsuoka, T.; Ogura, Y.; Matsumura, M. Retinal  nerve fiber layer defect as an early manifestation of diabetic  retinopathy.",Non-OADS,/arxiv_data1/oa_pdf/7b/dd/CN-14-805.PMC5333590.pdf
"[http://dx.doi.org/10.1097/00006982- 200212000-00012] [PMID: 12476103]  [24] Yang, C.S.",OADS,/arxiv_data1/oa_pdf/7b/dd/CN-14-805.PMC5333590.pdf
"[http://dx.doi.org/10.1034/j.1600-0420.2001.790311.x] [PMID:  11401636]  [25] Cabrera DeBuc, D.; Somfai, G.M.",Non-OADS,/arxiv_data1/oa_pdf/7b/dd/CN-14-805.PMC5333590.pdf
"[http://dx.doi.org/10.12659/MSM.893221] [PMID:  26084958]  [27] Shahidi, A.M.; Sampson, G.P.",Non-OADS,/arxiv_data1/oa_pdf/7b/dd/CN-14-805.PMC5333590.pdf
"[http://dx.doi.org/10.1111/  j.1464-5491.2012.03588.x] [PMID: 22269030]  [28] Ciresi, A.; Amato, M.C.",OADS,/arxiv_data1/oa_pdf/7b/dd/CN-14-805.PMC5333590.pdf
"[http://dx.doi.org/10.1136/bjo.2006.111534] [PMID: 17383994]  [30] van Dijk, H.W.",Non-OADS,/arxiv_data1/oa_pdf/7b/dd/CN-14-805.PMC5333590.pdf
"[http://dx.doi.org/10.1167/iovs.08-3143] [PMID: 19151397]  [31] Araszkiewicz, A.; Zozulińska-Ziółkiewicz, D.; Meller, M.;  Bernardczyk-Meller, J.; Piłaciński, S.; Rogowicz-Frontczak, A.;  Naskręt, D.; Wierusz-Wysocka, B. Neurodegeneration of the retina  in type 1 diabetic patients.",OADS,/arxiv_data1/oa_pdf/7b/dd/CN-14-805.PMC5333590.pdf
"[http://dx.doi.org/10.1016/  S0278-5846(03)00023-X] [PMID: 12657367]  [33] Juen, S.; Kieselbach, G.F. Electrophysiological changes in juvenile  diabetics without retinopathy.",OADS,/arxiv_data1/oa_pdf/7b/dd/CN-14-805.PMC5333590.pdf
[http://dx.doi.org/10.2337/db05-1635] [PMID: 16936187],Non-OADS,/arxiv_data1/oa_pdf/7b/dd/CN-14-805.PMC5333590.pdf
http://onlinelibrary.wiley.com/doi/10.,Non-OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
[http://dx.doi.org/10.1111/j.1753-4887.1977.,Non-OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1038/nrn3346] [PMID:  22968153]  [4] Rush, A.J.",OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1038/nri2515] [PMID:  19343057]  [7] Di Bella, J.M.",Non-OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1016/j.tig.2012.09.005]  [PMID: 23140990]  [10] Qin, J.; Li, R.; Raes, J.; Arumugam, M.; Burgdorf, K.S.",OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1038/nature08821] [PMID: 20203603]  [11] Arumugam, M.; Raes, J.; Pelletier, E.; Le Paslier, D.; Yamada, T.;  Mende, D.R.",Non-OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1126/science.1177486] [PMID: 19892944]  [13] Sekirov, I.; Russell, S.L.",OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1152/physrev.00045.2009] [PMID: 20664075]  [14] Dominguez-Bello, M.G.",Non-OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1038/nri1373] [PMID:  15173836]  [17] Cryan, J.F.",OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1038/nrn3346] [PMID: 22968153]  [18] Wei, B.; Su, T.T.",OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1016/j.cell.2005.05.007] [PMID: 16009137]  [20] Chu, H.; Mazmanian, S.K.",OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1038/ni.2635] [PMID:  23778794]  [21] Collins, SM; De nou, E; Verdu, EF; Bercik, P The putative role of  the intestinal microbiota in the irritable bowel syndrome.",Non-OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1002/bies.201400075] [PMID:  25145752]  [24] De Palma, G.; Collins, S.M.",Non-OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1113/jphysiol.2014.273995] [PMID: 24756641]  [25] Moloney, R.D.",OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1007/s00335-013-9488-5]  [PMID: 24281320]  [26] O’Malley, D.; Julio-Pieper, M.; Gibney, S.M.",Non-OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/  10.3109/10253890903067418] [PMID: 20214436]  [27] Dinan, T.G.",Non-OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/  10.1016/j.psyneuen.2012.03.007] [PMID: 22483040]  [28] Sudo, N.; Chida, Y.; Aiba, Y.; Sonoda, J.; Oyama, N.; Yu, X.N.",OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1038/mp.2012.77] [PMID: 22688187] [30] Diaz Heijtz, R.; Wang, S.; Anuar, F.; Qian, Y.; Björ kholm, B.;  Samuelsson, A.; Hibberd, M.L.",OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
609.e1-3 [http://dx.doi.org/10.1053/j.gastro.2011.04.,Non-OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1016/j.bbi.2003.08.002] [PMID: 15050651]  [37] Goehler, L.E.",OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1016/j.bbi.2007.08.009] [PMID:  17920243]  [38] Lyte, M.; Li, W.; Opitz, N.; Gaykema, R.P.",OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1097/YCO.0000000000000117]  [PMID: 25415497]  [40] Diagnostic and Statistical Manual of Mental Disorders: DSM-5,  5th ed; American Psychiatric Association: Washington, D.C, 2013 .",Non-OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1038/nrn2297] [PMID: 18073775]  [42] Ait-Belgnaoui, A.; Durand, H.; Cartier, C.; Chaumaz, G.;  Eutamene, H.; Ferrier, L.; Houdeau, E.; Fioramonti, J.; Bueno, L.;  Theodorou, V. Prevention of gut leakiness by a probiotic treatment  leads to attenuated HPA response to an acute psychological stress  in rats.",Non-OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1016/j.ejphar.2005.10.021] [PMID: 16313900]  [46] Jembrek, M.J.; Vlainić, J.; Šuran, J. Zolpidem withdrawal induced  uncoupling of GABA( A) receptors in vitro  associated with altered  GABA( A) receptor subunit mRNA expression.",OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/  10.1016/j.brainres.2007.09.039] [PMID: 17945202]  [48] Pericić, D.; Strac, D.S.",OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1007/s00210-007-0152- z] [PMID: 17377772]  [49] Wikoff, W.R.; Anfora, A.T.; Liu, J.; Schultz, P.G.",OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/  10.1073/pnas.0812874106] [PMID: 19234110]  [50] Bercik, P.; Park, A.J.",OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1111/j.1365-2982.2011.01796.x] [PMID:  21988661]  [51] Park, A.J.",OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/  10.1111/nmo.12153] [PMID: 23773726]  [52] Tannock, G.W.",OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1007/s00213- 010-2010-9]  [54] Pyndt Jørgensen, B.; Hansen, J.T.",Non-OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1016/j.jpsychires.2008.03.009] [PMID:  18456279]  [56] Davari, S.; Talaei, S.A.; Alaei, H.; Salami, M. Probiotics treatment  improves diabetes-induced impairment of synaptic activity and  cognitive function: behavioral and electr ophysiological proofs   for microbiome-gut-brain axis.",Non-OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1016/j.neuroscience.2013.02.055] [PMID:  23500100]  [57] Diop, L.; Guillou, S.; Durand, H. Probiotic food supplement  reduces stress-induced gastrointestinal symptoms in volunteers: a  double-blind, placebo-controlled, randomized trial.",Non-OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1016/j.nutres.2007.10.001]  [PMID: 19083380]  [58] Yamamura, S.; Morishima, H.; Kumano-go, T.; Suganuma, N.;  Matsumoto, H.; Adachi, H.; Sigedo, Y.; Mikami, A.; Kai, T.;  Masuyama, A.; Takano, T.; Sugita, Y.; Takeda, M. The effect of  Lactobac illus helveticus  fermented milk on sleep and health perception in elderly subjects.",OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1038/sj.ejcn.1602898] [PMID: 17851460]  [59] Tillisch, K.; Labus, J.; Kilpatrick, L.; Jiang, Z.; Stains, J.; Ebrat, B.;  Guyonnet, D.; Legrain-Raspaud, S.; Trotin, B.; Naliboff, B.;  Mayer, E.A.",OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1371/journal.pone.0046231] [PMID:  23056268]  [62] Saulnier, D.M.",Non-OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/  10.1016/j.anaerobe.2013.06.002] [PMID: 23791918]  [64] Song, Y.; Könönen, E.; Rautio, M.; Liu, C.; Bryk, A.; Eerola, E.;  Finegold, S.M.",OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1186/1757-4749-1-6] [PMID: 19338686]  [68] Messaoudi, M.; Violle, N.; Bisson, J.F.",Non-OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.4161/gmic.2.4.16108] [PMID:  21983070]  [69] Messaoudi, M.; Lalonde, R.; Violle, N.; Javelot, H.; Desor, D.;  Nejdi, A.; Bisson, J.F.",Non-OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.1017/  S0007114510004319] [PMID: 20974015]  [70] Jembrek, M.J.; Vlainić, J. GABA receptors: pharmacological  potential and pitfalls.",Non-OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/10.2174/1381612821666150914121624] [PMID:  26365137]  [71] Jiang, H; Ling, Z; Zhang, Y; Mao, H; Ma, Z; Yin, Y; Wang, W;  Tang, W; Tan, Z; Shi, J; Li, L; Ruan, B Altered fecal microbiota  composition in patients with major depressive disorder.",Non-OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
[http://dx.doi.org/  10.1016/j.bbi.2015.03.016],OADS,/arxiv_data1/oa_pdf/e9/d1/CN-14-952.PMC5333591.pdf
"[http://dx.doi.org/  10.1038/nature05162] [PMID: 17036007]  [4] Könczöl, K.; Bodnár, I.; Zelena, D.; Pintér, O.; Papp, R.S.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.18632/aging.100207] [PMID: 20966530]  [6] Stengel, A.; Goebel, M.; Wang, L.; Rivier, J.; Kobelt, P.;  Mönnikes, H.; Lambrecht, N.W.",Non-OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/  10.1016/j.cmet.2009.09.002] [PMID: 19883614]  [9] Yosten, G.L.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1002/oby.20736] [PMID: 24596169]  [12] Atsuchi, K.; Asakawa, A.; Ushikai, M.; Ataka, K.; Tsai, M.;  Koyama, K.; Sato, Y.; Kato, I.; Fujimiya, M.; Inui, A. Centrally  administered nesfatin-1 inhibits feeding behaviour and gastro-  duodenal mo tility in mice.",Non-OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1515/jpem-2013-0475] [PMID: 24825087]  [20] Kohno, D.; Nakata, M.; Maejima, Y.; Shimizu, H.; Sedbazar, U.;  Yoshida, N.; Dezaki, K. ; Onaka, T.; Mori, M.; Yada, T. Nesfatin-1  neurons in paraventricular and supraoptic nuclei of the rat  hypothalamus coexpress oxytocin and vasopressin and are  activated by refeeding.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1210/en.2007-1276] [PMID: 18048495]  [21] Darambazar, G.; Nakata, M.; Okada, T.; Wang, L.; Li, E.;  Shinozaki, A.; Motoshima, M.; Mori, M.; Yada, T. Paraventricular  NUCB2/nesfatin-1 is directly targeted by leptin and mediates its  anorexigenic effect.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1016/j.bbrc.2014.12.065] [PMID:  25534851]  [22] Gantulga, D.; Maejima, Y.; Nakata, M.; Yada, T. Glucose and  insulin induce Ca2+ signaling in nesfatin-1 neurons in the  hypothalamic paraventricular nucleus.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
[http://dx.doi.org/10.1016/j.bbrc.,OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1016/  j.bbrc.2013.03.090] [PMID: 23583201]  [24] Rosenwasser, A.M.; Boulos, Z.; Terman, M. Circadian  organization of food intake and meal patterns in the rat.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1016/0031-9384  (81)90296-1] [PMID: 7267801]  [25] Goebel-Stengel, M.; Wang, L.; Stengel, A.; Taché, Y. Localization of  nesfatin-1 neurons in the mouse brain and functional implication.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1016/  j.brainres.2011.04.031] [PMID: 21555116]  [26] Guo, F.F.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1111/ejn.12366] [PMID: 24289827]  [28] Wang, Q.; Guo, F.; Sun, X.; Gao, S.; Li, Z.; Gong, Y.; Xu, L.  Effects of exogenous nesfatin-1 on gastric distention-sens itive  neurons in the central nucleus of the amygdala and gastric motility  in rats.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
[http://dx.doi.org/  10.1016/j.neulet.2014.09.003] [PMID: 25220707],OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1007/s10620- 014-3505-8] [PMID: 25563722]  [30] Szlachcic, A.; Sliwowski, Z.; Krzysiek-Maczka, G.; Majka, J.;  Surmiak, M.; Pajdo, R.; Drozdowicz, D.; Konturek, S.J.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
[http://dx.doi.org/10.1016/j.peptides.,OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1016/j.jss.2014.06.057] [PMID:  25082746]  [32] Özsavcí, D.; Erşahin, M.; Şener, A.; Özakpinar, O.B.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1227/NEU.0b013  e318210f258] [PMID: 21336215]  [33] Xia, Z.F.",Non-OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.3748/wjg.v16.i14.1735] [PMID: 20380005]  [35] Gonkowski, S.; Rychlik, A.; Nowicki, M.; Nieradka, R.; Bulc, M.;  Całka, J.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
[http://dx.doi.org/10.1016/j.bbrc.,OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1016/j.neuroscience.2008.07.054] [PMID:  18761059]  [39] Goebel-Stengel, M.; Wang, L. Central and peripheral expression and  distribution of NUCB2/nesfatin-1.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.2174/138161281939131127124814]  [PMID: 23537079]  [40] Brailoiu, G.C.",Non-OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1210/en.2007-0701] [PMID:  17627999]  [41] Mimee, A.; Ferguson, A.V.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.2174/138161281939131127125347] [PMID:  23537077]  [42] Goebel, M.; Stengel, A.; Wang, L.; Taché, Y.",Non-OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1210/  edrv.22.4.0436] [PMID: 11493581]  [45] Rotllant, D.; Nadal, R.; Armario, A.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
[http://dx.doi.org/10.1016/j.brainres.2009.12.,OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1016/  j.psyneuen.2015.06.014] [PMID: 26143537]  [52] Merali, Z.; Cayer, C.; Kent, P.; Anisman, H. Nesfatin-1 increases  anxiety- and fear-related behaviors in the rat.",Non-OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1007/s00213- 008-1252-2] [PMID: 18670764]  [53] Ge, J.F.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/  10.1016/j.brainres.2015.10.027] [PMID: 26498879]  [54] Xu, Y.Y.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1016/j.npep.2015.08.003] [PMID:  26297350]  [55] Luckey, A.; Livingston, E.; Taché, Y. Mechanisms and treatment  of postoperative ileus.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1001/archsurg.138.2.206] [PMID: 12578422]  [56] Kehlet, H. Postoperative ileus--an update on preventive techniques.",Non-OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1038/ncpgasthep1230] [PMID: 18695704]  [57] Wang, L.; Goebel-Stengel, M.; Stengel, A.; Wu, S.V.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
[http://dx.doi.org/10.1016/j.brainres.2011.,OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1152/  ajpgi.00018.2011] [PMID: 21636529]  [59] Stengel, A.; Goebel, M.; Wang, L.; Taché, Y. Abdominal surgery  activates nesfatin-1 immunoreactive brain nuclei in rats.",Non-OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
[http://dx.doi.org/10.1016/j.peptides.2009.,OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1016/j.regpep.2013.10.001]  [PMID: 24120633]  [61] Bonnet, M.S.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1186/1742-2094-6-27] [PMID: 19778412]  [62] Stengel, A.; Goebel-Stengel, M.; Jawien, J.; Kobelt, P.; Taché, Y.;  Lambrecht, N.W.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1111/j.1365- 2826.2012.02375.x] [PMID: 22958274]  [64] Yang, M.; Zhang, Z.; Wang, C.; Li, K.; Li, S.; Boden, G.; Li, L.;  Yang, G. Nesfatin-1 action in the brain increases insulin sensitivity  through Akt/AMPK/TORC2 pathway in diet-induced insulin  resistance.",Non-OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1248/bpb.b12-00505] [PMID: 23037168]  [66] Riva, M.; Nitert, M.D.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.12659/MSM.892611] [PMID:  25841171]  [69] Ghanbari-Niaki, A.; Kraemer, R.R.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1007/s00421-010-1531-6] [PMID: 20625762]  [70] Mohebbi, H.; Nourshahi, M.; Ghasemikaram, M.; Safarimosavi, S.  Effects of exercise at individual anaerobic threshold and maximal fat  oxidation intensities on plasma levels of nesfatin-1 and metabolic  health biomarkers.",Non-OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1007/s13105-015-0383-2] [PMID: 25637303]  [71] Ahmadizad, S.; Avansar, A.S.; Ebrahim, K.; Avandi, M.;  Ghasemikaram, M. The effects of short-term high-intensity interval  training vs. moderate-intensity continuous training on plasma levels  of nesfatin-1 and inflammatory markers.",Non-OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1515/hmbci- 2014-0038] [PMID: 25581765]  [72] Bustos, G.; Abarca, J.; Campusano, J.; Bustos, V.; Noriega, V.;  Aliaga, E. Functional interactions between somatodendritic dopamine  release, glutamate receptors and brain-derived neurotrophic factor  expression in mesencephalic structures of the brain.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1016/j.yfrne.2004.05.001]  [PMID: 15589267]  [74] Maejima, Y.; Kumamoto, K.; Takenoshita, S.; Shimomura, K.  Projections from a single NUCB2/nesfatin-1 neuron in the  paraventricular nucleus to different brain regions involved in  feeding.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1007/s00429-015-1150-4] [PMID: 26639940]  [75] Pan, W.; Hsuchou, H.; Kastin, A.J.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.1016/j.peptides.2007.09.005] [PMID: 17950952]  [76] Price, T.O.",OADS,/arxiv_data1/oa_pdf/d1/8d/CN-14-882.PMC5333592.pdf
"[http://dx.doi.org/10.2337/db05-1635] [PMID: 16936187]  [5] Barber, A.J.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1167/iovs.10-6293] [PMID: 21357409]  [6] Curtis, T.M.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.2337/diacare.27.10.2568]  [PMID: 15451946]  [9] Gardner, T.W.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1001/  archophthalmol.2010.362] [PMID: 21320973]  [10] Varma, R.; Choudhury, F.; Klein, R.; Chung, J.; Torres, M.; Azen,  S.P.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.2337/dc12-0790] [PMID: 23275374]  [12] Davidović, S.P.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1167/iovs.04-1340] [PMID: 15914643]  [15] Gastinger, M.J.; Singh, R.S.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.2337/diabetes.47.5.815] [PMID:  9588455]  [18] Rungger-Brändle, E.; Dosso, A.A.; Leuenberger, P.M. Glial  reactivity, an early feature of diabetic retinopathy.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.2174/157339911795843168] [PMID:  21438851]  [23] Abhary, S.; Burdon, K.P.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/  10.1167/iovs.09-3694] [PMID: 19553626]  [24] Ruberte, J.; Ayuso, E.; Navarro, M.; Carretero, A.; Nacher, V.;  Haurigot, V.; George, M.; Llombart, C.; Casellas, A.; Costa, C.;  Bosch, A.; Bosch, F. Increased ocular levels of IGF-1 in transgenic  mice lead to diabetes-like eye disease.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1172/JCI19478] [PMID: 15085194]  [25] Praidou, A.; Papakonstantinou, E.; Androudi, S.; Georgiadis, N.;  Karakiulakis, G.; Dimitrakos, S. Vitreous and serum levels of  vascular endothelial growth fact or and platelet-derived growth  factor and their correlation in patients with non-proliferative  diabetic retinopathy and clinically significant macula oedema.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1167/iovs.10-5931] [PMID: 20926810]  [33] Metea, M.R.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1016/j.preteyeres.2012.04.004] [PMID:  22580107]  [35] Buerk, D.G.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1006/  mvre.1996.0040] [PMID: 8812749]  [36] Maenhaut, N.; Boussery, K.; Delaey, C.; Van de Voorde, J.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1080/  10739680601072131] [PMID: 17365660]  [37] Nakahara, T.; Mori, A.; Kurauchi, Y.; Sakamoto, K.; Ishii, K.  Neurovascular interactions in the retina: physiological and  pathological roles.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1254/jphs.13R03CP] [PMID: 24067498]  [38] Metea, M.R.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
[http://dx.doi.org/10.1523/JNEUROSCI.,Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1007/  s10633-011-9298-6] [PMID: 22057379]  [42] Nguyen, T.T.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1016/  j.jdiacomp.2011.11.004] [PMID: 22226482]  [45] Abu El-Asrar, A.M.; Al-Mezaine, H.S.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1016/j.neuint.2011.06.010]  [PMID: 21756956]  [50] Zhang, Y.; Bhavnani, B.R.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/  10.2337/db12-0926] [PMID: 23474487]  [52] Simó, R.; Lecube, A.; Sararols, L.; García-Arumí, J.; Segura, R.M.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.2337/  diacare.28.8.1941] [PMID: 16043736]  [54] Cervia, D.; Casini, G.; Bagnoli, P. Physiology and pathology of  somatostatin in the mammalian retina: a current view.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1007/s00125-010-1900-z]  [PMID: 20835858]  [56] Simó, R.; Hernández, C. Neurodegeneration is an early event in  diabetic retinopathy: therapeutic implications.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
[http://dx.doi.org/10.1016/j.tem.2013.,OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1016/j.visres.2003.09.019] [PMID:  14611938]  [59] Gonzalez-Fernandez, F.; Ghosh, D. Focus on Molecules:  interphotoreceptor retinoid-binding protein (IRBP).",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
[http://dx.doi.org/10.1016/j.exer.2006.09.,OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1056/NEJMcibr022629] [PMID: 12477950]  [61] Rex, T.S.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1016/j.exer.2009.06.017] [PMID:  19591826]  [62] Shen, J.; Wu, Y.; Xu, J.Y.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1167/iovs.09-3544] [PMID: 19628748]  [63] Chen, J.; Connor, K.M.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.2337/diabetes.55.04.06.db05-0744] [PMID:  16567541]  [66] Gordon, W.C.; Bazan, N.G.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1097/  00001756-200311140-00012] [PMID: 14600499]  [70] Ali, T.K.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1007/s12177-011-9072-8] [PMID:  23316263]  [72] Joussen, A.M.; Poulaki, V.; Le, M.L.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1155/2007/95103]  [74] Gerhardinger, C.; Costa, M.B.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1167/iovs.04-0860] [PMID: 15623795]  [75] Zhong, Y. Li, j.; Chen, Y.; Wang, J.J.; Ratan, R.; Zhang, S.X.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/  10.2337/db11-0315] [PMID: 22228718]  [76] Wilkinson-Berka, J.L.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/  10.1016/j.biocel.2005.08.002] [PMID: 16165393]  [77] Downie, L.E.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
[http://dx.doi.org/10.1076/ceyr.,Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1016/j.exer.2004.06.007] [PMID: 15381031]  [88] Fukuda, R.; Hirota, K.; Fan, F.; Jung, Y.D.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1097/  WNR.0b013e32831743fb] [PMID: 18841090]  [91] Mehrhof, F.B.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1002/cyto.a.20480] [PMID: 18000872]  [94] Abu El-Asrar, A.M.; Struyf, S.; Verbeke, H.; Van Damme, J.;  Geboes, K. Circulating bone-marrow-derived endothelial precursor  cells contribute to neovascularization in diabetic epiretinal  membranes.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/  10.1161/01.RES.86.12.1198] [PMID: 10864908]  [97] Li, B.; Sharpe, E.E.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
[http://dx.doi.org/10.5483/BMBRep.2006.,Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1158/0008-5472.CAN-07-3217]  [PMID: 18199548]  [101] Abu El-Asrar, A.M.; Siddiquei, M.M.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1016/j.mce.2011.10.018]  [PMID: 22040599]  [103] Fang, L.; Barber, A.J.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
[http://dx.doi.org/10.1126/science.,Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1007/s40259-013-0013-x] [PMID: 23456652]  [107] Xiao, Y.; Xu, A.; Law, L.S.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1172/JCI118074] [PMID: 7542286]  [111] Cohen, R.A.; Tong, X. Vascular oxidative stress: the common link  in hypertensive and diabetic vascular disease.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1097/  FJC.0b013e3181d89670] [PMID: 20422735]  [112] Xia, Y.; Zweier, J.L.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.2174/  0929867053363207] [PMID: 15723618]  [114] Hein, T.W.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/  10.1042/bj3360001] [PMID: 9806879]  [117] Zhang, W.; Baban, B.; Rojas, M.; Tofigh, S.; Virmani, S.K.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.2353/ajpath.2009.081115] [PMID: 19590038]  [118] Berkowitz, D.E.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/  10.1161/01.CIR.0000092948.04444.C7] [PMID: 14517171]  [119] Ryoo, S.; Berkowitz, D.E.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.4097/kjae.2011.61.1.3] [PMID: 21860744]  [120] Zahedi, K.; Hu ttinger, F.; Morrison, R.; Murray-Stewart, T.;  Casero, R.A.; Strauss, K.I.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1089/neu.2009.1097] [PMID: 19968558]  [121] Wood, P.L.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1016/  j.brainres.2006.04.038] [PMID: 16730673]  [122] Takano, K.; Ogura, M.; Nakamura, Y.; Yoneda, Y. Neuronal and  glial responses to polyamines in the ischemic brain.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.2174/  1567202054368335] [PMID: 16181115]  [123] Chen, B.; Calvert, A.E.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1001/archopht.119.4.499] [PMID: 11296015]  [129] Wu, W.C.; Lin, R.I.; Shih, C.P.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"published online 20 February 2014, accessed 07.2015  [http://dx.doi.org/10.1038/cddis.2014.23]  [133] Elms, S.C.; Toque, H.A.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1016/j.cell.2005.12.023] [PMID: 16413476]  [137] Askari, A.T.; Unzek, S.; Popovic, Z.B.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/  10.1016/S0140-6736(03)14232-8] [PMID: 12957092]  [138] Butler, J.M.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1172/JCI22869] [PMID: 15630447]  [139] Sonmez, K.; Drenser, K.A.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1016/  S0002-9440(10)62483-2] [PMID: 15920158]  [147] Mohammed, F.F.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.4049/jimmunol.176.2.721] [PMID:  16393953]  [150] Horiuchi, K.; Le Gall, S.; Schulte, M. Substrate selectivity of EGF- receptor ligand sheddases and their regulation by phorbol esters  and calcium influx.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1091/mbc.E06-01-0014] [PMID: 17079736]  [151] Le Gall, S.; Bobe, P.; Reiss, K. ADAMs 10 and 17 represent  differentially regulated components of a general shedding  machinery for membrane proteins such as TGFα, L-Selectin and  TNFα.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/  10.1091/mbc.E08-11-1135] [PMID: 19158376]  [152] Blobel, C.P.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1242/dev.01966] [PMID: 16079154]  [156] Chalaris, A.; Adam, N.; Sina, C.; Rosenstiel, P.; Lehmann-Koch,  J.; Schirmacher, P.; Hartmann, D.; Cichy, J.; Gavrilova, O.;  Schreiber, S.; Jostock, T.; Matthews, V.; Häsler, R.; Becker, C.;  Neurath, M.F.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1084/jem.20092366]  [PMID: 20603312]  [157] Xiang, N.; Zhao, M.J.; Li, X.Y.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1159/000316134] [PMID: 20720439]  [158] Zhao, M.; Shi, X.; Liang, J.; Miao, Y.; Xie, W.; Zhang, Y.; Li, X.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1038/ncomms1232] [PMID: 21407195]  [161] Swendeman, S.; Mendelson, K.; Weskamp, G.; Horiuchi, K.;  Deutsch, U.; Scherle, P.; Hooper, A.; Rafii, S.; Blobel, C.P.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1038/ncomms1232]  [PMID: 21407195]  [163] Takita, H.; Yoneya, S.; Gehlbach, P.L.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1167/iovs.03-0052] [PMID: 14507898]  [164] Yoshida, Y.; Yamagishi, S.; Matsui, T.; Jinnouchi, Y.; Fukami, K.;  Imaizumi, T.; Yamakawa, R. Protective role of pigment  epithelium-derived factor (PEDF) in early phase of experimental  diabetic retinopathy.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1007/s10571-011-9779-x]  [167] Zhang, J.; Wu, Y.; Jin, Y.; Ji, F.; Sinclair, S.H.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1167/iovs.07-0721] [PMID: 18235022]  [168] Wang, Q.; Gorbey, S.; Pfister, F.; Höger, S.; Dorn-Beineke, A.;  Krügel, K.; Berrone, E.; Wu, L. · Korff, T.; Lin, J.; Busch, S.;  Reichenbach, A.; Feng, Y.; Hammes H.P.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1159/000330085] [PMID:  21691094]  [169] McVicar, C.M.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.5966/sctm.2011-0005] [PMID:  23197778]  [171] Semeran, K.; Pawłowski, P.; Lisowski, Ł.; Szczepaniak, I.;  Wójtowicz, J.; Ławicki, S.; Bakunowicz-Łazarczyk, A.;  Bossowski, A.",OADS,/arxiv_data1/oa_pdf/7e/ee/CN-14-792.PMC5333593.pdf
"[http://dx.doi.org/10.1007/s00125-012-2621-2] [PMID: 22782286]  [3] IDF Diabetes Atlas, 2009.",Non-OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
"[http://dx.doi.org/10.1111/pedi.12165] [PMID: 25041509]  [7] Usher-Smith, J.A.",OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
"[http://dx.doi.org/10.1007/s00125-012-2690-2] [PMID: 22933123]  [8] Rewers, A.; Klingensmith, G.; Davis, C. Diabetic ketoacidosis at  onset of diabetes: the SEARCH for diabetes in youth study.",Non-OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
"[http://dx.doi.org/10.2337/dc06-2281] [PMID: 17392547]  [11] Ciechanowska, M.; Starzyk, J.",OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
"[http://dx.doi.org/10.1111/pedi.12155] [PMID: 24866063]  [17] Edge, J.A.",OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
"[http://dx.doi.org/10.1007/s00125-006-0363-8] [PMID: 16847700]  [19] Glaser, N.S.",Non-OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
"[http://dx.doi.org/10.1111/j.1399-543X.2006.00156.x] [PMID: 16629712]  [22] Czech, A.; Cypryk, K.; Czupryniak, L.; Gajewska, D.; Grzeszczak,  W.; Gumprecht, J.; Idzior-Walus, B.; Jarosz-Chobot, P.; Kalarus,  Z .",OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
"[http://dx.doi.org/  10.1097/00008480-200206000-00001] [PMID: 12011666]  [24] Levitsky, L.L.",Non-OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
"[http://dx.doi.org/10.1007/  s11892-001-0009-7] [PMID: 12762956]  [26] Wootton-Gorges, S.L.",Non-OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
"[http://dx.doi.org/10.1007/s00247-007-0536-8] [PMID:  17619872]  [27] Glaser, N.S.",Non-OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
"[http://dx.doi.org/10.1136/bjophthalmol-2011- 300169] [PMID: 22241926]  [30] Kaniuka, A.; Stanowicka, M.; Kosiak, W. In the blink of an eye:  evaluation of the optic nerve sheath.",Non-OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
"[http://dx.doi.org/10.1007/BF01383383] [PMID: 8805599] [39] Helmke, K.; Hansen, H.C.",OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
"[http://dx.doi.org/10.1007/BF01383384] [PMID: 8805600]  [40] Shah, S.; Kimberly, H.; Marill, K.; Noble, V.E.",Non-OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
"[http://dx.doi.org/  10.1007/s00134-011-2224-2] [PMID: 21505900]  [43] Boynton, J.R.; Pheasant, T.R.",OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
"[http://dx.doi.org/  10.1097/ ANA.0b01 3e318185996a] [PMID: 19098619]  [45] Kimberly, H.H.",Non-OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
"[http://dx.doi.org/10.1007/s00134-008-1149-x] [PMID: 18509619]  [47] Soldatos, T.; Karakitsos, D.; Chatzimichail, K.; Papathanasiou, M.;  Gouliamos, A.; Karabinis, A.",Non-OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
"[http://dx.doi.org/10.1186/cc6897] [PMID: 18477382]  [48] Goel, R.S.",Non-OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
"[http://dx.doi.org/10.1007/s00381- 008-0713-6] [PMID: 18810461]  [53] Schumacher, R.G.",Non-OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
"[http://dx.doi.org/10.1007/s00247-008-0788-y] [PMID: 18299822]  [54] Helmke, K.; Burdelski, M.; Hansen, H.C.",OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
"[http://dx.doi.org/10.1097/  00007890-200007270-00029] [PMID: 10933171]  [55] Haratz, K.; Viñals, F.; Lev, D.; Feit, H.; Ben-Sira, L.; Lerman- Sagie, T.; Malinger, G. Fetal optic nerve sheath measurement as a",Non-OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
"[http://dx.doi.org/10.1016/S0009-9260(99)91176-5] [PMID: 10580764]  [57] Körber, F.; Scharf, M.; Moritz, J.; Dralle, D.; Alzen, G.  [Sonography of the optical nerve -- experience in 483 children].",OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
"[http://dx.doi.org/10.1007/s00381-013-2172-y] [PMID: 23728433]  [60] Beare, N.A.",Non-OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
"[http://dx.doi.org/10.1097/PRS.0b013e31825dc1f1] [PMID: 22929269]  [64] Romagnuolo, L.; Tayal, V.; Tomaszewski, C.; Saunders, T.;  Norton, H.J.",Non-OADS,/arxiv_data1/oa_pdf/09/18/CN-14-784.PMC5333594.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.2147/CEG.S58153] [PMID: 25733921]  [3] Shapiro, Y.; Alkan, M.; Epstein, Y.; Newman, F.; Magazanik, A.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1016/j.cbpa.2010.01.008] [PMID: 20096800]  [5] Oliver, S.R.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1097/  SHK.0b013e31817fc310] [PMID: 18650780]  [7] Ding, L.A.; Li, J.S.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1002/  bjs.1800831113] [PMID: 9026331]  [11] Xu, D.; Qi, L.; Guillory, D.; Cruz, N.; Berg, R.; Deitch, E.A.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1097/00005373-199305000-00010] [PMID:  8497002]  [12] Wang, J.F.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1053/gast.2002.36019] [PMID: 12360472]  [16] Konturek, P.C.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1136/  gutjnl-2011-300474] [PMID: 22234979]  [18] Jones, M.P.",Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1053/gast.2002.32392] [PMID:  11910364]  [20] Henningsen, P.; Zimmermann, T.; Sattel, H. Medically unexplained  physical symptoms, anxiety, and depression: a meta-analytic  review.",Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/  10.1097/01.PSY.0000075977.90337.E7] [PMID: 12883101]  [21] Graff, L.A.; Walker, J.R.; Bernstein, C.N.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1002/ibd.20873] [PMID: 19161177]  [22] Lackner, J.M.",Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
[http://dx.doi.org/10.1097/01.PSY.,Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1111/apt.12669] [PMID: 24588323]  [25] Shah, E.; Rezaie, A.; Riddle, M.; Pimentel, M. Psychological  disorders in gastrointestinal disease: epiphenomenon, cause or  consequence?",Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1152/physrev.00041.2006] [PMID:  17615391]  [27] Drossman, D.A.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1177/0004867415569801] [PMID: 25710826]  [29] Israeli, E.; Hershcovici, T.; Berenshtein, E.; Zannineli, G.;  Wengrower, D.; Weiss, O.; Chevion, M.; Goldin, E. The effect of  restraint stress on the normal colon and on intestinal inflammation  in a model of experimental colitis.",Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1007/s10620-007-9827-z] [PMID: 17565472]  [30] Chowdrey, H.S.",Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1159/000125544] [PMID: 1697661]  [31] Soderholm, J.D.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1016/0006-8993(91)90378-9]  [PMID: 1708306]  [33] Mazelin, L.; Theodorou, V.; More, J.; Emonds-Alt, X.; Fioramonti,  J.; Bueno, L. Comparative effects of nonpeptide tachykinin  receptor antagonists on experimental gut inflammation in rats and  guinea-pigs.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/  10.1016/S0024-3205(98)00271-9] [PMID: 9698038]  [34] Martínez, C.; González-Castro, A.; Vicario, M.; Santos, J.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1016/S1383-5742(99)  00009-5] [PMID: 10415430]  [36] McKenzie, S.J.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1002/ibd.21112] [PMID: 19821510]  [40] Ananthakrishnan, A.N.",Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1016/j.cgh.2012.08.032] [PMID: 22944733]  [41] Ghia, JE; Blennerhassett, P; Deng, Y; Verdu, EF; Khan, WI;  Collins, SM R eactivation of inflammatory bowel disease in a  mouse model of depression.",Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1002/ibd.22888]  [PMID: 22294486]  [48] Mawdsley, J.E.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1159/000104861] [PMID:  17709955]  [49] Rampton, D. Does stress influence inflammatory bowel disease?",Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1159/000268124] [PMID: 20203500]  [50] Mawdsley, J.E.",Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.3899/jrheum.110904] [PMID:  22045978]  [52] Singh, S.; Graff, L.A.; Bernstein, C.N.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1038/ajg.2009.15]  [PMID: 19337242]  [53] Maunder, R.G.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
[http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1001/archinte.164.9.1010]  [56] Tuglu, C.; Kara, S.H.",Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1007/s00213-003-1566-z]  [PMID: 12955291]  [57] Mawdsley, J.E.",Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/  10.1053/j.gastro.2006.05.017] [PMID: 16890594]  [58] Goodhand, J.R.; Greig, F.I.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1002/ibd.21846] [PMID:  22234954]  [59] Wahed, M.; Corser, M.; Goodhand, J.R.; Rampton, D.S.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1002/ibd.21098] [PMID: 19774642]  [60] Horst, S.; Chao, A.; Rosen, M.; Nohl, A.; Duley, C.; Wagnon, J.H.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1007/s10620-014-3375-0] [PMID:  25274158]  [61] Matthes, H.; Krummenerl, T.; Giensch, M.; Wolff, C.; Schulze, J.",Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/  10.1186/1472-6882-10-13] [PMID: 20398311]  [62] Henker, J.; Müller, S.; Laass, M.W.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1055/s-2008-1027463] [PMID:  18810672]  [63] Konturek, P.C.",Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1053/j.gastro.2010.06.063] [PMID: 20600016]  [65] Ghia, J.E.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1111/imm.12114] [PMID:  23600521]  [67] Bitton, A.; Sewitch, M.J.; Peppercorn, M.A.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1080/08964289.1991.9937553]  [PMID: 1932843]  [69] Targownik, L.E.",Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1038/ajg.2015.147] [PMID:  26077178]  [70] Gué, M.; Bonbonne, C.; Fioramonti, J.; Moré, J.; Del Rio-Lachèze,  C.; Coméra, C.; Buéno, L. Stress-induced enhancement of colitis in  rats: CRF and arginine vasopressin are not involved.",Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1111/j.1365-2982.2010.01620.x] [PMID:  21054680]  [76] Cremon, C.; Carini, G.; De Giorgio, R.; Stanghe llini, V.;  Corinaldesi, R.; Barbara, G. Intestinal dysbiosis in irritable bowel  syndrome: etiological factor or epiphenomenon?",Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1586/erm.10.33]  [PMID: 20465494]  [77] Qiu, B.S.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1038/13503] [PMID: 10502822]  [78] Novosad, V.L.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1152/ajpgi.00166.2013]  [PMID: 23868412]  [79] Rush, B.F., Jr; Sori, A.J.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
"[http://dx.doi.org/10.1126/scitranslmed.3005046] [PMID: 23345609]  [87] Lee, C.Y.",OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
[http://dx.doi.org/10.1016/j.bbi.,OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
[http://dx.doi.org/10.1159/000086318] [PMID:  16088265],Non-OADS,/arxiv_data1/oa_pdf/60/a4/CN-14-892.PMC5333596.pdf
[http://dx.doi.org/10.1002/j.1552-4604.1981.,Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1111/j.1369-1600.2008.00108.x]  [PMID: 18482430]  [6] Niesink, R.J.; van Laar, M.W.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.3389/fpsyt.2013.00130] [PMID: 24137134]  [7] Pertwee, R.G.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
[http://dx.doi.org/10.1098/rstb.2011.,Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1038/nrd1495] [PMID:  15340387]  [9] Devane, W.A.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1038/346561a0] [PMID: 2165569]  [11] Devane, W.A.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1126/science.1470919] [PMID: 1470919]  [12] Munro, S.; Thomas, K.L.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1038/365061a0] [PMID: 7689702]  [13] Sugiura, T.; Kondo, S.; Suka gawa, A.; Nakane, S.; Shinoda, A.;  Itoh, K.; Yamashita, A.; Waku, K. 2-Arachidonoylglycerol: a  possible endogenous cannabinoid receptor ligand in brain.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/  10.1006/bbrc.1995.2437] [PMID: 7575630]  [14] Sugiura, T.; Itoh, K.; Waku, K.; Hanahan, D.J.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1021/  jm00038a020] [PMID: 8021930]  [17] Compton, D.R.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1016/S0968-0896(99)00219-9] [PMID:  10658595]  [21] Murineddu, G.; Lazzari, P.; Ruiu, S.; Sanna, A.; Loriga, G.; Manca,  I.; Falzoi, M.; Dessì, C.; Curzu, M.M.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1111/febs.12212] [PMID: 23441874]  [29] Fowler, C.J.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
[http://dx.doi.org/10.1016/j.tips.2012.,OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1038/nm803]  [PMID: 12461523]  [31] Makriyannis, A.; Mechoulam, R.; Piome lli, D. Therapeutic  opportun ities through modulation of the endocannabinoid system.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1016/S0014-5793  (00)02082-2] [PMID: 11033355]  [35] Högestätt, E.D.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
[http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1021/  jm058183t] [PMID: 16078824]  [37] Roques, B.P.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1096/fj.15-270637]  [PMID: 25757568]  [41] Long, J.Z.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/  10.1371/journal.pone.0031111] [PMID: 22363560]  [43] Piscitelli, F.; Di Marzo, V. “Redundancy” of endocannabinoid  inactivation: new challenges and opportunities for pain control.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1016/j.bmc.2011.11.028] [PMID: 22172309]  [45] Beltramo, M.; Stella, N.; Calignano, A.; Lin, S.Y.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1126/science.1115740] [PMID:  16224028]  [49] Pacher, P.; Mechoulam, R. Is lipid signaling through cannabinoid 2  receptors part of a protective system?",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1016/j.plipres.2011.01.001]  [PMID: 21295074]  [50] Di Carlo, G.; Izzo, A.A. Cannabinoids for gastrointestinal diseases:  potential therapeutic applications.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1517/13543784.12.1.39]  [PMID: 12517253]  [51] Esposito, G.; Filippis, D.D.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1002/ptr.4781] [PMID:  22815234]  [52] Kunos, G.; Pacher, P. Cannabinoids cool the intestine.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1016/S0016-5085(03)01134- X] [PMID: 12949741]  [55] Izzo, A.A.; Coutts, A.A. Cannabinoids and the digestive tract ;  Handb.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1016/  j.brainresbull.2004.09.004] [PMID: 15561471]  [58] Coruzzi, G.; Adami, M.; Guaita, E.; Menozzi, A.; Bertini, S.;  Giovannini, E.; Soldani, G. Effects of cannabinoid receptor  agonists on rat gastric acid secretion: discrepancy between in vitro   and in vivo  data.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1007/  s002109900054] [PMID: 10494894]  [61] Krowicki, Z.K.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1016/  S0014-2999(99)00165-X] [PMID: 10357256]  [62] Landi, M.; Croci, T.; Rinaldi-Carmona, M.; Maffrand, J.P.; Le Fur,  G.; Manara, L. Modulation of gastric emptying and gastrointestinal  transit in rats through intestinal cannabinoid CB(1) receptors.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1016/  S0014-2999(02)02053-8] [PMID: 12176112]  [63] Pertwee, R.G.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/  10.1159/000136851] [PMID: 704660]  [66] Kinsey, S.G.; Cole, E.C.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1016/j.ejphar.2013.06.001] [PMID:  23769745]  [67] Kinsey, S.G.; Nomura, D.K.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
[http://dx.doi.org/10.1124/jpet.110.,Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1007/s002100000360] [PMID:  11218077]  [69] Dembiński, A.; Warzecha, Z.; Ceranowicz, P.; Dembiński, M.;  Cieszkowski, J.; Pawlik, W.W.; K onturek, S.J.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1016/j.mce.2013.10.002] [PMID: 24145131]  [74] Naidu, P.S.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1124/jpet.108.143487]  [PMID: 19118134]  [75] Sasso, O.; Bertorelli, R.; Bandiera, T.; Scarpelli, R.; Colombano,  G.; Armirotti, A.; Moreno-Sanz, G.; Reggiani, A.; Piomelli, D.  Peripheral FAAH inhib ition causes profound antinociception and  protects against indomethacin-induced gastric lesions.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
[http://dx.doi.org/10.1016/j.phrs.2012.,OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1186/ar2401] [PMID: 18416822]  [77] Singer, I.I.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1016/S0016-5085(98)70196- 9] [PMID: 9679035]  [78] Suárez, J.; Romero-Zerbo, Y.; Márquez, L.; Rivera, P.; Iglesias,  M.; Bermúdez-Silva, F.J.; Andreu, M.; Rodríguez de Fonseca, F.  Ulcerative colitis impairs the acylethanolamide-based anti- inflammatory system reversal by 5-aminosalicylic acid and  glucocorticoids.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1016/j.gastro.2005.05.026] [PMID: 16083701]  [83] Marquéz, L.; Suárez, J.; Iglesias, M.; Bermudez-Silva, F.J.;  Rodríguez de Fonseca, F.; Andreu, M. Ulcerative co litis i nduces  changes on the expression of the endocannabinoid system in the  human coloni c tissue.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
[http://dx.doi.org/10.1002/cne.,Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1038/sj.bjp.0707486] [PMID: 17906675]  [86] Duncan, M.; Mouihate, A.; Mackie, K.; Keenan, C.M.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1152/ajpgi.90285.2008] [PMID: 18483180]  [87] Muccioli, G.G.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1016/j.drudis.2010.03.007] [PMID:  20304091]  [88] Bashashati, M.; Nasser, Y.; Keenan, C.M.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1038/  sj.bjp.0704293] [PMID: 11588110]  [92] D’Argenio, G.; Valenti, M.; Scaglione, G.; Cosenza, V.; Sorrentini,  I.; Di Marzo, V. Up-regulation of anandamide levels as an  endogenous mechanism and a pharmacological strategy to limit  colon inflammation.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1007/s00109-009-0512-x] [PMID: 19690824]  [94] Duncan, M.; Thomas, A.D.; Cluny, N.L.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1152/ajpgi.00407.2005] [PMID: 16574988]  [97] Storr, M.A.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1007/s00109-008-0359-6] [PMID:  18493729]  [98] Alhouayek, M.; Lambert, D.M.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1096/  fj.10-176602] [PMID: 21551239]  [99] Engel, M.A.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
[http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1038/nature11582] [PMID:  23128233]  [104] Matos, I.; Bento, A.F.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
[http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1002/ibd.20960] [PMID:  19408320]  [106] Sałaga, M.; Mokrowiecka, A.; Zakrzewski, P.K.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
[http://dx.doi.org/10.1016/j.crohns.,OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1159/000332079]  [PMID: 22095142]  [110] Lal, S.; Prasad, N.; Ryan, M.; Tangri, S.; Silverberg, M.S.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
[http://dx.doi.org/10.1016/j.taap.2011.11.005] [PMID:  22119709],OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1152/ajpgi.00482.2003] [PMID: 14701723]  [117] Izzo, A.A.; Sharkey, K.A.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
[http://dx.doi.org/10.1016/j.pharmthera.2009.12.,Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1111/j.1476-5381.2011.01589.x] [PMID:  21745190]  [119] Turcotte, C.; Chouinard, F.; Lefebvre, J.S.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1371/journal.pone.0028159] [PMID:  22163000]  [123] Carrier, E.J.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/  10.1111/j.1365-2982.2004.00549.x] [PMID: 15601431]  [127] Massa, F.; Sibaev, A.; Marsicano, G.; Blaudzun, H.; Storr, M.;  Lutz, B. Vanilloid r eceptor (TRPV1)-deficient mice show  increased susceptibility to dinitrobenzene sulfonic acid induced  colitis.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/  10.1007/s00109-005-0016-2] [PMID: 16389550]  [128] Fichna, J.; Bawa, M.; Thakur, G.A.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1124/jpet.110.169946]  [PMID: 20571060]  [132] Li, Y.Y.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1038/labinvest.2012.177]  [PMID: 23381627]  [133] Tourteau, A.; Andrzejak, V.; Body-Malapel, M.; Lemaire, L.;  Lemoine, A.; Mansouri, R.; Djouina, M.; Renault, N.; El Bakali, J.;  Desreumaux, P.; Muccioli, G.G.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1016/  j.bmc.2013.06.010] [PMID: 23849204]  [134] Jäger, S.; Stange, E.F.; Wehkamp, J.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1007/s00423-012-1030-9] [PMID:  23160753]  [135] Keita, A.V.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/  10.1111/j.1749-6632.2012.06502.x] [PMID: 22731725]  [136] Salim, S.Y.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1124/jpet.110.168237]  [PMID: 20592049]  [138] Muccioli, G.G.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1038/msb.2010.46] [PMID: 20664638]  [139] Aviello, G.; Romano, B.; Izzo, A.A. Cannabinoids and  gastrointestinal motility: animal and human studies.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1159/000339072] [PMID: 22699400]  [142] Izzo, A.A.; Mascolo, N.; Borre lli, F.; Capasso, F. Excitatory  transmission to the circular muscle of the guinea-pig ileum:  evidence for the involvement of cannabinoid CB1 receptors.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1038/  sj.bjp.0701964] [PMID: 9723946]  [143] Mulè, F.; Amato, A.; Baldassano, S.; Serio, R. Evidence for a  modulatory role of cannabi noids on the ex citatory NANC  neurotransmission in mouse colon.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1016/j.phrs.2007.04.019] [PMID:  17574859]  [144] Storr, M.; Sibaev, A.; Marsicano, G.; Lutz, B.; Schusdziarra, V.;  Timmermans, J.P.; Allescher, H.D.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1152/ajpgi.00148.2003] [PMID:  12893627]  [145] Grider, J.R.; Mahavadi, S.; Li, Y.; Qiao, L.Y.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1152/ajpgi.00064.2009] [PMID: 19589944]  [146] Izzo, A.A.; Pinto, L.; Borrelli, F.; Capasso, R.; Mascolo, N.;  Capasso, F. Central and periphe ral cannabinoid modulation of  gastrointestinal transit in physiological states or during the  diarrhoea induced by croton oil.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1124/jpet.102.047829] [PMID:  12606641]  [149] Tyler, K.; Hillard, C.J.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1054/plef.2001.0362] [PMID: 12052040]  [151] Malan, T.P., Jr; Ibrahim, M.M.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1016/S1471-4892(02)00004- 8] [PMID: 12550743]  [152] Hosking, R.D.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1517/13543784.14.6.695] [PMID:  16004597]  [154] Brusberg, M.; Arvidsson, S.; Kang, D.; Larsson, H.; Lindström, E.;  Martinez, V. CB1 receptors mediate the analgesic effects of  cannabinoids on colorectal distension-induced visceral pain in rodents.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1254/jphs.FP0071599] [PMID: 18270474]  [157] H illsley, K.; McCaul, C.; Aerssens, J.; Peeters, P.J.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1111/j.1365-2982.2007.00950.x]  [PMID: 17539892]  [158] Donovan, J.; Grundy, D. Endocannabinoid modulation of jejunal  afferent responses to LPS.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1111/j.1365- 2982.2012.01961.x] [PMID: 22734449]  [159] Rousseaux, C.; Thuru, X.; Gelot, A.; Barnich, N.; Neut, C.;  Dubuquoy, L.; Dubuquoy, C.; Merour, E.; Geboes, K.; Chamaillard,  M.; Ouwehand, A.; Leyer, G.; Carcano, D.; Colombel, J.F.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1038/nm1521] [PMID:  17159985]  [160] Naftali, T.; Bar-Lev Schleider, L.; Dotan, I.; Lansky, E.P.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1016/j.cgh.2013.04.034] [PMID:  23648372]  [161] Campbell, F.A.",OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
[http://dx.doi.org/10.1016/j.neuropharm.,OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1007/s00213-006-0689- 4] [PMID: 17279376]  [165] Ghosh, S.; Kinsey, S.G.; Liu, Q.S.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1124/jpet.115.222851] [PMID: 25998048]  [166] Andrzejak, V.; Muccioli, G.G.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.1159/000336871] [PMID:  22414698]  [169] Capasso, R.; Borre lli, F.; Aviello, G.; Romano, B.; Scalisi, C.;  Capasso, F.; Izzo, A.A. Cannabidiol, extracted from Cannabis  sativa, selectively inhibits inflammatory hypermotility in mice.",Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
[http://dx.doi.org/10.1111/bph.12120] [PMID: 23373571],Non-OADS,/arxiv_data1/oa_pdf/88/ee/CN-14-935.PMC5333598.pdf
"[http://dx.doi.org/10.3181/00379727-53- 14227]  [3] Ihász, M. Vagotomy ; Akadémiai Kiadó: Budapest, 1980 .",Non-OADS,/arxiv_data1/oa_pdf/09/f4/CN-14-901.PMC5333601.pdf
"[http://dx.doi.org/10.1016/0005-2736(69)  90178-3]  [7] Mózsik, G. Some feed-back mechanisms by drugs in the  interrelationship between the active transport system and adenyl  cyclase system localized in the cell membrane.",OADS,/arxiv_data1/oa_pdf/09/f4/CN-14-901.PMC5333601.pdf
"[http://dx.doi.org/10.1016/0014-2999(69)  90099-5] [PMID: 4242776]  [8] Mózsik, G. Direct inhibitory effect of adenosine monophosphates  on Na+-K+-dependent ATPase from human gastric mucosa.",OADS,/arxiv_data1/oa_pdf/09/f4/CN-14-901.PMC5333601.pdf
"[http://dx.doi.org/10.1021/  bi00851a033] [PMID: 4972613]  [11] Kolm, R.; Komarov, S.A.; Shay, H. Experimental studies on the  excretion of neutral red by the stomach.",Non-OADS,/arxiv_data1/oa_pdf/09/f4/CN-14-901.PMC5333601.pdf
"[http://dx.doi.org/10.1016/0016-5085(85)  90132-5] [PMID: 3967802]  [27] Karádi, O.; Nagy, Z.; Bódis, B.; Mózsik, G. Atropine-induced  gastrointestinal cytoprotection dependences to the intact of vagal  nerve against indomethacin-induced gastrointestinal mucosal and  microvascular damage in rats.",Non-OADS,/arxiv_data1/oa_pdf/09/f4/CN-14-901.PMC5333601.pdf
"[http://dx.doi.org/10.1016/S0928-4257(01)00006-7] [PMID:  11595415]  [28] Király, Á.; Sütő, G.; Vincze, Á.; Jávor, T.; Mózsik, G.Y.",OADS,/arxiv_data1/oa_pdf/09/f4/CN-14-901.PMC5333601.pdf
"[http://dx.doi.org/10.1111/j.1749-6632.1990.tb16175.x] [PMID:  2167035]  [31] Mózsik, G.; Király, Á.; Garamszegi, M.; Jávor, T.; Nagy, L.; Sütő,  G. Tóth Gy, Vincze Á.",OADS,/arxiv_data1/oa_pdf/09/f4/CN-14-901.PMC5333601.pdf
"[http://dx.doi.org/10.1016/0262-1746(83)  90032-X] [PMID: 6322205]  [39] Mózsik, G.Y.",OADS,/arxiv_data1/oa_pdf/09/f4/CN-14-901.PMC5333601.pdf
"[http://dx.doi.org/10.1007/978-1-4615-1867-9_18]  [40] Karádi, O.; Bódis, B.; Király, Á.; Abdel-Salam, O.M.",Non-OADS,/arxiv_data1/oa_pdf/09/f4/CN-14-901.PMC5333601.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/63/9a/clep-9-127.PMC5333638.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/63/9a/clep-9-127.PMC5333638.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2017:9 127–139Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 127 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S129335 Cohort description: The Danish study   of Functional Disorders  Thomas Meinertz Dantoft,1  Jeanette Frost Ebstrup,1 Allan  Linneberg,1–3 Sine Skovbjerg,1  Anja Lykke Madsen,1 Jesper  Mehlsen,4 Louise Brinth,4  Lene Falgaard Eplov,5 Tina  Wisbech Carstensen,6,7  Andreas Schroder,6,7  Per Klausen Fink,6,7 Erik  Lykke Mortensen,8 T orben  Hansen,9 Oluf Pedersen,9  T orben Jørgensen1,10,11 1Research Centre for Prevention and  Health, The Capital Region of Denmark,   Glostrup, 2Department of Clinical  Medicine, Faculty of Health and Medical Sciences, University of Copenhagen,   Copenhagen,  3Department of Clinical  Experimental Research, Rigshospitalet,   Glostrup, 4Coordinating Research Centre,   Bispebjerg and Frederiksberg Hospital,  Frederiksberg,  5Mental Health Centre  Copenhagen, Research Unit, Mental Health Services, Capital Region of Denmark,   Copenhagen,  6The Research Clinic for  Functional Disorders and Psychosomatics,   Aarhus University Hospital, 7Faculty of  Health Sciences, University of Aarhus,  Aarhus,  8Department of Public Health and  Center for Healthy Aging, 9Novo  Nordisk  Foundation Center for Basic Metabolic Research,  10Department of Public  Health, Faculty of Health and Medical Sciences, University of Copenhagen,   11Faculty of Medicine, Aalborg University,   Aalborg,  DenmarkAbstract: The Danish study of Functional Disorders (DanFunD) cohort was initiated to  outline the epidemiology of functional somatic syndromes (FSS) and is the first larger coor - dinated epidemiological study focusing exclusively on FSS.",Non-OADS,/arxiv_data1/oa_pdf/63/9a/clep-9-127.PMC5333638.pdf
"The common name for these conditions has been interchanging but will in this article be referred to as functional somatic syndromes (FSS), represented by irritable bowel syndrome, 7–10 fibromyalgia,11  chronic fatigue syndrome,12–14 whiplash-associated disorders,15 multiple chemical Correspondence: Thomas Meinertz Dantoft   Research Centre for Prevention and Health,   The Capital Region of Denmark, Nordre  Ringvej 57, Building 84/85, 2600 Glostrup,  Denmark  Tel +45 3863 4248  Fax +45 3863 3977  Email thomas.meinertz.dantoft@regionh.dkJournal name: Clinical Epidemiology Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Dantoft et alRunning head recto: The Danish study of Functional DisordersDOI: http://dx.doi.org/10.2147/CLEP .S129335",Non-OADS,/arxiv_data1/oa_pdf/63/9a/clep-9-127.PMC5333638.pdf
"For more information, please contact DanFunD administrative and scientific officer Thomas Dantoft or visit our webpage at http://www.danfund.org.",Non-OADS,/arxiv_data1/oa_pdf/63/9a/clep-9-127.PMC5333638.pdf
"Clinical Epidemiology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/63/9a/clep-9-127.PMC5333638.pdf
Or use: http://youtu.be/Z42vYgvVChQ,Non-OADS,/arxiv_data1/oa_pdf/63/9a/clep-9-127.PMC5333638.pdf
Clinical Trial Registration—URL: http://www.clinicaltrials.gov .,Non-OADS,/arxiv_data1/oa_pdf/16/5c/hcq-10-e003387.PMC5333724.pdf
"Key Words: anxiety ◼ coronary artery disease ◼ depression ◼ health status ◼ quality of life   ◼ sex ◼ Type D personality Circ Cardiovasc Qual Outcomes is available at http://circoutcomes.ahajournals.org DOI: 10.1161/CIRCOUTCOMES.116.003387Received November 1, 2016; accepted January 20, 2017.",Non-OADS,/arxiv_data1/oa_pdf/16/5c/hcq-10-e003387.PMC5333724.pdf
The Data Supplement is available at http://circoutcomes.ahajournals.org/lookup/suppl/doi:10.1161/CIRCOUTCOMES.116.003387/-/DC1.Correspondence to Paula M.C.,OADS,/arxiv_data1/oa_pdf/16/5c/hcq-10-e003387.PMC5333724.pdf
Accessed October 2016. http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/16/5c/hcq-10-e003387.PMC5333724.pdf
Available at: http://www.towerswatson.com/en-US/Insights/ IC-Types/Survey-Research-Results/2014/05/full-report-towers-watson-nbgh-2013-2014-employer-survey-on-purchasing-value-in-health-care.,OADS,/arxiv_data1/oa_pdf/58/0f/joem-59-304.PMC5333725.pdf
Available at: http://www.businessgrouphealth.org/pub/a0d30d2b-782b-cb6e-2763- 7380d7691b8a.,Non-OADS,/arxiv_data1/oa_pdf/58/0f/joem-59-304.PMC5333725.pdf
Available at: https://www.gpo.gov/fdsys/pkg/PLAW-111publ148/html/ PLAW-111publ148.htm.,Non-OADS,/arxiv_data1/oa_pdf/58/0f/joem-59-304.PMC5333725.pdf
Available at: http://www.ecfr.gov/ cgi-bin/text-idx?SID=c1b8b95a8472ee176ff966c11b9ad041&mc=true&no- de=pt45.1.146.,Non-OADS,/arxiv_data1/oa_pdf/58/0f/joem-59-304.PMC5333725.pdf
Avail- able at: http://www.cdc.gov/healthyweight/assessing/index.html.,Non-OADS,/arxiv_data1/oa_pdf/58/0f/joem-59-304.PMC5333725.pdf
Available at: Missouri Census Data Center website: www.http://mcdc2.missouri.edu/.,OADS,/arxiv_data1/oa_pdf/58/0f/joem-59-304.PMC5333725.pdf
2015. http://dx.doi.org/10.13023/ VAD.2015.08.,Non-OADS,/arxiv_data1/oa_pdf/52/96/jinfn-40-92.PMC5333726.pdf
Doi: http://dx.doi.org/10.1016/j.cardfail.2014.06.180.,OADS,/arxiv_data1/oa_pdf/52/96/jinfn-40-92.PMC5333726.pdf
http://srtr.transplant.hrsa.gov/annual_reports/2012/ pdf/05_heart_13.pdf.,Non-OADS,/arxiv_data1/oa_pdf/52/96/jinfn-40-92.PMC5333726.pdf
https://www.hcup-us.ahrq.gov/reports/statbriefs/sb132.,OADS,/arxiv_data1/oa_pdf/52/96/jinfn-40-92.PMC5333726.pdf
"Mediterr  J Hematol Infect Dis 201 7, 9(1): e2017025 ,  DOI: http://dx.doi.org/10.4084/MJHID.2017.025      Published:  March 1 , 201 7 Received:  January 11 , 201 7 Accepted : February 23 , 201 7    This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by -nc/4.0 ),  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/97/mjhid-9-1-e2017025.PMC5333730.pdf
2009;114:937 -51. https://doi.org/10.1182/b lood-2009 -03- 209262     PMid:19357394     2.,Non-OADS,/arxiv_data1/oa_pdf/ef/97/mjhid-9-1-e2017025.PMC5333730.pdf
2013;121:2996 -3004. https://doi.org/10.1182/blood -2012 - 08-448068     PMid:23412096      PMCid:PMC3624944   3.,Non-OADS,/arxiv_data1/oa_pdf/ef/97/mjhid-9-1-e2017025.PMC5333730.pdf
2004;306:1774 -6.  https://doi.org/10.1126/science.1102443     PMid:15576619       PMCid:PMC1256034   5.,Non-OADS,/arxiv_data1/oa_pdf/ef/97/mjhid-9-1-e2017025.PMC5333730.pdf
2004;104 :3872 -7.  https://doi.org/10.1182/blood -2004 -06-2161     PMid:15339847     6.,Non-OADS,/arxiv_data1/oa_pdf/ef/97/mjhid-9-1-e2017025.PMC5333730.pdf
2016  Jun 1;176(6):816 -25.  https://doi.org/10.1001/jamainternmed.2016.1548    7.,Non-OADS,/arxiv_data1/oa_pdf/ef/97/mjhid-9-1-e2017025.PMC5333730.pdf
2005;41:998 -1006 https://doi.org/10.1016/j.ejca.2005.01.006     PMid:15862748     8.,OADS,/arxiv_data1/oa_pdf/ef/97/mjhid-9-1-e2017025.PMC5333730.pdf
2013;179:361 -82.  https://doi.org/10.1667/RR2892.1     PMid:23398354        PMCid:PMC3875218   9.,Non-OADS,/arxiv_data1/oa_pdf/ef/97/mjhid-9-1-e2017025.PMC5333730.pdf
https://doi.org/10.2105/AJPH.2004.059204      PMid:16030331     11.,Non-OADS,/arxiv_data1/oa_pdf/ef/97/mjhid-9-1-e2017025.PMC5333730.pdf
( http://irep.nci.nih.gov ).,OADS,/arxiv_data1/oa_pdf/ef/97/mjhid-9-1-e2017025.PMC5333730.pdf
https://doi.org/10.1097/01.HP.0000291191.49583.f7      PMid:18545036      PMCid:PMC4018571   12.,Non-OADS,/arxiv_data1/oa_pdf/ef/97/mjhid-9-1-e2017025.PMC5333730.pdf
( http://irep.nci.nih.gov/radrat ).,OADS,/arxiv_data1/oa_pdf/ef/97/mjhid-9-1-e2017025.PMC5333730.pdf
2012;32: 205 -22.  https://doi.org/10.1088/0952 -4746/32/3/20 5    PMid:22810503       PMCid:PMC3816370,Non-OADS,/arxiv_data1/oa_pdf/ef/97/mjhid-9-1-e2017025.PMC5333730.pdf
"Mediterr J Hematol  Infect Dis 201 7, 9(1): e201 7014, DOI: http://dx.doi.org/10.4084/MJHID.2017.014      Published:  February 15 , 201 7 Received:  October 10 , 201 6 Accepted:  January  12, 201 7    This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by -nc/4.0 ),  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2010 Dec;376(9757):2018 -31. https://doi.org/10.1016/S0140 - 6736(10)61029 -X   2.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2014 Dec 1;2014(1):468 -74.  https://doi.org/10.1182/asheducation -2014.1.468     PMid:25696896     3.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2010 Apr 29;115(17):3447 -52. https://doi.org/10.1182/blood -2009 - 07-233700     PMid:20194891      PMCid:PM C2867259   4.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
1996 Aug  8;335(6):369 -76. https://doi.org/10.1056/NEJM199608083350601      PMid:8663884     5.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
1998 Jul;22(1):1 -6.  https://doi.org/10.1038/sj.bmt.1701291     PMid:9678788     6.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2007 Oct 1;110(7):2749 -56.  https://doi.org/10.1182/blood -2007 -03-079665     PMid:17606762     8.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2007;137(5):479 -85. https://doi.org/10.1111/j.136 5- 2141.2007.06592.x     PMid:17459050     9.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2011 Jan  22;46(1):27 -33. https://doi.org/10.1038/bmt.2010.60      PMid:20305698     10.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2014  May;165(3):402 -8. https://doi.org/10.1111/bjh.12737      PMid:24433465     11.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2012 Aug;59(2):372 -6. https://doi.org/10.1002/pbc.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2015 Apr;62(4):680 -6.  https://doi.org/10.1002/pbc.25376     PMid:25557687     14.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2014;49(3):366 -9. https://doi.org/10.1038/bmt.2013.188,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2014;49(11):1376 -81.  https://doi.org/10.1038/bmt.2014.167     PMid:25068420     16.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2013 Dec 1;2013(1):370 -6. https://doi.org/10.1182/asheducation - 2013.1.370     PMid:24319206     17.,OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2003  Apr;31(7):547 -50. https://doi.org/10.1038/sj.bmt.1703887      PMid:12692619     18.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2015 Jul;62(7):1285 -7. https://doi.org/10.1002/pbc.25439      PMid:25663074     19.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2014 Jul 24;371(4):339 -48.  https://doi.org/10.1056/NEJM sa1311707     PMid:25054717     20.,OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2011 Sep;17(9):1375 -82.  https://doi.org/10.1016/j.bbmt.2011.01.012     PMid:21277376       PMCid:PMC3395002   21.,OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2013 Aug  8;122(6):1072 -8. https://doi.org/10.1182/blood -2013 -03-489112      PMid:23692854     22.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2015 Dec;90(12):1093 -8.  https://doi.org/10.1002/ajh .24183     PMid:26348869     23.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
20 13 Apr;90(4):308 -12.  https://doi.org/10.1111/ejh.12082     PMid:23369103     24.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2014 Sep; https://doi.org/10.1016/j.bbmt.2014.08.020      PMid:25196857      PMCid:PMC4324724   25.,OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2015 Jun;169(5):726 -36. https://doi.org/10.1111/bjh.13352      PMid:25818248    27.,OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
1970  Nov;13(6):1173 -5. https://doi.org/10.1021/jm00300a034      PMid:5479859     28.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2006 Jan;34(1):115 -21.  https://doi.org/10.1016/j.exphem.2005.09.015     PMid:16413398     29.,OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2012  Jul 12;120(2):473 -6. https://doi.org/10.1182/blood -2012 -04- 423822     PMid:22645178     30.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2011 Apr  21;117(16):4367 -75. https://doi.org/10.1182/blood -2010 -10- 312082     PMid:21325 599     31.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2013 Apr 22;48(4):491 -501.  https://doi.org/10.1038/bmt.2012.188     PMid:23085832     32.,OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2014 Jan 1;99(1):180 -4.  https://doi.org/10.3324/haematol.2013.094730     PMid:24162790       PMCid:PMC4007927   33.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2015  Feb 19;94(2):297 -306. https://doi.org/10.1007/s00277 -014-2196 -8     PMid:2 5231927     35.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2016 May 23; https://doi.org/10.1182/blood - 2016 -03-7040 15    PMid:27216217     36.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2014 May 1;99(5):811 - 20. https://doi.org/10.3324/haematol.2013.099747      PMid:24790059      PMCid:PMC4008115   37.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2013  May;19(5):820 -30. https://doi.org/10.1016/j.bbmt.2013.02.010      PMid:23416852      PMCid:PMC4712646   38.,OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2014 Jul  31;124(5):822 -6. https://doi.org/10.1182/blood -2014 -03-563817      PMid:24869942     39.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
1998 Jul 2;339(1):5 -11.  https://doi.org/10.1056/NEJM199807023390102     PMid:9647873     41.,OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2013 Jun 4;39:36.  https://doi.org/10.1186/1824 -7288 -39-36    PMid:23735165       PMCid:PMC3704731   42.,OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2010;16(2):263 -72.  https://doi.org/10.1016/j.bbmt.2009.10.005     PMid:19822218       PMCid:PMC2919571   44.,OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2001  Dec;7(12):665 -73.  https://doi.org/10.1053/bbmt.2001.v7.pm11787529      PMid:11787529     45.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2008;14(11):1270 -8. https://doi.org/10.1016/j .bbmt.2008.08.016      PMid:18940682     46.,OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2003;102(13):4582 -93.  https://doi.org/10.1182/blood -2003 -03-0712     PMid:12933586    47.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2011  Jan 1;96(1):128 -33. https://doi.org/10.3324/haematol.2010.031013      PMid:20935000      PMCid:PMC3012776   48.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2008 Jan 15;111(2):963 -4; author reply 964.  https://doi.org/10.1182/blood -2007 -08-102244     PMid:18182580     49.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2004 Apr 1;103(7):2822 -6.  https://doi.org/10.1182/blood -2003 -06-1972     PMid:14684415     51.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2003 Aug;9(8):519 -28. https://doi.org/10.1016/S1083 - 8791(03)00192 -7   53.,OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2005 Jan 8;35(2):171 -7.  https://doi.org/10.1038/sj.bmt.1704745     PMid:15531901     54.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2009 Dec 10;361(24):2309 -17.  https://doi.org/10.1056/NEJMoa0904971     PMid:20007560       PMCid:PMC3627532   55.,OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2016 Mar;22(3):441 -8.  https://doi.org/10.1016/j.bbmt.2015.08.036     PMid:26348889    56.,OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2015 Oct 29;373(18):1755 -60.  https://doi.org/10.1056/nejmcp1307341    57.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2012;120(22):4285 -91. https://doi.org/10.1182/blood -2012 -07- 438408     PMid:22955919      PMCid:PMC3507140   58.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2016 May 25;51(5):668 -74.  https://doi.org/10.1038/bmt.2015.343     PMid:26808573     59.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2016 Mar 9;51(3):438 -9.  https://doi.org/10.1038/bmt.2015.258     PMid:26551775     60.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2002  Feb 1;99(3):850 -5. https://doi.org/10.1182/blood.V99.3.850      PMid:11806986     61.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
2009 Jan;11(4):464 -71.  https://doi.org/10.1080/14653240902849788     PMid:19513902       PMCid:PMC2747259,Non-OADS,/arxiv_data1/oa_pdf/05/d4/mjhid-9-1-e2017014.PMC5333731.pdf
"Mediterr J Hematol Infect Dis 201 7, 9(1): e201 7019, DOI: http://dx.doi.org/10.4084/MJHID.2017.019      Published:  March 1 , 201 7 Received:  November 21 , 201 6 Accepted:  February  7, 201 7    This is an Open Access article distributed under the terms of the Crea 21tive Commons Attribution License (https://creativecommons.org/licenses/by -nc/4.0 ),  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is pr operly cited.",Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Ann Intern Med 2006;144(10):  705-714. https://doi.org/10.7326/0003 -4819 -144-10-200605160 - 00004     PMid:16702586     2.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Clinics  in liver disease 2008;12(3): 637 -659.  https://doi.org/10.1016/j.cld.2008.03.010     PMid:18625432     3.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Clinical  Gastroenterology and Hepatology 2010;8(10): 877 -883.  https://doi.org/10.1016/j.cgh.2010.03.025     PMid:20362695       PMCid:PMC3771318   4.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
"Karasu Z, Tekin F, Ersoz G, Gunsar F, Batur Y, Ilter T, Akarca  US: Liver fibrosis is associated with decreased peripheral platelet  count in patients wit h chronic hepatitis B and C. Digestive diseases  and sciences 2007;52(6): 1535 -1539.  https://doi.org/10.1007/s10620 -006-9144 -y    PMid:17464564     5.",Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
J Viral Hepat 2011;18(1): 1 -7.  https://doi.org/10.1111/j.1365 -2893.2010.01366.x      PMid:20796208     7.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Hematology 2009;14(5):  277-281. https://doi.org/10.1179/102453309X439818      PMid:19843383     8.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
American journal of hematology 1996;53(4): 284 -284.  https://doi.org/10.1002/(SICI)1096 -8652(199612)53:4<284::AID - AJH20>3.0.CO;2 -B   9.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Aliment Pharmacol Ther 2007;26 Suppl 1: 13 -19.  https://doi.org/10.1111/j.1365 -2036.2007.03512.x      PMid:17958515     11.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
British journal of haematology  2001;113(3): 590 -595. https://doi.org/10.1046/j.1365 - 2141.2001.02824.x    13.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Journal of  hepatology 2002;37(5): 572 -577. https://doi.org/10.1016/S0168 - 8278(02)00274 -X   14.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Clinical  and Applied Thrombosis/Hemostasis 2012;18(3): 272 -280.  https://doi.org/10.1177/107 6029611429124     PMid:22327815     15.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Clinics in liver disease 2005;9(4): 601 -616.  https://doi.org/10.1016/j.cld.2005.07 .007    PMid:16207566     16.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
N Engl J Med 20 15;373(27):  2599 -2607. https://doi.org/10.1056/NEJMoa1512610      PMid:26571066     18.,OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
N Engl J Med 2015;373(27): 2608 -2617.  https://doi.org/10.1056/NEJMoa1512612     PMid:26575258   19.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Liver International 2015; 35(11): 2358 -2362.  https://doi.org/10.1111/liv.12931       21.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
"[Epub  ahead of print] https://doi.org/10.1111/liv.13256   22.  van der Meer AJ, Maan R, Veldt BJ, Feld JJ, Wedemeyer H,  Dufour JF, Lammert F, Duarte -Rojo A, Manns MP, Z euzem S,  Hofmann WP, de Knegt RJ, Hansen BE, Janssen HL: Improvement  of platelets after SVR among patients with chronic HCV infection  and advanced hepatic fibrosis.",Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
J Gastroenterol Hepatol 2016;31(6):  1168 -1176. https://doi.org/10.1111/jgh.13252    PMid:26 647353      23.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
World J Hepatol 2016;8(26):  1116 -1118. https://doi.org/10.4254/wjh.v8.i26.1116      PMid:27660680      PMCid:PMC5026995   24.,OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
"Dienstag JL, McHutchison JG: American Gastroenterological  Association technical review on the management of hepatitis C.  Gastroenterology 2006;130(1): 231 -264.  https://doi.org/10.1053/j.gastro.2005.11.010     PMid:16401486     26.",Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
"McHutchison JG, Manns M, Patel K, Poynard T, Lindsay KL,  Trepo C, Dienstag J, Lee WM, Mak C, Garaud JJ: Adherence to  combination therapy enhances sustained response in  genotype -1– infected patients with chronic hepatitis C. Gastroenterology  2002;123(4): 1061 -1069. https://doi.org/10.1053/gast.2002.35950      PMid:12360468     27.",Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Pharmacoepidemiol Drug Saf  2014;23(5): 480 -488. https://doi.org/10.1002/pds.3585      PMid:24677630     28.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
BMC Gastroenterol 2012;12: 7.  https://doi.org/10.1186/1471 -230X -12-7    PMid:22257364       PMCid:PMC3275508   29.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
The New Eng land journal of  medicine 1998;339(11): 746 -754.  https://doi.org/10.1056/NEJM199809103391107     PMid:9731092     30.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Blood Coagulation & Fi brinolysis 1991;2(2): 389 -396.  https://doi.org/10.1097/00001721 -199104000 -00026      PMid:1893071     31.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
J Hepatol 2008;48(6): 1000 -1007.  https://doi.org/10.1016/j.jhep.2008.03.00  9   PMid:18433919     32.,OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Best Practice &  Research Clinical Gastroenterology 2000;14(6): 1009 -1031.  https://doi.org /10.1053/bega.2000.0144     PMid:11139352     34.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
J Gastroenterol Hepatol 2012;27(2) : 286 -290.  https://doi.org/10.1111/j.1440 -1746.2011.06870.x      PMid:21793908     36.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Transplantation 2005;79(11): 1634 -1635.  https://doi.org/10.1097/01.TP.0000155424.52939.3D      PMid:15940057     37.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
BMC Res Notes 2014;7: 59.  https://doi.org/10.1186/1756 -0500 -7-59    PMid:24457056       PMCid:PMC3915622   38.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Acta haematologica 1998;99(4): 217 -220.  https://doi.org/10.1159/000040842      PMid:9644300     39.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
American journal of  hematology 2001;68(3): 202 -209. https://doi.org/10.1002/ajh.1180    PMid:11754404     40.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Aliment Pharmacol  Ther 2007;26 Suppl 1: 29 -39. https://doi.org/10.1111/j.1365 - 2036.2007.03511.x     PMid:179585 17     41.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Ann Intern Med  1997;126(9): 673 -681. https://doi.org/10.7326/0003 -4819 -126-9- 199705010 -00001     PMid:9139552     42.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Blood 2001;98(12): 3241 -3248.  https://doi.org/10.1182/blood.V98.12.3241     PMid:11719360     45.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Stem  Cells 1999;17(4): 203 -209. https://doi.org/10.1002/stem.170203      PMid:10437983     46.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Stem Cells 1998;16(S1): 21 -29.  https://doi.org/10.1002/stem.5530160705     PMid:11012174     47.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Annals of  the New York Academy of Sciences 2001;938(1): 131 -138.  https://doi.org/10.1111/j.1749 -6632.2001.tb03582.x      PMid:11458500     48.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Cytokine 2004;25(2): 52 -60.  https://doi.org/10.1016/j.cyto.2003.05.001     PMid:14693160     49.,OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
The Lancet 2008;371(9610): 395 -403.  https://doi.org/10.1016/S0140 -6736(08)60203 -2   51.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
New  England Journal of Medicine 2010;363(20): 1889 -1899.  https://doi.org/10.1056/NEJMoa1002625     PMid:21067381     52.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
J Gastroenterol Hepatol 2013;28(2): 335 -341.  https://doi.org/10.1111/j.1440 -1746.2012.07246.x      PMid:22849409     53.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Eur J   Gastroenterol Hepatol 2012;24(12): 1455 -1458.  https://doi.org/10.1097/MEG.0b013e328357d5f2      PMid:22890208     54.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
"McHutchison JG, Dusheiko G, Shiffman ML, Rodriguez -Torres M,  Sigal S, Bourliere M, Berg T, Gordon SC, Campbell FM, Theodore  D: Eltrombopag for thrombocytopenia in patients with cirrhosis   associated with hepatitis C. New England Journal of Medicine  2007;357(22): 2227 -2236. https://doi.org/10.1056/NEJMoa073255      PMid:18046027     57.",Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Blood 2009;113(10):  2161 -2171. https://doi.org/10.1182/blood -2008 -04-150078      PMid:18981291     59.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Blood 2005;105(2): 562 -566.  https://doi.org/10.1182/blood -2004 -04-1482     PMid:15374889     62.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
The American journal of  gastroenterology 2004;99(12): 2359 -2364.  https://doi.org/10.1111/j.1572 -0241.2004.40047.x      PMid:15571583     63.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
https://doi.org/10.3949/ccjm.71.Suppl_3.S17     PMid:15468613     64.,OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
https://doi.org/10.1016/S0016 -5085(03)83891 - X   65.,OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Am J Gastroenterol  2004;99(12): 2359 -2364. https://doi.org/10.1111/j.1572 - 0241.2004.40047.x     PMid:15571583     66.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Alimentary  pharmacology & therapeutics 2004;20(4): 437 -443.  https://doi.org/10.1111/j.1365 -2036.2004.02088.x      PMid:15298638     67.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Journa l of hepatology 1994;21(3): 376 - 380. https://doi.org/10.1016/S0168 -8278(05)80316 -2   68.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
World journal of gastroenterology: WJG 2011;17(39):  4414. https://doi.org/10.3748/wjg.v17.i39.4414     PMid:22110268       PMCid:PMC3218156   70.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
J Gastroenterol 2005;40(2): 148 -156.  https://doi.org/10.1007/s00535 -004-1519 -2    PMid:15770398     71.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Intervirology 2003;46(5): 296 -307.  https://doi.org/10.1159/000073209     PMid:14555850     72.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
J  Hepatol 1996;24(2): 135 -140. https://doi.org/10.1016/S0168 - 8278(96)80021 -3   73.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Clin Diagn Lab Immunol 2000;7(2): 241 -244.  https://doi.org/10.1128/cdli.7.2.241 -244.2000    74.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Gastroenterolog y 2008;134(4): A -772.  https://doi.org/10.1016/S0016 -5085(08)63605 -7   75.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Drug Alcohol Depend 2004;74(1): 15 -19.  https://doi.org/10.1016/j.drugalcdep.2003.11.006      PMid:15072803     76.,OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
"Taliani G, Duca F, Clementi C, De Bac C: Platelet -associated  immunoglobulin G, thrombocytopenia and response to i nterferon  treatment in chronic hepatitis C. J Hepatol 1996;25(6): 999.  https://doi.org/10.1016/S0168 -8278(96)80309 -6   78.",Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
"Borroni G, Ceriani R, Cazzaniga M, Tommasini M, Roncalli M,  Maltempo C, Fell ine C, Salerno F: Comparison of simple tests for  the non -invasive diagnosis of clinically silent cirrhosis in chronic  hepatitis C. Aliment Pharmacol Ther 2006;24(5): 797 -804.  https://doi.org/ 10.1111/j.1365 -2036.2006.03034.x      PMid:16918883     79.",Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Eur J  Gastroenterol Hepatol 2000;12(1): 67 -74.  https://doi.org/10.1097/00042737 -200012010 -00013      PMid:10656213     80.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Hepatolo gy 1996;23(2): 199 -204.  https://doi.org/10.1002/hep.510230201     PMid:8591841     83.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Am J Gastroenterol 2001;96(11): 3165 -3174.  https://doi.org/10.1111/j.1572 -0241.2001.05275.x      PMid:11721766     84.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Eur J Clin Invest 2003;33(2): 161 -168.  https://doi.org/10.1046/j.1365 -2362.2003.01110.x      PMid:12588291     85.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Hepatology 1999;29(4):  1311 -1316. https://doi.org/10.1002/hep.510290424      PMid:10094980     86.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
J Korean Med Sci 1999;14(6): 629 -634.  https://doi.org/10.3346/jkms.1999.14.6.629     PMid:10642940       PMCid:PMC3054447   87.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Am J Gastroenterol 2001;96(5): 1657 -1659.  https://doi.org/10.1111/j.1572 -0241.2001.03830.x       PMid:11374731     88.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
"Cicardi M, Cesana B, Del Ninno E, Pappalardo E, Silini E,  Agostoni A, Colombo M: Prevalence and risk factors for the  presence of serum cryoglobulins in patients wit h chronic hepatitis  C. J Viral Hepat 2000;7(2): 138 -143.  https://doi.org/10.1046/j.1365 -2893.2000.00204.x      PMid:10760044     89.",Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Gastroenterol Clin Biol  2005;29(4) : 347 -352. https://doi.org/10.1016/S0399 - 8320(05)80779 -1   90.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
Clin Infect Dis 2004;39(6):  790-796. https://doi.org/10.1086/423384     PMid:15472809     91.,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
World J Gastroenterol 2011;17(39): 4414 -4420.  https://doi.org/10.3748/wjg.v17.i39.4414     PMid:22110268       PMCid:PMC3218156,Non-OADS,/arxiv_data1/oa_pdf/76/1c/mjhid-9-1-e2017019.PMC5333732.pdf
"Mediterr J Hematol Infect Dis 201 7, 9(1): e201 7015, DOI: http://dx.doi.org/10.4084/MJHID.2017.015      Published:  February 15, 201 7 Received:  December 12 , 201 6 Accepted:  January 20 , 201 7    This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by -nc/4.0 ),  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Justus Liebigs  Ann Chem 1869; 150:242 -52.   https://doi.org/10.1002/jlac.18691500212    2.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Klin  Wochenschr 1928; 7:972 -7.  https://doi.org/10.1007/BF01716922    3.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Clin Pharmacol   Ther 1964; 5:574 -80.   https://doi.org/10.1002/cpt196455574    5.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Hydroxyurea therapy in chronic myelogenous  leukemia.Cancer 1972; 29:1052 -6. https://doi.org/10.1002/1097 - 0142(197204)29:4<1052::AID -CNCR2820290454>3.0.CO;2 -7   7.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
JAMA Oncol 20 15; 1:97 -105.  https://doi.org/10.1001/jamaoncol.2015.89   PMid:26182311     8.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
N Engl J Med 1995; 332:1132 -6.  https://doi.org/10.1056/NEJM199504273321704   PMid:7700286     9.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Am J Hematol 2014; 89:915 -25.  https://doi.org/10.1002/ajh.23703   PMid:25124313     11.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Arch Dermatol 1970; 102:144 -50.   https://doi.org/10.1001/archderm.1970.04000080016003    12.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Arch Intern Med 1910;  6:517 -21. https://doi.org/10.1001/archinte.1910.00050330050003    13.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Science 1949; 109:443.    https://doi.org/10.1126/science.110.2865.543    14.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
"Allison AC.The distribution of the sickle -cell trait in East Africa  and elsewhere, and its apparent relationship to the incidence of  subtertianmalaria.Trans R SocTrop Med Hyg 1954; 48:312 -8.  https://doi.org/10.1016/0035 -9203(54)90101 -7   15.",OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Lancet Infect Dis 2012; 12:457 -68.   https://doi.org/10.1016/S1473 -3099(12)70055 -5   16.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
A specific chemical difference between the globins of  normal human and sickle -cell anaemiahaemoglobin.Nature 1956;  178:792 -4. https://doi.org/10.1038/178792a0   PMid:13369537    17.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Evaluation of proficiency in the  performance of tests for abnormal he moglobins.Am J ClinPathol  1974; 62:664 -9. https://doi.org/10.1093/ajcp/62.5.664     PMid:4413315     18.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
JAMA 1970;  214:731 -4. https://doi.org/10.1001/jama.1970.03180040039008      PMid:5 536114     19.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Semin  Perinatol 2010; 34: 134 - 44. https://doi.org/10.1053/j.semperi.2009.12.006       PMid:20207263     20.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Blood  2010; 115:3447 -52. https://doi.org/10.1182/blood -2009 -07-233700      PMid:20194891  PMCid:PMC2867259   21.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
JAMA 2014; 312:2115 -25.  https://doi.org/10.1001/jama.2014.15063   PMid:25393378   PMCid:PMC4356116   22.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Am J Hum Genet 2012; 91:794 -808.  https://doi.org/10.1016/j.ajhg.2012.08.031    PMid:23103231 PMCid:PMC3487117   23.,OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
J Clin Invest 1984;  74 :652 -6. https://doi.org/10.1172/JCI111464    PMid:6205021  PMCid:PMC370519   24.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
N Engl J Med 1991; 325:11 -6.  https://doi.org/10.1056/NEJM199107043250103  PMid:1710777   25.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
N Engl J Med 2008; 359:2254 -65.   https://doi.org/10.1056/NEJMra0804411   PMid:19020327     27.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
N Engl J  Med 1994; 330:1639 -44.   https://doi.org/10.1056/NEJM1994060933 02303   PMid:7993409     28.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
N Engl J  Med 1995; 332:1317 -22.   https://doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Ann Intern Med  2008; 148:932 -8. https://doi.org/10.7326/0003 -4819 -148-12- 200806170 -00220  PMid:18458 271     31.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
The effect of fetal  hemoglobin on the survival characteristics of sickle cells.Blood  2006; 108:1073 -6. https://doi.org/10.1182/blood -2005 -09-008318      PMid:16861353  PMCid:PMC1895865   32.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
N  Engl J Med 2008; 358:1362 -9.   https://doi.org/10.1056/NEJMct0708272   PMid:18367739     33.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Br J Haematol 2003; 120:177 -86.   https://doi.org/10.1046/j.1365 -2141.2003.03849.x      PMid:12542474     34.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Science 1984;  223:470 -1. https://doi.org/10.1126/science.6197757       PMid:6197757     35.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Bailliere's Clinical Haematology 1993; 6:57 -91.  https://doi.org/10.1016/S0950 -3536(05)80066 -6   37.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
J Clin Invest 2003; 111:231 -9.  https://doi.org/10.1172/JCI200316672     PMid:12531879        PMCid:PMC151872   38.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
N Engl J Med 1984; 310:869 -73.  https://doi.org/10.1056/NEJM198404053101401  PMid:6199670     39.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Blood 2014;  124:3850 -7. https://doi.org/10.1182/blood -2014 -08-435768       PMid:25287707  PMCid:PMC4271176   40.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Lancet 2011;  377:1663 -72. https://doi.org/10.1016/S0140 -6736(11)60355 -3,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Blood 2012; 119:3925 -32.   https://doi.org/10.1182/blood -2011 -11-392340   PMid:22318199        PMCid:PMC3350359   43.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Hemoglobin 2012; 36:323 -32.   https://doi.org/10.3109/03630269.2012.697948   PMid:22734586     44.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Br J Haematol 2011;  152:771 -6. https://doi.org/10.1111/j.1365 -2141.2010.08523.x       PMid:21275961     45.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Am J Hematol 2013; 88:932 -8.  https://doi.org/10.1002/ajh.23547   PMid:23861242        PMCid:PMC4631259   46.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Pediatr Blood  Cancer 2012; 59:675 -8. https://doi.org/10.1002/pbc.24037       PMid:22190441  PMCid:PMC3337342   47.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Blood 2012; 12 0:4304 -10.  https://doi.org/10.1182/blood -2012 -03-419879   PMid:22915643        PMCid:PMC3507142   48.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Am J Hematol 2011; 86:846 -50.   https://doi.org/10.1002/ajh.22142   PMid:21898530     49.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Am J Hematol 2011; 86:958 -61.   https://doi.org/10.1002/ajh.22146   PMid:21948113     50.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Blood Cells Mol Dis 2009; 42:25 -31.   https://doi.org/10.1016/j.bcmd.2008.08.003   PMid:18954999     51.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Br J Haematol 2013; 161:852 -60.   https://doi.org/10.1111/bjh.12323   PMid:23590693     52.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Acta  Haemato l  2011; 125:145 -52. https://doi.org/10.1159/000322248    53.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Hemoglobin 2012; 36:409 -20.   https://doi.org/10.3109/03630269.2012.709897   PMid:22881992     54.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Am J Hematol 2013;  88:E261 -4. https://doi.org/10.1002/ajh.23531   PMid:23828131     55.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Eur J Haematol 2013; 90:519 -24.   https://doi.org/10.1111/ejh.12103   PMid:23489171     56.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Indian J Pharmacol 2010;  42:32 -5. https://doi.org/10.4103/0253 -7613.62409       PMid:20606834  PMCid:PMC2885637   57.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Am J Hematol 2010; 85:403 -8.   https://doi.org/10.1002/ajh.21699    58.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Blood 2010; 115:2354 -63.  https://doi.org/10.1182/blood -2009 -05-221333   PMid:19903897     59.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Blood 2005; 105:2685 -90.  https://doi.or g/10.1182/blood -2004 -07-2704  PMid:15604217     60.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Blood 2005; 106:2269 -75. https://doi.org/10.1182/blood - 2004 -12-4973   PMid:16172253 PMCid:PMC1895275   61.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Indian Pediatr 2013; 50:929 -33.   https://doi.org/10.1007/s13312 -013-0264 -0 PMid:23798623     62.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Pediatr Hematol  Oncol 1999; 16:221 -32. https://doi.org/10.1080/088800199277272      PMid:10326220     63.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
J  Pediatr Hematol Oncol 1998; 20:26 -31.   https://doi.org/10.1097/00043426 -199801000 -00004    64.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Sao Paulo Med J  2013; 131:238 -43.   https://doi.org/10.1590/1516 -3180.2013.1314467      PMid:24141294     65.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Br J Haematol 2013; 162:836 -41.   https://doi.org/10.1111/bjh.12453   PMid:23829561   PMCid:PMC3759564   66.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Blood 2009; 114:4639 -44. https://doi.org/10.1182/blood -2009 -04- 218040   PMid:19724057  PMCid:PMC2780300   67.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Pedi atrics 2008; 121:777 -82.   https://doi.org/10.1542/peds.2007 -0730   PMid:18381543     68.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Haematologica 2007; 92:738 -43.   https://doi.org/10.3324/haematol.11136   PMid:17550845     69.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Eur   Respir J 2012; 39:112 -8.   https://doi.org/10.1183/09031936.00134410   PMid:21778170     70.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
N Engl J Med 2011;  365:44 -53. https://doi.org/10.1056/NEJMoa1005565       PMid:21732836     71.,OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Pediatr Blood Cancer 2010; 54:398 -402.  https://doi.org/10.1002/pbc.22306   PMid:19827138     72.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Br J  Haematol 2006; 134:109 -15. https://doi.org/10.1111/j.1365 - 2141.2006.06110.x   PMid:16803576     73.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Am J Hematol 2008;  83:19 -25. https://doi.org/10.1002/ajh.21058   PMid:17724699     74.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Br J Haematol 2015;  169:262 -6. https://doi.org/10.1111/bjh.13280   PMid:25612463        PMCid:PMC4631316   76.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Blood 2011;  118:4985 -91. https://doi.org/10.1182/blood -2011 -07-364190     PMid:21876119 PMCid:PMC3208303   77.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Hematology (Educational Sessions of the American Society of  Hematology) 2015; 436 -43. https://doi.org/10.1182/asheducation - 2015.1.436   PMid:26637755     79.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Am J Hematol 2015; 90:273 -5. https://doi.org/10.1002/ajh.23945      PMid:25639238     80.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Mutat Res 2010; 698:38 -42.   https://doi.org/10.1016/j.mrgentox.2010.03.001  PMid:20230905     81.,OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
J Natl  Med Assoc 2009; 101:1046 -51.   https://doi.org/10.1016/S0027 -9684(15)31072 -5   82.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Pediatr Blood Cancer 2012;  59:668 -74. https://doi.org/10.1002/pbc.24100   PMid:22294512        PMCid:PMC3396762   83.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Pediatr Blood Cancer 2008; 50:293 -7.  https://doi.org/10.1002/pbc.21271   PMid:17554794     84.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Am J Hematol 2013; 88:116 -9.   https://doi.org/10.1002/ajh.23365  PMid:23255310    PMCid:PMC4673980   85.,OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Br J Haematol 2013; 161:402 -5.  https://doi.org/10.1111/bjh.12238   PMid:23384083     86.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
J Pediatr  Hematol  Oncol 2007;  29:140 -4. https://doi.org/10.1097/mph.0b013e3180335081    87.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
J Pediatr  1996; 129:559 -65. https://doi.org/10.1016/S0022 -3476(96)70121 - X   88.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Blood 2001; 97:3628 -32.   https://doi.org/10.118 2/blood.V97.11.3628  PMid:11369660     90.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Arch Dis Child 2013; 98:908 -14.   https://doi.org/10.1136/archdischild -2012 -302387      PMid:23995076  PMCid:PMC3812872   91.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
J Pe diatr 2004; 145:346 -52.   https://doi.org/10.1016/j.jpeds.2004.04.058   PMid:15343189     93.,OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Blood 2007; 110:1043 -7.   https://doi.org/10.1182/blood -2006 -11-057893  PMid:17429008     94.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Am J Hematol 2015; 90:1099 -105.   https://doi.org/10.1002/ajh.24198  PMid:26414435        PMCid:PMC4715740   95.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
A two -year pilot trial of  hydroxyurea in very young children with sickle -cell anemia J Pediatr 2001; 139:790 -6. https://doi.org/10.1067/mpd.2001.119590      PMid:11743503     96.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
J Pediatr 2002; 140:225 -9.   https://doi.org/10.1067/mpd.2002.121 383  PMid:11865275     97.,OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Clin Lab Haematol 2001; 23:149 -54.   https://doi.org/10.1046/j.1365 -2257.2001.00344.x      PMid:11553054     98.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Blood 2014; 123:481 -5.  https://doi.org/10.1182/blood -2013 -09-528067   PMid:24222332     100.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Br J Haematol 2012; 156:259 -64.   https://doi.org/10.1111/j.1365 -2141.2011.08916.x      PMid:22017641     101.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Cytometry 1995; 20:261 -7.   https://doi.org/10.1002/cyto.990200310   PMid:7587712     102.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Am J Hematol 2012; 87:795 -803.   https://doi.org/10.1002/ajh.23232   PMid:22641398        PMCid:PMC4562292   104.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Genet Epi demiol 1996; 13:501 -12.   https://doi.org/10.1002/(SICI)1098 -2272(1996)13:5<501::AID - GEPI6>3.0.CO;2 -4   106.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Am J Med Genet C Semin Med  Genet 2008; 148C:15 -22. https://doi.org/10.1002/ajmg.c.30160      PMid:18200513     108.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Blood 2010; 115:4331 -6.  https://doi.org/10.1182/blood -2010 -01-251348   PMid:20233970        PMCid:PMC2881491   109.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
https://doi.org/10.1371/journal.pmed.1001484      PMid:23874164  PMCid:PMC3712914   110.,OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
JAMA 2014; 12:1033 -48.   https://doi.org/10.1001/jama.2014.105 17  PMid:25203083     112.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Pediatr Blood Cancer 2015; 62:1862 -4.  https://doi.org/10.1002/pbc.25563   PMid:25929458     113.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Am J Hematol 2000; 64:26 -31.  https://doi.or g/10.1002/(SICI)1096 -8652(200005)64:1<26::AID - AJH5>3.0.CO;2 -F   115.,OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Blood 2016; 127:810 -9.   https://doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Br J Haematol 2008;  141:126 -9. https://doi.org/10.1111/j.1365 -2141.2008.07027. x      PMid:18324975     118.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
J Med Chem 2011; 54:5811 -9.  https://doi.org/10.1021/jm200531f   PMid:21766854     119.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Blood 2011; 118:248 - 58. https://doi.org/10.1182/blood -2010 -11-319137       PMid:21536862 PMCid:PMC3148160   120.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Expert Opin Investig Drugs  2009; 18:231 -9. https://doi.org/10.1517/13543780802708011       PMid:19236269     122.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Artif Organs 2014; 38:702 -7.  https://doi.org/10.1111/aor.12341   PMid:25113835     123.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Blood 2010; 116:1779 -86. https://doi.org/10.1182/blood - 2009 -12-260513  PMid:20508165 PMCid:PMC2947397   124.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Thromb Haemost 2007; 98:392 -6.  https://doi.org/10.1160/th06 -12-0718    127.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Clin  Transl Sci 2012; 5:437 -44. https://doi.org/10.1 111/cts.12005       PMid:23253664  PMCid:PMC3762678   128.,OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Blood 2013; 121:3329 -34.   https://doi.org/10.1182/blood -2012 -11-465963    PMid:23377438   PMCid:PMC3637009   131.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Expert Rev Hematol 2009; 2:57 -68.   https://doi.or g/10.1586/17474086.2.1.57   PMid:21082995     133.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Blood 2008;  111:915 -23. https://doi.org/10.1182/blood -2007 -04-084061       PMid:17932253 PMCid:PMC2200843   134.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Br J Haematol 2011; 153:655 -63.   https://doi.org/10.1111/j.1365 -2141.2010.08480.x      PMid:21477202  PMCid:PMC3601917   135.,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
Bone  Marrow Transplant 2008; 41:109 -17.   https://doi.org/10.1038/sj.bmt.1705943  PMid:18059330,Non-OADS,/arxiv_data1/oa_pdf/6b/5b/mjhid-9-1-e2017015.PMC5333733.pdf
"Mediterr J Hematol Infect Dis 201 7, 9(1): e201 7018, DOI: http://dx.doi.org/10.4084/MJHID.2017.018      Published:  February 20 , 201 7 Received:  November 20 , 201 6 Accepted:  February 5 , 201 7    This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by -nc/4.0 ),  which permits unrestricted use, distribu tion, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
A  complete updated list of β -thalassemia variants is  available through the Globin Gene Server Web  Site ( http://www.globin.cse.psu.edu ).,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Oxford: Blackwell Science Ltd 2001   https://doi.org/10.1002/9780470696705    2.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
https://doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
doi:  10.1101/cshperspect.a011775  https://doi.org/10.1101/cshperspect.a011775    4.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
doi:  10.1371/journal.pone.010 3020. eCollection 2014   https://doi.org/10.1371/journal.pone.0103020    5.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Eur J  Haematol .2013; 90: 313 -322   https://doi.org/10.1111/ejh.12076   PMid:23331260     6.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
2012 Sep 1;2(9):a011692  https://doi.org/10.1101/cshperspect.a011692       PMid:22951448  PMCid:PMC3426822   7.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
2007;31:233 -241 https://doi.org/10.1080/03630260701296735      PMid:17486506     8.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Hum  Hered.1995;45:278 –285   https://doi.org/10.1159/000154314  PMid:7590760     10.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
1985;22:54 -58  https://doi.org/10.1136/jmg.22.1.54   PMid:2580095 PMCid:PMC1049378   12.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
1999;107:903 –904   https://doi.org /10.1046/j.1365 -2141.1999.01821.x      PMid:10671033     15.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
1991;15:11 –21   https://doi.org/10.3109/03630269109072481   PMid:1917531     16.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
2005;78:27 -32   https://doi.org/10.1002/ajh.20199   PMid:15609277     17.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Sci Rep. 2016 May 20;6:26371. doi:  10.1038/srep26371 https://doi.org/10.1038/srep26371    19.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
1992; 81: 607 -609   https://doi.org/10.1111/j.1365 -2141.1992.tb03000.x      PMid:1390250     20.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Hemoglobin 2009;33:81 -94   https://doi.org/10.1080/03630260902813502    PMid:19373583     21.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
1962;8:5 -14   https://doi.org/10.1111/j.1365 -2141.1962.tb06489.x    22.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Br.J  Haem.1990;74:342 -346   https://doi.org/10.1111/j.1365 -2141.1990.tb02593.x    24.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Hemoglobin 2014;38:305 -307   https://doi.org/10.3109/03630269.2014.938163   PMid:25030194     25.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
2001;73:661 -674  https://doi.org/10.1353/hub.2001.0075  PMid:11758688     26.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
2013;4:147 -167 https://doi.org/10.1007/s12687 -012-0127 -8   PMid:23224852  PMCid:PMC3666833   28.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
2008;12:563 -568   https://doi.org/10.1089/gte.2008.0058    PMid:18976160     29.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
2008;80:67 -70 https://doi.org/10.1111/j.1600 -0609.2007.00989.x      PMid:18173741     30.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
1995;5:327 –328   https://doi.org/10.1002/humu.1380050409   PMid:7627187     31.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Hemoglobin 2 000;24:1 –13   https://doi.org/10.3109/03630260009002268   PMid:10722110     32.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Hemoglobin  2000;24:269 –276   https://doi.org/10.3109/03630260008993133     PMid:11186256     33.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
1995;5:351 –353   https://doi.org/10.1002/humu.1380050416   PMid:7627194     34.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
1998;850:407 –409  https://doi.org/10.1111/j.1749 -6632.1998.tb10505.x      PMid:9668568     35.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Hum  Genet 1997;99:271 -274 https://doi.org/ 10.1007/s004390050352      PMid:9048934     36.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
2014 Nov 1;6(1):e2014071   https://doi.org/10.4084/mjhid.2014.071   PMid:25408857  PMCid:PMC4235483   37.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Hemoglobin  2013;37:444 -453   https://doi.org/10.3109/03630269.2013.810641   PMid:23826747     38.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Hemoglobin 2007;31:121 -127   https://doi.org/10.1080/03630260701288815   PMid:17486492     39.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
2009; 33:214 -219   https://doi.org/10.1080/03630260903081398   PMid:19657835     40.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Hemoglobin 2010;34:1 -23   https://doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
2001;1:129 -132   https://doi.org/10.1155/S1110724301000298    PMid:12488606  PMCid:PMC129059   42.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Hemoglobin  1994;18:325 –332  https://doi.org/10.3109/03630269408996198   PMid:7852087     44.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
1994;92:176 –181   https://doi.org/10.1159/000204216   PMid:7701914     45.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
1991;15:11 –21   https://doi.org/10.3109/036302 69109072481   PMid:1917531     46.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Epub 2012 Dec 18   https://doi.org/10.1100/2012/635183    49.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
1998;Suppl 27:137 -176   https://doi.org/10.1002/(SICI)1096 -8644(1998)107:27+<137::AID - AJPA6>3.0.CO;2 -Q   51.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
2006;79:230 -237 https://doi.org/10.1086/505436      PMid:16826514  PMCid:PMC1559480  52.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Science  2011;331:453 -456   https://doi.org/10.1126/science.1199113   PMid:21273486     55.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Science 2005; 308: 965 -966   https://doi.org/10.1126/science.1113261   PMid:15890867     56.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Nature  2000;405:24 -25  https://doi.org/10.1038/35011166   PMid:10811201     57.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
1998;8:141 –163 https://doi.org/10.1017/S0959774300001815    59.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
2012; pp.1 -264  https://doi.org/10.1093/acprof:osobl/9780199549061.003.0001    61.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
20 07;58:131 -145   https://doi.org/10.1093/jxb/erl133   PMid:17050642     62.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
J  Archaeol Sci.2013;40: 2286 –2297   https://doi.org/10.1016/j.jas.2012.12.040    64.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Aust J Plant Physiol.1993;20:117 –128  https://doi.org/10.1071/PP9930117    67.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Lancet  1963;1;907 -909 https://doi.org/10.1016/S0140 -6736(63)91688 -X   73.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
1998;11:1 - 51 https://doi.org/10.1016/S0950 -3536(98)80069 -3   74.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Nature  2005;435:1117 –1121 https://doi.org/10.1038/nature03631   PMid:15973412     79.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Science 2011;334:1283 -1286   https://doi.org/10.1126/science.1213775   PMid:22075726     81.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
2005  May;2(5):e128 https://doi.org/10.1371/journal.pmed.0020128       PMid:15916466  PMCid:PMC1140945   82.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Blood 2012 Apr  19;119(16):3808 -14. doi:  10.1182/blood -2011 -08-371062   https://doi.org/10.1182/blood -2011 -08-371062    83.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
2011 Sep  22;10:280. doi: 10.1186/1475 -2875 -10-280   https://doi.org/10.1186/1475 -2875 -10-280   84.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
2011;204:1750 – 1761 https://doi.org/10.1093/infdis/jir638    PMid:21998476  PMCid:PMC3203232   85.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
2005;191:1631 –1638   https://doi.org/10 .1086/429832   PMid:15838789     86.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
20 04;104:3364 –3371   https://doi.org/10.1182/blood -2003 -11-3820   PMid:15280204     87.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
2015; 35: 1238 -1242  https://doi.org/10.1002/pd.4684     PMid:26296249     91.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
2010;1202 :17–23 https://doi.org/10.1111/j.1749 - 6632.2010.05546.x     PMid:20712767     92.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Blood 2010;115:4331 –4336  https://doi.org/10.1182/blood -2010 -01-251348     PMid:20233970       PMCid:PMC28 81491   93.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
Science 1966;153:760 -763  https://doi.org/10.1126/science.153.3737.760     PMid:532867 9     94.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
1990;82:403 -411  https://doi.org/10.1002/ajpa.1330820402   PMid:2205102     95.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
1996;101:11 -27  https://doi.org/10.1002/(SICI)1096 -8644(199609)101:1<11::AID - AJPA2>3.0.CO;2 -G   97.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
1987;74:521 -526  https://doi.org/10.1002/ajpa.1330740410   PMid:3327384     99.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
2001;Suppl  33:106 -147 https://doi.org/10.1002/ajpa.10024   PMid:11786993     100.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
1995;9:365 -368  https://doi.org/10.1038/ ng0495 -365  PMid:7795641     103.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
2014 Jul 1;9:97. doi:  10.1186/1750 -1172 -9-97 https://doi.org/10.1186/1750 -1172 -9-97   107.,Non-OADS,/arxiv_data1/oa_pdf/75/34/mjhid-9-1-e2017018.PMC5333734.pdf
"Mediterr  J Hematol Infect Dis 201 7, 9(1): e20170 24, DOI:  http://dx.doi.org/10.4084/MJ HID.2017.024      This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by -nc/4.0 ),  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/45/mjhid-9-1-e2017024.PMC5333735.pdf
2014;10(8 ):2387 -94.  https://doi.org/10.4161/hv.29094     PMid:25424946       PMCid:PMC4896784  3.,Non-OADS,/arxiv_data1/oa_pdf/9b/45/mjhid-9-1-e2017024.PMC5333735.pdf
Epub 2013 Mar 18.    https://doi.org/10.1111/ejh.12094    4.,Non-OADS,/arxiv_data1/oa_pdf/9b/45/mjhid-9-1-e2017024.PMC5333735.pdf
4 / 4     https://doi.org/10.1016/j.vaccine.2010.12.113     PMid:21216315     5.,Non-OADS,/arxiv_data1/oa_pdf/9b/45/mjhid-9-1-e2017024.PMC5333735.pdf
http://www.salute.gov.it/imgs/C_17_tavole_19_allegati_iitemAlleg ati_0_fileAllegati_itemFile_3_file.pdf    7.,OADS,/arxiv_data1/oa_pdf/9b/45/mjhid-9-1-e2017024.PMC5333735.pdf
http://www.epicentro.iss.it/problemi/influenza/FluNews/FluNews_2015 -4.pdf      8.,Non-OADS,/arxiv_data1/oa_pdf/9b/45/mjhid-9-1-e2017024.PMC5333735.pdf
2016  Aug;132:178 -85. https://doi.org/10.1016/j.antiviral.2016.06.001      PMid:27265623,OADS,/arxiv_data1/oa_pdf/9b/45/mjhid-9-1-e2017024.PMC5333735.pdf
"Mediterr J Hematol Infect  Dis 201 7, 9(1): e201 7021, DOI: http://dx.doi.org/10.4084/MJHID.2017.021      Published:  March 1 , 201 7 Received:  December 12 , 201 6 Accepted:  January 27 , 201 7    This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by -nc/4.0 ),  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
"Existing  data, taken collectively, indicate a role for iron  chelati on therapy in MDS, and this is reflected by  its inclusion in a number of societies and national  guidelines.17,61,62 We are currently coordinating the  phase II randomized TELESTO trial (URL:  http://clinicalTrials.gov/ct2/show/NCT00940602 ),  which has completed the recruitment of patients  with low and intermediate -1 risk MDS to receive  either deferasirox monotherapy or placebo.",Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2011; 35: 1591 -6. https://doi.org/10.1016/j.leukres.2011.06.001      PMid:21708407     2.,OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2007;  109:1536 -42. https://doi.org/10.1002/cncr.22570     PMid:17345612     3.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2009;  538-51.  https://doi.org/10.3748/wjg.15.538     PMid:19195055       PMCid:PMC2653344   4.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
N Engl J Med 2011; 364: 146 -56.  https://doi.org/10.1056/NEJMct1004810     PMid:21226580       PMCid:PMC3078566   5.,OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2010;  142: 24 -38. https://doi.org/10.1016/j.cell.2010.06.028      PMid:20603012     6.,OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
https://doi.org/10.1371/journal.pone.0023109    7.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2013;  368:2325 -7. https://doi.org/10.1056/NEJMcibr1304338      PMid:23758239     8.,OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2012;  120: 3829 -36. https://doi.org/10.1182/blood -2012 -07-440743      PMid:22990014      PMCid:PMC3488893   9.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2011; 117: 4590 -9. https://doi.org/10.1182/blood -2010 -10-315507      PMid:2 1355094      PMCid:PMC3099575   10.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2012; 119: 5021 -9.  https://doi.org/10.1182/blood -2012 -01-401885     PMid:22490684       PMCid:PMC3426375   11.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2009; 84: 480 -3.  https://doi.org/10.1002/ajh.21456     PMid:19536851       PMCid:PMC2884400   12.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2016; 22: S14 -21.  https://doi.org/10.1016/S0268 -960X(08)70004 -3   13.,OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2014:23 -40.  https://doi.org/10.1016/j.freeradbiomed.2014.03.039      PMid:24726864      PMCid:PMC4940047   14.,OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
Circulation 2009; 120: 1937 -9.  https://doi.org/10.1161/CIRCULATIONAHA.109.907196      PMid:19884464      PMCid:PMC2884388   15.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2010: 56: 1001 -12.  https://doi.org/10.1016/j.jacc.2010.,OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2010; 34: 1576 -88.  https://doi.org/10.1016/j.leukres.2010.01.018     PMid:20149927     18.,OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2011; 25: 17 -31.  https://doi.org/10.1016/j.blre.2010.09.003     PMid:21030120     19.,OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
Leuk Res 2016; 31: S2 -6.  https://doi.org/10.1016/S0145 -2126(07)70459 -9   20.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2005; 23: 7594 - 603. https://doi.org/10.1200/JCO.2005.01.7038     PMid:16186598     21.,OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2015; 94: 779 -87.  https://doi.org/10.1007/s00277 -014-2274 -y    PMid:25516455     22.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
"2011: 90: 1 -10. https://doi.org/10.1007/s00277 -010-1091 -1     PMid:20938663     23. de Swart L, Smith A, Fenaux P, Sanz G, Hellstrom -Lindberg E,  Symeonidis A, CermakJ, Germing U, Stauder R, Georgescu O,  MacKenzie M, Malcovati L, Holm MS, Madry K, Park S, Beyne - Rauzy O, Dro ste J, Bowen D, de Witte T. Early Mortality in 1000  Newly Diagnosed MDS Patients with Low - and Intermediate -1  Risk MDS in the European Leukemianet MDS (EUMDS) Registry.",Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2011;96: 441 -9.  https://doi.org /10.3324/haematol.2010.033506     PMid:21134982       PMCid:PMC3046276   26.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2010; 28: 2847 -52.  https://doi.org/10.1200/JCO.2009.25.2395     PMid:20421543     27.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2008; 83: 611 -3. https://doi.org/10.1002/ajh.21192      PMid:18442062     28.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2007; 78: 487 -94. https://doi.org/10.1111/j.1600 - 0609.2007.00842.x     PMid:17391310     29.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2012; 36: 525 -36.  https://doi.org/10.1016/j.leukres.2012.01.006     PMid:2230 0879     30.,OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2008;166 -75. https://doi.org/10.1182/asheducation -2008.1.166      PMid:19074076     31.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2007;  82: 1013 -6. https://doi.org/10.1002/ajh.20980     PMid:17654681     32.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2008; 93: 1385 -8.  https://doi.org/10.3324/haema tol.12759     PMid:18603557     33.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
Eur H eart J 2001; 22: 2171 - 79 https://doi.org/10.1053/euhj.2001.2822     PMid:11913479     34.,OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
Br J Haematol 2013;162: 413 - 5 https://doi.org/10.1111/bjh .12368     PMid:23656172     35.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2013; 92: 191 -8. https://doi.org/10.1007/s00277 -012-1594 -z     PMid:23073603     36.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2010; 34: 1560 -5.  https://doi.org/10.1016/j.leukres.2010.06.013   PMid:20615548     38.,OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2009; 88: 301 -10. https://doi.org/10.1007/s00277 -008- 0588 -3    PMid:18758781     39.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2012; 30:  2134 -9. https://doi.org/10.1200/JCO.2010.34.1222      PMid:22547607     41.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2010; 34:1143 -50.  https://doi.org/10.1016/j.leukres.2010.03.009     PMid:20451251     42.,OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2012; 97: 1364 -71.  https://doi.org/10.3324/haematol.201 1.048546     PMid:22419577       PMCid:PMC3436237   43.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2010;2010:164045. https://doi.org/10.1155/2010/164045      PMid:20368773      PMCid:PMC2846339   44.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2012; 91: 1345 -9.  https://doi.org/10.1007/s00277 -012-1481 -7    PMid:22569854     45.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
Acta Haematol 2009; 121: 19 -20.  https://doi.org/10.1159/000209206     PMid:19287132     46.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
Int J Hematol 2010; 91: 333 -5.  https://doi.org/10.1007/s12185 -010-0500 -5    PMid:20127527     47.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2015; 95 :52 -6.  https://doi.org/10.1111/ejh.12476     PMid:25764148     49.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2013; 98: 1045 -1048.  https://doi.org/10.3324/haematol.2012.077669     PMid:23585526       PMCid:PMC3696607   52.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
Eur J Haematol 2014; 92: 527 -36.  https://doi.org/10.1111/ejh.12300     PMid:24580147     53.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2010: 1433 -4. https://doi.org/10.3324/haematol.2010.024992     PMid:20421274       PMCid:PMC2913096   54.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2013; 37: 327 -32.  https://doi.org/10.1016/j.leukres.2012.11.005     PMid:23259989     55.,OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
Science 2001;292: 468 -72.  https://doi.org/10.1126/science.1059796     PMid:11292861     57.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2014; 38: 149 -54.  https://doi.org/10.1016/j.leukres.2013.11.004     PMid:24314590     59.,OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2012;36:1067 -70. https://doi.org/10.1016/j.leukres.2012.04.006      PMid:22564985     60.,OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2008; 88: 24 -9.  https://doi.org/10.1007/s12185 -008-0118 -z    PMid:18581200       PMCid:PMC2516534   62.,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
2008; 83: 858 -61.  https://doi.org/10.1002/ajh.21269     PMid:18767130,Non-OADS,/arxiv_data1/oa_pdf/f7/b0/mjhid-9-1-e2017021.PMC5333736.pdf
"1 / 1      Mediterranean Journal of Hematology and Infectious Diseases     Letters to Editor      Zika Virus Infection - Proposed Management Strategies  –     Comment on  “Zika virus : a Review from the Virus Basics to Proposed Management Strategies ”   (Mediterr J Hematol Infect Dis 2016)  https://doi.org/10.4084/mjhid.2016.056     Published:  March 1 , 2017  Received:   November 24 , 2016 Accepted:   January 20 , 2017    Citation:   Wiwanitkit V .",Non-OADS,/arxiv_data1/oa_pdf/5d/0c/mjhid-9-1-e2017016.PMC5333737.pdf
"Mediterr  J Hematol Infect Dis 201 7, 9(1): e201 7016, DOI:  http://dx.doi.org/10.4084/MJHID.2017.016      This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by -nc/4.0),  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/0c/mjhid-9-1-e2017016.PMC5333737.pdf
https://doi.org/10.4084/mjhid.2016.056     PMid:27872736       PMCid:PMC5111539   2.,Non-OADS,/arxiv_data1/oa_pdf/5d/0c/mjhid-9-1-e2017016.PMC5333737.pdf
https://doi.org/10.1016/j.jfma.2016.06.003    3.,OADS,/arxiv_data1/oa_pdf/5d/0c/mjhid-9-1-e2017016.PMC5333737.pdf
Ann Trop Med Public  Health 2016;9:361 -2. https://doi.org/10.4103/1755 -6783.190206,Non-OADS,/arxiv_data1/oa_pdf/5d/0c/mjhid-9-1-e2017016.PMC5333737.pdf
"1 / 2      Mediterranean Journal of Hematology and Infectious Diseases     Letter  to Editor      The Importance of Updating and Continuous Education on Imported Emerging  Diseases      Response to Comment  on  “Zika Virus: a Review from the Virus Basics to Proposed Management Strategies ”  (Mediterr J Hematol Infect Dis  2016) http://dx.doi.org/10.4084/MJHID.2016.056 ;   (Mediterr J Hematol Infect Dis 2017) http://dx.doi.org/10.4084/MJHID.2017.016     Keywords:  Zika virus , Emerging Diseases .",Non-OADS,/arxiv_data1/oa_pdf/0d/f0/mjhid-9-1-e2017022.PMC5333738.pdf
"Mediterr  J Hematol Infect Dis 201 7, 9(1): e20170 22, DOI: http://dx.doi.org/10.4084/MJHID.2017.022      This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by -nc/4.0 ),  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/f0/mjhid-9-1-e2017022.PMC5333738.pdf
http://dx.doi.org/10.4084/MJHID.2017.016    2.,Non-OADS,/arxiv_data1/oa_pdf/0d/f0/mjhid-9-1-e2017022.PMC5333738.pdf
http://dx.doi.org/10.4084/MJHID.2016.05 6    3.,Non-OADS,/arxiv_data1/oa_pdf/0d/f0/mjhid-9-1-e2017022.PMC5333738.pdf
DOI:  http://dx.doi.org/10.15585/mmwr.mm6539e1    4.,Non-OADS,/arxiv_data1/oa_pdf/0d/f0/mjhid-9-1-e2017022.PMC5333738.pdf
2016 Sep ;115(9):822. doi:  http://dx.doi.org/10.1016/j.jfma.2016.06.003       6.,OADS,/arxiv_data1/oa_pdf/0d/f0/mjhid-9-1-e2017022.PMC5333738.pdf
Article DOI:  http://dx.doi.org/10.2807/1560 -7917.ES2014.19.4.20685    7.,Non-OADS,/arxiv_data1/oa_pdf/0d/f0/mjhid-9-1-e2017022.PMC5333738.pdf
DOI:  http://dx.doi.org/10.4269/ajtmh.15 -0022 .,Non-OADS,/arxiv_data1/oa_pdf/0d/f0/mjhid-9-1-e2017022.PMC5333738.pdf
Available  from  http://www.cdc.gov/EID/content/15/9/1347.htm,OADS,/arxiv_data1/oa_pdf/0d/f0/mjhid-9-1-e2017022.PMC5333738.pdf
"Mediterr J Hematol Infect Dis 201 7, 9(1): e201 7023, DOI:  http://dx.doi.org/10.4084/MJHID.2017.023      Published:  March 1 , 201 7 Received:  December 12 , 201 6 Accepted:  February 14 , 201 7    This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by -nc/4.0 ),  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/d8/mjhid-9-1-e2017023.PMC5333739.pdf
https://doi.org/10.4084/mjhid.2012.065     PMid:23170194       PMCid:PMC3499995   2.,Non-OADS,/arxiv_data1/oa_pdf/80/d8/mjhid-9-1-e2017023.PMC5333739.pdf
"Article available at  http://www.aieop.org/files/files_htm larea/tutto%20giu12.pdf   last  accessed on November 12th, 2016.",Non-OADS,/arxiv_data1/oa_pdf/80/d8/mjhid-9-1-e2017023.PMC5333739.pdf
"Article available at  http://sickle.bwh.harvard.edu/sickle_trait.html , last accessed on  November  12th,  2016   4.",Non-OADS,/arxiv_data1/oa_pdf/80/d8/mjhid-9-1-e2017023.PMC5333739.pdf
"Hyg., 2014;91(6):1094 –1100  https://doi.org/10.4269/ajtmh.14 -0190     PMid:25294615      PMCid:PMC4257629   5.",Non-OADS,/arxiv_data1/oa_pdf/80/d8/mjhid-9-1-e2017023.PMC5333739.pdf
"Article available at  http://emedicine.medscape.com/article/193718 -workup#c5 , last  accessed on January 30th, 2017   6.",Non-OADS,/arxiv_data1/oa_pdf/80/d8/mjhid-9-1-e2017023.PMC5333739.pdf
Malar J  2010;9: 288. https://doi.org/10.1186/1475 -2875 -9-288     PMid:20955610      PMCid:PMC2984568   7.,OADS,/arxiv_data1/oa_pdf/80/d8/mjhid-9-1-e2017023.PMC5333739.pdf
"Mediterr J Hematol Infect Dis 2015, 7(1): e2015057  https://doi.org/10.4084/mjhid.2015.057     PMid:26543526       PMCid:PMC4621170",Non-OADS,/arxiv_data1/oa_pdf/80/d8/mjhid-9-1-e2017023.PMC5333739.pdf
"Citation:  Della Porta M.G., Picone  C.  Diagnostic utility of flow  cytometry in myelodysplastic syndromes..  Mediterr J Hematol Infect Dis  2017, 9(1): e201 7017, DOI: http://dx.doi.org/10.4084/MJHID.2017.017      Published:  15 February , 201 7 Received:  November 14 , 2016 Accepted:   January 20 , 201 7    This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by -nc/4.0 ),  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
2008;112:45 -55.  https://doi.org/10.1182/blood -2008 -01-134858     PMid:18443215     2.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
2011;38:627 -634 https://doi.org/10.1053/j.seminoncol.2011.04.007     PMid:21943669     3.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
2013;122:4021 - 4023 https://doi.org/10.1182/blood -2013 -09-381665       PMid:24136165 PMCid:PMC3862275   4.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
J Clin Oncol  2011 ;29:504 -515. https://doi.org/10.1200/JCO.2010.31.1175,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
J  Clin Oncol 2005;23:7594 -7603.   https://doi.org/10.120 0/JCO.2005.01.7038   PMid:16186598     6.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
Nature  2008;451:335 -339. https://doi.org/10.1038/nature06494       PMid:18202658  PMCid:PMC3771855   7.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
2013;122:3616 - 3627. https://doi.org/10.1182/blood -2013 -08-518886       PMid:24030381 PMCid:PMC3837510   8.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
2016;127:2391 - 2405.   https://doi.org/10.1182/blood -2016 -03-643544   PMid:27069254     9.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
Leuk Res  1999;23:283 -290. https://doi.org/10.1016/S0145 -2126(98)00166 -0   10.,OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
Haematologica 2008;93: 1712 - 1717. https://doi.org/10.3324/haematol.13405   PMid:18838480     11.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
2015;29:66 -75.   https://doi.org/10.1038/leu.2014.161   PMid:24935723     12.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
J Clin Oncol 2009 ;27:754 -762.  https://doi.org/10.1200/JCO.2008.18.2246   PMid:19103730     13.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
Blood 2008;111:3941 -3967.   https://doi.org/10.1182/blood -2007 -11-120535  PMid:18198345     14.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
Blood 2002;100:3887 -3896.   https://doi.org/10.1182/blood -2002 -01-0222    PMid:12393641     15.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
Cytometry 1997;30:249 -263 https://doi.org/10.1002/(SICI)1097 - 0320(19971015)30:5<249::AID -CYTO6>3.0.CO;2 -C   16.,OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
Blood 2001;98:979 -987.   https://doi.org/10.1182/blood.V98.4.979   PMid:11493442     17.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
Leukemia 2005;19:776 - 783.  https://doi.org/10.1038/sj.leu.2403680   PMid:15789068     18.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
"Blood  2003;102:394 -403. https://doi.org/10.1182/blood -2002 -09-2768       PMid:12649150     19. van de Loosdrecht AA, Westers TM, Westra AH, Drager AM, van  der Velden VH, Ossenkoppele GJ.",Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
Blood  2008;111:1067 -1077. https://doi.org/10.1182/blood -2007 -07- 098764     PMid:17971483     20.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
"Cancer  2010;116:4549 -45633 https://doi.org/10.1002/cncr.25353      PMid:20572043    21. van de Loosdrecht AA, Alhan C, Ben e MC, et al.",Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
Haematologica  2009;94:1124 -1134. https://doi.org/10.3324/haematol.2009.005801      PMid:19546437  PMCid:PMC2719035   22.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
2013;122:2943 -2964 https://doi.org/10.1182/blood -2013 -03- 492884   PMid:23980065  PMCid:PMC3811170   23.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
Leuk Res 2008;32:699 -707.   https://doi.org/10.1016/j.leukres.2007.08.022   PMid: 17936901     24.,OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
Leuk Res 2008;32:215 -224.  https://doi.org/10.1016/j.leukres.2007.06.012   PMid:17675229     25.,OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
Leuk Lymphoma 2009;50:401 -409.   https://doi.org/10.1080/10428190902755497   PMid:19294559     26.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
2016;30:658 -665.   https://doi.org/10.1038/leu.2015.2 95  PMid:26503643     27.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
2012;26:1730 -1741.   https://doi.org/10.1038/leu.2012.30   PMid:22307178     28.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
2016;30:1769 -1772.   https://doi.org/10.1038/leu.2016.44   PMid:26922887     29.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
"2014;28:1793 -1798.   https://doi.org/10.1038/leu.2014.191   PMid:24919805     30. van de Loosdrecht AA, Ireland R, Kern W, et al.",OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
2013;54:472 -475.   https://doi.org/10.3109/104281 94.2012.718341   PMid:22916713     31.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
Leuk Res 2004;28:1171 - 1175 https://doi.org/10.1016/j.leukres.2004.03.014       PMid:15380341     32.,OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
Bloo d. 2006;108:1037 -1044   https://doi.org/10.1182/blood -2005 -12-4916   PMid:16574954     33.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
Blood 2005;106:2982 -2991. https://doi.org/10.1182/blood -2005 - 04-1543     PMid:16076868     34.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
Am J  Clin Pathol 2008;129:300 -308.   https://doi.org/10.1309/4W2G3NDXUPG5J33N     PMid:18208811     35.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
20 08;22:530 -537.   https://doi.org/10.1038/sj.leu.2405069   PMid:18094717     36.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
Haematologica 2009;94:1066 -1074.  https://doi.org/10.3324/haematol.2009.008532   PMid:1 9546439,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
2012;97:1209 -1217.  https://doi.org/10.3324/haematol.2011.048421   PMid:22315489   PMCid:PMC3409819   38.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
2015;100:472 -478.   https://doi.org/10.3324/haematol.2014.112755  PMid:25637056        PMCid:PMC4380720   39.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
Leukemia 2006;20:549 -555   https://doi.org/10.1038/sj.leu.2404142   PMid:16498394     41.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
2013;27:1981 -1987.   https://doi.org/10.1038/leu.2013.178   PMid:23765225     42.,Non-OADS,/arxiv_data1/oa_pdf/60/59/mjhid-9-1-e2017017.PMC5333741.pdf
"Mediterr J Hematol Infect Dis 201 7, 9(1): e201 7013, DOI:  http://dx.doi.org/10.4084/MJHID.2017.013      Published:  February 15 , 201 7 Received:  October 9 , 201 6 Accepted:   January 9, 201 7    This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by -nc/4.0 ),  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
2010; 34: 135 -44.  http://dx.doi.org/10.3109/03630261003677213     4.,Non-OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
Vox Sang  1990; 58( 1): 50 -5. http://dx.doi.org/10.1111/j.1423 - 0410.1990.tb02055.x     7.,Non-OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
Transfusion 2002 Jan; 42(1):  37-43. http://dx.doi.org/10.1046/j.1537 -2995.2002.00007.x     9.,OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
J. Haematol 199 9 Jan; 104(1): 189 -94.  http://dx.doi.org/10.1046/j.1365 -2141.1999.01127.x     11.,Non-OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
Biol Res 2005; 38:  675-682 http://dx.doi.org/10.1590/s0100 -879x2005000500004     12.,Non-OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
2013;122(6):1062 -71.   https://doi.org/10.1182/blood -2013 -03-490623     13.,Non-OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
2013;53(4):704 -9.   https://doi.org/10.1111/j.1537 -2995.2012.03796.x     14.,Non-OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
"N Eng J Med 1990, 322: 1617 -21.  http://dx.doi.org/10.1056/nejm199006073222301     17.",OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
2016 Jan -Jun;10(1):88 -92.    http://dx.doi.org/10.4103/0973 -6247.172179    18.,Non-OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
2014  Apr;54(4):972 -81; quiz 971. http://dx.doi.org/10.1111/trf.12348     20.,Non-OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
Transfus Apher  Sci.2008;39:199 -204.  http://dx.doi.org/10.1016/j.transci.2008.09.013     22.,OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
Transfusion 1985 Mar -Apr; 25(2)110 -2.  http://dx.doi.org/10.1046/j.1537 -2995.1985.25285169198.x     23.,Non-OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
Hematol 2001 Jan; 38(1 suppl 1): 14 -22  http://dx.doi.org/10.1053/shem.2001.20140     24.,OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
J Hematol 1996 Jul; 52(3): 197 -200.   http://dx.doi.org/10.1002/(sici)1096 -8652(199607)52:3<197::aid - ajh11> 3.0.co;2 -d,OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
2016 Aug;91(8):763 -9.   http://dx.doi.org/10.1002/ajh.24397    26.,Non-OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
1994; (1): 27 -34.  http://dx.doi.org/10.1016/s1246 -7820(05 )80054 -0    27.,Non-OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
Braz J Med Biol Res 2005 May;  38(5) : 675 -82.   http://dx.doi.org/10.1590/s0100 -879x20050 00500004     28.,Non-OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
https://doi.org/10.1002/ajh.20959     29.,Non-OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
https://doi.or g/10.1182/blood -2007 -03- 083105     30.,Non-OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
https://doi.org/10.1590/s0 100-879x2005000500004     31.,Non-OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
Am  Soc Hematol Educ program 2009: 178 -84.   http://dx.doi.,OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
Haematologica 2008 se p;93(9):  1408 -10.   http://dx.doi.org/10.3324/haematol.12766     34.,Non-OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
Transfusion 2001 Sep; 41(9): 1086 -92.  http://dx.doi.org/10.1046/j.1537 -2995.2001.41091086.x     35.,OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
1996  Sept; 6(3):273 -83.  http://dx.doi.org/10.1111/j.1365 -3148.1996.tb00079.x     36.,Non-OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
Pediatr Hematol Oncol 2011  Mar; 28(2): 124 -33.  http://dx.doi.org/10.3109/08 880018.2010.505506     37.,Non-OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
Transfusions 2002 Jun; 42:684 -90.  http://dx.doi.org/10.1046/j.1537 -2995.2002.00126.x     38.,OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
2016 Oct;30(4):197 -201.  http://dx.doi.org/10.1016/j.tmrv.2016.05.011,OADS,/arxiv_data1/oa_pdf/96/43/mjhid-9-1-e2017013.PMC5333756.pdf
"Mediterr  J Hematol Infect Dis  2017, 9(1): e201 7020, DOI: http://dx.doi.org/10.4084/MJHID.2017.020     This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by -nc/4.0 ),  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/9c/mjhid-9-1-e2017020.PMC5333762.pdf
2013 Oct 10;122(15):2751 - 6. https://doi.org/10.1182/blood -2013 -07-513473   2.,Non-OADS,/arxiv_data1/oa_pdf/7a/9c/mjhid-9-1-e2017020.PMC5333762.pdf
2016 Nov;22(11):2056 -2064.  https://doi.org/10.1016/j.bbmt.2016.08.006   3.,OADS,/arxiv_data1/oa_pdf/7a/9c/mjhid-9-1-e2017020.PMC5333762.pdf
2014;124(5):822 – 6. https://doi.org/10.1182/blood -2014 -03-563817    PMid:24869942     4.,Non-OADS,/arxiv_data1/oa_pdf/7a/9c/mjhid-9-1-e2017020.PMC5333762.pdf
2015 J un;50Su ppl 2:S37 -9.    https://doi.org/10.1038/bmt.2015.93   5.,Non-OADS,/arxiv_data1/oa_pdf/7a/9c/mjhid-9-1-e2017020.PMC5333762.pdf
2016 Nov;   23(6):515 -523. https://doi.org/10.1097/MOH.0000000000000280     PMid:27537474    6.,Non-OADS,/arxiv_data1/oa_pdf/7a/9c/mjhid-9-1-e2017020.PMC5333762.pdf
https://doi.org/10.1101/cshperspect.a011825   7.,Non-OADS,/arxiv_data1/oa_pdf/7a/9c/mjhid-9-1-e2017020.PMC5333762.pdf
doi: 1 0.4081/pr.2011.s2.e13   https://doi.org/10.4081/pr.2011.s2.e13   8.,Non-OADS,/arxiv_data1/oa_pdf/7a/9c/mjhid-9-1-e2017020.PMC5333762.pdf
2015 Jul 10;8:84   https://doi.org/10.1186/s13045 -015-0182 -9   PMid:26156584       PMCid:PMC4496923   9.,OADS,/arxiv_data1/oa_pdf/7a/9c/mjhid-9-1-e2017020.PMC5333762.pdf
https://doi.org/10.3389/fimmu.2016.00307   10.,Non-OADS,/arxiv_data1/oa_pdf/7a/9c/mjhid-9-1-e2017020.PMC5333762.pdf
"Medite rr J Hematol Infect Dis 2016, 8(1):   e2016048   https://doi.org/10.4084/mjhid.2016.048   11.",Non-OADS,/arxiv_data1/oa_pdf/7a/9c/mjhid-9-1-e2017020.PMC5333762.pdf
Epub 2010  Jun 25. https://doi.org/10.1182/blood -2010 -05-283051   12.,Non-OADS,/arxiv_data1/oa_pdf/7a/9c/mjhid-9-1-e2017020.PMC5333762.pdf
2010 Nov;45(11):1618 -24. https://doi.org/10.1038/bmt.2010.24   13.,Non-OADS,/arxiv_data1/oa_pdf/7a/9c/mjhid-9-1-e2017020.PMC5333762.pdf
https://doi.org/10.1182/blood -2014 -09-599993    PMid:25769621     14.,Non-OADS,/arxiv_data1/oa_pdf/7a/9c/mjhid-9-1-e2017020.PMC5333762.pdf
2011 Jun  6;585(11) :1563 -7.    https://doi.org/10.1016/j.febslet.2011.04.061   15.,OADS,/arxiv_data1/oa_pdf/7a/9c/mjhid-9-1-e2017020.PMC5333762.pdf
https://doi.org/10.1111/tan.12262,Non-OADS,/arxiv_data1/oa_pdf/7a/9c/mjhid-9-1-e2017020.PMC5333762.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 109",Non-OADS,/arxiv_data1/oa_pdf/7f/a3/i0006-3363-95-5-109.PMC5333933.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 95",Non-OADS,/arxiv_data1/oa_pdf/74/f4/i0006-3363-95-5-95.PMC5333934.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 60",Non-OADS,/arxiv_data1/oa_pdf/46/91/i0006-3363-95-3-60.PMC5333935.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 62",Non-OADS,/arxiv_data1/oa_pdf/8c/ec/i0006-3363-95-3-62.PMC5333936.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 73",Non-OADS,/arxiv_data1/oa_pdf/93/c9/i0006-3363-95-4-73.PMC5333937.pdf
"Sequences of primer pairs Esr1, Esr2, and 18S rRNA (18S) were obtained from National Institutes of Health quantitative PCR primer depot (https://mouseprimerdepot.nci.nih.gov).",OADS,/arxiv_data1/oa_pdf/93/c9/i0006-3363-95-4-73.PMC5333937.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 74",Non-OADS,/arxiv_data1/oa_pdf/1f/5c/i0006-3363-95-4-74.PMC5333938.pdf
http://www.gbif.org/resource/81287.,Non-OADS,/arxiv_data1/oa_pdf/1f/5c/i0006-3363-95-4-74.PMC5333938.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 92",Non-OADS,/arxiv_data1/oa_pdf/e5/7f/i0006-3363-95-4-92.PMC5333939.pdf
"Overrepresented Gene Ontology Terms, Upstream Regulators, and Pathway Analysis To further interrogate the differences in transcript abundance associated with the sex of the conceptus, the list of DEGs was subjected to analysis using the functional annotation tool in DAVID (http://david.abcc.ncifcrf.gov/) togenerate overrepresented biological processes and molecular functions.",OADS,/arxiv_data1/oa_pdf/e5/7f/i0006-3363-95-4-92.PMC5333939.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 121",Non-OADS,/arxiv_data1/oa_pdf/3c/4b/i0006-3363-95-6-121.PMC5333941.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 122",Non-OADS,/arxiv_data1/oa_pdf/d8/5b/i0006-3363-95-6-122.PMC5333942.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 123",Non-OADS,/arxiv_data1/oa_pdf/0e/60/i0006-3363-95-6-123.PMC5333943.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 125",Non-OADS,/arxiv_data1/oa_pdf/46/f2/i0006-3363-95-6-125.PMC5333944.pdf
"These same correlations between  the level of PRK correction and the healing of the cornea with  or without anterior stromal fibrosis are also noted in human  corneas that are not treated with mitomycin C except that the  proportion of human corneas that develop haze after high- correction PRK is much lower (2% to 5%) [ 21,22] than it is in  the rabbit (100%) [ 1], and the time course for the development  of maximal fibrosis is much longer in humans (approximately  3 to 4 months) [ 21,22] than it is in the rabbit (approximately  1 month) [ 1].Molecular Vision  2017; 23:39-51 <http://www.molvis.org/molvis/v 23/39> Received 30 October 2016 | Accepted 23 February 2017 | Published 26 February 2017© 2017 Molecular Vision 39EBM regeneration and changes in EBM component mRNA  expression in stromal cells after corneal injury Abirami Santhanam,1 Gustavo K. Marino,1, 2 Andre A. M. Torricelli,1, 2 Steven E. Wilson1 1Cole Eye Institute, Cleveland Clinic, Cleveland, OH; 2University of Sao Paulo, Sao Paulo, Brazil Purpose:  To investigate the production of the epithelial basement membrane (EBM) component mRNAs at time points  before lamina lucida and lamina densa regeneration in anterior stromal cells after corneal injury that would heal with  and without fibrosis.",Non-OADS,/arxiv_data1/oa_pdf/10/c3/mv-v23-39.PMC5334000.pdf
Molecular Vision  2017; 23:39-51 <http://www.molvis.org/molvis/v 23/39> © 2017 Molecular Vision  40 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/10/c3/mv-v23-39.PMC5334000.pdf
"Molecular Vision  2017; 23:39-51 <http://www.molvis.org/molvis/v 23/39> © 2017 Molecular Vision  41The corneal EBM is assembled from four primary  components: collagens (including collagen type IV), lami - nins (including laminin 332), heparan sulfate proteoglycans  (HSPGs; including perlecan, Hspg2), and nidogens (1 and  2) [23-26].",Non-OADS,/arxiv_data1/oa_pdf/10/c3/mv-v23-39.PMC5334000.pdf
"Molecular Vision  2017; 23:39-51 <http://www.molvis.org/molvis/v 23/39> © 2017 Molecular Vision  42Ultrathin 85 nm thick sections were cut with a diamond knife,  stained with 5% uranyl acetate and lead citrate, and observed  using a Phillips CM12 transmission electron microscope  operated at 60 kV (FEI Company, Hillsboro, OR).",Non-OADS,/arxiv_data1/oa_pdf/10/c3/mv-v23-39.PMC5334000.pdf
"Molecular Vision  2017; 23:39-51 <http://www.molvis.org/molvis/v 23/39> © 2017 Molecular Vision  43for the most part had no ultrastructural regeneration of the  lamina lucida or the lamina densa, but there were small areas  where nascent lamina lucida and lamina densa regeneration  was detected.",Non-OADS,/arxiv_data1/oa_pdf/10/c3/mv-v23-39.PMC5334000.pdf
"Molecular Vision  2017; 23:39-51 <http://www.molvis.org/molvis/v 23/39> © 2017 Molecular Vision  44Assessing the purity of the LCM specimens:  To confirm the  specificity and purity of each LCM cDNA sample extracted  from the LCM fragments combined from a single cornea, all  samples were screened for epithelial and stromal cell markers  with real-time PCR.",Non-OADS,/arxiv_data1/oa_pdf/10/c3/mv-v23-39.PMC5334000.pdf
Molecular Vision  2017; 23:39-51 <http://www.molvis.org/molvis/v 23/39> © 2017 Molecular Vision  45 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/10/c3/mv-v23-39.PMC5334000.pdf
"Molecular Vision  2017; 23:39-51 <http://www.molvis.org/molvis/v 23/39> © 2017 Molecular Vision  46At 4 days post-PRK (Figure 5), the relative nidogen-1  mRNA levels were not statistically significantly different  in the anterior stroma of the −4.5D PRK, −9.0D PRK, and  non-wounded control corneas.",Non-OADS,/arxiv_data1/oa_pdf/10/c3/mv-v23-39.PMC5334000.pdf
"Molecular Vision  2017; 23:39-51 <http://www.molvis.org/molvis/v 23/39> © 2017 Molecular Vision  47development of myofibroblast cells from keratocyte- and  bone marrow–derived precursor cells (Figure 1D) [ 1-4,7,8].",Non-OADS,/arxiv_data1/oa_pdf/10/c3/mv-v23-39.PMC5334000.pdf
Molecular Vision  2017; 23:39-51 <http://www.molvis.org/molvis/v 23/39> © 2017 Molecular Vision  48proteins in rabbit corneas.,Non-OADS,/arxiv_data1/oa_pdf/10/c3/mv-v23-39.PMC5334000.pdf
"Molecular Vision  2017; 23:39-51 <http://www.molvis.org/molvis/v 23/39> © 2017 Molecular Vision  49undergo apoptosis when they are deprived of high levels  of epithelial TGFβ and PDGF needed for survival [ 8,36].",Non-OADS,/arxiv_data1/oa_pdf/10/c3/mv-v23-39.PMC5334000.pdf
Molecular Vision  2017; 23:39-51 <http://www.molvis.org/molvis/v 23/39> © 2017 Molecular Vision  506.,Non-OADS,/arxiv_data1/oa_pdf/10/c3/mv-v23-39.PMC5334000.pdf
Molecular Vision  2017; 23:39-51 <http://www.molvis.org/molvis/v 23/39> © 2017 Molecular Vision  5130.,Non-OADS,/arxiv_data1/oa_pdf/10/c3/mv-v23-39.PMC5334000.pdf
"Given  the presence of various pockets of positively charged amino  acids on these viral glycoproteins, developing antivirals that Molecular Vision  2017; 23:26-38 <http://www.molvis.org/molvis/v 23/26> Received 9 September 2016 | Accepted 23 February 2017 | Published 26 February 2017© 2017 Molecular Vision 26Zinc oxide tetrapods inhibit herpes simplex virus infection of  cultured corneas Neil Duggal,1 Dinesh Jaishankar,1,2 Tejabhiram Yadavalli,1 Satvik Hadigal,1 Yogendra Kumar Mishra,4 Rainer  Adelung,4 Deepak Shukla1,2,3 1Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, IL; 2Department of Bioengineering,  University of Illinois at Chicago, IL; 3Department of Microbiology and Immunology, University of Illinois at Chicago, IL;  4Functional Nanomaterials, Institute for Materials Science, Kiel University, Kiel, Germany Purpose:  Infection of the human cornea by herpes simplex virus type-1 (HSV-1) can cause significant vision loss.",Non-OADS,/arxiv_data1/oa_pdf/32/5d/mv-v23-26.PMC5334001.pdf
Molecular Vision  2017; 23:26-38 <http://www.molvis.org/molvis/v 23/26> © 2017 Molecular Vision  27contain negatively charged molecules has yielded promising  results [ 8].,Non-OADS,/arxiv_data1/oa_pdf/32/5d/mv-v23-26.PMC5334001.pdf
"Molecular Vision  2017; 23:26-38 <http://www.molvis.org/molvis/v 23/26> © 2017 Molecular Vision  28(2 mM MgCl2, 0.01% deoxycholate, 0.02% NP-40) overnight  (corneas) or 20 min (HCE cells).",Non-OADS,/arxiv_data1/oa_pdf/32/5d/mv-v23-26.PMC5334001.pdf
Molecular Vision  2017; 23:26-38 <http://www.molvis.org/molvis/v 23/26> © 2017 Molecular Vision  29less than 0.05 was considered statistically significant between  the control and treatment groups.,Non-OADS,/arxiv_data1/oa_pdf/32/5d/mv-v23-26.PMC5334001.pdf
Molecular Vision  2017; 23:26-38 <http://www.molvis.org/molvis/v 23/26> © 2017 Molecular Vision  30 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/32/5d/mv-v23-26.PMC5334001.pdf
Molecular Vision  2017; 23:26-38 <http://www.molvis.org/molvis/v 23/26> © 2017 Molecular Vision  31 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/32/5d/mv-v23-26.PMC5334001.pdf
Molecular Vision  2017; 23:26-38 <http://www.molvis.org/molvis/v 23/26> © 2017 Molecular Vision  32 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/32/5d/mv-v23-26.PMC5334001.pdf
Molecular Vision  2017; 23:26-38 <http://www.molvis.org/molvis/v 23/26> © 2017 Molecular Vision  33 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/32/5d/mv-v23-26.PMC5334001.pdf
Molecular Vision  2017; 23:26-38 <http://www.molvis.org/molvis/v 23/26> © 2017 Molecular Vision  34 Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/32/5d/mv-v23-26.PMC5334001.pdf
"Molecular Vision  2017; 23:26-38 <http://www.molvis.org/molvis/v 23/26> © 2017 Molecular Vision  35DISCUSSION Characterizing herpes simplex virus and its ability to infect  cornea tissue is an important concern, as HSV-1 is known  to cause keratitis, which results in loss of vision.",Non-OADS,/arxiv_data1/oa_pdf/32/5d/mv-v23-26.PMC5334001.pdf
Molecular Vision  2017; 23:26-38 <http://www.molvis.org/molvis/v 23/26> © 2017 Molecular Vision  36reducing the spread of infection and decreasing the produc - tion of the viral proteins necessary for secondary infection to  occur.,Non-OADS,/arxiv_data1/oa_pdf/32/5d/mv-v23-26.PMC5334001.pdf
Molecular Vision  2017; 23:26-38 <http://www.molvis.org/molvis/v 23/26> © 2017 Molecular Vision  37REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/32/5d/mv-v23-26.PMC5334001.pdf
Molecular Vision  2017; 23:26-38 <http://www.molvis.org/molvis/v 23/26> © 2017 Molecular Vision  3827.,Non-OADS,/arxiv_data1/oa_pdf/32/5d/mv-v23-26.PMC5334001.pdf
"This review discusses the pathophysiology of SCI and introduces the therapeutic candidates that have been developed so far.Keywords: Spinal cord injuries, Neuroprotective, Neuroregenerative, PathophysiologyReview Article    Clinics in Orthopedic Surgery 2017;9:1-9   •  https://doi.org/10.4055/cios.2017.9.1.1 Copyright © 2017 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/62/cios-9-1.PMC5334017.pdf
"Keywords: Hip fractures, Mortality, Risk factors, EpidemiologyOriginal Article    Clinics in Orthopedic Surgery 2017;9:10-18   •  https://doi.org/10.4055/cios.2017.9.1.10 Copyright © 2017 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/23/ed/cios-9-10.PMC5334018.pdf
"Keywords: Metadiaphyseal junction, Forearm fractures, Adolescent, Flexible intramedullary nailingOriginal Article    Clinics in Orthopedic Surgery 2017;9:101-108   •  https://doi.org/10.4055/cios.2017.9.1.101 Copyright © 2017 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/3b/cios-9-101.PMC5334019.pdf
"This disease entity should be considered in the differential diagnosis of limb pain or motor disturbance in children to avoid unnecessary diagnostic work-up.Keywords: Camurati-Engelmann syndrome, Transforming growth factor beta 1, Phenotype Original Article    Clinics in Orthopedic Surgery 2017;9:109-115   •  https://doi.org/10.4055/cios.2017.9.1.109 Copyright © 2017 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/cd/cios-9-109.PMC5334020.pdf
Available from: http://www.ncbi.nlm.nih.gov/ books/NBK1156/.,Non-OADS,/arxiv_data1/oa_pdf/34/cd/cios-9-109.PMC5334020.pdf
"Primary cancer type, serum albumin level and visceral metastasis influenced survival.Keywords: Pelvic bones, Neoplasm metastasis, Bone neoplasms, Surgery, Disease progressionOriginal Article    Clinics in Orthopedic Surgery 2017;9:116-125   •  https://doi.org/10.4055/cios.2017.9.1.116 Copyright © 2017 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/22/cios-9-116.PMC5334021.pdf
"Our  centre employs a fairly restrictive transfusion policy and is  governed by a team of senior intensive care specialists who Blood Transfusion Rates as a Primary Outcome  Measure: The Use of Predetermined Triggers  and Display of Clinical Indications in Providing  Accurate Comparative Transfusion Rates David Skipsey, MBChB *, Felix Allen, MBBS *, Anwar Hussein, FRCA *,   Deiary Kader, MBChB *, Tomislav Smoljanovic, MD *,† *The South West London Elective Orthopaedic Centre, Epsom and St Helier University Hospitals NHS Trust, Surrey, UK, †Department of Orthopaedic Surgery, University Hospital Center Zagreb, School of Medicine, Zagreb University, Zagreb, CroatiaLetter to the Editor    Clinics in Orthopedic Surgery 2017;9:126-128   •  https://doi.org/10.4055/cios.2017.9.1.126 Copyright © 2017 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/22/cios-9-126.PMC5334022.pdf
"Received September 11, 2016; Accepted December 27, 2016 Correspondence to: David Skipsey, MBChB  The South West London Elective Orthopaedic Centre, Epsom and St Helier  University Hospitals NHS Trust, Dorking Road, Epsom, Surrey, KT18 7EG, UKTel: +44-13-7273-5825, Fax: +44-13-7273-5815  E-mail: david.skipsey@nhs.net https://doi.org/10.4055/cios.2017.9.1.126Table 1.",Non-OADS,/arxiv_data1/oa_pdf/74/22/cios-9-126.PMC5334022.pdf
"Two permanent neurologic complications occurred in patients with a limb lengthening over 3.5 cm.Conclusions: With proper selection of the bearing surface coupled with adjustment of lengthening, cementless total hip arthro-plasty using trochanteric osteotomy without subtrochanteric osteotomy might be a favorable treatment option for high hip disloca-tion.Keywords: Congenital hip dislocation, Hip replacement, Dislocations, Osteotomy, Leg length inequalityOriginal Article    Clinics in Orthopedic Surgery 2017;9:19-28   •  https://doi.org/10.4055/cios.2017.9.1.19 Copyright © 2017 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/cd/cios-9-19.PMC5334023.pdf
"We observed no differences among the healing patterns  on CT scans with regard to age, gender, etiology, staging, preoperative lesion type, preoperative intact area, percentage of necrotic area, direction of rotation and immediate postoperative intact area.Conclusions: The majority of the hips showed incomplete regeneration of the transposed osteonecrotic lesion with cysts, sclero-sis, and fragmentation, whereas repair with normal trabecular bone was observed only in one-third of the hips that were preserved after Sugioka TRO.Keywords: Femur head necrosis, Osteotomy, Repair, Computed tomographyOriginal Article    Clinics in Orthopedic Surgery 2017;9:29-36   •  https://doi.org/10.4055/cios.2017.9.1.29 Copyright © 2017 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/42/cios-9-29.PMC5334024.pdf
"Patients affected by VTE were older and hospitalized longer than the unaffected patients.Conclusions: The results of this study suggest that IPC might be an effective and safe method for the prevention of postoperative VTE.Keywords: Venous thromboembolism, Prevention, Pneumatic compressionOriginal Article    Clinics in Orthopedic Surgery 2017;9:37-42   •  https://doi.org/10.4055/cios.2017.9.1.37 Copyright © 2017 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/23/5b/cios-9-37.PMC5334025.pdf
[February 2015]; http://www.naemt.org/education/TCCC/guidelines_curriculum).,Non-OADS,/arxiv_data1/oa_pdf/e0/5d/cios-9-43.PMC5334026.pdf
"Conclusions: QCG was not significantly effective for reducing perioperative bleeding volume or the blood transfusion rate com-pared with standard gauze during TKA.Keywords: Knee, Replacement, Arthroplasty, Hemostasis, QuikClot Combat GauzeOriginal Article    Clinics in Orthopedic Surgery 2017;9:43-49   •  https://doi.org/10.4055/cios.2017.9.1.43 Copyright © 2017 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/5d/cios-9-43.PMC5334026.pdf
"Furthermore, meticulous surgical procedures and optimal alignment are required to reduce pain of intra-articular origin re-lated to implant wear, instability, and patellar maltracking.Keywords: Non-infective, Chronic pain, Causes, Total knee arthroplastyOriginal Article    Clinics in Orthopedic Surgery 2017;9:50-56   •  https://doi.org/10.4055/cios.2017.9.1.50 Copyright © 2017 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/f1/cios-9-50.PMC5334027.pdf
"LLD was not directly correlated with sacral slanting.Keywords: Scoliosis, Adolescent, Sacrum, Pelvis, Leg length inequalityOriginal Article    Clinics in Orthopedic Surgery 2017;9:57-62   •  https://doi.org/10.4055/cios.2017.9.1.57 Copyright © 2017 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/20/cios-9-57.PMC5334028.pdf
"Thus, when selecting a cervical implant, surgeons should consider patient height as well as estimated normal disc height.Keywords: Cervical spine, Intervertebral disc, Zygapophyseal joint, Disc degenerationOriginal Article    Clinics in Orthopedic Surgery 2017;9:63-70   •  https://doi.org/10.4055/cios.2017.9.1.63 Copyright © 2017 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/4a/cios-9-63.PMC5334029.pdf
"Keywords: Intervertebral disc displacement, Nerve root compression, Radiculopathy Original Article    Clinics in Orthopedic Surgery 2017;9:71-76   •  https://doi.org/10.4055/cios.2017.9.1.71 Copyright © 2017 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/24/cios-9-71.PMC5334030.pdf
"Careful sur - gical planning and rehabilitation is particularly important for crutch users and in the case of dominant arm involvement in disabled patients.Keywords: Rotator cuff, Disability, Paralysis, Treatment outcomeOriginal Article    Clinics in Orthopedic Surgery 2017;9:77-82   •  https://doi.org/10.4055/cios.2017.9.1.77 Copyright © 2017 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/90/cios-9-77.PMC5334031.pdf
"Complications such as loosening and scapular fractures did not occur.Conclusions: The eccentric glenosphere in RSA was more effective in reducing the rate of notching than the concentric gleno-sphere although clinical outcomes were not significantly different in the short-term follow-up.Keywords: Shoulder, Replacement, Reverse, Eccentric glenosphere, Scapular notchingOriginal Article    Clinics in Orthopedic Surgery 2017;9:83-90   •  https://doi.org/10.4055/cios.2017.9.1.83 Copyright © 2017 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/23/d6/cios-9-83.PMC5334032.pdf
"Therefore, it is necessary to consider the possibility of schwan-noma if a mass near the digital nerve or cutaneous nerve branch is accompanied by dull pain and tenderness.Keywords: Hand, Schwannoma, UltrasonographyOriginal Article    Clinics in Orthopedic Surgery 2017;9:91-95   •  https://doi.org/10.4055/cios.2017.9.1.91 Copyright © 2017 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/61/cios-9-91.PMC5334033.pdf
"Keywords: Carpal tunnel syndrome, Patient preferenceOriginal Article    Clinics in Orthopedic Surgery 2017;9:96-100   •  https://doi.org/10.4055/cios.2017.9.1.96 Copyright © 2017 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/14/cios-9-96.PMC5334034.pdf
"http://immunenetwork.org 1pISSN 1598-2629 · eISSN 2092-6685 Host-microbial Cross-talk in Inflammatory Bowel Disease Hiroko Nagao-Kitamoto and Nobuhiko Kamada* Division of Gastroenterology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USAhttps://doi.org/10.4110/in.2017.17.1.1REVIEW ARTICLE INTRODUCTION In recently years, technological advances in microbio- logical research, such as next generation sequencing, improved anaerobic culture methods, high-throughput analysis of luminal metabolites, and wider availability of gnotobiotic (GB) mouse models, have revolutionized our understanding of the functional impact gut microbiota has on host physiology and disease.",Non-OADS,/arxiv_data1/oa_pdf/0f/ea/in-17-1.PMC5334117.pdf
"The Gut Microbiota in IBD http://immunenetwork.org 3Table I. IBD-associated dysbiosis in the gut Disease Sample source Phylum Family Species possible mechanisms References Decreased beneficial bacteria    UC and CD Ileum, Fecal Firmicutes ClostridiaceaeFaecalibacterium prausnitzii Butyrate↓, anti-inflammatory effect ↓ (IL-10↓,     NF- IL-12↑, IFNg↑, TNF-a↑, IL-8↑, NF- kB activation)14, 15, 18,    19, 20, 21    UC Fecal Firmicutes LachnospiraceaeRoseburia hominis Butyrate↓ 21    CD Fecal Firmicutes Eubacteriaceae Butyrate↓ 14    CD Fecal Firmicutes VeillonellaceaeDialister invisus Propinate↓, acetate↓ 15    CD Fecal Firmicutes RuminococcaceaeRuminococcus albus Cellulose degradation↓, Acetate 14, 28    CD Fecal Firmicutes RuminococcaceaeRuminococcus callidus Polysaccharides degradation↓ (e.g.",Non-OADS,/arxiv_data1/oa_pdf/0f/ea/in-17-1.PMC5334117.pdf
The Gut Microbiota in IBD http://immunenetwork.org 5island of pathogenicity that encodes multi-enzymatic  machinery for the production of a bacterial genotoxin called colibactin (52) (Table I).,Non-OADS,/arxiv_data1/oa_pdf/0f/ea/in-17-1.PMC5334117.pdf
The Gut Microbiota in IBD http://immunenetwork.org 7phenotypes are also observed in donor stool samples.,Non-OADS,/arxiv_data1/oa_pdf/0f/ea/in-17-1.PMC5334117.pdf
The Gut Microbiota in IBD http://immunenetwork.org 9differentiation of colonic regulatory T cells.,Non-OADS,/arxiv_data1/oa_pdf/0f/ea/in-17-1.PMC5334117.pdf
The Gut Microbiota in IBD http://immunenetwork.org 1173.,Non-OADS,/arxiv_data1/oa_pdf/0f/ea/in-17-1.PMC5334117.pdf
"http://immunenetwork.org 13pISSN 1598-2629 · eISSN 2092-6685 The Specific Roles of Vitamins in the Regulation of  Immunosurveillance and Maintenance of Immunologic Homeostasis in the Gut Koji Hosomi1 and Jun Kunisawa1,2,3,4* 1Laboratory of Vaccine Materials, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085,  2Graduate School of Medicine, Graduate School of Pharmaceutical Sciences, Graduate School of Dentistry, Osaka University, Osaka   565-0871, 3Division of Mucosal Immunology, Department of Microbiology and Immunology and International Research and Development  Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, 4Department of Microbiology  and Immunology, Kobe University Graduate School of Medicine, Hyogo 650-0017, Japanhttps://doi.org/10.4110/in.2017.17.1.13REVIEW ARTICLE INTRODUCTION Gastrointestinal tracts are continuously exposed to en- vironmental factors including pathogenic microorga-nisms (e.g., bacteria, virus, toxins, etc.).",Non-OADS,/arxiv_data1/oa_pdf/0e/21/in-17-13.PMC5334118.pdf
Vitamins in Gut Immunity http://immunenetwork.org 15roxyvitamin D3)-vitamin D receptor axis strengthens  the epithelial tight junction in the gut by upregulating  tight junction proteins such as claudins (Fig.,Non-OADS,/arxiv_data1/oa_pdf/0e/21/in-17-13.PMC5334118.pdf
"Vitamins in Gut Immunity http://immunenetwork.org 17cells, especially mucosal associated invariant T (MAIT)  cells, an abundant population of innate-like T cells (Fig.",Non-OADS,/arxiv_data1/oa_pdf/0e/21/in-17-13.PMC5334118.pdf
Vitamins in Gut Immunity http://immunenetwork.org 19activation.,Non-OADS,/arxiv_data1/oa_pdf/0e/21/in-17-13.PMC5334118.pdf
"20pISSN 1598-2629 · eISSN 2092-6685 Microbiota Influences Vaccine and Mucosal Adjuvant  Efficacy Yun-Gi Kim* Division of Biochemistry, Faculty of Pharmacy, Keio University, Tokyo 105-8512, Japanhttps://doi.org/10.4110/in.2017.17.1.20REVIEW ARTICLE INTRODUCTION The human gut harbors trillions of bacteria that contribute  to host physiological and immunological functions such as nutrient acquisition, maintenance of the gut immune system, and protection against exogenous pathogens (1-3).",Non-OADS,/arxiv_data1/oa_pdf/fe/41/in-17-20.PMC5334119.pdf
Microbiota and Vaccine Efficacy http://immunenetwork.org 21role of bacterial metabolites in the gut immune response.,Non-OADS,/arxiv_data1/oa_pdf/fe/41/in-17-20.PMC5334119.pdf
"Microbiota and Vaccine Efficacy http://immunenetwork.org 23CONClUDINg RemaRKs It is well known that the efficacy of oral vaccines depends  on several factors such as genetic background, prior exposure to antigen via natural infection or vaccination, and nutritional status.",Non-OADS,/arxiv_data1/oa_pdf/fe/41/in-17-20.PMC5334119.pdf
"http://immunenetwork.org 25pISSN 1598-2629 · eISSN 2092-6685 Pathogenesis of Inflammatory Bowel Disease and Recent  Advances in Biologic Therapies Duk Hwan Kim1 and Jae Hee Cheon2,3,4* 1Digestive Disease Center, CHA Bundang Hospital, CHA University, Seongnam 13496, 2Department of Internal Medicine and Institute  of Gastroenterology, Yonsei University College of Medicine, 3Severance Biomedical Science Institute, Yonsei University College of  Medicine, 4Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul 03722, Koreahttps://doi.org/10.4110/in.2017.17.1.25REVIEW ARTICLE INTRODUCTION The entire surface of the human intestine reaches 200~  400 m2 (1).",Non-OADS,/arxiv_data1/oa_pdf/84/a1/in-17-25.PMC5334120.pdf
Mucosal Immunity in Inflammatory Bowel Disease http://immunenetwork.org 27ted.,Non-OADS,/arxiv_data1/oa_pdf/84/a1/in-17-25.PMC5334120.pdf
Mucosal Immunity in Inflammatory Bowel Disease http://immunenetwork.org 29treatment of intestinal inflammation (75).,Non-OADS,/arxiv_data1/oa_pdf/84/a1/in-17-25.PMC5334120.pdf
Mucosal Immunity in Inflammatory Bowel Disease http://immunenetwork.org 31Inhibition of TGF- b1 in healthy human intestines results  in increased production of proinflammatory cytokines  (133).,Non-OADS,/arxiv_data1/oa_pdf/84/a1/in-17-25.PMC5334120.pdf
"Mucosal Immunity in Inflammatory Bowel Disease http://immunenetwork.org 33over, future IBD therapy should be approached in terms  of “patient-customized treatment,” and it is anticipated that it will be a great help in clinical practice to have a drug repertoire targeting various mechanisms of the disease.",Non-OADS,/arxiv_data1/oa_pdf/84/a1/in-17-25.PMC5334120.pdf
Mucosal Immunity in Inflammatory Bowel Disease http://immunenetwork.org 35IL23R as an inflammatory bowel disease gene.,Non-OADS,/arxiv_data1/oa_pdf/84/a1/in-17-25.PMC5334120.pdf
Mucosal Immunity in Inflammatory Bowel Disease http://immunenetwork.org 37remission from ulcerative colitis.,Non-OADS,/arxiv_data1/oa_pdf/84/a1/in-17-25.PMC5334120.pdf
Mucosal Immunity in Inflammatory Bowel Disease http://immunenetwork.org 39T-cell differentiation and inflammatory bowel disease.,Non-OADS,/arxiv_data1/oa_pdf/84/a1/in-17-25.PMC5334120.pdf
"http://immunenetwork.org 41pISSN 1598-2629 · eISSN 2092-6685 Regulatory Eosinophils in Inflammation and Metabolic  Disorders Bo-Gie Yang1*, Ju-Yong Seoh2 and Myoung Ho Jang3 1Severance Biomedical Research Institute, Yonsei University College of Medicine, Seoul 03722, 2Department of Microbiology, Raduate  School of Medicine, Ewha Womans University, Seoul 07984, Korea, 3WPI Immunology Frontier Research Center, Osaka University,  Suita 565-0871, Japanhttps://doi.org/10.4110/in.2017.17.1.41REVIEW ARTICLE INTRODUCTION Eosinophils are potent effector cells implicated in  allergic responses and helminth infections and have cytotoxic granules containing major basic protein (MBP), eosinophil cationic protein (ECP), eosinophil peroxidase (EPO), and eosinophil-derived neurotoxin (EDN) (1).",Non-OADS,/arxiv_data1/oa_pdf/d6/bd/in-17-41.PMC5334121.pdf
"Regulatory Eosinophils http://immunenetwork.org 43activate dendritic cells (DCs) through a release of EPO  and promote their migration from the intestine to draining lymph nodes, thus initiating a primary Th2 immune response (19).",Non-OADS,/arxiv_data1/oa_pdf/d6/bd/in-17-41.PMC5334121.pdf
Regulatory Eosinophils http://immunenetwork.org 45by producing large amounts of IL-1Ra and thus alleviate  metabolic diseases.,Non-OADS,/arxiv_data1/oa_pdf/d6/bd/in-17-41.PMC5334121.pdf
Regulatory Eosinophils http://immunenetwork.org 47the new brown.,Non-OADS,/arxiv_data1/oa_pdf/d6/bd/in-17-41.PMC5334121.pdf
"Pohang University of Science and Technology, Pohang 37673, Koreahttps://doi.org/10.4110/in.2017.17.1.48REVIEW ARTICLE INTRODUCTION Metazoans have co-evolved with microorganisms by  establishing a trans-kingdom symbiotic relationship that influences many physiological functions of the host, including nutrient absorption, resistance to pathogenic infection, immune defense, and tissue repair (1).",Non-OADS,/arxiv_data1/oa_pdf/3f/d0/in-17-48.PMC5334122.pdf
Regulation of Allergic Responses by Commensal Microbiota http://immunenetwork.org 49in recent years.,Non-OADS,/arxiv_data1/oa_pdf/3f/d0/in-17-48.PMC5334122.pdf
"Regulation of Allergic Responses by Commensal Microbiota http://immunenetwork.org 51rhinitis (hay fever) is not reduced, but rather increased  during allergy season (44).",Non-OADS,/arxiv_data1/oa_pdf/3f/d0/in-17-48.PMC5334122.pdf
"Regulation of Allergic Responses by Commensal Microbiota http://immunenetwork.org 53Regulation of intestinal permeability to food allergens  In addition to the capacity of intestinal microbiota to pro- mote intestinal pTreg cells, Clostridium species can lead  to the production of IL-22 from ROR gt+ type 3 innate  lymphoid cells (ILC3s) and CD4+ T cells in colonic LP.",Non-OADS,/arxiv_data1/oa_pdf/3f/d0/in-17-48.PMC5334122.pdf
Regulation of Allergic Responses by Commensal Microbiota http://immunenetwork.org 55not only influence immune disorders directed towards  self- and foreign- antigens but also affect the pathogenesis of metabolic or neurological disorders.,Non-OADS,/arxiv_data1/oa_pdf/3f/d0/in-17-48.PMC5334122.pdf
Regulation of Allergic Responses by Commensal Microbiota http://immunenetwork.org 5739.,Non-OADS,/arxiv_data1/oa_pdf/3f/d0/in-17-48.PMC5334122.pdf
Regulation of Allergic Responses by Commensal Microbiota http://immunenetwork.org 59Dietary fiber and bacterial SCFA enhance oral tolerance and  protect against food allergy through diverse cellular pathways.,Non-OADS,/arxiv_data1/oa_pdf/3f/d0/in-17-48.PMC5334122.pdf
"60pISSN 1598-2629 · eISSN 2092-6685 Immune Cell Responses and Mucosal Barrier Disruptions  in Chronic Rhinosinusitis Roza Khalmuratova1, Jong-Wan Park1,2,3,4 and Hyun-Woo Shin1,2,3,4,5* 1Obstructive Upper airway Research (OUaR) Laboratory, Department of Pharmacology, Seoul National University College of Medicine,  2Department of Biomedical Sciences, Seoul National University College of Medicine, 3Ischemic/Hypoxic Disease Institute, Seoul  National University College of Medicine, 4Cancer Research Institute, Seoul National University College of Medicine, 5Department of  Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul 03080, Koreahttps://doi.org/10.4110/in.2017.17.1.60REVIEW ARTICLE INTRODUCTION Chronic rhinosinusitis (CRS) is a common upper airway  disease that affects 5 to 16% of the global population and has a significant socioeconomic impact.",Non-OADS,/arxiv_data1/oa_pdf/e2/db/in-17-60.PMC5334123.pdf
"Immune Cell Responses and Mucosal Barrier Disruptions in Chronic Rhinosinusitis http://immunenetwork.org 61is distinguished by stromal tissue edema, formation  of pseudocysts, and significant immune cell infiltrate.",Non-OADS,/arxiv_data1/oa_pdf/e2/db/in-17-60.PMC5334123.pdf
Immune Cell Responses and Mucosal Barrier Disruptions in Chronic Rhinosinusitis http://immunenetwork.org 63EMT.,Non-OADS,/arxiv_data1/oa_pdf/e2/db/in-17-60.PMC5334123.pdf
"Immune Cell Responses and Mucosal Barrier Disruptions in Chronic Rhinosinusitis http://immunenetwork.org 65Holtappels, R. N. De, C. Schmidt-Weber, C. Akdis, C. P. Van,  C. Bachert, and P. Gevaert.",Non-OADS,/arxiv_data1/oa_pdf/e2/db/in-17-60.PMC5334123.pdf
Immune Cell Responses and Mucosal Barrier Disruptions in Chronic Rhinosinusitis http://immunenetwork.org 67Immunol.,Non-OADS,/arxiv_data1/oa_pdf/e2/db/in-17-60.PMC5334123.pdf
"68pISSN 1598-2629 · eISSN 2092-6685 Emerging Roles of Lymphatic Vasculature in Immunity Ki-Wook Kim1#* and Joo-Hye Song2#* 1Department of Pathology and Immunology, Washington University in St. Louis, MO 63110, USA, 2Center for Vascular Research,  Institute of Basic Science, Daejeon 34141, Koreahttps://doi.org/10.4110/in.2017.17.1.68REVIEW ARTICLE INTRODUCTION The lymphatic vasculature system is important for at  least three functions; first, it controls the absorbance of nutrients including proteins and lipids from blood vasculature into peripheral tissues.",OADS,/arxiv_data1/oa_pdf/45/01/in-17-68.PMC5334124.pdf
Lymphatic Vasculature and Immune Modulation http://immunenetwork.org 69discuss studies from the perspective that the lymphatic  system is closely linked with the pathophysiology of inflammatory conditions and can control them.,Non-OADS,/arxiv_data1/oa_pdf/45/01/in-17-68.PMC5334124.pdf
"Lymphatic Vasculature and Immune Modulation http://immunenetwork.org 71In this regard, LECs participate in the immune response  by releasing an appropriate chemokine and cytokines in response to environmental changes in peripheral tissues.",Non-OADS,/arxiv_data1/oa_pdf/45/01/in-17-68.PMC5334124.pdf
Lymphatic Vasculature and Immune Modulation http://immunenetwork.org 73lipids.,Non-OADS,/arxiv_data1/oa_pdf/45/01/in-17-68.PMC5334124.pdf
Lymphatic Vasculature and Immune Modulation http://immunenetwork.org 75Regulated release of nitric oxide by nonhematopoietic stroma  controls expansion of the activated T cell pool in lymph nodes.,Non-OADS,/arxiv_data1/oa_pdf/45/01/in-17-68.PMC5334124.pdf
OHDSI (http://www.ohdsi.org) (Figure 1) is an organi- zation of international collaborators with more than 120 researchers committed to making this clinical big data analysis a reality.,Non-OADS,/arxiv_data1/oa_pdf/c3/ef/hir-23-1.PMC5334126.pdf
"2017 January;23(1):1-3. https://doi.org/10.4258/hir.2017.23.1.1pISSN 2093-3681  •  eISSN 2093-369X  Editorial This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/ef/hir-23-1.PMC5334126.pdf
"2 www.e-hir.orgRae Woong Park https://doi.org/10.4258/hir.2017.23.1.1virtually all diagnoses, prescriptions, and procedures that  have occurred in the country.",Non-OADS,/arxiv_data1/oa_pdf/c3/ef/hir-23-1.PMC5334126.pdf
"2017 January;23(1):16-24.  https://doi.org/10.4258/hir.2017.23.1.16pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: August 2, 2016Revised: November 20, 2016Accepted: November 25, 2016 Corresponding Author  Cristina Palacios, PhDNutrition Program, Graduate School of Public Health, Medical Sciences Campus, University of Puerto Rico, San Juan 00936, Puerto Rico.",Non-OADS,/arxiv_data1/oa_pdf/74/06/hir-23-16.PMC5334127.pdf
"1433), E-mail: cristina.palacios@upr.edu This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/06/hir-23-16.PMC5334127.pdf
18 www.e-hir.orgDesiree López et al https://doi.org/10.4258/hir.2017.23.1.161.,Non-OADS,/arxiv_data1/oa_pdf/74/06/hir-23-16.PMC5334127.pdf
"Spe-cifically, Dietary Reference Intakes for calculating energy requirements (based on age, gender, weight, height, and physical activity; http://fnic.nal.usda.gov/fnic/interac - tiveDRI/) and MyPlate webpage, which has practical information on the Dietary Guidelines for Americans, for calculating the number of servings per food group by ca-loric level (http://www.choosemyplate.gov/supertracker-tools/daily-food-plans.html).",Non-OADS,/arxiv_data1/oa_pdf/74/06/hir-23-16.PMC5334127.pdf
20 www.e-hir.orgDesiree López et al https://doi.org/10.4258/hir.2017.23.1.16requirement [1].,Non-OADS,/arxiv_data1/oa_pdf/74/06/hir-23-16.PMC5334127.pdf
"22 www.e-hir.orgDesiree López et al https://doi.org/10.4258/hir.2017.23.1.16about the app, such as taking into consideration the budget  and food specials (14.3%), using multiple supermarkets, and providing food portions.",Non-OADS,/arxiv_data1/oa_pdf/74/06/hir-23-16.PMC5334127.pdf
Available from: https://www.nal.usda.gov/fnic/dri-nutrient-reports.,Non-OADS,/arxiv_data1/oa_pdf/74/06/hir-23-16.PMC5334127.pdf
24 www.e-hir.orgDesiree López et al https://doi.org/10.4258/hir.2017.23.1.164.,Non-OADS,/arxiv_data1/oa_pdf/74/06/hir-23-16.PMC5334127.pdf
Available from: http://www.cdc.gov/brfss/brfssprevalence/.,OADS,/arxiv_data1/oa_pdf/74/06/hir-23-16.PMC5334127.pdf
Available from: http://www.mayoclinic.org/diseases-conditions/obesity/basics/risk-factors/con-20014834.,Non-OADS,/arxiv_data1/oa_pdf/74/06/hir-23-16.PMC5334127.pdf
Available from: http://health.gov/dietaryguide-lines/2015/guidelines/executive-summary/.,Non-OADS,/arxiv_data1/oa_pdf/74/06/hir-23-16.PMC5334127.pdf
Available from: http://www.health.gov/dietaryguidelines/work-shops/DGA_Workshops_Complete.pdf.,Non-OADS,/arxiv_data1/oa_pdf/74/06/hir-23-16.PMC5334127.pdf
Avail-able from: http://health.gov/dietaryguidelines/dga2010/dietaryguidelines2010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/74/06/hir-23-16.PMC5334127.pdf
Available from: http://www.andeal.org/vault/pq132.pdf.,Non-OADS,/arxiv_data1/oa_pdf/74/06/hir-23-16.PMC5334127.pdf
"2017 January;23(1):25-34.  https://doi.org/10.4258/hir.2017.23.1.25pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: January 3, 2017Revised: January 24, 2017Accepted: January 24, 2017 Corresponding Author  Kyoung Jun Lee, PhDSchool of Management, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea.",Non-OADS,/arxiv_data1/oa_pdf/29/cb/hir-23-25.PMC5334128.pdf
"Tel: +82-2-961-0490, E-mail: klee@khu.ac.kr This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/29/cb/hir-23-25.PMC5334128.pdf
26 www.e-hir.orgArum Park et al https://doi.org/10.4258/hir.2017.23.1.25increase from 15.6% in the latter half of 2010 to 25.6% in  2040.,OADS,/arxiv_data1/oa_pdf/29/cb/hir-23-25.PMC5334128.pdf
28 www.e-hir.orgArum Park et al https://doi.org/10.4258/hir.2017.23.1.25ing four service models were planned to enhance the quality  of healthcare services by providing innovative services to patients and medical staff.,Non-OADS,/arxiv_data1/oa_pdf/29/cb/hir-23-25.PMC5334128.pdf
30 www.e-hir.orgArum Park et al https://doi.org/10.4258/hir.2017.23.1.25agement system ( ⑨).,OADS,/arxiv_data1/oa_pdf/29/cb/hir-23-25.PMC5334128.pdf
"32 www.e-hir.orgArum Park et al https://doi.org/10.4258/hir.2017.23.1.25ogy to automate the current work process, which is time  consuming and error prone.",Non-OADS,/arxiv_data1/oa_pdf/29/cb/hir-23-25.PMC5334128.pdf
Available from: http://www.rfidjournal.com/articles/view?10511/2.,Non-OADS,/arxiv_data1/oa_pdf/29/cb/hir-23-25.PMC5334128.pdf
Available from: https://www.nfcworld.com/ 2011/09/06/39716/50000-dutch-nurses-now-using-nfc-phones/.,Non-OADS,/arxiv_data1/oa_pdf/29/cb/hir-23-25.PMC5334128.pdf
34 www.e-hir.orgArum Park et al https://doi.org/10.4258/hir.2017.23.1.2542(5):492-8.,Non-OADS,/arxiv_data1/oa_pdf/29/cb/hir-23-25.PMC5334128.pdf
Available from: https://www2.deloitte.com/uk/en/pages/consumer-business/articles/unlocking-the-power-of-the-connect-ed-consumer.html.,Non-OADS,/arxiv_data1/oa_pdf/29/cb/hir-23-25.PMC5334128.pdf
Available from: https://www.technologyreview.com/s/520786/its-all-e-commerce-now/#comments.,Non-OADS,/arxiv_data1/oa_pdf/29/cb/hir-23-25.PMC5334128.pdf
Available from: http://www.cancer.go.kr/2010/04/22/Recommendations_Distress_Management_version1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/29/cb/hir-23-25.PMC5334128.pdf
Available from: http://www.rfidjournal.com/articles/view?611.,Non-OADS,/arxiv_data1/oa_pdf/29/cb/hir-23-25.PMC5334128.pdf
"2017 January;23(1):35-42.  https://doi.org/10.4258/hir.2017.23.1.35pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: November 2, 2016Revised: January 24, 2017Accepted: January 25, 2017 Corresponding Author  Yong Uk Song, PhDDivision of Business Administration, Yonsei University Wonju Cam-pus, 1, Yeonsedae-gil, Heungeop-myeon, Wonju 26493, Korea.",Non-OADS,/arxiv_data1/oa_pdf/49/a5/hir-23-35.PMC5334129.pdf
"Tel: +82-33-760-2340, E-mail: yusong@yonsei.ac.kr This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/a5/hir-23-35.PMC5334129.pdf
36 www.e-hir.orgKyoung Won Cho et al https://doi.org/10.4258/hir.2017.23.1.35reducing outpatients’ waiting times [4].,Non-OADS,/arxiv_data1/oa_pdf/49/a5/hir-23-35.PMC5334129.pdf
38 www.e-hir.orgKyoung Won Cho et al https://doi.org/10.4258/hir.2017.23.1.35tion of EMR.,Non-OADS,/arxiv_data1/oa_pdf/49/a5/hir-23-35.PMC5334129.pdf
"40 www.e-hir.orgKyoung Won Cho et al https://doi.org/10.4258/hir.2017.23.1.35that the service rates from the digital and observed data were  similar to each other and the service rates obtained from digital data, which were based on huge data sets, were more accurate than the service rates obtained from observed data, which were based on a limited number of data sets.",OADS,/arxiv_data1/oa_pdf/49/a5/hir-23-35.PMC5334129.pdf
42 www.e-hir.orgKyoung Won Cho et al https://doi.org/10.4258/hir.2017.23.1.3510.,Non-OADS,/arxiv_data1/oa_pdf/49/a5/hir-23-35.PMC5334129.pdf
Available from: http://www.math.vu.nl/~koole/publications/2005report1/art.pdf.,Non-OADS,/arxiv_data1/oa_pdf/49/a5/hir-23-35.PMC5334129.pdf
"2017 January;23(1):4-15.  https://doi.org/10.4258/hir.2017.23.1.4pISSN 2093-3681  •  eISSN 2093-369X  Review Article Submitted: December 15, 2016Revised: 1st, January 20, 2017; 2nd, January 24, 2017Accepted: January 24, 2017 Corresponding Author  Mostafa Haghi, MScCenter for Life Science Automation, University of Rostock, Rostock 18051, Germany.",Non-OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
"Tel: +49-17665592690, E-mail: Mostafa.haghi@celisca.de This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
6 www.e-hir.orgMostafa Haghi et al https://doi.org/10.4258/hir.2017.23.1.4maintains sufficient activity in the daily routine to maintain  a healthy life.,Non-OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
"8 www.e-hir.orgMostafa Haghi et al https://doi.org/10.4258/hir.2017.23.1.4identify the benefits, some expected merits have to be deter - mined and comparison is performed based on it.",Non-OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
10 www.e-hir.orgMostafa Haghi et al https://doi.org/10.4258/hir.2017.23.1.4the cloth from the inside.,Non-OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
"12 www.e-hir.orgMostafa Haghi et al https://doi.org/10.4258/hir.2017.23.1.4terruption, power loss is becoming more important.",Non-OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
Available from: https://www.gartner.com/doc/2804217/hype-cycle-internet-things-.,Non-OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
Available from: http://www.businesswire.com/,Non-OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
Available from: https://technology.ihs.com/527159/infonetics-survey-unveils-businesses-plans-for-mobile-security-internet-of-things-wearables.,Non-OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
Available from: http://www.cisco.com/c/dam/en_us/about/ac79/docs/innov/IoT_IBSG_0411FINAL.pdf 6.,OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
Avail-able from: http://www.techradar.com/reviews/gadgets/google-glass-1152283/review.,Non-OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
Available from: https://www.indi-egogo.com/projects/hicon-smartwristband-with-social-network-icons#/.,Non-OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
Available from: https://www.spec-sensors.com/product-category/gas-sensor-developer-kits/.,Non-OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
Avail-able from: https://www.iworldonline.com.au/index.php/blog/best-fitness-trackers-2015-jawbone-misfit-fitbit-,Non-OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
14 www.e-hir.orgMostafa Haghi et al https://doi.org/10.4258/hir.2017.23.1.4garmin-and-more/.,Non-OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
Available from: http://misfit.com/products/shine?locale=en.,Non-OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
Available from: http://www.st.com/con - tent/ccc/resource/technical/document/datasheet/56/ec/ac/de/28/21/4d/48/DM00027543.pdf/files/DM00027543.pdf/jcr:content/translations/en.DM00027543.pdf.,Non-OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
Available from: http://www.st.com/content/ccc/resource/technical/document/datasheet/04/46/d6/00/be/d9/46/ae/CD00265057.pdf/files/CD00265057.pdf/jcr:content/translations/en.CD00265057.pdf.,OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
Available from: http://www.pcadvisor.co.uk/test-centre/wearable-tech/best-fit-nessfitnesstrackers-2016-uk-summary-april-3498368/.,Non-OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
Available from: https://www.cnet.com/products/fitbit-flex/.,Non-OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
Available from: http://www.withings.com/eu/en/products/pulse?.,OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
Available from: http://fitness-trackers-review.toptenreviews.com/.,Non-OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
Available from: https://twitter.com/jawbone/status/548633718261161985.,Non-OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
Available from: http://arduino.cc/.50.,Non-OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
Available from: https://www.cooking-hacks.com/ehealth-sensors-complete-kit-biometric-medical-arduino-raspberry-pi.,Non-OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
Avail-able from: https://www.cooking-hacks.com/ehealth-sensor-shield-biometric-medical-arduino-raspberry-pi.,Non-OADS,/arxiv_data1/oa_pdf/56/7d/hir-23-4.PMC5334130.pdf
2017 January;23(1):43-52.  https://doi.org/10.4258/hir.2017.23.1.43pISSN 2093-3681  •  eISSN 2093-369X  Original Article Reviewed January FebruaryMarchApril May June JulyAugust September October November December I.,Non-OADS,/arxiv_data1/oa_pdf/0e/3a/hir-23-43.PMC5334131.pdf
"Tel: +82-53-580-3919, E-mail: soo1005@kmu.ac.kr This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0e/3a/hir-23-43.PMC5334131.pdf
"44 www.e-hir.orgMikyung Moon and Soo-Kyoung Lee https://doi.org/10.4258/hir.2017.23.1.43ance, a social insurance for Korean older people, which  provides physical and social support for older people and helps relieve caregivers’ financial burdens [7,8].",Non-OADS,/arxiv_data1/oa_pdf/0e/3a/hir-23-43.PMC5334131.pdf
46 www.e-hir.orgMikyung Moon and Soo-Kyoung Lee https://doi.org/10.4258/hir.2017.23.1.43Table 1.,Non-OADS,/arxiv_data1/oa_pdf/0e/3a/hir-23-43.PMC5334131.pdf
48 www.e-hir.orgMikyung Moon and Soo-Kyoung Lee https://doi.org/10.4258/hir.2017.23.1.43Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/0e/3a/hir-23-43.PMC5334131.pdf
50 www.e-hir.orgMikyung Moon and Soo-Kyoung Lee https://doi.org/10.4258/hir.2017.23.1.43did not reflect dressing types.,Non-OADS,/arxiv_data1/oa_pdf/0e/3a/hir-23-43.PMC5334131.pdf
Available from: http://longtermcare.or.kr/npbs/e/e/100/index.web.,OADS,/arxiv_data1/oa_pdf/0e/3a/hir-23-43.PMC5334131.pdf
Available from:  http://www.khiss.go.kr/treeManager.do?task=treeFrm& vw_cd=MT_ITITLE&list_id=358_E&htxt_code=125369725751510746110771881221239.,OADS,/arxiv_data1/oa_pdf/0e/3a/hir-23-43.PMC5334131.pdf
Available from: https://www.emc.com/collateral/analyst-reports/frost-sullivan-reducing-information-technology-complexi-ties-ar.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0e/3a/hir-23-43.PMC5334131.pdf
Available from: http://www.mfds.go.kr/index.do?mid=1015&pageNo=6&seq=6325&sitecode= 2013-04-05&cmd=v.,OADS,/arxiv_data1/oa_pdf/0e/3a/hir-23-43.PMC5334131.pdf
Available from: https://kssc.kostat.go.kr:8443/ksscNew_web/link.do?gubun= 004.,Non-OADS,/arxiv_data1/oa_pdf/0e/3a/hir-23-43.PMC5334131.pdf
52 www.e-hir.orgMikyung Moon and Soo-Kyoung Lee https://doi.org/10.4258/hir.2017.23.1.43and specificity.,Non-OADS,/arxiv_data1/oa_pdf/0e/3a/hir-23-43.PMC5334131.pdf
"2017 January;23(1):53-59.  https://doi.org/10.4258/hir.2017.23.1.53pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: October 23, 2016Revised: December 18, 2016Accepted: January 6, 2017 Corresponding Author  Jae Mok Ahn, PhDDepartment of Electronics Engineering, College of Engineering, Hallym University, 1 Hallymdaehak-gil, Chuncheon 24252, Korea.",Non-OADS,/arxiv_data1/oa_pdf/0a/f2/hir-23-53.PMC5334132.pdf
"Tel: +82-33-248-2347, E-mail: ajm@hallym.ac.kr This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/f2/hir-23-53.PMC5334132.pdf
54 www.e-hir.orgJae Mok Ahn https://doi.org/10.4258/hir.2017.23.1.53for motion artifact removal remains a significant issue for  the development of vascular monitoring tools to detect the presence of atherosclerotic disorders.,Non-OADS,/arxiv_data1/oa_pdf/0a/f2/hir-23-53.PMC5334132.pdf
56 www.e-hir.orgJae Mok Ahn https://doi.org/10.4258/hir.2017.23.1.53systolic peak (LSP) to early systolic peak (ESP) as follows  [11]: AI = ESP–LSP × 100%.,OADS,/arxiv_data1/oa_pdf/0a/f2/hir-23-53.PMC5334132.pdf
"58 www.e-hir.orgJae Mok Ahn https://doi.org/10.4258/hir.2017.23.1.53ever, in this study, the SI and age exhibited negligible correla­ tion (r  = –0.031, p  = 0.7713).",OADS,/arxiv_data1/oa_pdf/0a/f2/hir-23-53.PMC5334132.pdf
"2017 January;23(1):60-66.  https://doi.org/10.4258/hir.2017.23.1.60pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: May 31, 2016Revised: November 10, 2016Accepted: December 4, 2016 Corresponding Author  Adebowale I. Ojo, PhDSchool of Management, IT & Governance, University of KwaZulu-Natal, Durban, South Africa.",Non-OADS,/arxiv_data1/oa_pdf/54/08/hir-23-60.PMC5334133.pdf
"Tel: +27-631452675, E-mail: ojoa@ukzn.ac.za This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/08/hir-23-60.PMC5334133.pdf
"62 www.e-hir.orgAdebowale I. Ojo https://doi.org/10.4258/hir.2017.23.1.60use is said to be an alternative measure to use for some  other context, depending on the nature of the informa-tion system [4].",Non-OADS,/arxiv_data1/oa_pdf/54/08/hir-23-60.PMC5334133.pdf
"64 www.e-hir.orgAdebowale I. Ojo https://doi.org/10.4258/hir.2017.23.1.60yond 0.7 and 0.5, respectively, as recommended by Nunnally  and Bernstein [22].",Non-OADS,/arxiv_data1/oa_pdf/54/08/hir-23-60.PMC5334133.pdf
66 www.e-hir.orgAdebowale I. Ojo https://doi.org/10.4258/hir.2017.23.1.60model of information systems success.,OADS,/arxiv_data1/oa_pdf/54/08/hir-23-60.PMC5334133.pdf
Available from: http://statwiki.kolobkreations.com.,OADS,/arxiv_data1/oa_pdf/54/08/hir-23-60.PMC5334133.pdf
"2017 January;23(1):67-73.  https://doi.org/10.4258/hir.2017.23.1.67pISSN 2093-3681  •  eISSN 2093-369X  Case Report Submitted: October 2, 2016Revised: 1st, November 9, 2016; 2nd, December 19, 2016Accepted: December 29, 2016 Corresponding Author  Marina Bitsaki, PhDResearch and Innovation Department, OpenIT, Idaiou Androu 9, Her-aklion 71202, Greece.",Non-OADS,/arxiv_data1/oa_pdf/5b/c6/hir-23-67.PMC5334134.pdf
"Tel: +30-6972003446, E-mail: bitsaki@tsl.gr This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/c6/hir-23-67.PMC5334134.pdf
"68 www.e-hir.orgMarina Bitsaki et al https://doi.org/10.4258/hir.2017.23.1.67patients and promptly recognize impeding complications,  resulting in the reduction of cost and time spent by doctors, patients, and patient escorts.",Non-OADS,/arxiv_data1/oa_pdf/5b/c6/hir-23-67.PMC5334134.pdf
70 www.e-hir.orgMarina Bitsaki et al https://doi.org/10.4258/hir.2017.23.1.672.,OADS,/arxiv_data1/oa_pdf/5b/c6/hir-23-67.PMC5334134.pdf
72 www.e-hir.orgMarina Bitsaki et al https://doi.org/10.4258/hir.2017.23.1.67 Note that the percentages of cost reduction in Tables 3 and  4 are the same because the rates of patients subject to hip  and knee replacement are taken to be the same in the two groups.,Non-OADS,/arxiv_data1/oa_pdf/5b/c6/hir-23-67.PMC5334134.pdf
http://doi.org/10.1177/ 1460458216641480.,Non-OADS,/arxiv_data1/oa_pdf/5b/c6/hir-23-67.PMC5334134.pdf
Available from: https://www.it.nrw.de/presse/presse-mitteilungen/2015/pres_241_15.html.,Non-OADS,/arxiv_data1/oa_pdf/5b/c6/hir-23-67.PMC5334134.pdf
"Analysis Structural equation models were computed in M plusver- sion 5 (https://www.statmodel.com/; Muth /C19en & Muth /C19en 2007, Los Angeles, CA, USA) using full informationmaximum likelihood estimation, a method that handles missing data by estimating each parameter on the basis of all available data.",OADS,/arxiv_data1/oa_pdf/f8/01/DMCN-59-388.PMC5334138.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Encouraging Editorial Flexibility in Cases of Textual Reuse Because many technical descriptions of scientific processes and phenomena are difficult to  paraphrase and because an increasing proportion of contributors to the scientific literature  are not sufficiently proficient at writing in English, it is proposed that journal editors re- examine their approaches toward instances of textual reuse (similarity).",Non-OADS,/arxiv_data1/oa_pdf/8b/0e/jkms-32-557.PMC5334150.pdf
"Keywords:  Plagiarism; Publication Ethics; Periodicals as TopicMiguel Roig Department of Psychology, St. John’s University,  Staten Island, NY, USA Received: 10 January 2017 Accepted: 12 January 2017 Address for Correspondence: Miguel Roig, PhD Department of Psychology, St. John’s University, 300 Howard  Avenue, Staten Island, NY 10301, USA  E-mail: roigm@stjohns.eduhttps://doi.org/10.3346/jkms.2017.32.4.557  • J Korean Med Sci 2017; 32: 557-560 INTRODUCTION Plagiarism, a concept grounded in the humanities, refers to the  misappropriation of others’ work (e.g., ideas, text, images, de - sign elements, structural properties, data, processes, musical  notes) as one’s own.",Non-OADS,/arxiv_data1/oa_pdf/8b/0e/jkms-32-557.PMC5334150.pdf
"Roig M • Editorial Flexibility in Textual Reuse 558  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.557WRITING PRACTICES THAT MAY BE DEEMED AS  PLAGIARISM Evidence suggests that some authors, regardless of their disci - pline and language proficiency, engage in inappropriate writ - ing practices that could be construed as plagiarism (8,9).",Non-OADS,/arxiv_data1/oa_pdf/8b/0e/jkms-32-557.PMC5334150.pdf
Roig M  • Editorial Flexibility in Textual Reuse http://jkms.org   559 https://doi.org/10.3346/jkms.2017.32.4.557made up of unique terms that have no appropriate equivalents.,Non-OADS,/arxiv_data1/oa_pdf/8b/0e/jkms-32-557.PMC5334150.pdf
Roig M • Editorial Flexibility in Textual Reuse 560  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.557(http://brispe2016.org/).,Non-OADS,/arxiv_data1/oa_pdf/8b/0e/jkms-32-557.PMC5334150.pdf
ORCID Miguel Roig http://orcid.org/0000-0001-5311-5651   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8b/0e/jkms-32-557.PMC5334150.pdf
Available at https://ori.hhs.gov/images/ ddblock/vol3_no1.pdf [accessed on 9 January 2017].,Non-OADS,/arxiv_data1/oa_pdf/8b/0e/jkms-32-557.PMC5334150.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Socioeconomic Disparities in the Prevalence, Diagnosis, and  Control of Hypertension in the Context of a Universal Health  Insurance System  A lower use of preventive intervention in low socioeconomic populations has been  described in countries with universal coverage health care systems, but little is known  about the possible socioeconomic inequalities in secondary prevention in a universal health  insurance system.",Non-OADS,/arxiv_data1/oa_pdf/60/d6/jkms-32-561.PMC5334151.pdf
"Keywords:  Hypertension; Prevalence; Awareness; Control; Universal CoverageHoo-Yeon Lee Department of Social Medicine, Dankook University  College of Medicine, Cheonan, Korea Received: 17 September 2016 Accepted: 1 January 2017 Address for Correspondence: Hoo-Yeon Lee, MD, PhD Department of Social Medicine, Dankook University College of  Medicine, 201 Manghyang-ro, Dongnam-gu, Cheonan 31116,  Republic of Korea E-mail: hylee@dankook.ac.kr Funding:  This research was supported by the research fund of  Dankook University in 2014.https://doi.org/10.3346/jkms.2017.32.4.561  • J Korean Med Sci 2017; 32: 561-567 INTRODUCTION Hypertension, or high blood pressure, affected 26.4% of the  world’s adult population (972 million) in 2000, and this rate is  expected to increase to 29.2% (1.56 billion) by 2025 (1).",Non-OADS,/arxiv_data1/oa_pdf/60/d6/jkms-32-561.PMC5334151.pdf
Lee H-Y • Socioeconomic Disparities in Hypertension 562  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.561weaknesses within the context of the Korean universal health  insurance system.,Non-OADS,/arxiv_data1/oa_pdf/60/d6/jkms-32-561.PMC5334151.pdf
Lee H-Y • Socioeconomic Disparities in Hypertension http://jkms.org   563 https://doi.org/10.3346/jkms.2017.32.4.561Table 1.,Non-OADS,/arxiv_data1/oa_pdf/60/d6/jkms-32-561.PMC5334151.pdf
Lee H-Y • Socioeconomic Disparities in Hypertension 564  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.561among subjects without a family history and among current  smokers and drinkers.,Non-OADS,/arxiv_data1/oa_pdf/60/d6/jkms-32-561.PMC5334151.pdf
"Lee H-Y • Socioeconomic Disparities in Hypertension http://jkms.org   565 https://doi.org/10.3346/jkms.2017.32.4.561Canada, and 73% in England (17).",Non-OADS,/arxiv_data1/oa_pdf/60/d6/jkms-32-561.PMC5334151.pdf
Lee H-Y • Socioeconomic Disparities in Hypertension 566  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.561medical care.,Non-OADS,/arxiv_data1/oa_pdf/60/d6/jkms-32-561.PMC5334151.pdf
ORCID Hoo-Yeon Lee http://orcid.org/0000-0002-8426-2045  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/60/d6/jkms-32-561.PMC5334151.pdf
Lee H-Y • Socioeconomic Disparities in Hypertension http://jkms.org   567 https://doi.org/10.3346/jkms.2017.32.4.561lic Health  2006; 16: 361-7.,Non-OADS,/arxiv_data1/oa_pdf/60/d6/jkms-32-561.PMC5334151.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Association between Involuntary Smoking Exposure with  Urine Cotinine Level and Blood Cadmium Level in General   Non-Smoking Populations Unintentional environmental exposure to toxicants is associated with an aggravated health  status of the general population.",Non-OADS,/arxiv_data1/oa_pdf/d0/1d/jkms-32-568.PMC5334152.pdf
"Keywords:  Involuntary Smoking; Second-hand Smoking; Passive Smoking; Cotinine;  Cadmium; AdolescentWanhyung Lee,1,2,3 Seunghyun Lee,4  Jaehoon Roh,1,2,3,5 Jong-Uk Won,1,2,3,5   and Jin-Ha Yoon1,2,3,5 1The Institute for Occupational Health, Yonsei  University College of Medicine, Seoul, Korea; 2Graduate School of Public Health, Yonsei University  College of Medicine, Seoul, Korea; 3Incheon  Worker’s Health Center, Incheon, Korea; 4Department of Internal Medicine, University of  Occupational and Environmental Health,  Kitakyushu, Japan; 5Department of Preventive  Medicine, Yonsei University College of Medicine,  Seoul, Korea Received: 6 July 2016 Accepted: 11 December 2016 Address for Correspondence: Jin-Ha Yoon, MD, PhD Department of Preventive Medicine, Yonsei University College of  Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea E-mail: flyinyou@gmail.com Funding:  This work was supported by the Students’ Association  of the Graduate School of Yonsei University, funded by the  Graduate School of Yonsei University.https://doi.org/10.3346/jkms.2017.32.4.568  • J Korean Med Sci 2017; 32: 568-575 INTRODUCTION Humans have the right to the highest attainable standard of  health, and society has duties to protect individuals from unin - tentional exposure to hazards that cause health inequity.",Non-OADS,/arxiv_data1/oa_pdf/d0/1d/jkms-32-568.PMC5334152.pdf
• Involuntary Smoking Exposure and Blood Cadmium Level http://jkms.org   569 https://doi.org/10.3346/jkms.2017.32.4.568cigarette addiction status using cadmium as an indicator (10).,Non-OADS,/arxiv_data1/oa_pdf/d0/1d/jkms-32-568.PMC5334152.pdf
"• Involuntary Smoking Exposure and Blood Cadmium Level 570  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.568Determination of cadmium in whole blood To determine the concentrations of blood cadmium in whole  blood, 3 mL blood samples were collected from each participant  into a standard commercial evacuated tube containing sodium  heparin (Vacutainer®; BD, Franklin Lakes, NJ, USA).",Non-OADS,/arxiv_data1/oa_pdf/d0/1d/jkms-32-568.PMC5334152.pdf
• Involuntary Smoking Exposure and Blood Cadmium Level http://jkms.org   571 https://doi.org/10.3346/jkms.2017.32.4.568Table 1.,Non-OADS,/arxiv_data1/oa_pdf/d0/1d/jkms-32-568.PMC5334152.pdf
"• Involuntary Smoking Exposure and Blood Cadmium Level 572  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.568rooms, root vegetables, and shellfish) for adolescents.",Non-OADS,/arxiv_data1/oa_pdf/d0/1d/jkms-32-568.PMC5334152.pdf
"• Involuntary Smoking Exposure and Blood Cadmium Level http://jkms.org   573 https://doi.org/10.3346/jkms.2017.32.4.568level was significantly related to urine cotinine level in all of re - gression model l. In adults, after controlling for age, socio-de - mographics, lifestyle factors, and high cadmium-contained food  intake, each 1 hour per day exposure to IS was associated with  2.7252 ( ± 1.2769) and 5.4270 ( ± 0.7733) ng/mL increase in urine  cotinine level in men and women respectively.",Non-OADS,/arxiv_data1/oa_pdf/d0/1d/jkms-32-568.PMC5334152.pdf
• Involuntary Smoking Exposure and Blood Cadmium Level 574  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.568age group differences in the regression models.,Non-OADS,/arxiv_data1/oa_pdf/d0/1d/jkms-32-568.PMC5334152.pdf
ORCID Wanhyung Lee http://orcid.org/0000-0001-6408-7668 Seunghyun Lee http://orcid.org/0000-0001-7497-4930 Jaehoon Roh http://orcid.org/0000-0003-4228-7209 Jong-Uk Won http://orcid.org/0000-0002-9200-3297 Jin-Ha Yoon http://orcid.org/0000-0003-4198-2955   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d0/1d/jkms-32-568.PMC5334152.pdf
Available at http://www.who.int/fctc/cop/art%  208%20guidelines_english.pdf [accessed on 1 July 2016].,Non-OADS,/arxiv_data1/oa_pdf/d0/1d/jkms-32-568.PMC5334152.pdf
• Involuntary Smoking Exposure and Blood Cadmium Level http://jkms.org   575 https://doi.org/10.3346/jkms.2017.32.4.568olescents and adults in South Korea.,Non-OADS,/arxiv_data1/oa_pdf/d0/1d/jkms-32-568.PMC5334152.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Prevalence of Marfan Syndrome in Korea The aim of this study was to assess the prevalence of Marfan syndrome (MFS) in Korean  adults.",Non-OADS,/arxiv_data1/oa_pdf/a5/33/jkms-32-576.PMC5334153.pdf
"Keywords:  Prevalence; Marfan Syndrome; Republic of KoreaShin Yi Jang,1 Su Ra Seo,2   Seung Woo Park,1 and Duk-Kyung Kim1 1Division of Cardiology, Department of Medicine,  Heart Vascular Stroke Institute, Samsung Medical  Center, Sungkyunkwan University School of  Medicine, Seoul, Korea; 2The National Health  Insurance Service, Wonju, Korea Received: 7 October 2016 Accepted: 20 January 2017 Address for Correspondence: Duk-Kyung Kim, MD, PhD Division of Cardiology, Department of Medicine, Heart Vascular  Stroke Institute, Samsung Medical Center, Sungkyunkwan  University School of Medicine, 81 Irwon-ro, Gangnam-gu,   Seoul 06351, Korea E-mail: dukkyung.kim@samsung.comhttps://doi.org/10.3346/jkms.2017.32.4.576  • J Korean Med Sci 2017; 32: 576-580 INTRODUCTION Marfan syndrome (MFS) is an autosomal dominant disorder  (1,2) caused by mutations in the fibrillin-1 ( FBN1 ) gene on chro - mosome 15 (3).",Non-OADS,/arxiv_data1/oa_pdf/a5/33/jkms-32-576.PMC5334153.pdf
• Marfan Syndrome Prevalence in Korea http://jkms.org   577 https://doi.org/10.3346/jkms.2017.32.4.576Fig.,Non-OADS,/arxiv_data1/oa_pdf/a5/33/jkms-32-576.PMC5334153.pdf
• Marfan Syndrome Prevalence in Korea 578  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.576Table 1.,Non-OADS,/arxiv_data1/oa_pdf/a5/33/jkms-32-576.PMC5334153.pdf
• Marfan Syndrome Prevalence in Korea http://jkms.org   579 https://doi.org/10.3346/jkms.2017.32.4.576results in this study cannot be compared to those from other  geographic or ethnic groups.,Non-OADS,/arxiv_data1/oa_pdf/a5/33/jkms-32-576.PMC5334153.pdf
ORCID Shin Yi Jang http://orcid.org/0000-0003-4319-7029 Su Ra Seo http://orcid.org/0000-0002-9118-5682 Seung Woo Park http://orcid.org/0000-0002-2941-515X Duk-Kyung Kim http://orcid.org/0000-0001-9227-4196   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a5/33/jkms-32-576.PMC5334153.pdf
"• Marfan Syndrome Prevalence in Korea 580  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.576chholm K, Østergaard JR, Andersen NH, Gravholt CH.",Non-OADS,/arxiv_data1/oa_pdf/a5/33/jkms-32-576.PMC5334153.pdf
Available at http://www.nhis.or.kr/menu/boardRetrive - MenuSet.xx?menuId=F3321 [accessed on 20 December 2016].,Non-OADS,/arxiv_data1/oa_pdf/a5/33/jkms-32-576.PMC5334153.pdf
Available at http://www.nhis.or.kr/menu/boardRetrive - MenuSet.xx?menuId=F3321 [accessed on 20 December 2016].,Non-OADS,/arxiv_data1/oa_pdf/a5/33/jkms-32-576.PMC5334153.pdf
Available at http://www.nhis.or.kr/menu/boardRetrive - MenuSet.xx?menuId=F3321 [accessed on 20 December 2016].,Non-OADS,/arxiv_data1/oa_pdf/a5/33/jkms-32-576.PMC5334153.pdf
Available at http://www.nhis.or.kr/menu/boardRetrive - MenuSet.xx?menuId=F3321 [accessed on 20 December 2016].,Non-OADS,/arxiv_data1/oa_pdf/a5/33/jkms-32-576.PMC5334153.pdf
Available at http://www.nhis.or.kr/menu/boardRetrive - MenuSet.xx?menuId=F3321 [accessed on 20 December 2016].16.,Non-OADS,/arxiv_data1/oa_pdf/a5/33/jkms-32-576.PMC5334153.pdf
Available at http://www.nhis.or.kr/menu/boardRetrive - MenuSet.xx?menuId=F3321 [accessed on 20 December 2016].,Non-OADS,/arxiv_data1/oa_pdf/a5/33/jkms-32-576.PMC5334153.pdf
Available at http://www.nhis.or.kr/menu/boardRetrive - MenuSet.xx?menuId=F3321 [accessed on 20 December 2016].,Non-OADS,/arxiv_data1/oa_pdf/a5/33/jkms-32-576.PMC5334153.pdf
Available at http://www.nhis.or.kr/menu/boardRetrive - MenuSet.xx?menuId=F3321 [accessed on 20 December 2016].,Non-OADS,/arxiv_data1/oa_pdf/a5/33/jkms-32-576.PMC5334153.pdf
Available at http://kosis.kr/statistic - sList/statisticsList_01List.jsp?vwcd=MT_ZTITLE&parentId=D [accessed  on 1 December 2016].,OADS,/arxiv_data1/oa_pdf/a5/33/jkms-32-576.PMC5334153.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Descriptive Epidemiology of Patients Undergoing Total Hip  Arthroplasty in Korea with Focus on Incidence of  Femoroacetabular Impingement: Single Center Study We analyzed the causes leading to total hip arthroplasty (THA), aimed to clarify the  incidence of femoroacetabular impingement (FAI) among the causes, and compared the  incidence in Korea with those in other countries.",Non-OADS,/arxiv_data1/oa_pdf/96/b9/jkms-32-581.PMC5334154.pdf
2016- CF-008).https://doi.org/10.3346/jkms.2017.32.4.581  • J Korean Med Sci 2017; 32: 581-586 INTRODUCTION Total hip arthroplasty (THA) is an effective intervention for pa - tients with severe hip disease and has been shown to lead to  marked improvement in health outcomes (1).,Non-OADS,/arxiv_data1/oa_pdf/96/b9/jkms-32-581.PMC5334154.pdf
• Causes of Osteoarthritis of Hip in Korea 582  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.581THA.,Non-OADS,/arxiv_data1/oa_pdf/96/b9/jkms-32-581.PMC5334154.pdf
• Causes of Osteoarthritis of Hip in Korea http://jkms.org   583 https://doi.org/10.3346/jkms.2017.32.4.581ges of causes leading to THA showed that AVN has been decre- ased since the interval between 2003 and 2005 and fracture has  been increased (Fig.,Non-OADS,/arxiv_data1/oa_pdf/96/b9/jkms-32-581.PMC5334154.pdf
• Causes of Osteoarthritis of Hip in Korea 584  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.581Fig.,Non-OADS,/arxiv_data1/oa_pdf/96/b9/jkms-32-581.PMC5334154.pdf
• Causes of Osteoarthritis of Hip in Korea http://jkms.org   585 https://doi.org/10.3346/jkms.2017.32.4.581leading cause of disability (2-5).,Non-OADS,/arxiv_data1/oa_pdf/96/b9/jkms-32-581.PMC5334154.pdf
ORCID Woo-Yong Lee http://orcid.org/0000-0001-8706-6026 Deuk-Soo Hwang http://orcid.org/0000-0003-1009-3784 Chang-Kyun Noh http://orcid.org/0000-0002-6327-467X REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/96/b9/jkms-32-581.PMC5334154.pdf
• Causes of Osteoarthritis of Hip in Korea 586  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.581with osteoarthritis of the hip.,Non-OADS,/arxiv_data1/oa_pdf/96/b9/jkms-32-581.PMC5334154.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Entire Mitochondrial DNA Sequencing on Massively Parallel  Sequencing for the Korean Population Mitochondrial DNA (mtDNA) genome analysis has been a potent tool in forensic practice as  well as in the understanding of human phylogeny in the maternal lineage.",Non-OADS,/arxiv_data1/oa_pdf/f0/2b/jkms-32-587.PMC5334155.pdf
"Received: 6 October 2016 Accepted: 15 January 2017 Address for Correspondence: Soong Deok Lee, MD, PhD Department of Forensic Medicine, Seoul National University  College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080,  Korea E-mail: sdlee@snu.ac.kr Funding:  This research was supported by the research project  for practical use and advancement of forensic DNA analysis of  Supreme Prosecutors’ Office, Republic of Korea (1333-304-260,  2014).https://doi.org/10.3346/jkms.2017.32.4.587  • J Korean Med Sci 2017; 32: 587-592 INTRODUCTION Mitochondrial DNA (mtDNA) typing is a useful tool in forensic  analysis, especially in circumstances where only highly degrad - ed nuclear DNA (nDNA) remain, as well as for understanding  maternal lineage in phylogenetic studies (1,2).",Non-OADS,/arxiv_data1/oa_pdf/f0/2b/jkms-32-587.PMC5334155.pdf
"• Entire mtDNA Sequencing on MPS for Koreans 588  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.587MATERIALS AND METHODS Sample selection Considering the large number of individual mtDNA haplotypes,  it is not plausible to study all of them in MPS works.",Non-OADS,/arxiv_data1/oa_pdf/f0/2b/jkms-32-587.PMC5334155.pdf
"Focusing  on the branching patterns in the phylogenic tree, the most com - mon haplogroups in the Korean population were preferentially  considered for sampling based on previous studies and the pub - lic mtDNA database (16,17; available at http://www.mtdb.igp.",Non-OADS,/arxiv_data1/oa_pdf/f0/2b/jkms-32-587.PMC5334155.pdf
Haplogroup  assignment was processed with MitoTool (http://www.mitoto - ol.org) and HaploGrep2 (25; http://haplogrep.uibk.ac.at) ac - cording to the PhyloTree Build 16 database (26; Van Oven et al.,OADS,/arxiv_data1/oa_pdf/f0/2b/jkms-32-587.PMC5334155.pdf
mtDNA MPS raw data in Binary Alignment/Map (BAM)  format were also loaded on the mtDNA-Server (27; available at  http://mtdna-server.uibk.ac.at) in order to investigate the het - eroplasmic variants and confirm the data quality.,OADS,/arxiv_data1/oa_pdf/f0/2b/jkms-32-587.PMC5334155.pdf
"• Entire mtDNA Sequencing on MPS for Koreans http://jkms.org   589 https://doi.org/10.3346/jkms.2017.32.4.5871,200 X coverage data points per sample for all 186 samples.",OADS,/arxiv_data1/oa_pdf/f0/2b/jkms-32-587.PMC5334155.pdf
• Entire mtDNA Sequencing on MPS for Koreans 590  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.587 The non-haplogroup-defining variants commonly found in  the same haplogroup were investigated.,Non-OADS,/arxiv_data1/oa_pdf/f0/2b/jkms-32-587.PMC5334155.pdf
• Entire mtDNA Sequencing on MPS for Koreans http://jkms.org   591 https://doi.org/10.3346/jkms.2017.32.4.587reliable PHP according to mtDNA-Server (type = 1) (27).,OADS,/arxiv_data1/oa_pdf/f0/2b/jkms-32-587.PMC5334155.pdf
ORCID Sohyung Park http://orcid.org/0000-0002-1987-7908 Sohee Cho http://orcid.org/0000-0001-5764-5705 Hee Jin Seo http://orcid.org/0000-0002-9108-3942 Jihyun Lee http://orcid.org/0000-0002-9128-3215 Moon-Young Kim http://orcid.org/0000-0002-6381-9377 Soong Deok Lee http://orcid.org/0000-0003-4270-4279 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f0/2b/jkms-32-587.PMC5334155.pdf
"• Entire mtDNA Sequencing on MPS for Koreans 592  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.587chondrial DNA: applications, debates, and foundations.",Non-OADS,/arxiv_data1/oa_pdf/f0/2b/jkms-32-587.PMC5334155.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Nosocomial Infection in Adult Patients Undergoing Veno-Arterial  Extracorporeal Membrane Oxygenation Data on the frequency of nosocomial infections during extracorporeal membrane  oxygenation (ECMO) in adult populations remain scarce.",Non-OADS,/arxiv_data1/oa_pdf/fb/ea/jkms-32-593.PMC5334156.pdf
"Received: 18 August 2016 Accepted: 20 January 2017 Address for Correspondence: Byoung Hee Ahn, MD Department of Thoracic and Cardiovascular Surgery, Chonnam  National University Hospital, Chonnam National University  Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469,  Republic of Korea E-mail: bhahn@chonnam.ac.krhttps://doi.org/10.3346/jkms.2017.32.4.593  • J Korean Med Sci 2017; 32: 593-598 INTRODUCTION In the time since the first successful application of extracorpo - real membrane oxygenation (ECMO) support in 1972 (1), ECMO  has become one of the most important therapeutic modalities  for severe cardiopulmonary failure (2).",Non-OADS,/arxiv_data1/oa_pdf/fb/ea/jkms-32-593.PMC5334156.pdf
• Nosocomial Infection in Veno-Arterial Extracorporeal Membrane Oxygenation 594  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.593derwent VA-ECMO for cardiogenic shock.,Non-OADS,/arxiv_data1/oa_pdf/fb/ea/jkms-32-593.PMC5334156.pdf
• Nosocomial Infection in Veno-Arterial Extracorporeal Membrane Oxygenation http://jkms.org   595 https://doi.org/10.3346/jkms.2017.32.4.593ECMO-days.,Non-OADS,/arxiv_data1/oa_pdf/fb/ea/jkms-32-593.PMC5334156.pdf
• Nosocomial Infection in Veno-Arterial Extracorporeal Membrane Oxygenation 596  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.593The characteristics and ECMO outcomes of patients with  and without nosocomial infections The baseline characteristic data for 47 patients without nosoco - mial infection and 14 patients with nosocomial infection are  shown in Tables 4 and 5.,OADS,/arxiv_data1/oa_pdf/fb/ea/jkms-32-593.PMC5334156.pdf
• Nosocomial Infection in Veno-Arterial Extracorporeal Membrane Oxygenation http://jkms.org   597 https://doi.org/10.3346/jkms.2017.32.4.593An increase in creatinine levels reflects the presence of kidney  disease; an injured kidney may compromise the immune re - sponse via systemic release from leukocytes in the kidneys and  renal tubular cells (16-20).,Non-OADS,/arxiv_data1/oa_pdf/fb/ea/jkms-32-593.PMC5334156.pdf
ORCID Gwan Sic Kim http://orcid.org/0000-0002-0648-0178 Kyo Seon Lee http://orcid.org/0000-0001-7397-4680 Choung Kyu Park http://orcid.org/0000-0002-9898-2545 Seung Ku Kang http://orcid.org/0000-0001-7558-9102 Do Wan Kim http://orcid.org/0000-0003-2262-2882 Sang Gi Oh http://orcid.org/0000-0001-9394-4980 Bong-Suk Oh http://orcid.org/0000-0001-8389-190X Yochun Jung http://orcid.org/0000-0001-7165-3007 Seok Kim http://orcid.org/0000-0002-0850-169X Ju Sik Yun http://orcid.org/0000-0002-5167-3454 Sang Yun Song http://orcid.org/0000-0002-2084-8143 Kook Joo Na http://orcid.org/0000-0003-0923-1414 In Seok Jeong http://orcid.org/0000-0002-2249-0667 Byoung Hee Ahn http://orcid.org/0000-0002-7579-1359    REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/fb/ea/jkms-32-593.PMC5334156.pdf
"• Nosocomial Infection in Veno-Arterial Extracorporeal Membrane Oxygenation 598  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.593estel C, Pellegrino V .",Non-OADS,/arxiv_data1/oa_pdf/fb/ea/jkms-32-593.PMC5334156.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Increased Serum Antibody Titer against HPV-16 Antigen in  Patients with Behçet’s Disease Quadrivalent human papillomavirus (HPV) vaccine has been reported to be significantly  associated with Behçet’s disease (BD).",Non-OADS,/arxiv_data1/oa_pdf/e2/c8/jkms-32-599.PMC5334157.pdf
"Received: 30 August 2016 Accepted: 28 December 2016 Address for Correspondence: Dong Soo Kim, MD Department of Pediatrics, Yonsei University College of Medicine,  50 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea E-mail: DSKIM6634@yuhs.ac Funding:  This research was supported by the Basic Science  Research Program through the National Research Foundation of  Korea (NRF) funded by the Ministry of Education  (2014R1A1A2059503).https://doi.org/10.3346/jkms.2017.32.4.599  • J Korean Med Sci 2017; 32: 599-604 INTRODUCTION Behçet’s disease (BD) is a chronic, recurrent, multisystem vas - culitis with 4 cardinal symptoms, including oral ulcers, genital  ulcers, skin lesions, and eye lesions.",Non-OADS,/arxiv_data1/oa_pdf/e2/c8/jkms-32-599.PMC5334157.pdf
• HPV-16 Antibody in Behçet’s Disease 600  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.599freezer and thawed at room temperature before use.,Non-OADS,/arxiv_data1/oa_pdf/e2/c8/jkms-32-599.PMC5334157.pdf
"We used the latest version of the BDCAF  (http://www.behcet.ws/behcetwsData/Uploads/files/Behcets - DiseaseActivityForm.pdf; last accessed: on 26 January, 2016) in  this study.",Non-OADS,/arxiv_data1/oa_pdf/e2/c8/jkms-32-599.PMC5334157.pdf
• HPV-16 Antibody in Behçet’s Disease http://jkms.org   601 https://doi.org/10.3346/jkms.2017.32.4.599anti-HPV antibody titer of 0.578 OD was determined to differ - entiate BD patients from healthy controls.,Non-OADS,/arxiv_data1/oa_pdf/e2/c8/jkms-32-599.PMC5334157.pdf
• HPV-16 Antibody in Behçet’s Disease 602  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.599body titer < 0.578 were significantly younger than patients with  a titer ≥ 0.578 OD.,Non-OADS,/arxiv_data1/oa_pdf/e2/c8/jkms-32-599.PMC5334157.pdf
"• HPV-16 Antibody in Behçet’s Disease http://jkms.org   603 https://doi.org/10.3346/jkms.2017.32.4.599zoster virus, cytomegalovirus, Epstein-Barr virus, human her - pes viruses 6 and 7, hepatitis virus, human immunodeficiency  virus, and parvovirus B19 have been isolated from BD patients  (12).",Non-OADS,/arxiv_data1/oa_pdf/e2/c8/jkms-32-599.PMC5334157.pdf
ORCID Kyu Yeun Kim http://orcid.org/0000-0002-8035-4436,Non-OADS,/arxiv_data1/oa_pdf/e2/c8/jkms-32-599.PMC5334157.pdf
• HPV-16 Antibody in Behçet’s Disease 604  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.599Do Young Kim http://orcid.org/0000-0002-0194-9854 Jimyung Seo http://orcid.org/0000-0003-3416-9990 Yuri Ahn http://orcid.org/0000-0002-5298-6102 Dong Soo Kim http://orcid.org/0000-0002-3270-506X REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e2/c8/jkms-32-599.PMC5334157.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Spontaneous Renal Artery Dissection as a Cause of Acute Renal  Infarction: Clinical and MDCT Findings The purpose of this study was to assess the incidence of spontaneous renal artery dissection  (SRAD) as a cause of acute renal infarction, and to evaluate the clinical and multidetector  computed tomography (MDCT) findings of SRAD.",Non-OADS,/arxiv_data1/oa_pdf/9c/6d/jkms-32-605.PMC5334158.pdf
"Keywords:  Spontaneous Renal Artery Dissection; Renal Infarction; Incidence;  Multidetector Computed TomographyKibo Yoon,1 Soon-Young Song,1   Chang Hwa Lee,2 Byung-Hee Ko,1  Seunghun Lee,1 Bo Kyeong Kang,1   and Mi Mi Kim1 1Department of Radiology, Hanyang University  College of Medicine, Seoul, Korea; 2Department of Internal Medicine, Hanyang  University College of Medicine, Seoul, Korea Received: 22 September 2016 Accepted: 1 January 2017 Address for Correspondence: Soon-Young Song, MD Department of Radiology, Hanyang University College of  Medicine, 222-1 Wangsimni-ro, Seongdong-gu, Seoul 04763,  Korea E-mail: songsy01@gmail.comhttps://doi.org/10.3346/jkms.2017.32.4.605  • J Korean Med Sci 2017; 32: 605-612 INTRODUCTION Although there are many causes of acute renal infarction, the  most common cause is cardiogenic thromboembolism associ - ated with underlying disease, such as atrial fibrillation, intracar - diac thrombus, infective endocarditis, and valvular heart dis - ease.",Non-OADS,/arxiv_data1/oa_pdf/9c/6d/jkms-32-605.PMC5334158.pdf
"• Spontaneous Renal Artery Dissection 606  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.605(LDH), creatinine, blood urea nitrogen (BUN), the BUN/creati - nine ratio (BCR), and the estimated glomerular filtration rate  (eGFR).",Non-OADS,/arxiv_data1/oa_pdf/9c/6d/jkms-32-605.PMC5334158.pdf
"• Spontaneous Renal Artery Dissection http://jkms.org   607 https://doi.org/10.3346/jkms.2017.32.4.605sign (which is a sign of capsular collateral flow in renal infarc - tion), and an absence of major perirenal stranding or mass ef - fect (12,13).",Non-OADS,/arxiv_data1/oa_pdf/9c/6d/jkms-32-605.PMC5334158.pdf
• Spontaneous Renal Artery Dissection 608  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.605Table 2.,Non-OADS,/arxiv_data1/oa_pdf/9c/6d/jkms-32-605.PMC5334158.pdf
• Spontaneous Renal Artery Dissection http://jkms.org   609 https://doi.org/10.3346/jkms.2017.32.4.605low-up was 22 months (range 1–26 months).,Non-OADS,/arxiv_data1/oa_pdf/9c/6d/jkms-32-605.PMC5334158.pdf
• Spontaneous Renal Artery Dissection 610  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.605mmHg Month 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37180 160 140 120 100 80 60 40 20 0Blood pressure in patients with SRAD Systolilc DiastolilcPatient 1 Patient 2 Patient 3 Patient 4 A Patient 1 Patient 2 Patient 3 Patient 4 Patient 5mmHg Month 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37180 160 140 120 100 80 60 40 20 0Blood pressure in patients with an embolism Systolilc Diastolilc B Fig.,Non-OADS,/arxiv_data1/oa_pdf/9c/6d/jkms-32-605.PMC5334158.pdf
"• Spontaneous Renal Artery Dissection http://jkms.org   611 https://doi.org/10.3346/jkms.2017.32.4.605tion in younger patients more often than an embolism, and that  the incidence of classic cardiovascular risk factors is more fre - quent in patients with an embolism than in patients with SRAD.",Non-OADS,/arxiv_data1/oa_pdf/9c/6d/jkms-32-605.PMC5334158.pdf
• Spontaneous Renal Artery Dissection 612  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.605ORCID Kibo Yoon http://orcid.org/0000-0003-3447-0230 Soon-Young Song http://orcid.org/0000-0001-9919-3882 Chang Hwa Lee http://orcid.org/0000-0001-5786-3358 Byung-Hee Ko http://orcid.org/0000-0001-5607-1113 Seunghun Lee http://orcid.org/0000-0002-4348-7993 Bo Kyeong Kang http://orcid.org/0000-0001-6834-3825 Mi Mi Kim http://orcid.org/0000-0002-8266-0226 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9c/6d/jkms-32-605.PMC5334158.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Estimating Negative Effect of Abdominal Obesity on Mildly  Decreased Kidney Function Using a Novel Index of Body-Fat  Distribution Abdominal obesity is a major risk factor of chronic kidney disease (CKD).",Non-OADS,/arxiv_data1/oa_pdf/62/b1/jkms-32-613.PMC5334159.pdf
"Received: 4 December 2016 Accepted: 20 January 2017 Address for Correspondence: Joon-Sung Park, MD Department of Internal Medicine, Hanyang University College of  Medicine, 222-1 Wangsimni-ro, Seongdong-gu, Seoul 04763,  Korea E-mail: sjpjoon@hanyang.ac.krhttps://doi.org/10.3346/jkms.2017.32.4.613  • J Korean Med Sci 2017; 32: 613-620 INTRODUCTION Chronic kidney disease (CKD) is widely recognized as an inde - pendent risk factor for cardiovascular morbidity and mortality  (1-3).",Non-OADS,/arxiv_data1/oa_pdf/62/b1/jkms-32-613.PMC5334159.pdf
"• Abdominal Obesity and Kidney Function 614  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.613culator, its utility in the clinic is limited.",Non-OADS,/arxiv_data1/oa_pdf/62/b1/jkms-32-613.PMC5334159.pdf
"• Abdominal Obesity and Kidney Function http://jkms.org   615 https://doi.org/10.3346/jkms.2017.32.4.613between the lowest border of the rib cage and the uppermost  lateral border of the iliac crest, at the end of normal expiration.",Non-OADS,/arxiv_data1/oa_pdf/62/b1/jkms-32-613.PMC5334159.pdf
• Abdominal Obesity and Kidney Function 616  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.613Table 1.,Non-OADS,/arxiv_data1/oa_pdf/62/b1/jkms-32-613.PMC5334159.pdf
"• Abdominal Obesity and Kidney Function http://jkms.org   617 https://doi.org/10.3346/jkms.2017.32.4.613mokines, direct compression of the kidney and renal arteries,  and activation of the sympathetic nervous system or the renin- angiotensin-aldosterone system (25).",Non-OADS,/arxiv_data1/oa_pdf/62/b1/jkms-32-613.PMC5334159.pdf
• Abdominal Obesity and Kidney Function 618  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.613Fig.,Non-OADS,/arxiv_data1/oa_pdf/62/b1/jkms-32-613.PMC5334159.pdf
• Abdominal Obesity and Kidney Function http://jkms.org   619 https://doi.org/10.3346/jkms.2017.32.4.613DISCLOSURE The authors have no potential conflicts of interest to disclose.,Non-OADS,/arxiv_data1/oa_pdf/62/b1/jkms-32-613.PMC5334159.pdf
ORCID Il Hwan Oh http://orcid.org/0000-0003-4195-2561 Jong Wook Choi http://orcid.org/0000-0001-9624-6862 Chang Hwa Lee http://orcid.org/0000-0001-5786-3358 Joon-Sung Park http://orcid.org/0000-0003-4740-3061 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/62/b1/jkms-32-613.PMC5334159.pdf
• Abdominal Obesity and Kidney Function 620  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.613tients undergoing haemodialysis.,Non-OADS,/arxiv_data1/oa_pdf/62/b1/jkms-32-613.PMC5334159.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Characteristics and Impact Factors of Renal Threshold for  Glucose Excretion in Patients with Type 2 Diabetes Mellitus Sodium glucose co-transporter 2 (SGLT-2) inhibitors are newly developed but promising  medicine for type 2 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/dd/f9/jkms-32-621.PMC5334160.pdf
"15JCYBJC50300, 13JCZDJC30500).https://doi.org/10.3346/jkms.2017.32.4.621  • J Korean Med Sci 2017; 32: 621-627 INTRODUCTION Kidneys play an important role in the regulation of blood glu - cose (BG) homeostasis through gluconeogenesis, transporta - tion and utilizing glucose from the circulation, reabsorbing glu - cose from the glomerular filtrate and regulating hormones as - sociated with glucose metabolism (1).",Non-OADS,/arxiv_data1/oa_pdf/dd/f9/jkms-32-621.PMC5334160.pdf
"• Renal Threshold for Glucose Excretion 622  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.621continuous dynamic blood glucose monitoring system (CGMS)  (the inconsistent frequency between fingertip BG and CGMS  glucose were more than 4 times per day, or the correlation co - efficient between the corrected fingertip BG and CGMS glucose  was lower than 0.79); patients who were using SGLT-2 inhibi - tors; patients who were diagnosed with chronic kidney disease:  1) Kidney damage for ≥ 3 months, as defined by structural or  functional abnormalities (pathological abnormalities or abnor - malities in the composition of the blood or urine, or abnormali - ties in imaging tests) of the kidney, with or without decreased  GFR; 2) GFR < 60 mL/min/1.73 m2 for 3 months, with or with - out kidney damage (5), acute urinary tract infection, acute fe - ver, diabetic ketosis, diabetic hyperosmolar hyperglycemic state,  or other stress conditions and patients who recently underwent  surgery, trauma or in pregnancy.",Non-OADS,/arxiv_data1/oa_pdf/dd/f9/jkms-32-621.PMC5334160.pdf
• Renal Threshold for Glucose Excretion http://jkms.org   623 https://doi.org/10.3346/jkms.2017.32.4.621were presented in Table 2.,Non-OADS,/arxiv_data1/oa_pdf/dd/f9/jkms-32-621.PMC5334160.pdf
• Renal Threshold for Glucose Excretion 624  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.621Table 5.,Non-OADS,/arxiv_data1/oa_pdf/dd/f9/jkms-32-621.PMC5334160.pdf
"• Renal Threshold for Glucose Excretion http://jkms.org   625 https://doi.org/10.3346/jkms.2017.32.4.621of age, diabetes duration, BMI or HOMA-IR, the risk of high RT G  increased.",Non-OADS,/arxiv_data1/oa_pdf/dd/f9/jkms-32-621.PMC5334160.pdf
"• Renal Threshold for Glucose Excretion 626  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.621sistance, and other pathophysiological changes.",Non-OADS,/arxiv_data1/oa_pdf/dd/f9/jkms-32-621.PMC5334160.pdf
ORCID Xiao-Dan Yue http://orcid.org/0000-0001-7624-1204 Jing-Yu Wang http://orcid.org/0000-0002-8860-5623 Xin-Rong Zhang http://orcid.org/0000-0001-5449-637X Ju-Hong Yang http://orcid.org/0000-0003-3549-5392 Chun-Yan Shan http://orcid.org/0000-0002-0442-1983 Miao-Yan Zheng http://orcid.org/0000-0002-0775-0352 Hui-Zhu Ren http://orcid.org/0000-0002-2382-4331 Yi Zhang http://orcid.org/0000-0002-5375-360X Shao-Hua Yang http://orcid.org/0000-0003-4456-4388 Zhen-Hong Guo http://orcid.org/0000-0002-9007-7495 Bai Chang http://orcid.org/0000-0002-6808-1375 Bao-Cheng Chang http://orcid.org/0000-0002-6674-6644   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/dd/f9/jkms-32-621.PMC5334160.pdf
• Renal Threshold for Glucose Excretion http://jkms.org   627 https://doi.org/10.3346/jkms.2017.32.4.62110.,Non-OADS,/arxiv_data1/oa_pdf/dd/f9/jkms-32-621.PMC5334160.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Effects of Vitamin and Antioxidant Supplements in Prevention of  Bladder Cancer: a Meta-Analysis of Randomized Controlled  Trials This study aimed to investigate the effects of vitamin and antioxidant supplements in the  prevention of bladder cancer using a meta-analysis of randomized controlled trials (RCTs).",Non-OADS,/arxiv_data1/oa_pdf/2d/ba/jkms-32-628.PMC5334161.pdf
"Keywords:  Antioxidant; Bladder Cancer; Meta-Analysis; Randomized Controlled Trials;  VitaminSo-Jung Park,1,2 Seung-Kwon Myung,1,3,4,5  Yunju Lee,1 and Yong-Jae Lee6 1Department of Family Medicine, National Cancer  Center, Goyang, Korea; 2Department of Family  Medicine, Yonsei University Graduate School, Seoul,  Korea; 3Department of Cancer Control and Policy,  Graduate School of Cancer Science and Policy,  National Cancer Center, Goyang, Korea; 4Molecular  Epidemiology Branch, Division of Cancer  Epidemiology and Prevention, Research Institute,  National Cancer Center, Goyang, Korea; 5Center for  Cancer Prevention and Detection, Hospital, National  Cancer Center, Goyang, Korea; 6Department of  Family Medicine, Yonsei University College of  Medicine, Gangnam Severance Hospital, Seoul,  Korea Received: 17 October 2016 Accepted: 7 January 2017 Address for Correspondence: Seung-Kwon Myung, MD, PhD Department of Cancer Control and Policy, Graduate School of  Cancer Science and Policy, National Cancer Center, 323 Ilsan-ro,  Ilsandong-gu, Goyang 10408, Republic of Korea E-mail: msk@ncc.re.krhttps://doi.org/10.3346/jkms.2017.32.4.628  • J Korean Med Sci 2017; 32: 628-635 INTRODUCTION There were an estimated 429,000 new cases and 165,000 deaths  of bladder cancer in 2012 worldwide, ranking the ninth among  the most common cancers (1).",Non-OADS,/arxiv_data1/oa_pdf/2d/ba/jkms-32-628.PMC5334161.pdf
"• Vitamin and Antioxidant Supplements in Prevention of Bladder Cancer http://jkms.org   629 https://doi.org/10.3346/jkms.2017.32.4.628‘vitamin B 7, ’ ‘vitamin B 9, ’ ‘vitamin B 12, ’ ‘thiamine, ’ ‘riboflavin, ’  ‘niacin, ’ ‘nicotinic acid, ’ ‘pantothenic acid, ’ ‘pyridoxine, ’ ‘biotin, ’  ‘folic acid, ’ ‘cobalamin, ’ ‘vitamin C, ’ ‘ascorbic acid, ’ ‘vitamin D, ’  ‘vitamin E, ’ ‘alpha-tocopherol, ’ ‘selenium, ’ ‘lipoic acid, ’ ‘glutathi - one, ’ ‘catechin, ’ ‘isoflavone, ’ ‘lycopene, ’ ‘resveratrol, ’ or ‘coenzyme  q10, ’ and ‘bladder cancer.",Non-OADS,/arxiv_data1/oa_pdf/2d/ba/jkms-32-628.PMC5334161.pdf
• Vitamin and Antioxidant Supplements in Prevention of Bladder Cancer 630  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.628Table 1.,Non-OADS,/arxiv_data1/oa_pdf/2d/ba/jkms-32-628.PMC5334161.pdf
• Vitamin and Antioxidant Supplements in Prevention of Bladder Cancer http://jkms.org   631 https://doi.org/10.3346/jkms.2017.32.4.628180 articles were identified.,Non-OADS,/arxiv_data1/oa_pdf/2d/ba/jkms-32-628.PMC5334161.pdf
• Vitamin and Antioxidant Supplements in Prevention of Bladder Cancer 632  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.628ity RCTs among those trials (RR = 0.78; 95% CI 0.53–1.15; I2= 0.0%;  n = 2).,Non-OADS,/arxiv_data1/oa_pdf/2d/ba/jkms-32-628.PMC5334161.pdf
• Vitamin and Antioxidant Supplements in Prevention of Bladder Cancer http://jkms.org   633 https://doi.org/10.3346/jkms.2017.32.4.628Table 3.,Non-OADS,/arxiv_data1/oa_pdf/2d/ba/jkms-32-628.PMC5334161.pdf
• Vitamin and Antioxidant Supplements in Prevention of Bladder Cancer 634  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.628sic properties or biological environments in which it acts (37).,Non-OADS,/arxiv_data1/oa_pdf/2d/ba/jkms-32-628.PMC5334161.pdf
ORCID So-Jung Park http://orcid.org/0000-0002-5444-0250 Seung-Kwon Myung http://orcid.org/0000-0001-8911-1345 Yunju Lee http://orcid.org/0000-0002-4755-1868Yong-Jae Lee http://orcid.org/0000-0002-6697-476X   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/2d/ba/jkms-32-628.PMC5334161.pdf
"• Vitamin and Antioxidant Supplements in Prevention of Bladder Cancer http://jkms.org   635 https://doi.org/10.3346/jkms.2017.32.4.628bach LA, Marshall JR, Clark LC.",Non-OADS,/arxiv_data1/oa_pdf/2d/ba/jkms-32-628.PMC5334161.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Additional Drug Resistance Patterns among Multidrug-Resistant  Tuberculosis Patients in Korea: Implications for Regimen Design Detailed information on additional drug resistance patterns of multidrug-resistant  tuberculosis (MDR-TB) is essential to build an effective treatment regimen; however, such  data are scarce in Korea.",Non-OADS,/arxiv_data1/oa_pdf/30/a2/jkms-32-636.PMC5334162.pdf
"Keywords:  Drug Resistance; Tuberculosis; Tuberculosis, Multidrug-Resistant; Extensively  Drug-Resistant Tuberculosis; KoreaJeong Ha Mok,1 Bo Hyoung Kang,2  Taehoon Lee,3 Hyun-Kyung Lee,4   Hang Jea Jang,5 Yu Ji Cho,6   and Doosoo Jeon7,8 1Department of Internal Medicine, Pusan National  University Hospital, Busan, Korea; 2Department of  Internal Medicine, Dong-A University Hospital,  Busan, Korea; 3Department of Internal Medicine,  Ulsan University Hospital, Ulsan, Korea; 4Department  of Internal Medicine, Inje University Busan Paik  Hospital, Busan, Korea; 5Department of Internal  Medicine, Inje University Haeundae Paik Hospital,  Busan, Korea; 6Department of Internal Medicine,  Gyeongsang National University Hospital, Jinju,  Korea; 7Department of Internal Medicine, Pusan  National University Yangsan Hospital, Yangsan,  Korea; 8Research Institute for Convergence of  Biomedical Science and Technology, Pusan National  University Yangsan Hospital, Yangsan, Korea Received: 18 September 2016 Accepted: 7 January 2017 Address for Correspondence: Doosoo Jeon, MD Department of Internal Medicine, Pusan National University  Yangsan Hospital, 20 Geumo-ro, Mulgeum-eup, Yangsan 50612,  Republic of Korea E-mail: sooli10kr@yahoo.co.krhttps://doi.org/10.3346/jkms.2017.32.4.636  • J Korean Med Sci 2017; 32: 636-641 INTRODUCTION Multidrug-resistant tuberculosis (MDR-TB), defined as TB that  is resistant to at least isoniazid (INH) and rifampicin (RFP), is  difficult to treat.",Non-OADS,/arxiv_data1/oa_pdf/30/a2/jkms-32-636.PMC5334162.pdf
"• Resistance Patterns of MDR-TB http://jkms.org   637 https://doi.org/10.3346/jkms.2017.32.4.636tients, and the following data were collected: age, sex, history of  previous TB treatment, type of specimen, and results of pheno - typic DST.",Non-OADS,/arxiv_data1/oa_pdf/30/a2/jkms-32-636.PMC5334162.pdf
• Resistance Patterns of MDR-TB 638  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.636Table 2.,Non-OADS,/arxiv_data1/oa_pdf/30/a2/jkms-32-636.PMC5334162.pdf
"• Resistance Patterns of MDR-TB http://jkms.org   639 https://doi.org/10.3346/jkms.2017.32.4.636tients showed additional resistance to PZA (70.2%), SM (36.2%),  and MFX (74.5%).",Non-OADS,/arxiv_data1/oa_pdf/30/a2/jkms-32-636.PMC5334162.pdf
• Resistance Patterns of MDR-TB 640  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.636and private institutions as well as between regions.,Non-OADS,/arxiv_data1/oa_pdf/30/a2/jkms-32-636.PMC5334162.pdf
"Writing - review &  editing: Kang BH, Lee T, Lee HK, Jang HJ, Cho YJ, Jeon D.  ORCID Jeong Ha Mok http://orcid.org/0000-0001-7406-1373 Bo Hyoung Kang http://orcid.org/0000-0001-5809-8360 Taehoon Lee http://orcid.org/0000-0002-9224-0866 Hyun-Kyung Lee http://orcid.org/0000-0003-1032-0190 Hang Jea Jang http://orcid.org/0000-0001-7733-4365 Yu Ji Cho http://orcid.org/0000-0002-0247-802X Doosoo Jeon http://orcid.org/0000-0002-8206-9487   REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/30/a2/jkms-32-636.PMC5334162.pdf
Available at http://www.who.int/tb/Short_MDR_regimen_fact - sheet.pdf?ua=1 [accessed on 31 August 2016].,Non-OADS,/arxiv_data1/oa_pdf/30/a2/jkms-32-636.PMC5334162.pdf
• Resistance Patterns of MDR-TB http://jkms.org   641 https://doi.org/10.3346/jkms.2017.32.4.63617.,Non-OADS,/arxiv_data1/oa_pdf/30/a2/jkms-32-636.PMC5334162.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Outcome of Reinduction Chemotherapy with a Modified Dose of  Idarubicin for Children with Marrow-Relapsed Acute  Lymphoblastic Leukemia: Results of the Childhood Acute  Lymphoblastic Leukemia (CALL)-0603 Study This multicenter, prospective trial was conducted to develop an effective and safe  reinduction regimen for marrow-relapsed pediatric acute lymphoblastic leukemia (ALL) by  modifying the dose of idarubicin.",Non-OADS,/arxiv_data1/oa_pdf/72/41/jkms-32-642.PMC5334163.pdf
0520290 and 1420250).https://doi.org/10.3346/jkms.2017.32.4.642  • J Korean Med Sci 2017; 32: 642-649 INTRODUCTION The outcome of childhood acute lymphoblastic leukemia (ALL) has considerably im - proved during recent decades (1-4).,Non-OADS,/arxiv_data1/oa_pdf/72/41/jkms-32-642.PMC5334163.pdf
• Reinduction Chemotherapy in Relapsed Pediatric ALL http://jkms.org   643 https://doi.org/10.3346/jkms.2017.32.4.642was unacceptably toxic and had an inferior CR2 rate to a modi - fied dose of 10 mg/m2/week due to a higher toxic death rate (12).,Non-OADS,/arxiv_data1/oa_pdf/72/41/jkms-32-642.PMC5334163.pdf
"• Reinduction Chemotherapy in Relapsed Pediatric ALL 644  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.642Asan Medical Center, Seoul, Korea (IRB No.",Non-OADS,/arxiv_data1/oa_pdf/72/41/jkms-32-642.PMC5334163.pdf
• Reinduction Chemotherapy in Relapsed Pediatric ALL http://jkms.org   645 https://doi.org/10.3346/jkms.2017.32.4.642ly relapsers) and 17 relapsed after more than 24 months (late  relapsers).,Non-OADS,/arxiv_data1/oa_pdf/72/41/jkms-32-642.PMC5334163.pdf
• Reinduction Chemotherapy in Relapsed Pediatric ALL 646  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.642Fig.,Non-OADS,/arxiv_data1/oa_pdf/72/41/jkms-32-642.PMC5334163.pdf
"• Reinduction Chemotherapy in Relapsed Pediatric ALL http://jkms.org   647 https://doi.org/10.3346/jkms.2017.32.4.642relapsers (n = 20) were not (50.0% ± 17.7% vs. 50.0% ± 14.4%,  P= 0.649) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/72/41/jkms-32-642.PMC5334163.pdf
• Reinduction Chemotherapy in Relapsed Pediatric ALL 648  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.642blood cell count.,Non-OADS,/arxiv_data1/oa_pdf/72/41/jkms-32-642.PMC5334163.pdf
ORCID Kyung-Nam Koh http://orcid.org/0000-0002-6376-672X Ho Joon Im http://orcid.org/0000-0001-8799-4068 Hyery Kim http://orcid.org/0000-0003-2852-6832 Hyoung Jin Kang http://orcid.org/0000-0003-1009-6002 Kyung Duk Park http://orcid.org/0000-0002-6943-4398 Hee Young Shin http://orcid.org/0000-0003-2091-1947 Hyo Seop Ahn http://orcid.org/0000-0002-5618-7033 Ji Won Lee http://orcid.org/0000-0003-0084-1304 Keon Hee Yoo http://orcid.org/0000-0002-5980-7912 Ki Woong Sung http://orcid.org/0000-0001-5989-4772 Hong Hoe Koo http://orcid.org/0000-0001-8082-1412 Young Tak Lim http://orcid.org/0000-0002-3300-7239 Jun Eun Park http://orcid.org/0000-0003-4292-3500 Byung-Kiu Park http://orcid.org/0000-0001-9743-0610Hyeon Jin Park http://orcid.org/0000-0002-9557-3412 Jong Jin Seo http://orcid.org/0000-0002-0191-7836  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/72/41/jkms-32-642.PMC5334163.pdf
• Reinduction Chemotherapy in Relapsed Pediatric ALL http://jkms.org   649 https://doi.org/10.3346/jkms.2017.32.4.64214.,Non-OADS,/arxiv_data1/oa_pdf/72/41/jkms-32-642.PMC5334163.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Humidified High Flow Nasal Cannula versus Nasal Continuous  Positive Airway Pressure as an Initial Respiratory Support in  Preterm Infants with Respiratory Distress: a Randomized,  Controlled Non-Inferiority Trial Heated, humidified, high-flow nasal cannula (HHFNC) is frequently used as a noninvasive  respiratory support for preterm infants with respiratory distress.",Non-OADS,/arxiv_data1/oa_pdf/73/d5/jkms-32-650.PMC5334164.pdf
"Keywords:  High Flow Nasal Cannula; Continuous Positive Airway Pressure; Preterm  Infants; Noninvasive VentilationJeonghee Shin,1 Kyuhee Park,2   Eun Hee Lee,1 and Byung Min Choi1 1Department of Pediatrics, Korea University College  of Medicine, Seoul, Korea; 2So Pediatric Clinic, Seoul,  Korea Received: 14 July 2016 Accepted: 7 January 2017 Address for Correspondence: Byung Min Choi, MD, PhD Department of Pediatrics, Korea University Ansan Hospital,  Korea University College of Medicine, 123 Jeokgeum-ro,  Danwon-gu, Ansan 15355, Republic of Korea E-mail: cbmin@korea.ac.krhttps://doi.org/10.3346/jkms.2017.32.4.650  • J Korean Med Sci 2017; 32: 650-655 INTRODUCTION Non-invasive respiratory support, including nasal continuous  positive airway pressure (nCPAP), was shown to be effective in  treating infants in the initial phase of respiratory distress (1).",Non-OADS,/arxiv_data1/oa_pdf/73/d5/jkms-32-650.PMC5334164.pdf
"• Humidified High Flow Nasal Cannula in Preterm Infants http://jkms.org   651 https://doi.org/10.3346/jkms.2017.32.4.650after birth, but required non-invasive respiratory support for  respiratory distress within 24 hours after birth were enrolled in  this study.",Non-OADS,/arxiv_data1/oa_pdf/73/d5/jkms-32-650.PMC5334164.pdf
"• Humidified High Flow Nasal Cannula in Preterm Infants 652  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.650reduction of the set FiO 2 (minimum 0.25), followed by a reduc - tion of the PEEP to 4 cmH 2O and then a reduction of FiO 2 to 0.21.",Non-OADS,/arxiv_data1/oa_pdf/73/d5/jkms-32-650.PMC5334164.pdf
"• Humidified High Flow Nasal Cannula in Preterm Infants http://jkms.org   653 https://doi.org/10.3346/jkms.2017.32.4.650PAP although the difference was not significant (HHFNC, 38.1%  vs. nCPAP , 20.9%; P= 0.099) (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/73/d5/jkms-32-650.PMC5334164.pdf
"• Humidified High Flow Nasal Cannula in Preterm Infants 654  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.650term of the respiratory outcome, no significant differences were  found between the 2 groups in terms of the need for surfactant  and developments of BPD and air leak.",Non-OADS,/arxiv_data1/oa_pdf/73/d5/jkms-32-650.PMC5334164.pdf
• Humidified High Flow Nasal Cannula in Preterm Infants http://jkms.org   655 https://doi.org/10.3346/jkms.2017.32.4.650ment in preterm infants with respiratory distress.,Non-OADS,/arxiv_data1/oa_pdf/73/d5/jkms-32-650.PMC5334164.pdf
ORCID Jeonghee Shin http://orcid.org/0000-0003-3718-968X Kyuhee Park http://orcid.org/0000-0001-8640-3211 Eun Hee Lee http://orcid.org/0000-0002-1539-8184 Byung Min Choi http://orcid.org/0000-0003-0931-2353 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/73/d5/jkms-32-650.PMC5334164.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Epidemiology of Biliary Atresia in Korea Biliary atresia (BA) is the major cause of cholestasis and the leading indication for liver  transplantation (LT).",Non-OADS,/arxiv_data1/oa_pdf/43/da/jkms-32-656.PMC5334165.pdf
"2016-001).https://doi.org/10.3346/jkms.2017.32.4.656  • J Korean Med Sci 2017; 32: 656-660 INTRODUCTION Biliary atresia (BA) is the major cause of neonatal cholestatic  jaundice, and untreated BA can cause chronic liver disease, he - patic failure, and death in children (1-11).",Non-OADS,/arxiv_data1/oa_pdf/43/da/jkms-32-656.PMC5334165.pdf
"• Epidemiology of Biliary Atresia http://jkms.org   657 https://doi.org/10.3346/jkms.2017.32.4.656 We investigated the percentage of congenital anomalies such  as spleen anomalies, situs inversus, and heart disease in the new - ly diagnosed BA group.",Non-OADS,/arxiv_data1/oa_pdf/43/da/jkms-32-656.PMC5334165.pdf
"• Epidemiology of Biliary Atresia 658  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.656gitis, and their median age was 1 year (Table 2).",OADS,/arxiv_data1/oa_pdf/43/da/jkms-32-656.PMC5334165.pdf
• Epidemiology of Biliary Atresia http://jkms.org   659 https://doi.org/10.3346/jkms.2017.32.4.656of age) in the total BA group.,Non-OADS,/arxiv_data1/oa_pdf/43/da/jkms-32-656.PMC5334165.pdf
ORCID Kyung Jae Lee http://orcid.org/0000-0002-3969-384X Ju Whi Kim http://orcid.org/0000-0001-8011-3547 Jin Soo Moon http://orcid.org/0000-0001-9760-297X Jae Sung Ko http://orcid.org/0000-0002-3064-2974REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/43/da/jkms-32-656.PMC5334165.pdf
"• Epidemiology of Biliary Atresia 660  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.656Kistler W, Meuli M, Le Coultre C, Mentha G, et al.",Non-OADS,/arxiv_data1/oa_pdf/43/da/jkms-32-656.PMC5334165.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Vitamin D and Urinary Incontinence among Korean Women: a  Propensity Score-matched Analysis from the 2008–2009 Korean  National Health and Nutrition Examination Survey A recent study investigated the role of vitamin D in urinary incontinence (UI).",Non-OADS,/arxiv_data1/oa_pdf/7e/f9/jkms-32-661.PMC5334166.pdf
"Keywords:  Urinary Incontinence; Female; Vitamin DHyo Serk Lee1 and Jun Ho Lee2  1Department of Urology, Cheil General Hospital and  Women’s Healthcare Center, Dankook University  College of Medicine, Seoul, Korea; 2Department of  Urology, National Police Hospital, Seoul, Korea Received: 13 October 2016 Accepted: 11 December 2016 Address for Correspondence: Jun Ho Lee, MD Department of Urology, National Police Hospital, 123 Songi-ro,  Songpa-gu, Seoul 05715, Korea E-mail: sinbanpolee@gmail.comhttps://doi.org/10.3346/jkms.2017.32.4.661  • J Korean Med Sci 2017; 32: 661-665 INTRODUCTION Vitamin D plays an important role in calcium and phosphate  homeostasis and normal mineralization of bone (1).",Non-OADS,/arxiv_data1/oa_pdf/7e/f9/jkms-32-661.PMC5334166.pdf
• Vitamin D and Urinary Incontinence 662  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.661were included in this study.,Non-OADS,/arxiv_data1/oa_pdf/7e/f9/jkms-32-661.PMC5334166.pdf
• Vitamin D and Urinary Incontinence http://jkms.org   663 https://doi.org/10.3346/jkms.2017.32.4.661matching methods.,Non-OADS,/arxiv_data1/oa_pdf/7e/f9/jkms-32-661.PMC5334166.pdf
"• Vitamin D and Urinary Incontinence 664  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.661pause is a risk factor for UI (15,16).",Non-OADS,/arxiv_data1/oa_pdf/7e/f9/jkms-32-661.PMC5334166.pdf
ORCID Hyo Serk Lee http://orcid.org/0000-0002-6795-0057 Jun Ho Lee http://orcid.org/0000-0003-3567-0816 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7e/f9/jkms-32-661.PMC5334166.pdf
• Vitamin D and Urinary Incontinence http://jkms.org   665 https://doi.org/10.3346/jkms.2017.32.4.6614.,Non-OADS,/arxiv_data1/oa_pdf/7e/f9/jkms-32-661.PMC5334166.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Safety of Using Matrix Metalloproteinase Inhibitor in  Experimental Glaucoma Filtration Surgery We evaluated the safety of matrix metalloproteinase (MMP) inhibitor in experimental  glaucoma filtration surgery in an animal model.",Non-OADS,/arxiv_data1/oa_pdf/ae/71/jkms-32-666.PMC5334167.pdf
"Keywords:  Glaucoma; Filtration; Matrix Metalloproteinase InhibitorWool Suh,1 Kyung Eun Han,2   and Jae ryong Han1 1Department of Ophthalmology, Hallym University  Dongtan Sacred Heart Hospital, Hallym University  College of Medicine, Hwaseong, Korea; 2Department of Ophthalmology, Institute of  Ophthalmology and Optometry, Ewha Womans  University Mok-Dong Hospital, Ewha Womans  University School of Medicine, Seoul, Korea Received: 25 November 2016 Accepted: 7 January 2017 Address for Correspondence: Jae ryong Han, MD Department of Ophthalmology, Hallym University Dongtan  Sacred Heart Hospital, Hallym University College of Medicine,   7 Keunjaebong-gil, Hwaseong 18450, Republic of Korea E-mail: scarpel@hally.or.kr Funding:  This research was supported by Hallym University  Research Fund 2015 (HURF-2015-22).https://doi.org/10.3346/jkms.2017.32.4.666  • J Korean Med Sci 2017; 32: 666-671 INTRODUCTION The most common cause of failure in glaucoma filtering sur - gery is scarring of the filtering bleb, and the increased amount  of collagen in the surgical site suggests that proliferation of fi - broblasts with associated production of collagen and glycos - aminoglycans is important (1).",Non-OADS,/arxiv_data1/oa_pdf/ae/71/jkms-32-666.PMC5334167.pdf
• Matrix Metalloproteinase Inhibitor in Trabeculectomy http://jkms.org   667 https://doi.org/10.3346/jkms.2017.32.4.666group (10).,Non-OADS,/arxiv_data1/oa_pdf/ae/71/jkms-32-666.PMC5334167.pdf
• Matrix Metalloproteinase Inhibitor in Trabeculectomy 668  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.666Table 2.,Non-OADS,/arxiv_data1/oa_pdf/ae/71/jkms-32-666.PMC5334167.pdf
"• Matrix Metalloproteinase Inhibitor in Trabeculectomy http://jkms.org   669 https://doi.org/10.3346/jkms.2017.32.4.666glaucoma surgery during the treatment period and glaucoma  filtration surgery is usually first attempted to control IOP (13,14).",Non-OADS,/arxiv_data1/oa_pdf/ae/71/jkms-32-666.PMC5334167.pdf
"• Matrix Metalloproteinase Inhibitor in Trabeculectomy 670  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.666changed from 19 preoperatively to 31 at postoperative 28 days,  the average cell area also decreased from 659 to 374, and hex - agonality changed from 67 to 78.",Non-OADS,/arxiv_data1/oa_pdf/ae/71/jkms-32-666.PMC5334167.pdf
"Writing - review & editing: Suh W, Han KE, Han  JR. ORCID Wool Suh http://orcid.org/0000-0002-1953-5684 Kyung Eun Han http://orcid.org/0000-0001-8484-6086 Jae ryong Han http://orcid.org/0000-0003-1663-1440 REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/ae/71/jkms-32-666.PMC5334167.pdf
"• Matrix Metalloproteinase Inhibitor in Trabeculectomy http://jkms.org   671 https://doi.org/10.3346/jkms.2017.32.4.666ranov G, Shields MB, editors.",Non-OADS,/arxiv_data1/oa_pdf/ae/71/jkms-32-666.PMC5334167.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Bacterial Species and Antibiotic Sensitivity in Korean Patients  Diagnosed with Acute Otitis Media and Otitis Media with  Effusion Changes over time in pathogens and their antibiotic sensitivity resulting from the recent  overuse and misuse of antibiotics in otitis media (OM) have complicated treatment.",Non-OADS,/arxiv_data1/oa_pdf/5e/58/jkms-32-672.PMC5334168.pdf
"2011-0030072).https://doi.org/10.3346/jkms.2017.32.4.672  • J Korean Med Sci 2017; 32: 672-678 INTRODUCTION Otitis media (OM) is defined as inflammation of the middle ear and mastoid space, re - gardless of cause or pathogenesis (1).",Non-OADS,/arxiv_data1/oa_pdf/5e/58/jkms-32-672.PMC5334168.pdf
• Bacteriology in Otitis Media http://jkms.org   673 https://doi.org/10.3346/jkms.2017.32.4.672mended.,Non-OADS,/arxiv_data1/oa_pdf/5e/58/jkms-32-672.PMC5334168.pdf
"• Bacteriology in Otitis Media 674  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.672(23.5%), followed by methicillin-susceptible S. aureus  (MSSA)  from 50 (16.3%), methicillin-resistant S. aureus  (MRSA) from 41  (13.4%), and Streptococcus pneumonia  (SP) from 26 (8.49%).",Non-OADS,/arxiv_data1/oa_pdf/5e/58/jkms-32-672.PMC5334168.pdf
"• Bacteriology in Otitis Media http://jkms.org   675 https://doi.org/10.3346/jkms.2017.32.4.672high sensitivity to CIP (80%) and TOB (80%), but low sensitivity  to SPT (53.3%) and CL (33.3%) (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/5e/58/jkms-32-672.PMC5334168.pdf
• Bacteriology in Otitis Media 676  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.672the leading cause of biomaterial-related infections (13).,Non-OADS,/arxiv_data1/oa_pdf/5e/58/jkms-32-672.PMC5334168.pdf
"• Bacteriology in Otitis Media http://jkms.org   677 https://doi.org/10.3346/jkms.2017.32.4.672sulting in variations in bacteria causing OM (16,18).",Non-OADS,/arxiv_data1/oa_pdf/5e/58/jkms-32-672.PMC5334168.pdf
ORCID Sang Hoon Kim http://orcid.org/0000-0001-5045-5060 Eun-Ju Jeon http://orcid.org/0000-0003-4566-6802 Seok Min Hong http://orcid.org/0000-0001-7999-6258 Chang Hoon Bae http://orcid.org/0000-0002-0835-4060 Ho Yun Lee http://orcid.org/0000-0002-9590-3477 Moo Kyun Park http://orcid.org/0000-0002-3621-4524 Jae Yong Byun http://orcid.org/0000-0001-8273-0207,Non-OADS,/arxiv_data1/oa_pdf/5e/58/jkms-32-672.PMC5334168.pdf
• Bacteriology in Otitis Media 678  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.672Myung Gu Kim http://orcid.org/0000-0001-8169-3977 Seung Genu Yeo http://orcid.org/0000-0001-8021-1024 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5e/58/jkms-32-672.PMC5334168.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Therapeutic Effects of Korean Red Ginseng Extract in a Murine  Model of Atopic Dermatitis: Anti-pruritic and Anti-inflammatory  Mechanism Korean red ginseng (KRG) and ginsenosides exhibit diverse biological effects, including  anti-inflammatory and anti-allergic.",Non-OADS,/arxiv_data1/oa_pdf/2e/9a/jkms-32-679.PMC5334169.pdf
https://doi.org/10.3346/jkms.2017.32.4.679  • J Korean Med Sci 2017; 32: 679-687 INTRODUCTION Itching is the most serious clinical symptom and a major diag - nostic criterion of atopic dermatitis (AD) (1).,Non-OADS,/arxiv_data1/oa_pdf/2e/9a/jkms-32-679.PMC5334169.pdf
"• Therapeutic Effects of Ginseng in AD  680  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.679Induction of AD-like skin lesions TNCB was purchased from Sigma (St. Louis, MO, USA) and used  to induce AD-like skin lesions as previously described (7,8).",Non-OADS,/arxiv_data1/oa_pdf/2e/9a/jkms-32-679.PMC5334169.pdf
• Therapeutic Effects of Ginseng in AD  http://jkms.org   681 https://doi.org/10.3346/jkms.2017.32.4.679group consisted of 6 mice.,Non-OADS,/arxiv_data1/oa_pdf/2e/9a/jkms-32-679.PMC5334169.pdf
"• Therapeutic Effects of Ginseng in AD  682  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.679All calculations were performed in SPSS v19.0 (SPSS Inc., Chi - cago, IL, USA) and all values are expressed as mean ± standard  error of the mean (SEM).",OADS,/arxiv_data1/oa_pdf/2e/9a/jkms-32-679.PMC5334169.pdf
• Therapeutic Effects of Ginseng in AD  http://jkms.org   683 https://doi.org/10.3346/jkms.2017.32.4.679after the first TNCB challenge.,Non-OADS,/arxiv_data1/oa_pdf/2e/9a/jkms-32-679.PMC5334169.pdf
• Therapeutic Effects of Ginseng in AD  684  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.679between scratching-permitted and scratching-restricted sub - groups.,Non-OADS,/arxiv_data1/oa_pdf/2e/9a/jkms-32-679.PMC5334169.pdf
"• Therapeutic Effects of Ginseng in AD  http://jkms.org   685 https://doi.org/10.3346/jkms.2017.32.4.679vented the development of acute AD-like lesions and late-onset  chronic AD-like lesions (7,8).",Non-OADS,/arxiv_data1/oa_pdf/2e/9a/jkms-32-679.PMC5334169.pdf
• Therapeutic Effects of Ginseng in AD  686  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.679pothesize that the anti-pruritic effect of cyclosporine is mainly  due to its suppression of histamine release by mast cells.,Non-OADS,/arxiv_data1/oa_pdf/2e/9a/jkms-32-679.PMC5334169.pdf
ORCID Hyun Joo Lee http://orcid.org/0000-0003-0762-8717 Sang Hyun Cho http://orcid.org/0000-0001-8289-1190 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/2e/9a/jkms-32-679.PMC5334169.pdf
• Therapeutic Effects of Ginseng in AD  http://jkms.org   687 https://doi.org/10.3346/jkms.2017.32.4.67915.,Non-OADS,/arxiv_data1/oa_pdf/2e/9a/jkms-32-679.PMC5334169.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Differences in the Clinical Characteristics of Rapid Response  System Activation in Patients Admitted to Medical or Surgical  Services Variability in rapid response system (RRS) characteristics based on the admitted wards is  unknown.",Non-OADS,/arxiv_data1/oa_pdf/24/94/jkms-32-688.PMC5334170.pdf
"Box 6365, Truck Road, Ras Al Khaimah, United  Arab Emirates  E-mail: psh1399@gmail.comhttps://doi.org/10.3346/jkms.2017.32.4.688  • J Korean Med Sci 2017; 32: 688-694 INTRODUCTION The role of intensive care has rapidly expanded over the last 20  years, and critical care staff is involved in the care of critically ill  patients within the intensive care unit (ICU) and in general wards,  and following discharge from the ICU (1).",Non-OADS,/arxiv_data1/oa_pdf/24/94/jkms-32-688.PMC5334170.pdf
"• Difference of Rapid Response System-based Admission http://jkms.org   689 https://doi.org/10.3346/jkms.2017.32.4.688and causes for RRS activation, interventions performed, and  outcomes of patients admitted to medical and surgical services.",Non-OADS,/arxiv_data1/oa_pdf/24/94/jkms-32-688.PMC5334170.pdf
"• Difference of Rapid Response System-based Admission 690  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.688body temperature, oxygenation, lactic acid levels, and blood  gas analysis) or pain and neurological symptoms (72.6%, Table  2).",Non-OADS,/arxiv_data1/oa_pdf/24/94/jkms-32-688.PMC5334170.pdf
• Difference of Rapid Response System-based Admission http://jkms.org   691 https://doi.org/10.3346/jkms.2017.32.4.688Table 3.,Non-OADS,/arxiv_data1/oa_pdf/24/94/jkms-32-688.PMC5334170.pdf
"• Difference of Rapid Response System-based Admission 692  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.688interventions performed after RRS activation, we observed sim - ilar rates of ICU admission between groups.",Non-OADS,/arxiv_data1/oa_pdf/24/94/jkms-32-688.PMC5334170.pdf
"• Difference of Rapid Response System-based Admission http://jkms.org   693 https://doi.org/10.3346/jkms.2017.32.4.688team, familiarity with patient problems and the anticipated clin - ical course, and the integration of common causes for patient  deterioration in the system (16).",Non-OADS,/arxiv_data1/oa_pdf/24/94/jkms-32-688.PMC5334170.pdf
"Writing - review & editing: Lee YJ, Lee JH, Suh  JW, Jo YH, Kim K. ORCID  Yeon Joo Lee http://orcid.org/0000-0001-7697-4272 Dong Seon Lee http://orcid.org/0000-0002-4917-5990  Hyunju Min http://orcid.org/0000-0002-5974-3779  Yun Young Choi http://orcid.org/0000-0002-2813-4479 Eun Young Lee http://orcid.org/0000-0001-6718-6952  Inae Song http://orcid.org/0000-0001-9961-7593 Yeonyee E. Yoon http://orcid.org/0000-0002-8479-9889  Jin Won Kim http://orcid.org/0000-0002-1357-7015 Jong Sun Park http://orcid.org/0000-0003-3707-3636  Young-Jae Cho http://orcid.org/0000-0001-6943-4462  Jae Hyuk Lee http://orcid.org/0000-0003-2429-4085 Jung-Won Suh http://orcid.org/0000-0002-0397-6071 You Hwan Jo http://orcid.org/0000-0002-9507-7603 Kyuseok Kim http://orcid.org/0000-0002-7991-9428 Sangheon Park http://orcid.org/0000-0001-8563-7681 REFERENCES  1.",Non-OADS,/arxiv_data1/oa_pdf/24/94/jkms-32-688.PMC5334170.pdf
• Difference of Rapid Response System-based Admission 694  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.688ademic medical centers.,Non-OADS,/arxiv_data1/oa_pdf/24/94/jkms-32-688.PMC5334170.pdf
• Difference of Rapid Response System-based Admission http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.688Supplementary Table 1.,Non-OADS,/arxiv_data1/oa_pdf/24/94/jkms-32-688.PMC5334170.pdf
• Difference of Rapid Response System-based Admission http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.688Supplementary Table 2.,Non-OADS,/arxiv_data1/oa_pdf/24/94/jkms-32-688.PMC5334170.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Report on the Project for Establishment of the Standardized  Korean Laboratory Terminology Database, 2015 The National Health Information Standards Committee was established in 2004 in Korea.",Non-OADS,/arxiv_data1/oa_pdf/ce/ef/jkms-32-695.PMC5334171.pdf
"Keywords:  LOINC; K-LOINC; Standard Terminology; Laboratory Medicine TerminologyBo Kyeung Jung,1 Jeeyong Kim,1   Chi Hyun Cho,1 Ju Yeon Kim,1   Myung-Hyun Nam,1 Bong Kyung Shin,2  Eun Youn Rho,3 Sollip Kim,4   Heungsup Sung,5 Shinyoung Kim,6  Chang-Seok Ki,7 Min Jung Park,8   Kap-No Lee,9 and Soo-Young Yoon1  1Department of Laboratory Medicine, Korea  University College of Medicine, Seoul, Korea; 2Department of Pathology, Korea University College  of Medicine, Seoul, Korea; 3Department of  Laboratory Medicine, Seoul National University  College of Medicine, Seoul, Korea; 4Department of  Laboratory Medicine, Inje University College of  Medicine, Goyang, Korea; 5Department of Laboratory  Medicine, University of Ulsan College of Medicine,  Seoul, Korea; 6Department of Laboratory Medicine,  Yonsei University College of Medicine, Seoul, Korea; 7Department of Laboratory Medicine,  Sungkyunkwan University College of Medicine,  Seoul, Korea; 8Department of Laboratory Medicine,  Hallym University College of Medicine, Anyang,  Korea; 9Department of Laboratory Medicine,  Seegene Medical Foundation, Seoul, Korea Received: 12 November 2016 Accepted: 20 January 2017 Address for Correspondence: Soo-Young Yoon, MD Department of Laboratory Medicine, Korea University Guro  Hospital, Korea University College of Medicine, 148 Gurodong- ro, Guro-gu, Seoul 08308, Korea E-mail: labmd@korea.ac.kr Funding:  This project was financially supported by Department  of Healthcare Research and Development, Ministry of Health  and Welfare, Korea (project number: HI12C0566).https://doi.org/10.3346/jkms.2017.32.4.695  • J Korean Med Sci 2017; 32: 695-699 INTRODUCTION The National Health Information Standards Committee (NHISC) was established in  2004, under the Korean Ministry of Health and Welfare, in order to establish standard - ized laboratory terminology database in Korean language.",Non-OADS,/arxiv_data1/oa_pdf/ce/ef/jkms-32-695.PMC5334171.pdf
"Both LOINC and Regenstrief LOINC Mapping  Assistant (RELMA), designed to assist the mapping of local test codes to LOINC codes,  are available free of charge from http://www.regenstrief.org/loinc.",OADS,/arxiv_data1/oa_pdf/ce/ef/jkms-32-695.PMC5334171.pdf
• Standardizing Laboratory Terminology in Korea 696  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.695patient data (2).,Non-OADS,/arxiv_data1/oa_pdf/ce/ef/jkms-32-695.PMC5334171.pdf
"• Standardizing Laboratory Terminology in Korea http://jkms.org   697 https://doi.org/10.3346/jkms.2017.32.4.695KOSTOM names, LOINC numbers, classes, and statuses for  48,990 test observations (Table 1).",OADS,/arxiv_data1/oa_pdf/ce/ef/jkms-32-695.PMC5334171.pdf
"The synonym data - base will be uploaded to http://www.ssis.or.kr/, tentatively, to  be downloaded for free.",OADS,/arxiv_data1/oa_pdf/ce/ef/jkms-32-695.PMC5334171.pdf
"• Standardizing Laboratory Terminology in Korea 698  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.695DISCUSSION Long established coding systems, such as the International Clas - sification of Diseases (ICD) and Current Procedural Terminolo - gy (CPT), are used for insurance reimbursement and other ad - ministrative purposes.",Non-OADS,/arxiv_data1/oa_pdf/ce/ef/jkms-32-695.PMC5334171.pdf
"• Standardizing Laboratory Terminology in Korea http://jkms.org   699 https://doi.org/10.3346/jkms.2017.32.4.695Sung H, Kim S, Ki CS, Park MJ, Lee KN.",Non-OADS,/arxiv_data1/oa_pdf/ce/ef/jkms-32-695.PMC5334171.pdf
ORCID Bo Kyeung Jung http://orcid.org/0000-0002-9785-6440 Jeeyong Kim http://orcid.org/0000-0002-0426-2572 Chi Hyun Cho http://orcid.org/0000-0003-2262-2700 Ju Yeon Kim http://orcid.org/0000-0003-2686-5400 Myung-Hyun Nam http://orcid.org/0000-0002-8737-6902 Bong Kyung Shin http://orcid.org/0000-0001-9017-2831 Eun Youn Rho http://orcid.org/0000-0002-1787-7509 Sollip Kim http://orcid.org/0000-0003-0474-5897 Heungsup Sung http://orcid.org/0000-0002-6062-4451 Shinyoung Kim http://orcid.org/0000-0002-2609-8945 Chang-Seok Ki http://orcid.org/0000-0001-7679-8731 Min Jung Park http://orcid.org/0000-0002-2775-2128 Soo-Young Yoon http://orcid.org/0000-0002-2302-3825 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ce/ef/jkms-32-695.PMC5334171.pdf
Available  at https://loinc.org/ [accessed on 27 June 2014].,Non-OADS,/arxiv_data1/oa_pdf/ce/ef/jkms-32-695.PMC5334171.pdf
Available at http://loinc.org/downloads/ files/LOINCManual.pdf [accessed on 27 June 2014].,Non-OADS,/arxiv_data1/oa_pdf/ce/ef/jkms-32-695.PMC5334171.pdf
• Standardizing Laboratory Terminology in Korea http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.695Supplementary Table 1.,Non-OADS,/arxiv_data1/oa_pdf/ce/ef/jkms-32-695.PMC5334171.pdf
• Standardizing Laboratory Terminology in Korea http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.695Supplementary Table 2.,Non-OADS,/arxiv_data1/oa_pdf/ce/ef/jkms-32-695.PMC5334171.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Comparison of Early and Late Tuberculosis Deaths in Korea The cause of death in patients with tuberculosis (TB) may differ according to the phase of  anti-tuberculosis treatment.",Non-OADS,/arxiv_data1/oa_pdf/97/59/jkms-32-700.PMC5334172.pdf
"Keywords:  Tuberculosis; Early Deaths; Late Deaths; Drug Susceptibility TestJaehee Lee, Hyun Woo Nam, Sun Ha Choi,  Seung Soo Yoo, Shin Yup Lee,   Seung Ick Cha, Jae Yong Park,   and Chang Ho Kim Department of Internal Medicine, Kyungpook  National University, School of Medicine, Daegu,  Korea Received: 20 September 2016 Accepted: 20 January 2017 Address for Correspondence: Chang Ho Kim, MD Department of Internal Medicine, Kyungpook National  University School of Medicine, 680 Gukchaebosang-ro, Jung-gu,  Daegu 41944, Republic of Korea E-mail: kimch@knu.ac.kr Funding:  This work was supported by a grant of National  Research Foundation of Korea, funded by the Korea government  (2015R1C1A2A01052502).https://doi.org/10.3346/jkms.2017.32.4.700  • J Korean Med Sci 2017; 32: 700-703 Tuberculosis (TB) remains a significant cause of mortality world - wide.",Non-OADS,/arxiv_data1/oa_pdf/97/59/jkms-32-700.PMC5334172.pdf
• Deaths in Tuberculosis http://jkms.org   701 https://doi.org/10.3346/jkms.2017.32.4.700[IQR] 7–38) days.,Non-OADS,/arxiv_data1/oa_pdf/97/59/jkms-32-700.PMC5334172.pdf
"• Deaths in Tuberculosis 702  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.700the most common cause, followed by hepatic failure (n = 3),  and stroke (n = 2).",Non-OADS,/arxiv_data1/oa_pdf/97/59/jkms-32-700.PMC5334172.pdf
"• Deaths in Tuberculosis http://jkms.org   703 https://doi.org/10.3346/jkms.2017.32.4.700zid resistance was high; all 6 patients with early death and any  drug resistance had resistance to isoniazid, which is the most  commonly used drug for the treatment of subjects with LTBI.",Non-OADS,/arxiv_data1/oa_pdf/97/59/jkms-32-700.PMC5334172.pdf
ORCID Jaehee Lee http://orcid.org/0000-0001-8111-7320 Hyun Woo Nam http://orcid.org/0000-0003-0648-2023 Sun Ha Choi http://orcid.org/0000-0002-9665-7466 Seung Soo Yoo http://orcid.org/0000-0002-7309-9254 Shin Yup Lee http://orcid.org/0000-0002-2121-7335 Seung Ick Cha http://orcid.org/0000-0002-7246-0909 Jae Yong Park http://orcid.org/0000-0001-7993-4495 Chang Ho Kim http://orcid.org/0000-0002-1550-5752   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/97/59/jkms-32-700.PMC5334172.pdf
Available at http://www.who.int/tb/data [accessed on 9 February 2017].2.,OADS,/arxiv_data1/oa_pdf/97/59/jkms-32-700.PMC5334172.pdf
Available at http://www.lungkorea.,Non-OADS,/arxiv_data1/oa_pdf/97/59/jkms-32-700.PMC5334172.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357A Pediatric Case of Severe Fever with Thrombocytopenia  Syndrome in Korea Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease and  elderly people living in rural areas have the greatest risk of infection.",Non-OADS,/arxiv_data1/oa_pdf/34/5d/jkms-32-704.PMC5334173.pdf
"Keywords:  Severe Fever with Thrombocytopenia Syndrome Bunyavirus; Phlebovirus;  Child; KoreaTae Yang Song, Eun Mi Yang,   and Chan Jong Kim Department of Pediatrics, Chonnam National  University Hospital, Chonnam National University  Medical School, Gwangju, Korea Received: 17 November 2015 Accepted: 1 March 2016 Address for Correspondence: Eun Mi Yang, MD Department of Pediatrics, Chonnam National University  Hospital, Chonnam National University Medical School,   42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea E-mail: emyang@chonnam.ac.krhttps://doi.org/10.3346/jkms.2017.32.4.704  • J Korean Med Sci 2017; 32: 704-707 INTRODUCTION Between March and July of 2009, an emerging infectious disease  characterized by acute severe fever and thrombocytopenia of  unknown etiology was reported in the rural areas of Central Chi - na (1).",Non-OADS,/arxiv_data1/oa_pdf/34/5d/jkms-32-704.PMC5334173.pdf
"• SFTS in a Korean Child http://jkms.org   705 https://doi.org/10.3346/jkms.2017.32.4.704profile, kidney function test, and urinalysis were non-specific.",Non-OADS,/arxiv_data1/oa_pdf/34/5d/jkms-32-704.PMC5334173.pdf
"• SFTS in a Korean Child 706  http://jkms.org https://doi.org/10.3346/jkms.2017.32.4.704DISCUSSION In this article, we have described the first pediatric case of SFTS  in Korea.",Non-OADS,/arxiv_data1/oa_pdf/34/5d/jkms-32-704.PMC5334173.pdf
ORCID Tae Yang Song http://orcid.org/0000-0001-5543-8745 Eun Mi Yang http://orcid.org/0000-0001-9410-5855 Chan Jong Kim http://orcid.org/0000-0001-6519-2427 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/34/5d/jkms-32-704.PMC5334173.pdf
"• SFTS in a Korean Child http://jkms.org   707 https://doi.org/10.3346/jkms.2017.32.4.704XL, Cheng YL, et al.",Non-OADS,/arxiv_data1/oa_pdf/34/5d/jkms-32-704.PMC5334173.pdf
Avail- able at: http://www.restoresight.org/wp-content/uploads/2015/03/2014_Statistical_Report-FINAL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/23/64/cornea-36-476.PMC5334175.pdf
2 March 2017 135REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Neuroimaging of diabetes atherosclerosis,Non-OADS,/arxiv_data1/oa_pdf/78/67/JDI-8-134.PMC5334292.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/78/67/JDI-8-134.PMC5334292.pdf
2 March 2017 137REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Neuroimaging of diabetes atherosclerosis,Non-OADS,/arxiv_data1/oa_pdf/78/67/JDI-8-134.PMC5334292.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/78/67/JDI-8-134.PMC5334292.pdf
2 March 2017 139REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Neuroimaging of diabetes atherosclerosis,Non-OADS,/arxiv_data1/oa_pdf/78/67/JDI-8-134.PMC5334292.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/78/67/JDI-8-134.PMC5334292.pdf
2 March 2017 141REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Neuroimaging of diabetes atherosclerosis,Non-OADS,/arxiv_data1/oa_pdf/78/67/JDI-8-134.PMC5334292.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/78/67/JDI-8-134.PMC5334292.pdf
2 March 2017 143REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Neuroimaging of diabetes atherosclerosis,Non-OADS,/arxiv_data1/oa_pdf/78/67/JDI-8-134.PMC5334292.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/78/67/JDI-8-134.PMC5334292.pdf
2 March 2017 145REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Neuroimaging of diabetes atherosclerosis,Non-OADS,/arxiv_data1/oa_pdf/78/67/JDI-8-134.PMC5334292.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/78/67/JDI-8-134.PMC5334292.pdf
2 March 2017 147REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Neuroimaging of diabetes atherosclerosis,Non-OADS,/arxiv_data1/oa_pdf/78/67/JDI-8-134.PMC5334292.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/78/67/JDI-8-134.PMC5334292.pdf
2 March 2017 169ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi NC predicts GDM in Han Chinese women,Non-OADS,/arxiv_data1/oa_pdf/30/a4/JDI-8-168.PMC5334293.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/30/a4/JDI-8-168.PMC5334293.pdf
2 March 2017 171ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi NC predicts GDM in Han Chinese women,Non-OADS,/arxiv_data1/oa_pdf/30/a4/JDI-8-168.PMC5334293.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/30/a4/JDI-8-168.PMC5334293.pdf
2 March 2017 173ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi NC predicts GDM in Han Chinese women,Non-OADS,/arxiv_data1/oa_pdf/30/a4/JDI-8-168.PMC5334293.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a7/7e/JDI-8-235.PMC5334295.pdf
2 March 2017 237ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Validation of problem areas in diabetes,Non-OADS,/arxiv_data1/oa_pdf/a7/7e/JDI-8-235.PMC5334295.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a7/7e/JDI-8-235.PMC5334295.pdf
2 March 2017 239ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Validation of problem areas in diabetes,Non-OADS,/arxiv_data1/oa_pdf/a7/7e/JDI-8-235.PMC5334295.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a7/7e/JDI-8-235.PMC5334295.pdf
2 March 2017 241ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Validation of problem areas in diabetes,Non-OADS,/arxiv_data1/oa_pdf/a7/7e/JDI-8-235.PMC5334295.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a7/7e/JDI-8-235.PMC5334295.pdf
2 March 2017 255LETTER TO THE EDITOR http://onlinelibrary.wiley.com/journal/jdi Letter to the Editor,Non-OADS,/arxiv_data1/oa_pdf/54/6b/JDI-8-254.PMC5334297.pdf
The original computational methods for small variantdetection are available at: http://online.liebertpub.com/doi/ full/10.1089/cmb.2011.0201.,Non-OADS,/arxiv_data1/oa_pdf/53/ef/TCA-8-88.PMC5334298.pdf
Non-synonymous SNP information was extracted by comparing UCSC referencegene information (http://genome.Ucsc.edu/).,OADS,/arxiv_data1/oa_pdf/53/ef/TCA-8-88.PMC5334298.pdf
Information on cancer-related mutations was obtained from the cosmic cancer information database (http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/).,OADS,/arxiv_data1/oa_pdf/53/ef/TCA-8-88.PMC5334298.pdf
The Ingenuity Molecule Annotation System (MAS) (http://bioinfo.capitalbio.com/ mas3/) was used for functional interaction analysis of thegenes affected.,OADS,/arxiv_data1/oa_pdf/53/ef/TCA-8-88.PMC5334298.pdf
2 March 2017 153COMMENTARY http://onlinelibrary.wiley.com/journal/jdi Fatty liver to diabetes,Non-OADS,/arxiv_data1/oa_pdf/33/34/JDI-8-152.PMC5334299.pdf
"Journal of Diabetes Investigation p ublished by AASD and John Wiley & Sons Australia, LtdCOMMENTARY Kikuchi and Takamura http://onlinelibrary.wiley.com/journal/jdi",Non-OADS,/arxiv_data1/oa_pdf/33/34/JDI-8-152.PMC5334299.pdf
2 March 2017 211CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi IDegAsp twice daily in Japanese T2DM,Non-OADS,/arxiv_data1/oa_pdf/95/f0/JDI-8-210.PMC5334300.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/95/f0/JDI-8-210.PMC5334300.pdf
2 March 2017 213CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi IDegAsp twice daily in Japanese T2DM,Non-OADS,/arxiv_data1/oa_pdf/95/f0/JDI-8-210.PMC5334300.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/95/f0/JDI-8-210.PMC5334300.pdf
2 March 2017 215CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi IDegAsp twice daily in Japanese T2DM,Non-OADS,/arxiv_data1/oa_pdf/95/f0/JDI-8-210.PMC5334300.pdf
Availablefrom: http://www.pmda.go.jp/files/000152996.pdf.,Non-OADS,/arxiv_data1/oa_pdf/95/f0/JDI-8-210.PMC5334300.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/95/f0/JDI-8-210.PMC5334300.pdf
2 March 2017 217CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi IDegAsp twice daily in Japanese T2DM,Non-OADS,/arxiv_data1/oa_pdf/95/f0/JDI-8-210.PMC5334300.pdf
Available from URL: http://www.tsn.org.tw.,Non-OADS,/arxiv_data1/oa_pdf/0b/06/TCA-8-106.PMC5334301.pdf
Available from URL: http://seer.cancer.gov/csr/1975_2013/.,Non-OADS,/arxiv_data1/oa_pdf/0b/06/TCA-8-106.PMC5334301.pdf
"Journal of Diabetes Investigation p ublished by AASD and John Wiley & Sons Australia, LtdEDITORIAL Lee and Lam http://onlinelibrary.wiley.com/journal/jdi",Non-OADS,/arxiv_data1/oa_pdf/dd/e1/JDI-8-131.PMC5334302.pdf
2 March 2017 133EDITORIAL http://onlinelibrary.wiley.com/journal/jdi Editorial,Non-OADS,/arxiv_data1/oa_pdf/dd/e1/JDI-8-131.PMC5334302.pdf
2 March 2017 189ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Interactions of risk factors for T2DM,Non-OADS,/arxiv_data1/oa_pdf/f5/9c/JDI-8-188.PMC5334303.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/f5/9c/JDI-8-188.PMC5334303.pdf
2 March 2017 191ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Interactions of risk factors for T2DM,Non-OADS,/arxiv_data1/oa_pdf/f5/9c/JDI-8-188.PMC5334303.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/f5/9c/JDI-8-188.PMC5334303.pdf
2 March 2017 193ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Interactions of risk factors for T2DM,Non-OADS,/arxiv_data1/oa_pdf/f5/9c/JDI-8-188.PMC5334303.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/f5/9c/JDI-8-188.PMC5334303.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/3e/a5/JDI-8-227.PMC5334304.pdf
2 March 2017 229ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi OHA medication in Japanese T2DM cases,Non-OADS,/arxiv_data1/oa_pdf/3e/a5/JDI-8-227.PMC5334304.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/3e/a5/JDI-8-227.PMC5334304.pdf
2 March 2017 231ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi OHA medication in Japanese T2DM cases,Non-OADS,/arxiv_data1/oa_pdf/3e/a5/JDI-8-227.PMC5334304.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/3e/a5/JDI-8-227.PMC5334304.pdf
2 March 2017 233ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi OHA medication in Japanese T2DM cases,Non-OADS,/arxiv_data1/oa_pdf/3e/a5/JDI-8-227.PMC5334304.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/3e/a5/JDI-8-227.PMC5334304.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/b5/30/JDI-8-155.PMC5334308.pdf
2 March 2017 157ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi DPP-4 inhibitor lowers plasma lipids,Non-OADS,/arxiv_data1/oa_pdf/b5/30/JDI-8-155.PMC5334308.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/b5/30/JDI-8-155.PMC5334308.pdf
2 March 2017 159ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi DPP-4 inhibitor lowers plasma lipids,Non-OADS,/arxiv_data1/oa_pdf/b5/30/JDI-8-155.PMC5334308.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/b5/30/JDI-8-155.PMC5334308.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a0/d3/JDI-8-195.PMC5334309.pdf
2 March 2017 197ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Nutritional guidance for type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/a0/d3/JDI-8-195.PMC5334309.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a0/d3/JDI-8-195.PMC5334309.pdf
"Brussels, Belgium: 2015:12–15 Available from: http://www.diabetesatlas.org Accessed March, 2016.",Non-OADS,/arxiv_data1/oa_pdf/a0/d3/JDI-8-195.PMC5334309.pdf
2 March 2017 199ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Nutritional guidance for type 2 diabetes,Non-OADS,/arxiv_data1/oa_pdf/a0/d3/JDI-8-195.PMC5334309.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a0/d3/JDI-8-195.PMC5334309.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/ea/1e/JDI-8-201.PMC5334310.pdf
2 March 2017 203ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Yoga for T2DM,Non-OADS,/arxiv_data1/oa_pdf/ea/1e/JDI-8-201.PMC5334310.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/ea/1e/JDI-8-201.PMC5334310.pdf
2 March 2017 205ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Yoga for T2DM,Non-OADS,/arxiv_data1/oa_pdf/ea/1e/JDI-8-201.PMC5334310.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/ea/1e/JDI-8-201.PMC5334310.pdf
2 March 2017 207ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Yoga for T2DM,Non-OADS,/arxiv_data1/oa_pdf/ea/1e/JDI-8-201.PMC5334310.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/ea/1e/JDI-8-201.PMC5334310.pdf
2 March 2017 209ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Yoga for T2DM,Non-OADS,/arxiv_data1/oa_pdf/ea/1e/JDI-8-201.PMC5334310.pdf
"Journal of Diabetes Investigation p ublished by AASD and John Wiley & Sons Australia, LtdCOMMENTARY Shirakawa and Terauchi http://onlinelibrary.wiley.com/journal/jdi",Non-OADS,/arxiv_data1/oa_pdf/3b/dd/JDI-8-149.PMC5334311.pdf
2 March 2017 151COMMENTARY http://onlinelibrary.wiley.com/journal/jdi PKC fin adaptive b-cell proliferative,Non-OADS,/arxiv_data1/oa_pdf/3b/dd/JDI-8-149.PMC5334311.pdf
2 March 2017 175ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Telomere shortening predicts NAFLD,Non-OADS,/arxiv_data1/oa_pdf/c5/36/JDI-8-174.PMC5334312.pdf
The ultrasound hepatorenal sonographic indices were calculated by NIH image analysis software (https://imagej.nih.gov).,OADS,/arxiv_data1/oa_pdf/c5/36/JDI-8-174.PMC5334312.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c5/36/JDI-8-174.PMC5334312.pdf
2 March 2017 177ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Telomere shortening predicts NAFLD,Non-OADS,/arxiv_data1/oa_pdf/c5/36/JDI-8-174.PMC5334312.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c5/36/JDI-8-174.PMC5334312.pdf
2 March 2017 179ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Telomere shortening predicts NAFLD,Non-OADS,/arxiv_data1/oa_pdf/c5/36/JDI-8-174.PMC5334312.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c5/36/JDI-8-174.PMC5334312.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/7e/1e/JDI-8-243.PMC5334313.pdf
2 March 2017 245ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Duration of diabetes and diabetes therapy,Non-OADS,/arxiv_data1/oa_pdf/7e/1e/JDI-8-243.PMC5334313.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/7e/1e/JDI-8-243.PMC5334313.pdf
2 March 2017 247ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Duration of diabetes and diabetes therapy,Non-OADS,/arxiv_data1/oa_pdf/7e/1e/JDI-8-243.PMC5334313.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/7e/1e/JDI-8-243.PMC5334313.pdf
2 March 2017 249ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Duration of diabetes and diabetes therapy,Non-OADS,/arxiv_data1/oa_pdf/7e/1e/JDI-8-243.PMC5334313.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/41/f0/JDI-8-181.PMC5334314.pdf
2 March 2017 183ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Donor liver steatosis and NODAT,Non-OADS,/arxiv_data1/oa_pdf/41/f0/JDI-8-181.PMC5334314.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/41/f0/JDI-8-181.PMC5334314.pdf
2 March 2017 185ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Donor liver steatosis and NODAT,Non-OADS,/arxiv_data1/oa_pdf/41/f0/JDI-8-181.PMC5334314.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/41/f0/JDI-8-181.PMC5334314.pdf
2 March 2017 187ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Donor liver steatosis and NODAT,Non-OADS,/arxiv_data1/oa_pdf/41/f0/JDI-8-181.PMC5334314.pdf
2 March 2017 219CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Vildagliptin reduces plasma SDF-1 a,Non-OADS,/arxiv_data1/oa_pdf/06/fe/JDI-8-218.PMC5334315.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/06/fe/JDI-8-218.PMC5334315.pdf
2 March 2017 221CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Vildagliptin reduces plasma SDF-1 a,Non-OADS,/arxiv_data1/oa_pdf/06/fe/JDI-8-218.PMC5334315.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/06/fe/JDI-8-218.PMC5334315.pdf
2 March 2017 223CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Vildagliptin reduces plasma SDF-1 a,Non-OADS,/arxiv_data1/oa_pdf/06/fe/JDI-8-218.PMC5334315.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/06/fe/JDI-8-218.PMC5334315.pdf
2 March 2017 225CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Vildagliptin reduces plasma SDF-1 a,Non-OADS,/arxiv_data1/oa_pdf/06/fe/JDI-8-218.PMC5334315.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/06/fe/JDI-8-218.PMC5334315.pdf
2 March 2017 251SHORT REPORT http://onlinelibrary.wiley.com/journal/jdi baPWV and mortality after amputation,Non-OADS,/arxiv_data1/oa_pdf/d1/e5/JDI-8-250.PMC5334322.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/d1/e5/JDI-8-250.PMC5334322.pdf
2 March 2017 253SHORT REPORT http://onlinelibrary.wiley.com/journal/jdi baPWV and mortality after amputation,Non-OADS,/arxiv_data1/oa_pdf/d1/e5/JDI-8-250.PMC5334322.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/ee/1f/JDI-8-161.PMC5334332.pdf
2 March 2017 163ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Gestational diabetes in Scotland,Non-OADS,/arxiv_data1/oa_pdf/ee/1f/JDI-8-161.PMC5334332.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/ee/1f/JDI-8-161.PMC5334332.pdf
2 March 2017 165ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Gestational diabetes in Scotland,Non-OADS,/arxiv_data1/oa_pdf/ee/1f/JDI-8-161.PMC5334332.pdf
"Available from: http://apps.who.int/iris/bitstream/10665/85975/1/WHO_NMH_MND_13.2_eng.pdfAccessed December 5, 2015.",OADS,/arxiv_data1/oa_pdf/ee/1f/JDI-8-161.PMC5334332.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/ee/1f/JDI-8-161.PMC5334332.pdf
2 March 2017 167ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Gestational diabetes in Scotland,Non-OADS,/arxiv_data1/oa_pdf/ee/1f/JDI-8-161.PMC5334332.pdf
variant has been deposited in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/) under acces- sion number SCV000328979.,Non-OADS,/arxiv_data1/oa_pdf/3b/a3/HsiaoMCS001396.PMC5334470.pdf
The identified variants in the proband were filtered to include rare variants (mean allele frequency < 0.01) using publicly available Exome Variant Server (http://exac.broadinstitute.,Non-OADS,/arxiv_data1/oa_pdf/be/22/MortonMCS001560.PMC5334471.pdf
org) and 1000 Genomes (http://www.1000genomes.org) databases.,OADS,/arxiv_data1/oa_pdf/be/22/MortonMCS001560.PMC5334471.pdf
ADDITIONAL INFORMATION Data Deposition and Access Genetic variant data was submitted to ClinVar (https://www.ncbi.nlm.nih.gov/clinvar) under accession number SCV000484975.,Non-OADS,/arxiv_data1/oa_pdf/be/22/MortonMCS001560.PMC5334471.pdf
"2014) (https://www.hgsc.bcm.edu/content/mercury), achieving an aver- age coverage of 116× read depth (Supplemental Table 1).",Non-OADS,/arxiv_data1/oa_pdf/ca/79/Patelmcs000984.PMC5334472.pdf
The variants described in this study have been submitted to ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/) under accession numbers SCV000299173.1 through SCV000299199.1 (see Table 3 for full list).,Non-OADS,/arxiv_data1/oa_pdf/ca/79/Patelmcs000984.PMC5334472.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/83/main.PMC5334492.pdf
"With  grad- ual  improvement  in  the  symptoms  and  signs,  the  patient  returned to  daily  ambulatory  activities  with  cane  and  almost  recovered http://dx.doi.org/10.1016/j.ijscr.2017.02.017 2210-2612/© 2017  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/86/83/main.PMC5334492.pdf
This  is  an  open  access  article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/a7/main.PMC5334493.pdf
The  EWSs  were  inserted  through  an  endotracheal  tube under  local  anesthesia  with  moderate  sedation  to  allow  sponta- http://dx.doi.org/10.1016/j.ijscr.2016.11.025 2210-2612/© 2016  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ac/a7/main.PMC5334493.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/b5/main.PMC5334495.pdf
Materials  and  methods The  series  involved  retrospective  review  of  hepatobiliary  cases done  robotically  using  the  Da  Vinci  surgical  system  at  a  private tertiary  teaching  hospital  from  February  2015  to  January  2016. http://dx.doi.org/10.1016/j.ijscr.2017.02.022 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/4c/b5/main.PMC5334495.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/14/main.PMC5334497.pdf
"The  peripheral  white  blood cell  count  on  admission  was  4680//H9262L  (3000/ /H9262L–9000/ /H9262L)  with  a normal  differential,  and  C-reactive  protein  (CRP)  was  1.82  mg/L http://dx.doi.org/10.1016/j.ijscr.2017.02.021 2210-2612/© 2017  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/05/14/main.PMC5334497.pdf
This  is  an  open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/1e/main.PMC5334498.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.02.023 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/b6/1e/main.PMC5334498.pdf
"20  (2006)  486–487,  http://dx.doi.org/10.1111/ j.1468-3083.2006.01486.x .",Non-OADS,/arxiv_data1/oa_pdf/b6/1e/main.PMC5334498.pdf
"32  (2013)  83–85,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b6/1e/main.PMC5334498.pdf
"378  (2011)  2039–2047, http://dx.doi.org/10.1016/S0140-6736(10)62230-1 .",Non-OADS,/arxiv_data1/oa_pdf/b6/1e/main.PMC5334498.pdf
"Cordes,  Phospholipase  D  toxins  of  brown  spider  venom  convert lysophosphatidylcholine and sphingomyelin to cyclic phosphates,  PLoS  One  8 (2013) e72372,  http://dx.doi.org/10.1371/journal.pone.0072372 .",Non-OADS,/arxiv_data1/oa_pdf/b6/1e/main.PMC5334498.pdf
"34  (2016)  180–186,  http://dx.doi.org/10.1016/j.ijsu.2016.08.",Non-OADS,/arxiv_data1/oa_pdf/b6/1e/main.PMC5334498.pdf
"63  (2005)  1774–1778,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b6/1e/main.PMC5334498.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to:  Silvia Morbelli, MD, PhD,  Nuclear  Medicine Unit, IRCCS San Martino-IST, University of Genoa,  Largo R. Benzi 10, 16132 Genova,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/8e/71/WJR-9-27.PMC5334499.pdf
"However,  although the computed tomography-based response World Journal of  Radiology WJR Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4329/wjr.v9.i2.27World J Radiol  2017 February 28; 9(2): 27-33 ISSN 1949-8470 (online)",Non-OADS,/arxiv_data1/oa_pdf/8e/71/WJR-9-27.PMC5334499.pdf
World J Radiol   2017; 9(2): 27-33  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/8e/71/WJR-9-27.PMC5334499.pdf
com/ 1949-8470 /full/v9/i2/27.htm  DOI: http://dx.doi.org/10.4329/ wjr.v9.i2.27 TEXT The function of the immune system is characterized by  multiple checkpoints aiming to avoid its over-activation  against healthy cells (self-tolerance)[1].,Non-OADS,/arxiv_data1/oa_pdf/8e/71/WJR-9-27.PMC5334499.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/8e/71/WJR-9-27.PMC5334499.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to:  Athina C Tsili, MD, Assistant Professor,  Department of Clinical Radiology, University of Ioannina,  Medical School, University Campus, Ioannina, 45110 Epirus,  Greece.",Non-OADS,/arxiv_data1/oa_pdf/77/3d/WJR-9-34.PMC5334500.pdf
Non-World Journal of  Radiology WJR Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4329/wjr.v9.i2.34World J Radiol  2017 February 28; 9(2): 34-45 ISSN 1949-8470 (online),Non-OADS,/arxiv_data1/oa_pdf/77/3d/WJR-9-34.PMC5334500.pdf
wjgnet.com/ 1949-8470 /full/v9/i2/34.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/77/3d/WJR-9-34.PMC5334500.pdf
"Available from: URL:  http://www.auanet.org/common/pdf/education/clinical-guidance/ Varicocele-Archive.pdf 78 Jungwirth A , Giwercman A, Tournaye H, Diemer T, Kopa Z, Dohle  G, Krausz C. European Association of Urology guidelines on Male  Infertility: the 2012 update.",Non-OADS,/arxiv_data1/oa_pdf/77/3d/WJR-9-34.PMC5334500.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/77/3d/WJR-9-34.PMC5334500.pdf
"See: http://creativecommons.org/licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Emanuele Neri, MD, Professor  of  Radiology at the University of Pisa, Department of Translational  Research and New Technologies in Medicine and Surgery, Diagnostic Radiology, Radiodiagnostica 3 Ospedale S, Chiara ­  Edificio 18, Via Roma 67, 56126 Pisa,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/b4/04/WJR-9-46.PMC5334501.pdf
"In this setting, the purpose of this review  article is to illustrate the MR enterography technique and  the most relevant imaging findings of CD, in order to  discriminate among the various subtypes of CD (active,  fistulizing/perforating or chronic subtype) and to assess  disease activity.World Journal of  Radiology WJR Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4329/wjr.v9.i2.46World J Radiol  2017 February 28; 9(2): 46-54 ISSN 1949-8470 (online)",Non-OADS,/arxiv_data1/oa_pdf/b4/04/WJR-9-46.PMC5334501.pdf
"World J Radiol  2017; 9(2): 46-54  Available  from: URL:  http://www.wjgnet.com/ 1949-8470 /full/v9/i2/46.htm   DOI: http://dx.doi.org/10.4329/wjr.v9.i2.46 INTRODUCTION Crohn’s disease (CD) is a type of chronic inflammatory  bowel disease, characterized by typical fluctuating course  with relapses alternating with periods of remi ssion[1].",Non-OADS,/arxiv_data1/oa_pdf/b4/04/WJR-9-46.PMC5334501.pdf
"Available  from: URL: http://www.radreport.org/template/0000051 P- Reviewer : Anzola LK, Giudici F    S- Editor : Gong ZM     L- Editor : A    E- Editor : Wu HLMantarro A  et al.",Non-OADS,/arxiv_data1/oa_pdf/b4/04/WJR-9-46.PMC5334501.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/b4/04/WJR-9-46.PMC5334501.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Bhavya Rehani, MD, Assistant Professor,  Department of Radiology and Biomedical Imaging, University of  California, 1001 Potrero Ave, San Francisco, CA 94110,  United States.",Non-OADS,/arxiv_data1/oa_pdf/b3/60/WJR-9-55.PMC5334502.pdf
Survey questions  include length of medical school and residency training; World Journal of  Radiology WJR Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4329/wjr.v9.i2.55World J Radiol  2017 February 28; 9(2): 55-62 ISSN 1949-8470 (online) Basic Study,Non-OADS,/arxiv_data1/oa_pdf/b3/60/WJR-9-55.PMC5334502.pdf
World J Radiol  2017; 9(2): 55-62   Available from: URL:  http://www.wjgnet.com/ 1949-8470 /full/v9/ i2/55.htm  DOI: http://dx.doi.org/10.4329/wjr.v9.i2.55 INTRODUCTION Radiology provides cutting-edge imaging information  that guides clinical decision-making.,Non-OADS,/arxiv_data1/oa_pdf/b3/60/WJR-9-55.PMC5334502.pdf
"Available from: URL:  https://www.myesr.org/html/img/pool/ESR_brochure_05.pdf 4 Gunderman RB , Kang YP, Fraley RE, Williamson KB.",Non-OADS,/arxiv_data1/oa_pdf/b3/60/WJR-9-55.PMC5334502.pdf
Available from: URL: http://www.myesr.org/cms/website.,Non-OADS,/arxiv_data1/oa_pdf/b3/60/WJR-9-55.PMC5334502.pdf
Available from: URL: http://www.myesr.org/cms/website.,Non-OADS,/arxiv_data1/oa_pdf/b3/60/WJR-9-55.PMC5334502.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/b3/60/WJR-9-55.PMC5334502.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: James C L Chow, PhD, Radiation  Medicine Program, Princess Margaret Cancer Centre, Department  of Radiation Oncology, University of Toronto, 610 University  Avenue, Toronto, ON M5G 2M9,  Canada.",Non-OADS,/arxiv_data1/oa_pdf/1f/ce/WJR-9-63.PMC5334503.pdf
"RESULTS  It was found t hat among all nanoparticles, Au had the World Journal of  Radiology WJR Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4329/wjr.v9.i2.63World J Radiol  2017 February 28; 9(2): 63-71 ISSN 1949-8470 (online) Basic Study",OADS,/arxiv_data1/oa_pdf/1f/ce/WJR-9-63.PMC5334503.pdf
wjgnet.com/ 1949-8470 /full/v9/i2/63.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/ce/WJR-9-63.PMC5334503.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/1f/ce/WJR-9-63.PMC5334503.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Unsolicited manuscript Correspondence to:  Gianvincenzo Sparacia, MD,  Department  of Radiology, University of Palermo, Via del Vespro 127, 90127  Palermo, Italy.",Non-OADS,/arxiv_data1/oa_pdf/34/1e/WJR-9-72.PMC5334504.pdf
Six patients had areas with restricted diffusion World Journal of  Radiology WJR Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4329/wjr.v9.i2.72World J Radiol  2017 February 28; 9(2): 72-78 ISSN 1949-8470 (online) Retrospective Study,Non-OADS,/arxiv_data1/oa_pdf/34/1e/WJR-9-72.PMC5334504.pdf
World J  Radiol  2017; 9(2): 72-78  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/34/1e/WJR-9-72.PMC5334504.pdf
com/ 1949-8470 /full/v9/i2/72.htm  DOI: http://dx.doi.org/10.4329/ wjr.v9.i2.72 INTRODUCTION Wernicke’s encephalopathy (WE) is a neurologic disease  caused by thiamine (vitamin B1) deficiency[1].,Non-OADS,/arxiv_data1/oa_pdf/34/1e/WJR-9-72.PMC5334504.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/34/1e/WJR-9-72.PMC5334504.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Venkatesh Mani, PhD, Translational and  Molecular I maging Institute, Department of Radiology, Icahn  School of Medicine at Mount Sinai, 1470 Madison Avenue New  York, NY 10029, United States.",Non-OADS,/arxiv_data1/oa_pdf/cc/c1/WJR-9-79.PMC5334505.pdf
The 3D SPACE sequence at both 7T  and 3T MRI with isotropic voxels allowed for multi-planar World Journal of  Radiology WJR Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4329/wjr.v9.i2.79World J Radiol  2017 February 28; 9(2): 79-84 ISSN 1949-8470 (online) Observational Study,Non-OADS,/arxiv_data1/oa_pdf/cc/c1/WJR-9-79.PMC5334505.pdf
wjgnet.com/ 1949-8470 /full/v9/i2/79.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cc/c1/WJR-9-79.PMC5334505.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/cc/c1/WJR-9-79.PMC5334505.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Francesco Lassandro, MD,  Department  of Radiology, Monaldi Hospital, via Leonardo Bianchi, 80131  Naples, Italy.",Non-OADS,/arxiv_data1/oa_pdf/56/f3/WJR-9-85.PMC5334506.pdf
In 22 patients World Journal of  Radiology WJR Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4329/wjr.v9.i2.85World J Radiol  2017 February 28; 9(2): 85-90 ISSN 1949-8470 (online) Observational Study,Non-OADS,/arxiv_data1/oa_pdf/56/f3/WJR-9-85.PMC5334506.pdf
wjgnet.com/ 1949-8470 /full/v9/i2/85.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/f3/WJR-9-85.PMC5334506.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/56/f3/WJR-9-85.PMC5334506.pdf
This  is  an  open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6c/73/main.PMC5334518.pdf
"The  labora- tory  data  were  as  follows:  white  blood  cell  count,  8900//H9262L  (normal range,  3400–9500/ /H9262L);  and  C-reactive  protein  level,  7.68  mg/dL http://dx.doi.org/10.1016/j.ijscr.2017.02.028 2210-2612/© 2017  The  Author(s).",OADS,/arxiv_data1/oa_pdf/6c/73/main.PMC5334518.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/67/main.PMC5334519.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.10.008 90,OADS,/arxiv_data1/oa_pdf/90/67/main.PMC5334519.pdf
Available from: http://www.cancer.gov/ about-cancer/treatment/drugs/nivolumab .,Non-OADS,/arxiv_data1/oa_pdf/90/67/main.PMC5334519.pdf
2016. http://dx.doi.org/10.1111/ 1346-8138.13520 .,Non-OADS,/arxiv_data1/oa_pdf/90/67/main.PMC5334519.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/76/72/main.PMC5334520.pdf
http://dx.doi.org/10.1016/j.jdcr.2017.01.003 93,OADS,/arxiv_data1/oa_pdf/76/72/main.PMC5334520.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/c2/main.PMC5334521.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.11.009 95,OADS,/arxiv_data1/oa_pdf/9b/c2/main.PMC5334521.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/e6/main.PMC5334545.pdf
1936-5233/17http://dx.doi.org/10.1016/j.tranon.2017.01.006,OADS,/arxiv_data1/oa_pdf/87/e6/main.PMC5334545.pdf
http://dx.doi.org/10.1002/ijc.29210 .,Non-OADS,/arxiv_data1/oa_pdf/87/e6/main.PMC5334545.pdf
http://dx.doi.org/10.1200/jco.2006.09.6305 .,OADS,/arxiv_data1/oa_pdf/87/e6/main.PMC5334545.pdf
http://dx.doi.org/10.1200/jco.2012.46.2762 .,Non-OADS,/arxiv_data1/oa_pdf/87/e6/main.PMC5334545.pdf
http://dx.doi.org/10.1016/s1470-2045(10)70232-1 .,OADS,/arxiv_data1/oa_pdf/87/e6/main.PMC5334545.pdf
http://dx.doi.org/10.1172/jci113682 .,Non-OADS,/arxiv_data1/oa_pdf/87/e6/main.PMC5334545.pdf
http://dx.doi.org/10.1111/j.1365-2354.2008.00965.x .,Non-OADS,/arxiv_data1/oa_pdf/87/e6/main.PMC5334545.pdf
http://dx.doi.org/10.1016/j.ajog.2008.12.042 .,OADS,/arxiv_data1/oa_pdf/87/e6/main.PMC5334545.pdf
"Med Oncol 31(8), 80. http://dx.doi.org/10.1007/s12032 –014-0080-y .",Non-OADS,/arxiv_data1/oa_pdf/87/e6/main.PMC5334545.pdf
"Med Oncol 32(1), 407. http://dx.doi.org/10.1007/s12032 –014–0407-8 .",Non-OADS,/arxiv_data1/oa_pdf/87/e6/main.PMC5334545.pdf
http://dx.doi.org/10.1074/jbc.M301042200 .,Non-OADS,/arxiv_data1/oa_pdf/87/e6/main.PMC5334545.pdf
"Cytokine 31(1), 52 –63.http://dx.doi.org/10.1016/j.cyto.2005.03.002 .",OADS,/arxiv_data1/oa_pdf/87/e6/main.PMC5334545.pdf
http://dx.doi.org/10.1074/jbc.M113.468967 .,Non-OADS,/arxiv_data1/oa_pdf/87/e6/main.PMC5334545.pdf
http://dx.doi.org/10.1016/j.actbio.2011.06.007 .,OADS,/arxiv_data1/oa_pdf/87/e6/main.PMC5334545.pdf
http://dx.doi.org/10.1038/nrd1381 .,Non-OADS,/arxiv_data1/oa_pdf/87/e6/main.PMC5334545.pdf
http://dx.doi.org/10.1038/bjc.2012.17 .,Non-OADS,/arxiv_data1/oa_pdf/87/e6/main.PMC5334545.pdf
http://dx.doi.org/10.1371/journal.pone.0134732 .,Non-OADS,/arxiv_data1/oa_pdf/87/e6/main.PMC5334545.pdf
http://dx.doi.org/10.18632/oncotarget.8901 .,OADS,/arxiv_data1/oa_pdf/87/e6/main.PMC5334545.pdf
"Front Oncol 4, 70. http://dx.doi.org/10.3389/fonc.2014.00070 .",Non-OADS,/arxiv_data1/oa_pdf/87/e6/main.PMC5334545.pdf
http://dx.doi.org/10.1158/1078-0432.ccr-07-0374 .,Non-OADS,/arxiv_data1/oa_pdf/87/e6/main.PMC5334545.pdf
http://dx.doi.org/10.1158/0008-5472.can-10-0153 .,Non-OADS,/arxiv_data1/oa_pdf/87/e6/main.PMC5334545.pdf
http://dx.doi.org/10.1039/c0ib00147c .294 Serum ApoA-I in Patients with mCRC Quan et al.,Non-OADS,/arxiv_data1/oa_pdf/87/e6/main.PMC5334545.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.02.0122211-3355/© 2017 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/ea/20/main.PMC5334546.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/20/main.PMC5334546.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/ea/20/main.PMC5334546.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: ConcussionMRICerebral blood ﬂow Functional MRIDiffusion tensor imaging 1.,Non-OADS,/arxiv_data1/oa_pdf/e5/10/main.PMC5334547.pdf
http://dx.doi.org/10.1016/j.nicl.2017.02.015 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/10/main.PMC5334547.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/10/main.PMC5334547.pdf
http://dx.doi.org/10.1097/HTR.,Non-OADS,/arxiv_data1/oa_pdf/e5/10/main.PMC5334547.pdf
"Fastq data of the 1000 Genomes Project samples To compare with PCR-based approaches, we selected a total of 961 samples across 13 different populations in the 1000 Genomes Project database (http://www.1000genomes.org/) that had both exome data, which were sequenced by paired-end reads on Illumina sequencer (Genome Analyzer II or HiSeq 2000), and HLA type information experimentally determined by Sanger sequencing (Supplementary Table 1).",OADS,/arxiv_data1/oa_pdf/94/ef/jhg2016141a.PMC5334549.pdf
"Read mapping to hg19 reference genome After the exclusion of low-quality reads (base quality of o20 for more than 80% of bases) using FASTX toolkit (http://hannonlab.cshl.edu/fastx_toolkit/), sequence reads were mapped to the human reference genome GRCh37/hg19using Burrows-Wheeler Aligner (v0.7.10).",OADS,/arxiv_data1/oa_pdf/94/ef/jhg2016141a.PMC5334549.pdf
"31BAM ﬁles were generated using SAMTools (v0.1.19),32and possible PCR duplicated reads were removed using Picard v1.117 (http://broadinstitute.github.io/picard/).",OADS,/arxiv_data1/oa_pdf/94/ef/jhg2016141a.PMC5334549.pdf
"HLA coding DNA and genomic nucleotide sequences and feature annotation were obtainedfrom the IMGT/HLA (https://www.ebi.ac.uk/ipd/imgt/hla/) 1,2or dbMHC database (http://www.ncbi.nlm.nih.gov/projects/gv/mhc/).",OADS,/arxiv_data1/oa_pdf/94/ef/jhg2016141a.PMC5334549.pdf
"ACKNOWLEDGEMENTS The super-computing resource was provided by Human Genome Center, the Institute of Medical Science, the University of Tokyo (http://sc.hgc.jp/shirokane.html).",OADS,/arxiv_data1/oa_pdf/94/ef/jhg2016141a.PMC5334549.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by- nc-sa/4.0/ rThe Author(s) 2017 Supplementary Information accompanies the paper on Journal of Human Genetics website (http://www.nature.com/jhg)Comparison of exome-based HLAgenotyping tools KK i y o t a n i et al 405 Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/94/ef/jhg2016141a.PMC5334549.pdf
"Scripts are in https:// bitbucket.org/MAVERICLab /rnaseq-cba38-1-phage- host-time-series as well as in http://mirrors.iplantcollaborative.org/browse/iplant/home/shared/iVirus/ Cellulophaga_Transcripto mics, where additionally the Supplementary Data set S1 can be found.",OADS,/arxiv_data1/oa_pdf/3b/a0/ismej201681a.PMC5335546.pdf
"ce.gatech.edu/ani/http://enve-omics.ce.gatech.edu/ ani/ to obtain their average nucleotide identity.Genomes were further compared with Blastp (thresh- old of 50 on bit score, 0.001 on e-value and 99% of amino-acid identity of BLAST hit).",OADS,/arxiv_data1/oa_pdf/3b/a0/ismej201681a.PMC5335546.pdf
", 2005), to determine the frequency of visibly infected cells using a transmission electronmicroscope (CM12, Philips, Eindhoven, The Nether-lands) to count the phage particles within cells.Complete protocols are available at http://u.osu.edu/viruslab/protocols/#TransmissionElectronMicroscopy and raw data in the SupplementaryData set S1, tab TEM.",Non-OADS,/arxiv_data1/oa_pdf/3b/a0/ismej201681a.PMC5335546.pdf
"NC_021796.1) was reordered to accommodate the transcriptional pattern, that is, by making thefirst gene represented coincide with the first genetranscribed and can be found at http://mirrors.iplantcollaborative.org/browse/iplant/home/shared/iVirus/Cellulophaga_Transcriptomics.",Non-OADS,/arxiv_data1/oa_pdf/3b/a0/ismej201681a.PMC5335546.pdf
Statistical analyses of the phage and host transcriptomes Scripts for the following analyses are provided at https://bitbucket.org/MAVERICLab/rnaseq-cba38- 1-phage-host-time-series.,OADS,/arxiv_data1/oa_pdf/3b/a0/ismej201681a.PMC5335546.pdf
"To view a copyof this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on The I SME Journal website (http:/ /www.nature.",Non-OADS,/arxiv_data1/oa_pdf/3b/a0/ismej201681a.PMC5335546.pdf
"A map of the sample sites was created in python using the package ‘basemap ’, and the code to recreate the map is available at https://github.com/neavemj/microbiomeMap.",OADS,/arxiv_data1/oa_pdf/f7/8a/ismej201695a.PMC5335547.pdf
"In the interest of reproducibility, an R markdown document containing complete com- mands for the analysis is available here: https://github.com/neavemj/globalCoralMicrobiomes/ ‘cor- alMicrobiomes.Rmd ’.",Non-OADS,/arxiv_data1/oa_pdf/f7/8a/ismej201695a.PMC5335547.pdf
http://cran.r-project.org/package = vegan.,Non-OADS,/arxiv_data1/oa_pdf/f7/8a/ismej201695a.PMC5335547.pdf
http://cran.r-project.org/package =clustsig.,Non-OADS,/arxiv_data1/oa_pdf/f7/8a/ismej201695a.PMC5335547.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)Differential coral –Endozoicomonas specificity MJ Neave et al 200 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/f7/8a/ismej201695a.PMC5335547.pdf
http://doi.org/10.1183/20734735.012016  Breathe | December 2016 | Volume 12 | No 4 357 Cite as: Morley A. Cerebral  palsy and sleep disordered breathing.,Non-OADS,/arxiv_data1/oa_pdf/de/84/EDU-0120-2016.PMC5335572.pdf
"@ ERSpublications Despite the known correlation between neurodisability and sleep disordered breathing, cases are still missed http://ow.ly/2pNS305Kll3",Non-OADS,/arxiv_data1/oa_pdf/de/84/EDU-0120-2016.PMC5335572.pdf
"http://doi.org/10.1183/20734735.012116  Breathe | December 2016 | Volume 12 | No 4 e92 Obstructive sleep apnoea/hypopnoea syndrome (OSAHS) is characterised by repeated cycles of upper  airway obstruction during sleep, leading to diurnal symptoms.",Non-OADS,/arxiv_data1/oa_pdf/b5/f1/EDU-0121-2016.PMC5335573.pdf
"This is, in part, related to short stature, though Obstructive sleep apnoea/ hypopnoea syndrome in adults with Down syndrome @ ERSpublications Obstructive sleep apnoea/hypopnoea syndrome affects ∼40% of adults with Down syndrome cut can be treated effectively http://ow.ly/Jdco3062xP5Cite as: Hill EA.",Non-OADS,/arxiv_data1/oa_pdf/b5/f1/EDU-0121-2016.PMC5335573.pdf
"http://doi.org/10.1183/20734735.012616  Breathe | December 2016 | Volume 12 | No 4 329 Spinal cord injury (SCI) is characterised by profound respiratory compromise secondary to the level  of loss of motor, sensory and autonomic control associated with the injury.",Non-OADS,/arxiv_data1/oa_pdf/b4/c2/EDU-0126-2016.PMC5335574.pdf
"http://ow.ly/1Gcy305oQIYCite as: Berlowitz DJ, Wadsworth B, Ross J.",Non-OADS,/arxiv_data1/oa_pdf/b4/c2/EDU-0126-2016.PMC5335574.pdf
https://www.tac.vic.gov.au/about-the-tac/ our- organisation/research/tac-neurotrauma-research/ vni/   the20economic20cost20of20spinal20cord20injury   20and20traumatic20brain20injury20in20australia.pdf  5.,Non-OADS,/arxiv_data1/oa_pdf/b4/c2/EDU-0126-2016.PMC5335574.pdf
1956. https://catalog.hathitrust.org/Record/002066560  94.,Non-OADS,/arxiv_data1/oa_pdf/b4/c2/EDU-0126-2016.PMC5335574.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ © The Author(s) 2017OPEN",Non-OADS,/arxiv_data1/oa_pdf/f4/78/srep41668.PMC5335713.pdf
To view please visit the journal online (http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e4/83/bmjgh-2016-000121.PMC5335763.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a8/c8/bmjgh-2016-000082.PMC5335764.pdf
2013 (08 Mar 2016);http://www.who.int/healthinfo/global_burden_disease/projections/en/ 3.,Non-OADS,/arxiv_data1/oa_pdf/a8/c8/bmjgh-2016-000082.PMC5335764.pdf
15 Aug 2011. http://www.ats.ucla.edu/stat/stata/webbooks/reg/chapter2/statareg2.htm 13.,OADS,/arxiv_data1/oa_pdf/a8/c8/bmjgh-2016-000082.PMC5335764.pdf
http://resyst.lshtm.ac.uk/sites/resyst.lshtm.ac.uk/files/docs/reseources/Leadership%20workshop%20report_0.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/5a/2c/bmjgh-2016-000138.PMC5335765.pdf
http://resyst.lshtm.ac.uk/sites/resyst.lshtm.ac.uk/files/docs/reseources/WP4_Developing%20leadership%20and%20management%20competencies.pdf 8.,Non-OADS,/arxiv_data1/oa_pdf/5a/2c/bmjgh-2016-000138.PMC5335765.pdf
http://www.hst.org.za/uploads/files/finmanage.pdf 9.,Non-OADS,/arxiv_data1/oa_pdf/5a/2c/bmjgh-2016-000138.PMC5335765.pdf
Systems Trust; 1998. http://www.hst.org.za/publications/south- african-health-review-1998 10.,Non-OADS,/arxiv_data1/oa_pdf/5a/2c/bmjgh-2016-000138.PMC5335765.pdf
http://www.health.gpg.gov.za/dohDocuments/Annual%20Performance%20Plans/Annual%20Performance%20Plan%202011-12%20201314.pdf 14.,Non-OADS,/arxiv_data1/oa_pdf/5a/2c/bmjgh-2016-000138.PMC5335765.pdf
https://www.health-e.org.za/wp-content/uploads/2015/12/National-Health-Insurance-for-South-Africa-White-Paper.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/5a/2c/bmjgh-2016-000138.PMC5335765.pdf
Health Systems Trust; 2012. http://www.hst.,Non-OADS,/arxiv_data1/oa_pdf/5a/2c/bmjgh-2016-000138.PMC5335765.pdf
Health Systems Trust; 2011. http://www.hst.org.za/publications/south-african-health-review-2011 24.,Non-OADS,/arxiv_data1/oa_pdf/5a/2c/bmjgh-2016-000138.PMC5335765.pdf
Health SystemsTrust; 2001. http://www.hst.org.za/publications/south-african-health-review-2001 29.,Non-OADS,/arxiv_data1/oa_pdf/5a/2c/bmjgh-2016-000138.PMC5335765.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d5/02/bmjgh-2016-000139.PMC5335766.pdf
http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/d5/02/bmjgh-2016-000139.PMC5335766.pdf
http://www.who.int/cancer/publications/palliative-care-atlas/en/ (downloaded 28 January 2016).,Non-OADS,/arxiv_data1/oa_pdf/d5/02/bmjgh-2016-000139.PMC5335766.pdf
http://ushealthpolicygateway.com/ health-policy-intelligence-sources/f-health-policy-methods/cost-of-illness-measurement/ (accessed 21 Oct 2016).,Non-OADS,/arxiv_data1/oa_pdf/d5/02/bmjgh-2016-000139.PMC5335766.pdf
http://www.who.int/chp/chronic_disease_report/part2_ch2/en/index7.html (accessed 2 Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/d5/02/bmjgh-2016-000139.PMC5335766.pdf
http://www.who.int/chp/chronic_disease_report/part2_ch2/en/index5.html (accessed 7 Oct 2016).,Non-OADS,/arxiv_data1/oa_pdf/d5/02/bmjgh-2016-000139.PMC5335766.pdf
http://www.who.int/nmh/publications/ncd_report_full_en.pdf (accessed 21 Oct 2016).,OADS,/arxiv_data1/oa_pdf/d5/02/bmjgh-2016-000139.PMC5335766.pdf
2016. http://www.spherehandbook.org/en/introduction-5/ (accessed 14 Dec 2016).,Non-OADS,/arxiv_data1/oa_pdf/98/90/bmjgh-2017-000287.PMC5335767.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ BMJ Global Health 2017; 0:e000272corr1.,Non-OADS,/arxiv_data1/oa_pdf/53/0e/bmjgh-2016-000272corr1.PMC5335768.pdf
"Accessed April 7, 2014. http://icussri.files.wordpress.com/ 2008/09/download-php.pdf.",Non-OADS,/arxiv_data1/oa_pdf/e5/01/10.1177_0162243914532138.PMC5336138.pdf
"Accessed April 7, 2010. http://epublications.bond.edu.au/ working_through_communication/10/.",Non-OADS,/arxiv_data1/oa_pdf/e5/01/10.1177_0162243914532138.PMC5336138.pdf
"Analysis of gene expression patterns associated with human diseases Expression profiles of major UPR genes in human diseases were extracted from the  European Bioinformatics Institute of European Molecular Biology Laboratory (EMBL-EBI,  http://www.ebi.ac.uk/ ).",OADS,/arxiv_data1/oa_pdf/cb/ec/nihms811511.PMC5336312.pdf
"Determination of the correlation between gene knockout/dysfunction and animal  phenotypes Phenotypes of animal models with knockout or dysfunctional UPR genes were obtained  from the Mouse Genome Informatics database (MGI, http://www.informatics.jax.org/ ) and  the literature search of PubMed database ( www.ncbi.pubmed ).",OADS,/arxiv_data1/oa_pdf/cb/ec/nihms811511.PMC5336312.pdf
"We  analyzed expression signatures of the major UPR genes, including BIP, PERK, XBP1,  IREIα, IREIβ, and ATF6 , in human diseases based on the database from the EMBL-EBI  (http://www.ebi.ac.uk/ ).",OADS,/arxiv_data1/oa_pdf/cb/ec/nihms811511.PMC5336312.pdf
"Based on the MGI  database ( http://www.informatics.jax.org/ ) and the published literature from PubMed  (www.ncbi.pubmed ), we generated a profile of phenotypes related to deletion or dysfunction  of the UPR genes in mice [Figure 4].",OADS,/arxiv_data1/oa_pdf/cb/ec/nihms811511.PMC5336312.pdf
Data  were extracted and analyzed based on the database from European Bioinformatics Institute  of European Molecular Biology Laboratory ( http://www.ebi.ac.uk/ ).,OADS,/arxiv_data1/oa_pdf/cb/ec/nihms811511.PMC5336312.pdf
The animal phenotype information was summarized based on the  animal database from Mouse Genome Informatics ( http://www.informatics.jax.org/ ) and the  literature of PubMed database ( www.ncbi.pubmed )Zheng et al.,OADS,/arxiv_data1/oa_pdf/cb/ec/nihms811511.PMC5336312.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1602158/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/d1/c4/1602158.PMC5336349.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1601986/DC1 section S1.,Non-OADS,/arxiv_data1/oa_pdf/11/c2/1601986.PMC5336350.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1602417/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/0e/5e/1602417.PMC5336351.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1602462/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/95/9d/1602462.PMC5336352.pdf
Deuteri- um incorporation was analyzed and qua ntified using the Hexicon 2 software package (http://hx2.mpi mf-heidelberg.mpg.de) ( 53).,OADS,/arxiv_data1/oa_pdf/57/e1/1602498.PMC5336353.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/2/e1602498/DC1Supplementary Resultsfig.,Non-OADS,/arxiv_data1/oa_pdf/57/e1/1602498.PMC5336353.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1600891/DC1Supplementary Textfig.,Non-OADS,/arxiv_data1/oa_pdf/99/c4/1600891.PMC5336354.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1600448/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/e7/12/1600448.PMC5336355.pdf
"Copyright © 2016 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 9 http://e-eht.org/ Introduction In modern society, chemicals are indispensable for everyday  human life.",Non-OADS,/arxiv_data1/oa_pdf/de/b6/eht-31-e2016026.PMC5336359.pdf
"One recent report estimated  that as many as 80000 to 120000 chemicals are currently in use Act on the Registration and Evaluation of  Chemicals (K-REACH) and replacement,  reduction or refinement best practices Soojin Ha1, T roy Seidle2, Kyung-Min Lim1,2 1Department of Mechanistic T oxicology, Ewha Womans University College of Pharmacy, Seoul, Korea; 2Research and  T oxicology Department, Humane Society International, T oronto, Canada• Review ArticleOpen Access Environmental Health and Toxicology Volume: 31, Article ID: e2016026, 9 pages https://doi.org/10.5620/eht.e2016026 eISSN: 2233-6567  Objectives  Korea’s Act on the Registration and Evaluation of Chemicals (K-REACH) was  enacted for the protection of human health and the environment in 2015.",Non-OADS,/arxiv_data1/oa_pdf/de/b6/eht-31-e2016026.PMC5336359.pdf
"Keywords  Korea’s Act on the Registration and Evaluation of Chemicals, Replacement,  Reduction,  Refinement, Alternative to animal test, Safety evaluationCorrespondence:  Kyung-Min Lim   52 Ewhayeodae-gil, Seodaemun-gu, Seoul  03760, Korea Tel: +82-2-3277-3055  Fax: +82-2-3277-3760 E-mail: kmlim@ewha.ac.kr  Received:  September 28, 2016   Accepted:  November 4, 2016   Published:  December 19, 2016 This article is available from: http://e-eht.org/",Non-OADS,/arxiv_data1/oa_pdf/de/b6/eht-31-e2016026.PMC5336359.pdf
"http://e-eht.org/ Page 2 of 9Environmental Health and Toxicology    2016;31:e2016026 worldwide, with an additional 2000 chemicals newly intro - duced each year [1,2].",Non-OADS,/arxiv_data1/oa_pdf/de/b6/eht-31-e2016026.PMC5336359.pdf
"http://e-eht.org/ Page 3 of 9Soojin Ha, et al.",OADS,/arxiv_data1/oa_pdf/de/b6/eht-31-e2016026.PMC5336359.pdf
http://e-eht.org/ Page 4 of 9Environmental Health and Toxicology    2016;31:e2016026 like syndrome that is similar to the disease in humans) [17].,Non-OADS,/arxiv_data1/oa_pdf/de/b6/eht-31-e2016026.PMC5336359.pdf
"http://e-eht.org/ Page 5 of 9Soojin Ha, et al.",OADS,/arxiv_data1/oa_pdf/de/b6/eht-31-e2016026.PMC5336359.pdf
http://e-eht.org/ Page 6 of 9Environmental Health and Toxicology    2016;31:e2016026 and have been revised continuously by 3R concepts and with  the progression of science.,Non-OADS,/arxiv_data1/oa_pdf/de/b6/eht-31-e2016026.PMC5336359.pdf
"http://e-eht.org/ Page 7 of 9Soojin Ha, et al.",OADS,/arxiv_data1/oa_pdf/de/b6/eht-31-e2016026.PMC5336359.pdf
"http://e-eht.org/ Page 8 of 9Environmental Health and Toxicology    2016;31:e2016026 3R best practices, do not fall farther behind those of other devel - oped nations, K-REACH data requirements and TGs must be  immediately and frequently amended on regular basis to incor - porate all relevant OECD 3R TGs and related best practices, in - cluding mandatory data sharing, chemical grouping and read- across to ensure maximum possible reduction of vertebrate ani - mal use and no duplication of existing test results.",Non-OADS,/arxiv_data1/oa_pdf/de/b6/eht-31-e2016026.PMC5336359.pdf
Conflict of Interest The authors have no conflicts of interest associated with mate - rial presented in this paper.ORCID Soojin Ha http://orcid.org/0000-0002-4410-4405 T roy Seidle http://orcid.org/0000-0002-1341-2181 Kyung-Min Lim http://orcid.org/0000-0002-1517-7680 References 1.,Non-OADS,/arxiv_data1/oa_pdf/de/b6/eht-31-e2016026.PMC5336359.pdf
Available from: http://www.gao.,Non-OADS,/arxiv_data1/oa_pdf/de/b6/eht-31-e2016026.PMC5336359.pdf
Available  from: http://www.law.go.kr/lsInfoP.do?lsiSeq=140402#0000 (Kore - an).,Non-OADS,/arxiv_data1/oa_pdf/de/b6/eht-31-e2016026.PMC5336359.pdf
Available from:  http://www.mafra.go.kr/list.jsp?&newsid=155448053&section_id=b_ sec_1&pageNo=1&year=2016&listcnt=10&board_kind=C&board_ skin_id=C3&depth=1&division=B&group_id=3&menu_ id=1125&reference=&parent_code=3&popup_yn=&tab_yn=N (Ko - rean).,Non-OADS,/arxiv_data1/oa_pdf/de/b6/eht-31-e2016026.PMC5336359.pdf
Available from: http://home.kpn.nl/reach/downloads/reachtesting - needsfinal.pdf.,Non-OADS,/arxiv_data1/oa_pdf/de/b6/eht-31-e2016026.PMC5336359.pdf
Available from: http://publications.jrc.ec.europa.eu/reposito - ry/bitstream/JRC29111/EUR%2021405%20EN.pdf.,Non-OADS,/arxiv_data1/oa_pdf/de/b6/eht-31-e2016026.PMC5336359.pdf
"http://e-eht.org/ Page 9 of 9Soojin Ha, et al.",OADS,/arxiv_data1/oa_pdf/de/b6/eht-31-e2016026.PMC5336359.pdf
Available from: http://www.fda.gov/downloads/ ScienceResearch/SpecialTopics/CriticalPathInitiative/CriticalPathOp - portunitiesReports/UCM113411.pdf .,Non-OADS,/arxiv_data1/oa_pdf/de/b6/eht-31-e2016026.PMC5336359.pdf
Avail - able from: http://www.oecd.org/env/test-no-405-acute-eye-irritation- corrosion-9789264185333-en.htm.,Non-OADS,/arxiv_data1/oa_pdf/de/b6/eht-31-e2016026.PMC5336359.pdf
Available from: http://www.oecd.org/env/test-no-429-skin-sensi - tisation-9789264071100-en.htm.,Non-OADS,/arxiv_data1/oa_pdf/de/b6/eht-31-e2016026.PMC5336359.pdf
Available from: http://www.nier.go.kr/NIER/cop/ bbs/selectNoLoginBoardList.do?bbsId=BBSMSTR_000000000031& menuNo=15001 (Korean).,Non-OADS,/arxiv_data1/oa_pdf/de/b6/eht-31-e2016026.PMC5336359.pdf
Available from: https://echa.europa.eu/regulations/reach/legisla - tion.,Non-OADS,/arxiv_data1/oa_pdf/de/b6/eht-31-e2016026.PMC5336359.pdf
Available from: https://www.gov.,Non-OADS,/arxiv_data1/oa_pdf/de/b6/eht-31-e2016026.PMC5336359.pdf
"Keywords: Knee, a nterior cruciate ligament, r econstruction, three-dimensional computed tomography, a nteromedial portal technique,  outside-in techniqueOriginal Article Knee Surg Relat Res 2017;29(1):11-18https://doi.org/10.5792/ksrr.16.054pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received September 20, 2016; Revised December 12, 2016 Accepted January 2, 2017Correspondence to: Sang Hak Lee, MDDepartment of Orthopaedic Surgery, Center for Joint Diseases and Rheumatism, Kyung Hee University Hospital at Gangdong, 892 Dongnam-ro, Gangdong-gu, Seoul 05278, KoreaTel: +82-2-440-7497, Fax: +82-2-440-7498E-mail: sangdory@hanmail.net 11This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/eb/4b/ksrr-29-011.PMC5336365.pdf
"19This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/8f/ksrr-29-019.PMC5336366.pdf
Copyright © 2017 KOREAN KNEE SOCIETY www.jksrr.orgKnee Surg Relat Res 2017;29(1):19-25https://doi.org/10.5792/ksrr.15.061pISSN 2234-0726 · eISSN 2234-2451,Non-OADS,/arxiv_data1/oa_pdf/d8/8f/ksrr-29-019.PMC5336366.pdf
"Keywords: Knee, a nterior cruciate ligament, Suspensory device, o utside-in techniqueOriginal Article Knee Surgery & Related Research Received September 20, 2016; Revised October 19, 2016; Accepted November 7, 2016Correspondence to: Y ong Seuk Lee, MD Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 13620, Korea Tel: +82-31-787-7199, Fax: +82-31-787-4056E-mail: smcos1@snu.ac.kr 33This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Knee Surg Relat Res 2017;29(1):33-38https://doi.org/10.5792/ksrr.16.053pISSN 2234-0726 · eISSN 2234-2451 Copyright © 2017 KOREAN KNEE SOCIETY www.jksrr.org",Non-OADS,/arxiv_data1/oa_pdf/c3/a0/ksrr-29-033.PMC5336367.pdf
"Keywords: Knee, Meniscus, t ransplant, t issue scaffoldReview Article Knee Surg Relat Res 2017;29(1):3-10https://doi.org/10.5792/ksrr.16.059pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received October 1, 2016; Revised (1st) December 1, 2016;  (2nd) January 16, 2017; Accepted January 17, 2017Correspondence to: Filippo Familiari, MDDepartment of Orthopaedic and Trauma Surgery, Magna Græcia University, Viale Europa, (Località Germaneto), 88100 Catanzaro, ItalyTel: +39-0961-364-7352, Fax: +39- 0961- 364- 7104 E-mail: filippofamiliari@gmail.com 3This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/71/ksrr-29-003.PMC5336368.pdf
"Seong-Il Bin, MD, PhD Department of Orthopedic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaEditorial Knee Surg Relat Res 2017;29(1):1-2 https://doi.org/10.5792/ksrr.17.001pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Correspondence to: Seong-Il Bin, MD, PhDDepartment of Orthopedic Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, KoreaTel: +82-2-3010-3528, Fax: +82-2-488-7877E-mail: sibin@amc.seoul.kr 1This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/26/ksrr-29-001.PMC5336369.pdf
"Keywords: Knee, o steoarthritis, r adiographyOriginal Article Knee Surgery & Related Research Received August 15, 2016; Revised (1st) September 26, 2016;  (2nd) October 18, 2016; Accepted October 18, 2016Correspondence to: Yuji Arai, MDDepartment of Sports and Para-Sports Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajiicho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, JapanTel: +81-75-251-5549, Fax: +81-75-251-5841E-mail: yarai89046@nike.eonet.ne.jp This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Knee Surg Relat Res 2017;29(1):63-68https://doi.org/10.5792/ksrr.16.046pISSN 2234-0726 · eISSN 2234-2451 63Copyright © 2017 KOREAN KNEE SOCIETY www.jksrr.org",Non-OADS,/arxiv_data1/oa_pdf/d0/b8/ksrr-29-063.PMC5336370.pdf
"Keywords: Knee, a rthroplasty, Blood loss, h emoglobin, h ematocritOriginal Article Knee Surg Relat Res 2017;29(1):52-56https://doi.org/10.5792/ksrr.16.038pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received June 30, 2016; Revised September 28, 2016;  Accepted September 29, 2016Correspondence to: Mahdi Y acine Khalfaoui, MRCSDepartment of Trauma and Orthopaedics, Salford Royal NHS Foundation Trust, Stott Lane, Salford M6 8HD, UK Tel: +44-7742-781020, Fax: +44-0161-206-1048E-mail: Khalfaoui@doctors.org.uk 52This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/2d/ksrr-29-052.PMC5336371.pdf
Copyright © 2017 KOREAN KNEE SOCIETY www.jksrr.orgKnee Surg Relat Res 2017;29(1):52-56https://doi.org/10.5792/ksrr.16.038pISSN 2234-0726 · eISSN 2234-2451,Non-OADS,/arxiv_data1/oa_pdf/00/2d/ksrr-29-052.PMC5336371.pdf
"Keywords: Knee, a nterior cruciate ligament, r econstruction, t ibial tunnel, a perture wideningOriginal Article Knee Surg Relat Res 2017;29(1):26-32https://doi.org/10.5792/ksrr.16.033pISSN 2234-0726 · eISSN 2234-2451Knee Surg Relat Res <Y>;29(1):PB-1https://doi.org/10.5792/ksrr.16.033pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received June 15, 2016; Revised November 5, 2016;  Accepted December 10, 2016Correspondence to: Kyung Wook Nha, MDDepartment of Orthopedic Surgery, Inje University Ilsan Paik Hospital, 170 Juhwa-ro, Ilsanseo-gu, Goyang 10380, KoreaTel: +82-31-910-7312, Fax: +82-31-910-7319E-mail: kwnhamj@hotmail.com 26This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/99/ksrr-29-026.PMC5336372.pdf
"Keywords: Knee, Anterior cruciate ligament, Medial meniscus, TearOriginal Article Knee Surg Relat Res 2017;29(1):39-44https://doi.org/10.5792/ksrr.16.072pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received December 8, 2016; Revised February 1, 2017 Accepted February 1, 2017Correspondence to: Mandeep Singh Dhillon, MS, FRCSDepartment of Orthopaedics, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, IndiaTel: +91-172-269-4774, Fax: +91-172-275-6743E-mail: drdhillon@gmail.com 39This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/ec/ksrr-29-039.PMC5336373.pdf
"Keywords: Knee, a rthroplasty, t ranexamic acid, oral, Blood lossOriginal Article Knee Surg Relat Res 2017;29(1):57-62https://doi.org/10.5792/ksrr.16.074pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received December 21, 2016; Revised January 13, 2017;  Accepted January 17, 2017Correspondence to: Qunn Jid Lee, FRCSDepartment of Orthopaedics & Traumatology, Joint Replacement Center, Y an Chai Hospital, 7-11 Y an Chai Street, Tsuen Wan, Hong Kong, ChinaTel: +852-6626-6115, Fax: +852-2402-2585E-mail: leejasper@gmail.com 57This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/7d/ksrr-29-057.PMC5336374.pdf
"Keywords: Knee, f emur, f racture, o steocartilaginous, f ixation, a rthroscopyCase Report Knee Surgery & Related Research Received November 20, 2015; Revised (1st) February 10, 2016;  (2nd) February 29, 2016; Accepted March 21, 2016Correspondence to: Vikram Mhaskar, MS (Orth), MCh (Orth)Department of Knee & Shoulder Surgery, Knee & Shoulder Clinic, F7 East of Kailash, New Delhi 110065, IndiaTel: +91-01126286869, Fax: +91-981-880-6857E-mail: drvikrammhaskar@gmail.com 72This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/b0/ksrr-29-072.PMC5336375.pdf
Copyright © 2017 KOREAN KNEE SOCIETY www.jksrr.orgKnee Surg Relat Res 2017;29(1):72-75https://doi.org/10.5792/ksrr.15.071pISSN 2234-0726 · eISSN 2234-2451,Non-OADS,/arxiv_data1/oa_pdf/22/b0/ksrr-29-072.PMC5336375.pdf
"Keywords: f emur, e piphysis, f ibrous dysplasiaCase Report Knee Surg Relat Res 2017;29(1):69-71https://doi.org/10.5792/ksrr.16.014pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received February 20, 2016; Revised (1st) April 1, 2016;  (2nd) April 13, 2016; Accepted April 22, 2016Correspondence to:  Jung Ho Noh, MD, PhDDepartment of Orthopaedic Surgery, Kangwon National University School of Medicine, 1 Gangwondaehak-gil, Chuncheon 24341, KoreaTel: +82-33-258-9213, Fax: +82-33-258-2149E-mail: bestknee@hotmail.comSource of funding: This study was supported by 2015 Research Grant from Kangwon National University (no.",Non-OADS,/arxiv_data1/oa_pdf/44/a9/ksrr-29-069.PMC5336376.pdf
"69This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/a9/ksrr-29-069.PMC5336376.pdf
"Keywords: Knee, a nterior cruciate ligament, r econstruction, i nfectionOriginal Article Knee Surg Relat Res 2017;29(1):45-51https://doi.org/10.5792/ksrr.16.019pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received March 14, 2016; Revised June 27, 2016;  Accepted August 22, 2016Correspondence to: Hee-Soo Kyung, MDDepartment of Orthopaedic Surgery, Kyungpook National University Hospital, 130 Dongdeok-ro, Jung-gu, Daegu 41944, KoreaTel: +82-53-200-5636, Fax: +82-53-422-6605E-mail: hskyung@knu.ac.kr 45This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/b4/ksrr-29-045.PMC5336377.pdf
LB isEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 5327F06058F9862F .,Non-OADS,/arxiv_data1/oa_pdf/49/35/40121_2016_Article_138.PMC5336413.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercialuse, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/49/35/40121_2016_Article_138.PMC5336413.pdf
http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/49/35/40121_2016_Article_138.PMC5336413.pdf
(Available online: http://www.efsa.europa.eu/publications ).,Non-OADS,/arxiv_data1/oa_pdf/49/35/40121_2016_Article_138.PMC5336413.pdf
http://www.medengine.com/Redeem/ 9527F060087BCCAA .,Non-OADS,/arxiv_data1/oa_pdf/ec/8d/40121_2016_Article_139.PMC5336414.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ec/8d/40121_2016_Article_139.PMC5336414.pdf
"Antibiotic Resistance Threats in the United States, 2013. http://www.cdc.gov/drugresistance/threat- report-2013/ .",Non-OADS,/arxiv_data1/oa_pdf/ec/8d/40121_2016_Article_139.PMC5336414.pdf
"However, due to the spore-forming ability ofEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ B627F0601816F2B0 .",Non-OADS,/arxiv_data1/oa_pdf/cf/48/40121_2016_Article_140.PMC5336415.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/cf/48/40121_2016_Article_140.PMC5336415.pdf
https://clinicaltrials.gov/ ct2/show/NCT01670149?term=rifaximin ?clostridiu m&rank=1 .,Non-OADS,/arxiv_data1/oa_pdf/cf/48/40121_2016_Article_140.PMC5336415.pdf
http://www.mgb- biopharma.com/programs-overview-2/ .,Non-OADS,/arxiv_data1/oa_pdf/cf/48/40121_2016_Article_140.PMC5336415.pdf
https://clinicaltrials.gov/ct2/ results?term=ops-2071 ?phase ?1&Search=Search .,OADS,/arxiv_data1/oa_pdf/cf/48/40121_2016_Article_140.PMC5336415.pdf
"Clinical stage program targeting Clostridium difﬁcile Infection, a devastating GI-tract infection with suboptimal therapies http://www.crestonepharma.",Non-OADS,/arxiv_data1/oa_pdf/cf/48/40121_2016_Article_140.PMC5336415.pdf
http://www.romark.com/ research/products-in-development .,Non-OADS,/arxiv_data1/oa_pdf/cf/48/40121_2016_Article_140.PMC5336415.pdf
http://www.isrctn.,Non-OADS,/arxiv_data1/oa_pdf/cf/48/40121_2016_Article_140.PMC5336415.pdf
